{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6a954412",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CWD: c:\\Users\\gito2\\Downloads\\RAG\n"
     ]
    }
   ],
   "source": [
    "from openai import OpenAI\n",
    "from PIL import Image\n",
    "from io import BytesIO\n",
    "from dotenv import load_dotenv\n",
    "from langchain_postgres import PGVector\n",
    "from langchain_community.document_loaders import DirectoryLoader\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "from langchain_community.document_loaders import TextLoader\n",
    "from langchain_huggingface import HuggingFaceEmbeddings\n",
    "from langchain_core.language_models.chat_models import BaseChatModel\n",
    "from langchain_core.messages import BaseMessage\n",
    "from typing import List\n",
    "\n",
    "import pymupdf\n",
    "import base64\n",
    "import os\n",
    "\n",
    "\n",
    "print(\"CWD:\", os.getcwd())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8dd15a17",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b47d2903",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "API Key loaded: True\n"
     ]
    }
   ],
   "source": [
    "load_dotenv()\n",
    "\n",
    "api_key = os.getenv(\"GROQ_API_KEY\")\n",
    "print(\"API Key loaded:\", api_key is not None) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "e7a7ff34",
   "metadata": {},
   "outputs": [],
   "source": [
    "client = OpenAI(\n",
    "    api_key=os.getenv(\"GROQ_API_KEY\"),\n",
    "    base_url=\"https://api.groq.com/openai/v1\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "726ca7ea",
   "metadata": {},
   "outputs": [],
   "source": [
    "def encode_image(pdf_path):\n",
    "    base64_list = []\n",
    "    pdf_document = pymupdf.open(pdf_path)\n",
    "    for page in pdf_document:\n",
    "        pix = page.get_pixmap()\n",
    "        img = Image.frombytes(\"RGB\", [pix.width, pix.height], pix.samples)\n",
    "        buffered = BytesIO()\n",
    "        img.save(buffered, format=\"JPEG\")\n",
    "        omage_bytes = buffered.getvalue()\n",
    "        base64_image = base64.b64encode(omage_bytes).decode('utf-8')\n",
    "        base64_list.append(base64_image)\n",
    "    return base64_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "e2a60624",
   "metadata": {},
   "outputs": [],
   "source": [
    "def extract_pdf(base64_images):\n",
    "    api_key = os.getenv(\"GROQ_API_KEY\")\n",
    "    if not api_key:\n",
    "        raise ValueError(\"GROQ_API_KEY not found in environment variables.\")\n",
    "\n",
    "    client = OpenAI(\n",
    "        api_key=api_key,\n",
    "        base_url=\"https://api.groq.com/openai/v1\"\n",
    "    )\n",
    "\n",
    "    ocr_response = client.chat.completions.create(\n",
    "        model=\"meta-llama/llama-4-maverick-17b-128e-instruct\",\n",
    "        messages=[\n",
    "            {\n",
    "                \"role\": \"user\",\n",
    "                \"content\": [\n",
    "                    {\"type\": \"text\", \"text\": \"Extract the text from the image.\"},\n",
    "                    {\"type\": \"image_url\", \"image_url\": {\"url\": f\"data:image/jpeg;base64,{base64_images}\"}}\n",
    "                ]\n",
    "            }\n",
    "        ],\n",
    "        max_tokens=2000\n",
    "    )\n",
    "\n",
    "    return ocr_response.choices[0].message.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "3ed408ec",
   "metadata": {},
   "outputs": [],
   "source": [
    "path = \"C:/Users/gito2/Downloads/RAG/data/pdf/PIIS0022522319384089.pdf\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "0bf362c8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['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',\n",
       " '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',\n",
       " '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',\n",
       " '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',\n",
       " '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',\n",
       " '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',\n",
       " '/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0aHBwgJC4nICIsIxwcKDcpLDAxNDQ0Hyc5PTgyPC4zNDL/2wBDAQkJCQwLDBgNDRgyIRwhMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjL/wAARCAMYAkADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3+iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuRXx5bLPNFPaTAwM0coTkqwJz+G3B/GutJwCT0Fc3aa54V1lmWOS0Yh2kbzUC4dW2nOf4sj8qAK0XxB0x7KKQw3D3DhAIIkySziIgDn/pvH+vpS2HxD0bULq0to4rxZblgqq8P3Q2zaTjoCJF/OpZtZ8FWkklw1/owliaNJGSWMtH86qpbByAGKcngcVZW48JRzQzLc6OskUazROJYwVQhVVxz90gKAenSgCleeNBbatfWC2TN9ljZhKz4V2UAlR78iulsppbiygmnh8mV0DPHnO0kdM1kzS+Hhr62skUDancIDxAWJXqNzAYHTue1btABRRRQAUUUUAFFIxCqWPQDPAzSg5GaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqOG4huPM8mVJPLcxvsbO1h1B96AJKKrXGoWdqZBPdQxmNPMdWcAqucZx1xniiw1Gz1S0W6sLmK4gYkB42yMg4IPoQe1AFmioYru3ns1u4Z45bZ08xZY2DKy4zkEcEVXbWNPTTotQa6QWkxURy84YscL+ZNAF6iiigAopks0VvH5k0qRpkDc7ADJOByfen0AFFV7W+tb4TG1uI5hDK0Mmxs7HXqp9xVigAooooAKKKgivbWaSdIrmGR7dtsypICYzjOG9Dgg80AT0UisroGVgysMgg5BFLQAUUVC13brdJatcRC4dSyxFxvYDqQOpFAE1FRieFp2gEsZmUbjGGG4D1xTldHZlV1YocMAc4PXB/OgB1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAIRkEHvXJyfD3Q3mklhe5t5X2iRoZBlgCTzkHrk5711hzg469q4u68O+JZ7qa4i1OCB52O8R7gAApC4/MUAXpvAumSQKkc95A6PG6SxOu5WRkZSMqR1jXqD3qG3+H+iWN+L5ZZ/NDxyuXMfzOm35yduRnYMgEL1wBTdP8N67Z63ZzNrLyWEO7dCxJJBaQgEnrwyD/AIBU/iPw3danLdz2kyrJNFCgSRiUykhY5XpyDj3oAuXPhvT7vxHDrLSuLqLaSilcNgEKScbh1PAIB71uA5GRXm9r4E1+Fp86yFkktzCZhkkjaBgDqOh59DxXd6RazWOj2dpcSCSaGFUdx0YgYzzQBdooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAyddXVbiGOx0sm3a53LLf/ACt9mXB5CkgsxOAMcDqemD55o/gzxJBZyJKb2xS2N5cx29rfmMXc0spZA+1z8qqo6n+Lqea9ZooA8ntdEvPtFrodyl5lGtpDCb0tlY1LuThjjdIR16kd6lXR/F50O6gkj1ZbxLEtZtDqAUeeytu8w78sdzDGegUYIOc+pbRu3YGfWloA8pvNL8aNeyJb2eoCGFJ4YT9vURtH5YSIFN+GPLOWIzu74HHSeLNB1C88MWGk6SkqJbKGPlSBHHlp8ig+7Y59q7KigDyuLTvHYV5JptTLxeVbJHHMnzQnyw75MmGkxvIJGQSfmwAKbbeHvGN1pt9cXc+rW8kdtL9msRqRbzJHlkKgvuJ2onlqOcnJOa9WooA5PV9Pv7bRNFsdNtriZLd0MyiUBiqISAxLc5bHc1F4I07X9Nm1BNbu766GyHynuJQ6ltpZ9o6jBbbz12jk812NFAHktnpPjPTkuJUTUXluZILuSGOVFQSSTPJMg5HAUqmfrzjAq3Dp/jq7ktbma8v7Jx5fnRK6MvJZ345HA2oP1zXp9FAHlUD+Os2f2m11SXyTG7MsqoGURs7BgCCxZ8J7Adieeh8HWviPS7fU1126vr+SOKARPJt/eN5e5ygH+023nrtHvXaUUAeWy/8ACbwRwm2XVJ5JRKGLMoVQzgKxDcqyqTgZxxVZodesU1WYXF3bXOp+bCIZVGGuJJUjiZARyETlm5BB9uPW6jeCGSWOV4kaSPPluyglM9cHtQB5zaHxWkpM5v4LQ3TWjW9tbD9xApfYyHHJIVBuAwN5OeAFfbQeJVvVjEusAvqA8x5cFWgUBfvchScFugBzXo9FABXAappOpv8AE61v4LeU2eYDIhQmOQKJQZN/8LJuGF6Nnv27+igDkVsTL8Rkv7azeOOKCSK5d7TywzHBVlkwN+enfGKv6BbNb614kb7K8Mc98ksZMZUSDyIlZh6/Mrc/41v0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVT1e2mvdFvrS3cJPPbyRxuSQFZlIByPc15lafD7xemomR9YRLU3IkCNdyu0fMZMikKu7OxwEIwN+cmgD1misbSXupta11p7l3hhu0hghwAqL5ETntnJZ261s0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRVOPUY5NXn04IwkiiWQt2IJq5QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBj6KQ2peICDkf2go/wDJaCtisfQVAuNZbu2oMT/37jH8gK2KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDHtUH/AAleoP8AxeREPw5rYrJtf+Rn1D/rjF/WtagAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDH0EhpdXIII/tBxx/uJWxWL4dbedXbBAOoyjn2Cj+lbVABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBk2QDeJNUbc2VSFcduQTWtWTYf8jHrH+7B/6Ca1qACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAMjw9/qL/8A6/7j/wBDNa9Y/h4j7PfnPH2+4/8AQzTr3xT4f01tt7rmm27Host0isfoCcmgDWornl8baJNn7HJd3zDgCzsppgT/ALyqVH1JxUth4je81WOxn0bUbHzomkhluhGBJtxkYV2IPzDqB3oA3KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAxNNVh4p1xiTgrb49PutW3XCT+Lk0TxHqZvLCSRHZV3WsqybFSMsSwOCDjt2yK6nQ9Zi13TvtccE1uRI0TwzbdyMpwQdpIP4GgDSooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAIbtZXs50gbbM0bCM5xhscfrXk8/hP4kLdq0es3EsSkmbGplDMpxsRRsIjKkfM38QJ5r16igDz3wb4XOpaNKPFa2GsSRXtwoEtmuBIJCJGBPBDMucYFdrZaNpemqFsNNs7UDoIIFT+Qqr4a/wCQVN/1/wB7/wClMta9ABWJrQEWraHdngJdNEze0kbKB/31srbrP1uyfUNJmhhbbOuJIW9JFIZT+YFAGhRVPS79dT02G7VdpcfOh6ow4ZfwIIq5QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWVqetfZLlbGztnvdRkXesCHaFXpudjwq5/E9gaTUtaSCYWNkVuNRfhYlOfL/wBp/QD9an0rTF02B90hmupm3zzt1kb+gHQDsKAM4aPrd589/wCIprcnnyNNhjRF9i0iuzfUbc+g6U7/AIRaJ8mXWNakJ7/b3T/0DFb1FAHPnwsyn9zr+uRDGMC6D8f8DVvz603/AIQvTpSDfXerX2P4bnUZih+qKwQ/iK6KigDmNM8N6Rb6vqUcWmWUduFRUijhVVG5CHyBxyOvrW9p+nWWlWaWmn2sVtbpkrFEoVRk5PA96paZ/wAhnV/+ukf/AKDWtQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAU9WlvbfSLybToUmvY4meGJ84kYDIXj16fjXn58aeM4JkluvDjrE0PneSlnMxVGVnBaQZAZcKhTG4kkjAwK9MrM8RTajb6Bey6TEZb5Yz5SgAnPqAep9u9AHKal4119JrqLSPD897JES8atbSoJIjt2kMQBk5bPpjkVF4F8VeLdc127t/EejyaVDGmIYjYTAO3c+cfk49O+eK1NJudcfXbOO6k1U6ebTcHnt4lLyZOfO2qNpHGAuPxrr6AMjw1/yCpv8Ar/vf/SmWtesjw1/yCpv+v+9/9KZa16ACiiigDn8/2H4gwx26fqTcZ6Rz+n/AgPzFdBVbULGHUrGW0uATHIMZBwVPUEHsQcEfSqOh380yS6ffEf2jZnZLjjzF/hkHsw/I5HagDXooooAKKKKACiiigAooooAKKKKACiioLy8gsLV7m5cJEnU9ST2AHck8AUAPnnhtYHnuJUihQbnd2Cqo9STWT/bF9en/AIlWlNLF2ubuTyI2HqowXP8A3yAexpLSxn1SVNQ1eMqAd1vYtysI7M46NJ39F6DkFjt0AYjf8JQ7kL/ZEK9iRJIR+Hy5pfsOvygiXW7eLPe2sguP++2etqigDFXQrk/8fGv6nN+Mcf8A6Ai0f8IzbNjfqGrswzyNRmXr7BgK2qKAMJ/DETOSuq6woP8ACL+TA/M0f8I1tTbHrOrrznJuyx/8ezW7RQBg/wDCNy4x/b+r/wDf8f4Uf8IlYSDFzc6ldL3We+lZT/wHdj9K3qKAKlhpdjpcPlWNpDbp1IjQDNW6KKACiiigAoIyMUUUAeV3+i+ME8SXY8MXuLEyv5/2m4YsHKcHcSSQM8DkA9q7vwvbapaaHHFq8rPdB3I3S+YypuO0M+BuIGOafo//AB/at/19f+yitagDD1nxTZ6LcSQzW91MYbY3MzQopEUeSASSRySCABnpzgc1ij4paAltdSXaXltJazi3niaIOyOQTj5CQ3TsTXVXWk6be3CXF3p9pcTojRrJLCrsqtwygkZAPcd687N3Ara49v4P0yabRykNosVrtadC4+58uAByOO4oA31+JWiTMPskF9eRMZQs1tErqxjj8xgPmyTt7Yz2rf0DW7bxFotvqtorpDOCVSRkLLgkYbazAHjpnI6HByK840XT9X8U6rpmoyaXYWVrZX80l2kCPb+cJIVDAqwIkIJKsTjOOMV6dp2l2GkWpttOs4bWAsXMcKBQWPU8d6ALdFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGR4a/5BU3/X/e/+lMta9YvhZNmkTjdu/wCJjfHP1upTW1QAUUUUAFZmraY93su7OQQajAD5MpHDDuj+qn9OorTooAz9J1VNTgfdGYLqBvLuLdj80b/1B6g9xWhWNrGm3Jnj1TS9q6jCNpRjtW4jzkxt/Q9j7ZBt6VqkOrWQniV43UlJYZBh4nHVWHr/AD60AXqKKKACiiigAooooAKKKKAIri4itbd553CRIMsx7Vl2dtJqlxHqV9GyIh3Wts38H+2w/vfy+tRox17VSRzpllJgHtPMOv1Vf5/St2gAooooAKKKKACiiigAooooAKKyPEHiTTvDFpBdanI0UE0phVwMgMI3fn6hCPqRVDT/AB1pOo+JhoEazpetAs67wuGVkD9mJGAw5IAzwCaAOmorHbxNpotLq5R5pEtpxbygQspDkgYG4DIyRyOKydG+Iuka5qK2VvbXyOZjbtI8amNZcMQhZWIJIRiCMj1IPFAHXUV5mfjl4WSTy5bfUVbLcKkbkAYwcByed3QAkYOcYNdl4b8V6T4stZrnSJzNDC4RnxgEkA8fnQBtUhOASBn2paKAOFg8a2Oi3N1FqkFzBNcXspRdobGAgAznqSRgD1rr9N1GDVbGO8tt3lvkYdcMpBwQR2IIIrCTwxo2sXV/NqFlFcyLdSBWcfdyF6e/HWugsbG202yitLOJYoIxhUHagCxRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGH4UJOjzkrt/4mV+Mf9vctblYHg/H9iXGP+gpqP/pZNW/QAUUUUAFFFFABWNqWmTxXbarpW0XwUCWFjhLlR2Pow7N+B4rZooApaZqlvqkBeHckiHbLDINrxN6MO1Xay9S0j7TMt7Zy/ZdRjGFmA4cf3XH8S/qO1JpmsrdTGyvIvsmpIMtAx4cD+JD/ABL+o70AatFFFABRRRQAVi6vdS3VzHotk5Wedd08q9YIe5/3j0X8T0BqxrOqjS7VfLTzrydvLtrcHmRz/QdSewFO0nTBp1uxlfzryc77mfHMj/0A6AdhQBct7eK1t47eCNY4o1Coq9ABUlFFABRRRQAUUUUAFFFFABRXPeKJ9Whm0r+z1mNu1zi7MChnEe04xn/axXN3Gr+NJdeufs1jcJYeXJ9mDwrncMAbufqR60AdB421uLQNIhvp9NivYxPsYy52wgowLnCs33Sy/KpPzHtmuVh8S6XaXNiR4PWzRLx7ZJwVURyxhUG3aCdp3bQTgYFa93b+J7oRTQEzRGK3b7PewIB5nnKJNw5x+7BI9zXLXVx49hktpLmGwAVdsX2yJBI05ClyhGcAYcg9wOe1AGhL8SdOjt2TU/DYigncGVAyOSd5AYrgbsFMk9uK2PB8XhzUNZvZdO0G2tpNJlNtDcghmOcklfQYY8+5FY/jlNcSXVLjTLu1WMRQi1jZEbKkEycYJKniofCjeLpr6CWfS7ey069HmC506KPdg4CLJ/sqNxyM9RQBeTVvDGlQfbdN8KkC7vH0u4YxqjKMjg5P+rJxgDjntmpvD/i/TYdQ0e2stBg0qx1eN8SeYkeyVCR5WxRjPXvWJfWnxBluoIZrWO/SKIPHLNBG2JyzjBz0TaBkjnkVraJZeMbawaO+0jS3e2miNpHHGqqqc7yv91qAPSKK8xmX4gN4jaNJLlLBr2YLIqIQIWTCnn+6cEf3q6nwTeazqfg+2PiC0uLPU1UxTb8BnI/jGOBn+lAF/Q/9Zqv/AF/v/wCgrWtXk15aeOLO/H9gXDzaULqVbnkNOfu5bJ4JA6V6RoBv20GyOqAi98oedkAHd744zQBo0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRSMSEYqMkDgeteW+F7T4h2+u26apJevYLcHDyyRFWh+cuZRuZt+dgXacAD60Adp4O/wCQHcf9hTUf/Syat+ub8G208Gn3zyXLSRyanfMkRQAR/wClzdD1OevNdJQAUUUUAFFFFABRRRQAVR1PSrbVIVSYMsiHdFNGdrxN6qexq9RQBz9vq11pV0ljrrJtkbbb6gBtjlPZXHRH/Q9vSugqK5toLy2kt7mGOaCQbXjkUMrD0INYq6HqOmrt0XV2SAfdtb9DcIo9FbIdR9SwHYUAb9Z2rasmmRxokTXF5OdtvbRkbpG/oo7k9P0qkZ/Fudo07RMdPMN/L+e3yf03fjVnStGNlNLe3ly15qMwxJOy4Cr/AHEX+Ffbqe5NADdK0mWKdtS1ORZ9SlGCV+5Cv9yPPQep6nqa16KKACiiigAooooAKKKKACiiigAopsjiONnb7qgk1xsXxT8LTsqw3ckjFA5VYzlfvcH0PynigDtKxtd0L+2jakXJgMLOG+TdvR1KsPY4OQexHQ9Kz7b4g6Be6JqmrWlw09tpsPnT7F+bGzdgD17YPQ1l2Xxa0DUIr97eC+Y2MLTTqIgdoVivBzg8jGQce9AGlb+C/I1K01N9VnuL2zt2t4HmjTaUI43qoGceowa29E0waPo9tYCXzTEuC+Mbj1JA7DPauVk+LHhyExGY3Cxsm95VUOsQ/wBoqT+malb4qeFVvZLQ3r+ekTTFfLIyoVW4+obI+h9KAO1orlvEvjzS/DFyltdw3Ms0qK8KwKG8wEkHGSPu7cnPQEVGvxD0ddMvL64S5hWzZUnTy97KxJGBsJz07UAdbRXGP8S9Hj1Sexe3u1aCRUmkZVCojMqLIfmztLMBwM9TjAzW7p/iTS9VWQ2NwZikKzsqxtuCNkrxjOSBnHpj1oANBBEN5kEZu5CP0rWrjNG8c6CsM0N1frb3AaSUxzIyME3YHBHXpxXW2t1Be2sV1bSrLBKoZHQ5DA9xQBNRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGR4a/5BU3/AF/3v/pTLWvWR4a/5BU3/X/e/wDpTLWvQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAEc5UQSFxldpyPUYryKDxP8PpL23X/hHZIp1ZE+aIqV3ZUk+oAxk+9ewkAjB6VVOmWJlEps4C4QoG8sZCnqPpQBxOhnwxqmm+IGstBt4ZP30Fzb+YB9oZUG8cHp90Z/GuXW+tfsU2tad4XtWuLhLlb1IZpUDFF3FQFOGJD8Edya6XxL4s1nw14gmisvCjXelx+U0t3BExYhvlZQF+82SmPYH8F0vxbrcl5oVtfaCLFLhGXUR9lk/0WUEqACMqVkONp5wOucigDi4fEelwCKSL4fJLcQsEaBAxkDZxnB4xzznuRXQeEbPQNd1a906bwrYWkKQpINyOZJSyc4J/hAdlP1rovEt74ot9QKaJYo9q8Im+0rCGZeQGXB6sQdwH+zipPC+say1ybbXdPuVdokaK5WzKqwJ2/PtyFY/KSvbnsKAOTv8AxKLWcWp8FrLHYLPZqZAz72DDfHHwchlKMCeOvpXS6e2iMuialpekuJp9kTi1dkFuNuSJF6EAkjkVuu+t/btVUW8H2ZIg1i/ljLSbecnec88fdWuLu9W+IUN462mkN5DRxuHSGM7JCgymCwyC2ctngdqAMlvFujyakdQm8Hp9tYq5nkB+SQ7DufjhPnyD3KnvXUab4g0eyu7MweGp7K5mitomZLUqIxKm8KSB0XoffitCLVfET6lDBL4VC2r3TQTTiaM7Ygo2yYLDIJJ45IA6E11eB6CgDhofBGma/wCXq0895HdRyy+S8UgAjIkbkDHt3yK7DTdPg0rTYLG33eVCgRS5yT7k+tU/DX/ICi/66zf+jXrWoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAw/CMhm0DzCMF7y7Yj63ElblYXg8AeHUGCMXV0CD1z9okz+tbtABRRWdIGPiO1IvAqLaTBrXu5Lx4f/AIDgj/gdAGjRRRQAUUUUAFFFFABRRRQAUUVUspbmVroXEewJOyxcfeTAwfzzQBbooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqOdHkgkSOUxOykLIoBKn1weKkooA8ji8R+KNLlg02xR57SNXNxdtpzvtJlfMg2t8/uuBjPevTNDuru90Szub+DyLqWJWljwRtJHoeR9Kh8NAjQ4sgj97N1/66tWtQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBheDw48OpvzuN1dNz3zcSHP61u1h+EZDJ4djY4yLi5Xj2nkH9K3KAMzXPEOkeG7E3usX8NnBzhpG5YgZwo6scDoOaha/sjrEF15SmJtPeYX+75BHuQ7c9OchvwrWmhiuIJIJ40likUo8bqGVlIwQQeoIrLeGE69Faeegt/sDr9g2/Iy7kG7HTAHy4/2qAJ9O1vTdY0v+09MvIry0wSJIDu6dRjrn261j2vj/AEO7W02tchrsSGFRAZC3l5Lj5N2CAMkHnkcZOK6KG1gt7RLWGFI7dE2LGgwqr0wAOlULLw3pGnnda2ao2ZDuLszZfG7kknnav5UAZEPxF8PzWltdB7kQXCSOJPILBBHy28rnaR6Hkd6kHxA0BtPubwTT4tlVpo2gZXjywUAg4wckfnV638I6DbRSRx6bGRIXLmRmdm3qFbLMSTlVUfQCoF8D+G0jKJpiopj8ttsrgsuQ3JDcnIByeRigDehlE0CShWUOoYBuoz60+o4IUt4EhjBCIoVdzFjge55NSUAFFFFAGPqnirQdEvIbPUtVtra6mKiOF3+dtxwPlHOM96pt4l0TRJbgapfQad5168aNczbVkYKpJyeFH6V0E9vBdRiO4hjlQMHCyKGAYHIOD3BAIrM0yC1umuJXlF68F45jeVMmBsAFVJ6Y9R60AaqSJJGsiOrIwyGByCPXNYNv428PXGnvfLqIS3jiadjLE8ZEYCHdtYA4xIhHHIYYroK5qPwB4YisvsY0wPBt2lZZpJCV+T5SWYkr+6jG08YUDGKAFuPHegW8s8f2i4maDy9/2e0llA3428qpHOR+dT2Hi/R9Rvls4ZpVmkcJEJYXQS5WRsqSORiKTn/Z9xlLfwboltcLOlvKzJEsKB7iRlRFIIABOByB+VObwfoTPI6WTQySTLOXt55ImDjcAQyMCB87cDA+Y8c0AW9L1uz1mS8Wz81haTvbyO0TKpkVirBSeuCD0rRrP03RbLSJbx7NZUF3M08qNM7oHYlmKqxIXJJJxjk1oUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFQXt1DZWU1zcOEijQszEZwPwqemSnbC5PZSaAOd0LX9Ig0WxS41O0hklOESWZULFmJUAEg5PpXS1wVv4DsdYWz1Z768hleEJIkewpJHuLbfmUkZ4yQc13iqEUKowAMCgBaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAwPBn/ItJ/wBfV1/6USVv1zdp4b1LToZILLxDPHAZJZI43tomCF3ZzztycFjVpdM1sId3iBmfHX7JHgH6Y/rQBtVnsG/4SGI4t9otXGT/AK3O9en+z6++Ko/2Z4i/6GJP/AFP8aqHw5rh1ZNSPiMeekDQD/QkxtLBj365UUAdTRWD/ZniL/oYk/8AAFP8aP7M8Rf9DEn/AIAp/jQBvUVyGpx6hEY9OvPGltaXF4GWFTBHHI/HOzLZ49q0Le01qaCGWDxFbywlBtdLRWDj1zu5/CgDforGex15gANbgXnORZD+rUhsNfLEjXIQD2FkOP8Ax6gDaorI+x65/wBBe3/8A/8A7Kj7Hrn/AEF7f/wD/wDsqANes/SlZVu90kD5uXI8kAYHHB/2vWoPseuf9Be3/wDAP/7KuUub2002e6tG8Y2dnLBcC5uR9nIwx6gktjHTI7UAehUVhi08QOm6PW7IhhlT9hJGO38dIbHxLtGNbsd3cnTzj/0ZQBu0Vg/YfFH/AEHLD/wXH/45SrZeJxjOtaefrpzc/wDkWgDdorHFv4jAAOpaWT6mwk5/8jUvkeI/+gjpX/gBJ/8AHqANeiuLl1O6k1W3kj8a+HVdGe0Nt5RKySsUOCvn53jbgDr8x4rWNt4tycatogHbOly//JFAG9RWB9m8Xf8AQX0T/wAFcv8A8kU+O28VBv3mq6My+i6bKD/6PNAG5RWOIPEmOdS0on2sJP8A49SND4lCnZqGkk9gbGQf+1aANmisGVfFMabzfaKFVdzl7WVQvrz5nT3rNsbrxBcN9pt/EHh66hvWzb7EdlO0YYIRJz0JOPegDsKKwPL8W/8AP1on/gNL/wDHKPL8W/8AP1on/gNL/wDHKAN+isDy/Fv/AD9aJ/4DS/8Axyjy/Fv/AD9aJ/4DS/8AxygDfqO4/wCPaX/cP8qxPL8W/wDP1on/AIDS/wDxys6/1bVrRbmK88QeF7YxIDN5oZDGGwAWzLxkkYz6igDe8Pf8i/Y/9cRWlVHRbc2miWUBnS4KQqPOjHyvx94deDV6gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDmPEPgm08RanBfy3t3bSxosbCDZiRVcSLncpxhhnjGe9bWk6bHpGk22nwuzx26bFZ+pHvV2igAooooAKKKKACuR1v4c6Lrt1cXE82oQtcHdIkNyQhPGTtII5wM8c4rrqKAGRRiGFIlJIRQoJ68U+svxFqNzo/h2/wBStLYXMtpA0whJI3hRkgY74HFcHrXxbutClngufC99JLCzIzQgsm4LG2c4+7hzz7UAeoUVz3gvxJJ4r8Ox6rJbrbmR2XygSSmD0bPQ1y8Hxj0dNQvbfUbeaBIplSJ4x5hdSSASB93lTnPtQB6TRXNeEPFaeKEvmjQbIJFMci9HjdQ6E+jYOCP8a6WgDhR8MLLlDqt4IlngmjVY4g0YhLFFDbc/xH5vve9d1RRQAUUUUAFFFFAFHWtLi1vRb3S55JI4rqFomeM4YAjHHb8Dwe9cnp/w1gtPEdlrk+q3FxdWtxJKq+WEjKum0qEB2rzg5AHAwc9a7qigAooooAKKKKACvPtV+FltqepXty2pssd28jmNraNmRnZGJD9TgoMZzgdMHmvQaKAIrWD7LaQ2/mPJ5Uapvc5ZsDGSfWpaKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK5nxR4rbw7qGl2ot7eT7e7oHmnMYQgZHRGzk8VXtviDpaP9n1N0trw3L24hhLzcq4j5IUYyzAfU9aAOuoqrqV4dP0y6vBC0xgiaTy06tgZwKyPBvimPxfoh1KK3EKeYUAD7gcAHuAe+OR2oA6Giuc1bxPLpetSaa1kjPJaiayYzEfaJC4Qx/dO3BZOeeGzjill8ceH4JJo3vsvFKYWCRO3zjdkDA5xsfkf3TQB0VFc5L420dLeWQTMGUyKnmRuqsUXcTkA4Xkc4qyninSi8cbXI8xyVBVWKMwBLBWxg42t+VAG1RXOW3jPTJbuaKWRY4/NjS3kBLCZXjjcN0+UfvFH5etX4fEOlz2L3sdzm2SXyWk2nG7dt9PXjNAGpRXN33jbSrazkmtpRcSKBtTlQ/K5AbGMgMDjrirT+LNFSPe16AOBjac5LsgGMf3kYfhQBtUVhp4w0GREZNRiIdlVeuSTjH4cjmptQ8S6TpUrR3l2Iyo+Y7SQvGQCQMA4ycHsM0Aa1FYVx4y0G1kCTaggcl12hSSNjtG2eOMMrD8KsWniPSL7UDYW17HJdAEmMdeDg0AatFc5feMbKOe1tNP23l5c3AgjjDFRyjvuLYPykRuAemR9SHax4vsNIunt5AzNDLAk5wQI1lJCt79OgoA6Gis2y17TNSnaCxvYZ5hGJNqNngjg/qPzrGbx7pS6ANQ3r9pNuswsw+XBbbhTj/fXPsc0AdXRWNY+JLK50iTULh1tlglMFwHPEcinay57gHjNJJ4t0CFmWTVbVCuc7nAxzj+dAG0QCCCMg00xo2dyKc9cjrWGfGfh5VldtUgWONY2MhbCneCVAPckA8VFL4z0uLS5rsTwyyIJSsMUoYuEZ14PTJ8tuPYjtQB0KIkYwiqo64AxVaDS7C1Eggs4IxI5kfbGPmYnJJ/E1Faa3pt8Jvs95C7QLumVXBMYx39KrWPiKG/1SOwitbgO1ot2ztt2ojMVUNznJ2k4x2oA0bWxtLHzfsltFB5zmSTy0C7mIAycd8AflVisObxNBFrF1pYtLl7iDydoXZ+9Mm7AX5uwVic4wBV46raobszOIktSBI7nA56UAXqKxLTxNaahrD2VlieGKBZpblJF2IGzgdcn7pz6cUyx8UQ3tlBqQtZYtKnVnjvJGULsAJDsM5Ctjj8M4zQBvUVly+JdEgjMkurWaIEDlmmAAU9D9KXUtestLgs5pXMi3lxFbw+UN24yOqA/wC6CwJNAGnRWdqWuafpWUuLiMT7C6QbwHkAz0BPsapWfjLQL2GCSPUrcGWLzdpcfIOM7scAjIFAG9RWS/iTSYizTX1vHBsRkmaZNr7gxGOc9FJ6fToadc+I9ItEnaTUbbdAoZ081cjIyO/egDUorDfxVp8FtpVzc7reHUk3xvKVATKhgG56nPbNaVvqVldgm3u4ZQAWOxwcAEgn8wR+FAFqiqsWpWM9m15FdwvbJndKrgqMdcmoo9c0qUAx6hbMChfiQfdHU/QUAX6KoJrelyKzJqFswUZYiUcDO3+ZA/GlXWdMZGdb+2KoAWIkHGelAF6ioJ721tljae4ijEhwhdgN30qI6vpwjVzfW4RiVVjIMEjgj9RQBcoqqNTsCqN9sgxISEPmD5iOuPpilg1CzuXCQXUMrFdwCOCSPWgCzRVZtRsleVGu4Q0WPMBcZX601dUsGmniF3DvgZUlG8fKWG4A/Uc0AW6KzoNbsbjULqyjlBktUEkrZ+UA+/4VZgvrS5EZguIpPNTem1gdy+ooAsUVmSeINNj1GKyNyplkeSPIPyqyAFlJ7H5hxWgkscjMqSKxU4YA5xQA+iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAExznJ+lLRRQBj6jZ6Tda9pj3bf6fDve1XJ54w31rnrrwHp+pa7bazp1/JbtHM1wVUA5dpAznBHcrj9RW7q2m3kmu6Zqtokc32RZUeJ32EhwOQcHpiua1Xwrr83nmy+ziS5tYYXcXToUZVlBI+U5wzoeR2JxkCgDrbaz02fSrnR43a4t4S1tOkkhZgSAxUk89HB+hFZml2XhvRZvOs7go3nG3b94cPKccEdC3AqpougavaeK59VuAqJdSFpglwWBH2eCMcYAJ3xsc+mPpWfP4O1d3mmilKStrBvETzyYxHtwDtx97PNAHb3WmWd7d2d1cQLJPZu0kDkcoSpU4/A1kP4N0hmK5uAplkmSPzjtQuGD7R2B8xvzrmrPw54thl09nlGIblJZi2oMxb5l34G0AAqG4x3PPOK1/DXhy/wBJu9OubsvNOLF4rqWS7eQiQsp43dQce2KAHWek+Gbiaezt7xndllhaLzf7yhHAyOuAKnXwdozB7WOS6Xy3EoVZj+7Yg5K9huy2fr2rFm8J61cW0kCLDbMl9PeR3KTHzPmUhVGBxyeTntUq+E9cEiLFqM8ceY1kMl27lo2jZJsHOQwLBlPYigDV/wCEE0gGIq90vlhNoEvHyKiqcY6gRrz9fWp7+LQNI0JtK1CdYrKfeCsrcncxJ5HuaxbLw/4hN9bPf3NyyR3bSTlNQbbKoSXbhQBtBZo8g5+77c7XiawvNW8PJFDaqboywu0e8cBXVmG44zwDQBB/wieg6rAJ4TI1tId6LG+EVsBSwGODhcH8aba+EtDN/cvBcXDyRzAyR+dkRtuaULjHAzKT/wACrN1DRPEza5d3dtNI9t5iMlv9s8uOSHKFowoX5X4b5s4OT/eOM+48L+IluruayN3btcAIQl+TwII1BLEgkhlPzYycD6UAdNH4G0iC4huI2uUlhCqGEvVQMbTx0qW98M6VrE99I8s+LlPIuY4pcKxC7QSP7wB/lXKXHhjxXcLPA91dtBsdYF+37QBuJw/BLEjGDnjvVmXR/F8d15ltJcCFpGHlG9+6vnQOD15+RJV/4FjoaAOhtfBul2yXKM1zOlzFLFKs0m4MJJGkfsOSzsfxplppGgaNrMlzDdLBcCEb4WmGMAY3EHnOO+axrLQvEkGqW9w1zftGJY2dZL4uuPPkLjbuwR5ZQD6etP17wVLqutz3aS3KW2PNMaMm6SbjbtJ6KNoyG4PpQBraf4U0UXFhqVnLLL9lIa2ZZQyqoWRQo/2QJX/OrOoeF7HUb+S8mkuVeTyi6xyYUmMsV4x/tGuStPCviOyuIEe6vXhLxPN9mvPKTLyTNPhQV4w8YHH8PFW9Si1seHvCVlcyagNScCG9+zXWx2kFs+SzhgCPMCnOeeO5xQBv6F4R07w67GwecIyBNjsCBgAZ6ZzwKz4fh5pVtDJFBPdIjoisAw6rtAbOM5woHpWNpmgeLmuLWPWL/Un/AHo+1TQX6pGwA4KKMMq9ARnr2qrDoPjaC0tooZr1GgtUjVRfoI2IBEgf7xLN/CwxjIzjGCAdvHo2mPbappJmM0d07y3EBkBKeaST05AJ3EVRk8CaU87SI88at5eUVhglCCCTjOflGea5+XQvEQ1ttRtLfUYN8EcLK1+rMRm5Y7ju+YqZYgM5xjgnGahGh+M3RoJbjUzF5LCPbfIP3hQZ3k5JXOcY6e3WgDqLXwTYWckLxXFz+6lil2lhgmMttzx/tYqJPAem26Xnl3d3Gl2JDcjzBtkLO7knI7GRq5qXS/GFzDd232PUY7V9OeFYnvY+ZB5O3DCTgkLKPq3JIPHRaHba+tzrEmoLf/vPNFustxG0W3cxiCKpJVghCsSQMjPOc0AW9O8K6fZ6Vew6fOWivoXVXypADg8ggcjJJ61KnhlYru6uodQuYZrlY1kaMjgIuFAyOB1P4msXwzZ+J4dXt5NTS9WAQhJRJcRtHkRr0VWP8W7mrmhJ4iU6z/aMN2nmDfa+ZLG+G+YYUhiOynkKOenWgDXTQLOPU73U496393EsTT5yVCjA2jtUTeHo7iwuoLmZzLcTiYyqeVZSNv8AIfrXFLp3jWKOR2t9Qe5lgWFZY7xMKRM53MrScEqV4DHoRuqQ2njxmhm2X2WRFuI/tMQBAVN2zD4DE7+ePwoA67QNBstMN1NaXRuYrnh+QyltzFjx6szcVVbwta2+kx6ImqTwWZ+S2g3LkAc7ATyQAOB1AFcrBY+NLOPybGw1GCIRXAVZLmBjuZJChJ3/AHt+znn6gZFaVro/iGPxXpUt6l9eWlrOJEuJLiMrGjWzqwZdwJfzX6hT8uMHigCa5+HukRrA1xqMkZiAEZcqASucbgeG4J61r6t4W0XVbCx+2sQtmYjFOsxjwFdHA+UgYJRf6dq5zW7DxNe3UpSzv5JIbsyRsJ4vIKbHCFFLZBBIBzj8ahnh8ZCSQiO/aN8oIiYiiAeQQcZ9fN/DPtQB1mreFLTV757ieaRVlEQljXGGMTM0Zz2wWP1rKj8BWckSyQapKZNgjaVApDquAB+G2sYt44RbYi01Q3W4G7PmwtAzq43GNd24Iyk4yccfdzWleNqOm+FNPgH2qzuZtTaNxb7BIys8hGMnHI20AWU+H1qsdujX0rLBGkcYMY4CxTRD9J2/ECo4fhxZ27RyRX0qyxP5kT+UmVYrhsnqwOTwTgZrOht/G6WUj3c99JKXaMpCYwVIgyjL0+Uykg59BnjNQtF47gt7iONbg3rSSyRuGUxGY+XsByc+VjeP/r4oA62+8LQXmj2WnvcsEtYDb7ygO5Cmw/Q479qZonh9LS11Jtyp9vJ2+W28RpjHGeOSWb6sa5qJ/GJMTvDqasUXckhiZDNuHmcA/wCqK7sZrSl0/wASQeBtGtdGZrbUI41gmSQr8gZCu85znYxVsdwpHegCeTwfLaeENW0iyuvOlviWDSDbtJVVOPwXP1qjafDyR7dTeX4RzDJEyJCp4cEMSe7HdnNVZr7xvFNbbre7QyW7POscSSrEzJKwVemSreUp55xxx10tRu/E8fhOxuILe6/tHZKs0caq7btrbDyBxnB6ZAPNACzfDu3lkLJfFFLszKLdTuBeF8fnAv5mmT/D6CaWRY9UMRbzDIiQLyJJnl55yOXIH0rI+3ePHvFTy71LVpWPnJaxs4PBRCjEALjcCwJH3enONLwrDrsl1q93qkN5Fe3GnW6O8iKqidGn3rHjgqN64PcHrQBtah4V+3QWSC+aN7aD7OzGFXEi4H8J4ByAc1iH4Z2stpNDJqRkWRZl3GBTtMiopI9x5f6mpPDd14ne602G+S8VFhUTieEBSuwZYtj7+/PGelULWTxBBq505LS8XTp7y7MqtbZRkka5KndjjnyepGARx1IANCb4c2s9/Ldi+GyZ3cxmBSihm3DaM4GCTz3q7pXguHStZtdRt7tBHBAIRGsKqGG0AnI+ma5DTp/HFpBp1kv27+y1to0ZpNOV5vNVEDQkfLtj4bEh79zwT0F5Dfp4W0SK3ivo4/LdLmCOFixBjOFdcZAzQBQTwBf32p6nNdzxQw3UzuGCrIdhkZgq+gO9ic85xV64+G6XLo8moBv9XvVoAVYrCISSM+gBHpz61maVe+L7d7CwAv47OKRVEz6cHaQbYT5bD5dq/NKN/bbyfXa8S3fiS31K9k02e7W0hjtwEisBNy7sJGXjLlVCnaD3PFAFrQvBqaKt3Eb0zR3EBgAMYDbck5J7n5qi0rwQNO1C0uGvfMW2kEyhYwp3iEw7c9k2nOP7wzWb4Zl1+88VQz61HeCRIJI8tZeVFt+Uq2RkZbk43HHTiseaPxJaEw2Vld3UVtfmeCGW1ZFjm8yTaFYKN0ZUjLZIHqM4oA6PUfh9HqEl5vuYxHPNPMv7kbkaVQCc+oIyDWt4b8NL4fe7YSpKbiQtvCYY5JPzHPJGcVyb6941865W2tbyWIIrWLzWBQ3EuI98co2jy1BLgMQufU452/BB1CW71S71FbwTXCwMwuLUwhXCEOq/KAQDxnnPqaAOxooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5nxJ4qfQrryY7aOVlt2n2ySFDIB/CmActXLzeNtTn1G3uFeO3gxATAk6PG4Lyg5fHGQq59MV3t5qunWl8ltdSKs/lmZdyE4XOM5+pxWd/wkXhj96TPahLcKWcxfKuQzDBx2CsT6YOaAJ9B8QxatowvJgsE6BzNBk5j2uy85A/uH24OCRzXMw+MtWh+3R3cEazGaGe1Ey7B9mkcL27j+tdVbanp5t9SLxR29vYTG3mLKNuAqtnjth/51X1HXtCtYJpGNvPLFET5YUZIX+EEj26e1AGZ4o8QanZ30tlY+SjRnTpI2L4Mvm3flOh+U4XaOSBkZzR4f8cy65qa2h01IFCfO32kM2/bu+VcAsvUbuOR0rYfXNAmiSea5tTwAN4BIyxUDp13KRj1FJFr3huOIXMV7Yog2oHXA4YFgPpwT6cGgDm2+Il4cMmjQGMu4Ob0bgqEZyoU4bnocfWrGgeLrrVL/VryaIrZw6dDcw2cbb5Ad0+4HgYchFG3JA455rpL260axYC7+zI0gLAMgJb36d/1qrY61pw0uDVZLdbNL2VI4zs+aQu2Ezgd896AMWz8S6hrniewsIwLS2VWnle3lEglGyJ1XLJ/00IYDB6EGq914v1a31ZXMUDW8VzLBLbpJjKhkCtkqTu+bpkA1uaZ4i8PzWbXKta2ZhkkR0YKrId7KTx6lGOfY+laNxPo9vPi4Nqkjr5mWUfMM4zn64oAw7XxrJceF9S1ttNVFtE8yOL7SrGRcZ5xnYeowR2qq/j6e3kkjudMgVw06R7LosGaKZImz8gIzvBHXODW4useGpE+yrdaey3Mm0xfLiRiccjuScDnqcVWOr+F7i3jmj/s+Y3K+aiMqBpFZvvcjuV79SKAMubx20jeULQwK1vb3CSpOpYiRlBUAqRkbufalTx9cNOVOlR+UDF8wuckiSV4l42dd0Zz7EfStd7/AMOi6itRDZOuXJYRrtjK468d/wClWZZdFtrW2vFisfIkdRHMAgUdWBB9uT+dAHMJ8Smn0+K6t9KVt8aSMjXOCoNss5H3TyNxX6jtWxceLWtdBm1KWyG6G48l0WUsAMZ3ZC5xjrgVekXRLfSZdRisbWS2jR3JhgU5xkNjjr1Bqhd+IdCtZfsctmpVoUuivlLj5iAvHckkDigCjP4/a2Mgl0zb5E4huG80lY924q3C5IKhT043jOBk1GPHdyLRluLKOO4BCyGGXds8yaSJNoI+bBjy3TAIOO1bWnNoh0ue7l2LEty3nPfbcpKp2EEngYwFHtimvqPhotC0EdhdPJOsf7lUYq0rY3H0yc5+lAGN4c8bzXzwWcyeZdPHHJI0sqxjDKmdmFGTls4P59qsat48Ok61JYSaYzxC8jsUmWYf62REdSwx8qYflucY6Vsam2k6KbOV9MhLTXKxRGOFcrIRwfbgYzWVouo+GtRm1LUCsUcl4ElmN7sG5fJQ4Gf4QgXI+tAGefiOs7yW/wBjktpopvJJ8wEO6zCNwhK4K85zwcEHAyKfH4/kRY2mtVaeS3M3krMBGMbiRuIznA6dz6V0MkvhiC4SF10xZSxjAKJwUBJHTjG38CPamNceE1tpJw2kNCq+Y7II2GM9ePc/rQBV8PeNYdevXgNm9qhDmJ5ZF+fbIYyMdjkcVT8V+INa0TVGeHyTYtBthwA+2XkkyDghQvIx1xz1rUvpfC0NvJczDTs2zCY7dgcOG8we+dy5+oPvSzatocdpp+p3EEMcerqiCaVFGQ0ZcB2PbAx+VAFOPxRdWmjPPNbm8lS+azRlZY/NwMhvT2/CodL8ZyazrenW8MDW0cpfzI5CrFlMKyIQR0+9W5Jc+H4YEtpZ9MSKNhsid4wFY9MA9zn9aWP+xIYJr+zhsXNqhLPbqmUwvTI6fLgdRxQBzmpeNZ57m3sNOiMEl1c+VHcMQcKk4hkO0g4bJBAPUHPYirur+Mzo+oS2X9mXFyYjFGZUdQGd1JAxnPRTz0rXt7bRruV547ezacMs0uApdH6gtjoc5/I06W20XULeeeWOyuIJMedI211O3pk9OKAORn+JttG297O5iEUrI8OULt8jFc88AlchhkccnrUunePJIjJFqsKmVryWJDE67UUXAhC5OMkblOe4raQ+EXeQKdIOwhG5jx86nj0OVY/majnTwnHcWlq1npzh5JAjLGhSNwu9tx7EgA8+goAg0nxb/bup2S2qGK3dpklR9pJKqrKQQenzVi/8LCuLWWKC+jMZS6maSZUDLLBGZshQDlWGxevWuxs7HQrQtNZQ2MRgzueLaPL45zjpwKikg8OxSPKYrAzM5mwu0s7qCSQO5wT+fvQBgXHxO0+0e8SewulexjSa5ClG2xuEKsCD833+g5GD7ZtaZ4wkuLDV9TuLZza2yxSwQxlDIUdQRznGee5FXbGLwtc6faXcEFgkJQTR7woK5VTyO2AU4PT5farEMHhuOyuIYP7OS1kwZhG6hT6ZwaAMgfEGEyMn9ianuWWOAjEePNeRI9md+MhnHOcdajPxL09LVp5dOvogqJLtcx5KN5vIw5zgwuMdenbmuguNK0NLgXU9taJNK6ESNhSzKQVwe5yB+Q9Ky7Cx8L6vHcvFpsRgs3a3Msi4Q7GdWAOeQGLj8T60AV5PHkNncyW89jezMrvl440UKobaON+Tk+n5Crr+LYJdFsNVt45RDc3QgK7VZh94EH5gByuO5Hp6L9j8MXF7LYNBbmUxiQhm4dTzwc8jirqWmhy2UVtH9le3WTzUVZARvJPOc8nOf1oAy4vG0Nz4Y1DWodOuV+xxLKbeZkVmVo1kU5BI+649+vFUh4/Fjeaha6jY3MksNyYrYWsYYzDAwoG4ncMnJ4HpW0y+HrTw5c3SrbnSZYR5rIdySIqhQPfgAfhVcWfhm7ngtHs4zPeRGZY3B3FRjk88dqAJb/xdZ6b9h+0210n2yLzYgUAPDKGUjOdwD7iPRWPas1PiLZMtuzaTqkazqZFMkSriMGMb+W5H71Ome/pXSNDpimCJltgbb/VKcZjyCnHpkEj8ay9M0Lw3eWnm2enxiJHlt+4wUl2uvXoHiH/fIoAzz47VrRH/ALPuYHYK7OVWRI1M3l84cE5Pp096S88exW8thcfZpU0+43fMyAvLkL5Zjw3GWOMHnntW8vhvR1WRRYptkxuG484bf6/3uaiPhLQGQodMgKHd8vOPm69+P6dqALdvezanpC3NmjW08inal3EcxnOPmUEHt68+tcbH401mzsbXUtQSznspLieGVLaBlkURsw3Dc5B+7mu3stNtNPjMdpCIlIAIBPbPr35PPeqcvhnR5rRbWSxQwKzuE3NgF87j175NAFfTPFljq4vWtYbkxWqF/MaPCygEg7T3IKnj6etUIfiFpc3W1vkBXcpaIfN+6EoA56lDn+eK27XQNLsftX2a0WIXQIlCs2Gz1xzxnPbFVH8GeHpI1jfTUKrt2je/G2MRjv2QAUAUJPHlg9uDBDcB5LOW7jZowVCpkNnB5wR2/ClPj/S0lMTw3hKlg0ggOz5WRXIPoDIn/fXer58H6AYhGdOQqAyjLuThs7hnOcHJz9aU+EdCZCh09SpDqR5j9HZWbv3KKfwoApnxzpgHEN2zkgBFi3EkySR9v9qJv0rT0TX7PXoZJbQTKE2kiVCpwwyDg1XTwfoMd09ytgBK8nmFvMf725m6ZwOWY49zV7TtHsNJV1sbcQhwobDE5CjA6nsKAL1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGLrHhq21m7juZbieJ40CDy9uOGDA8g8gisa7+HFhdwXEH9o38cVyD56L5ZEjFXUscoeT5hPHAIGMV2dFAGVb6BbxWeo200stwmoSNJOZNoJJRUONoGOFB+pNY83w+0yWLyVuryOLamVVlOWUYDklSc4Jzzg56V1tFAHIQfD2xt7vz01G+2idJxEfLKgrM02PuZxuY980yL4c6fA1q8WoXqyW8ccSsREcqisuCCmOQ5zx2GMV2VFAGFq/hWz1icyyz3EW6IROsZXDAHI6gnIPpU1x4fhn0Wz0wXM6LaSQyRzDaXzGwYZyMc454rXooA42T4dWDXEVwl/drNEQQzLEwPzzMcgpjnz3H4L6Vtar4asNYaA3Qk/cxPEArY3Ky7Tn+nvWxRQBxsHw+tYfJP2+ZjEYSD5Ua58qZJl6KOpjAPtmpI/AVtHp8tn9vneNraG2VmRNyLG7suCB1+cg/QV11FAHHz+AYbm0itZdVu3ihBEIZIzsGQQPu/NjHfOa0b7wvDe6FaaWbhkS3dXDiJPmIBHK42456YxW/RQBi2nh2Oy8LvocdzKYmSRBI/JUOScD2GcAegFQX3hSLUkijurp2SBFWALGoKMuDnPU8qDiuhooAwX8MRSaFLpr3LsZrkXUsxUZZ/NEp46AZGMelUIfAsEE0Esd7IrQv5gxGvJ85pv5tj6CutooAyNW0aTVbawja72yWk6Tl/LB3soI6cYzk1zE/wxin057U6pIpMLQB1hHCNb+Q3BPUrzn1rvqKAONTwEqTyz/2i3mSTSSkeSNmXR1Y7exO/JxgEjOMkkpL4BWSUEagVjW2FuqCEYACgZ6+ozXZ0UAcKfhvGtybqLUitwskjxubaM8SBwwbjLffOOeK2Lvwol1oWk6X9pwunqqq7R7t+2Ix5Izx1zXRUUAcNpvw3ttPngY3izRwyCQB7dd7YXHL9T149K0NM8GJpvhnUtGS6jIvIXh81bdUIUoVBbH3mwev8q6migDndH8LtpLamy3pb7cB8ojwqN83zYJPJ3DPTOPXJqHTPCDWHhq90eW9WcXTly5iIAyFBGN2f4fUYrqKKAOMs/AZt57XztRFzBDcJcMkkPzMwtmt8bs9MEN0JyOtUpPhozyWMqawUmsxCsbLBwwiRlQsN2CTvO49+OBivQKKAOc0PwnFpNte280sVwl3uVysARmViSdx5LHkjPpWWPh4scccceonBWHznki3OzxSGRWU5G3JOGHOV44rt6KAPPv+FbThfJGrxfZjGqlDancWEEUJOd/QiFTjHUnk1JefDg3EvmRX9vGAzHy2tSyNly2GAcZ4OO1d7RQBzWueFDq8EEK3ghVLSSzfMW75H2ZZORtcbBg8gehqRfDlwnhS40cXsImmlmk8/wCz/KPMlaT7m7/ax1966GigDz2f4aT3VnFby6xGNigeclsRICCxGGLnA+bkHOfUVPF4Au4dUS9TVYF33EU9xH9mO0+XJvAT5/lBzg5z/Su7ooAwNP0G407whBoiy2c7wxiINLAfLZAe6buuPfr+VU9M8ERaXrNnqMeo3LGCJo2hb7hyOAPQDsOa6uigDh9a8BSapd3lylzbJLOJ9jtCcoXEYU8HkrsP510Hh/TLzSbWW3uJ4JUe4nuB5cZUhpZ5JSMkngbwOnatiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAxvFN9ead4durmx4nXaN+3d5algGfHfAJP4VgzeLRos95EJLm/ihIHnXLoqg+WXG1lX5s47gYPSuuv72DTrKS6uN3lIPm2jJrIh1vSby0u4rCKKRre2+0+W0YC8gkcUAYz+Or5rny0023SI3ccKyvcE5QzrE5I2jH3gRyf05oWvj/UbKFbS6sFvLp5pBDM1wsSunmzgbyVCqQIsADOcitq18XeH5Y4lltylxIQssS2pYoeDyAOhJBqO98W6KmnrLp9pFcys4VovKHyASBSW9MFvzP1oAkufEWoXXgfWNWhiSylgil+zMkglOUyMkFcdR05rB0zx/qVn/AGjb39rLdy2pMoLlQxiCxEqrIu13zISFAHAAJzXTaz4m03TI57OOASzBhGsXl/u3kJHy/X5gTTL/AFqPS44raTTI2uYFtZpFjj/dr5swiOzvuHzEfSgDnrb4hX737TCxSSO7t7V7e2a6VBDuE7NuYqMPiNQVOcEda6HSfFlxqsGosbBLdreF5YT5u8OFLLzwMcr78Gp9N17QNXultrONXlmXzTm3wN2N2GOOG5zWLb+LzDBHPd6daQw3cs8ETxAnmNiCHGOhwTxQBXi8dXek6QrXNtJfzKP3jPKqsXMBn4AQDy8ZUN13YHPWuj1nxBeaRFpwOmrNcXO/zI0n4j2oXbB2/NwDjgVUn8TaAnkSvFCEIeKRng+6qLKxQcdR5LHB7Cpz4s0eSd5JmRxCokjxHudFKks30x3HrQBlf8J3dz2pxpJiMtu80Ukd0j8KuSchWAIGOo/CkT4hSfZZZ10pnt4XEbSG4UvncUJKKNw+fZ26Nntituw1/wAP3lvdJbGIQW6s0gMO1SuSCRxyCePeobLWba88QpY6ZYRCPyi93K0ewrtO1V46kEd+3SgDJ/4T6eRbO6j02ULcwr5cEkoQFmkjjO7K7gVd2HoQCcdKv6L42Gs6zDp8dgY90XmSOZc7DjPTHI7Zz+FPXxNodzruq2E9vDu0yES+ayK+9Qx37R1+VgAR61lJqHh2HUp9WsbB1nhBY+ZEUz+7LfIMcHA+lAC3XjXUbXVIJHto2tEa+ingSQZxDcQxLICVzuw7fLnBzWxpni/+0tH1DUhYNHFbR+bGDKpMi4PBA+6cqQQf15qrp2uaZdGQahY2ovGk+aOGAuwUrG25+M/8tI8/h6Up8UaRDo9w8MNs11LbPdtAke1JsDJySOTjGc0AV/8AhYe1GMultGcsiZnXDMApx69GHQE+1RzfEmOK2luV0qVoEtmn3eauSRbmcrj/AHQR9cVe1C+tjdzWdpo1lO9taC8mEqKBtI4VeOpx19qr2ni7wbJpiXSQwxxFRlRacDMRYj7uDiMMTj+HNABdfEaytJ2SS1YIss0Qk3jazIzKADjHO3POOD3wcOm8aT+dNEdPeNbaWJJJYriNwS+cAeoIHsat/wBq+EbdZsQ2iCHYrBbTHEhKLgbecnIqezvPDN/aXAtIrVoIow8myADaAOO3UdvSgDKsPHs+oanaWkelCPz4HuNz3C4K7NygHpknIPpjNaGvaneQazolpb3i2kd4JzKxVW+7HuHXtnrimaR/wjE8Vto1jbRTR/ZnkQtAD8oPltk4+91B+lVU8TeG7y7sLWe0h+yNb5tZbiDIX5zFt5Hy5wPrmgC14V8VXOvLsuLHyjEv7y4DgRu2SAVUndghc/jWV4y8S6z4e1Z1gZ5IHiju4UjhU/u4mP2pST38shgfXita51/Rhpaalp1vbXiNdRWzFUAwSQAckds8VZv/ABHpVhcXK6s0UKRMY0dlL7l8tXcnAOAAwznsKAL2i3cl7p63csmRcM00KsApEJPycf7uDzzzVPw9qk+oXesRzzLIlvetDBgAfIFU9uvWok8TaCrzfabi2hlhLxHKniMSMnXHTKHI6DFQ2viXwha7Etbi2j2AsvlQMAueD0XqcdKAMnSvG88mp6xDqMqw2+mSXT58r5rmOJmGE9SoXLd8kcAU3UfG2oSai1nYQCGUW77kl2khy9tsYMDgjbOePUVpDWPCqXEqXENtG1u8s5cQkqnz+WzE44JJwf1q5OPC1pbxzSw2kcSs8anyTwUbDdB0BQc9PlHtQBJ4WvdQv7a6mv5kcpcPCgWMLgJxngnr19q3qxPDeowalb3UtnaLBaLcOiMp/wBYwOGbGPX8626ACq9+9xHYXD2ixtcCM+UJDhS2OMn0zVimTQx3ETRTIrxsMMrDINAGVpGpXM/hsXtyjyXUav5saxhSXQkFQASOowME5rI07xBd/wDCPabrl3dxTG+SItZxKoEbykBVVicjBYBi3ueOldZFFHBEscSLHGowFUYAFYEtx4eW9gtYLW0uZdQZlxAqNkDBcn6blJ785oAxrH4hpcalPB9juJS0oSOJEUGPGQ+TnB5H5VPF8RrVgjzaXeQxsofe7xYAKSOpPzd/KcflmtuS28N+cyyR6Z5tuQ7BtmYyOhPpTVsPDVy/2NIdNldkDeSNjEqAQDt9MOfwb3oAy08f2rvZhdOuitxJIhfcmE2TJESfmyQTIpGB0NQa34l1PTtU1nyZrcw6dHBItu8eTNv6qCDkH04rZjh8MrLIqLpyPDN5Lj5VxJ8rbfrwp+oHpTmn8NyX6XDTadJcy8rJuVidvv7UAReGNal1OzvZb2WNWiv54EHC4VHKjPvgc0v9rTr43n015UWzTTUuApAB3mRlPPpgCnXFj4ZcSQTLp4Nxv3KXUFic7yOevXJ69aZfXXh6bUrHzktbq5vz5MToVclQGbnn7vyt7ZoApaV41gu7m3s3hmMs0xiDtsHO5x0B/wBjtVB/FGqWl9eStcQ3EMWtR6cLQxjeY3KDcpHO5d+TkEEKenWt/Hh61vd08FhazW77Y5ZtinJ5+Uk57/rTom8NJeLcQvpjXdyS6MroXlJyDt5yScEcUAZnjLxRceHrjRXt8SW93NIk2E3YURMwfI6KCASRnjNMvfHdtpWYWguNQMUSNLdW6ARksMgjnpj64q/pU/hu60TSp4DapbxWcc1skzKHhidBjIJ+X5WA/GhbfwgSEVNK/dxAgjZhUJ4wfTOaAMG4+JMAngmSJ4rWGST7Sh2s8iiKRlK4PQlBg9CD161vaT4ofWNTlsI9Mubd4oFlkllZNqbmkVeA2TnyyenQjOKqSXvhKAahmztfMspNksQjQuQwA3Be6nzevTk1rwDRtMt7q4sYrZRbR7JRahcqFy20ge5JwfU0AZ/h+/1O51TU4b6+hkjspxAAsGzeSoOc5OOSeKj1fxa2meK9PsfKU6fJILa6nOcxTSDMQ9McAHPeRaki1Hw3f+Vs8gx3ii8aUMu3K4xubPDDIrSm/sOeKaGaSxeOQi4lRnUg4wQ559l5+lAHOS/EOOXzba3064jun3rbea8YV9pmBbO7gfuH69cj1pln8RFXR4Lm8064OI4hJMrxhXkZFZtq7s/xelatk3hfUtEGpG2so7EySQ77gIFykrqeTxgvuI55z71aa18MyWwBTTGg+8OU29AM/lj8KAOdb4hL/bKlLeV7KaLZbxKF3yS+aUz1+UYHf+fFa2ua/cwWOiXFkRE19cxI8cihnVGUkjg4BHryOKmMXhB0nc/2MynBlbdH3bIJPb5h+dXoI9EvZoHt/sM8kMWITEVYpGRgbcdBg/rQBzGjeK9WlbSftCwXo1CKRjHCojeIq2MklsbcfTkd60pNV1K/8Q6xplrdQ6eunxRGN5Yt/nO6ltxyR8g4GBzkHmm3N9omj6lHpa6JP5k4Oww26lWC4Y4Oeg4Nacj+H9Tnjkkk0+4m5RcujMeMlevPrigDn7zx/GpLRQvEltdIk5YBxJGfMGUIPrGf/wBfSO+8YX813Fa2cD20lwIxGziORQGb74Ifk+xxW7bWvhZ2D2y6YxeQKDGyHL5JA4PX5jx/tUy4h8N6RqGnWT2ltBPcuVtlSMD5l57dKAMqy8fQnT1kkt5p2i2Rzy/u4sO6gr8pc8cjkE/oaanxCguYVnS1ngtjHZzeYwVmHnTPGVK7hjBjIyM9enTOw9n4TkuBbumlGfKxhNybwd2VA75yOO/FVL9/DmlahHp/9kLJOsIlEcEQJWPeSCBnJw2Tx0oArN8RrRZ0i/su9YsqSFlMe1Y3xtY/Nnow4HNdmCCAR0NYX2HwuisNmnKqv5ZG9RhiR8vXrwOK3RgAAdO1AC0UUUAFFFFABRRRQAUUUUAFFFFABRRRQBleJG06PQriXVvMFlHteQxlgwwQQRt5646VTtNL0LT7h7RFeOVohb/vpmJKsCdoJPXGelaOt6YNZ0a608ymHz0KiQAHaexwetYupeGb/VV86a8tEuiTx9nMkYGwr0J56554oAZJ4c8LvqqWbJL9puYXk4uJMSp8iEE5weicevNMvPDXhjSWtIZLe6MtxMVjWOeRnc8M2fmyVHlhiDxx6mqtv4Aliks3e5tnNpK0sZMJyC11HOcZJx9wrx/e9sVueItAPiA24S6EPkCVSyjLAvGU49CN2aAH3Xh3RdRujcypvkkYOCk7AbgR8wAOM8DkelTX+iabqF2JbnzPOVYidk7JkRyeYhIBGcOM/nWRofg6HSddl1e4Fm08qbVEcO0RMSPuZ6ZxUGr+Bjq2s313NJaSw3RjYLPCzsm3y8oPm27SIwfu5z34oA1tL8N6JpF0LixDxuydPtLsrD+9gnBODjd1xxUcPhDQliZEikdCHI3XLts3ncxXJ+XJ7isCL4czQCVEvLRo2fzUEltkxMHdgiHPEZD4Ix/ex97iOf4cXbyTmO+tVjuI5A6GE/KzKwwvPQbs/hQB1MvhrRpgf3RT981yTFMyEuyGMsSD/dLCqMHg3w7Gxigtp0HlKTIsrhWQgjbuzg5HUfQ+lc9qnge4gF++liyxJZPaJbW0YjZd4hBbAIBIMWeeucexSy+Hc1zDG11bWUaEgvDIgJkIkmcswAwCTLnHQYx7UAdhb+F9Ft1uIYrchZojFInmscKWLYAzxye1T6foWnaZdvPbCQXDx7HZpmYsNxOSCeue/wCFch4N8Majo/iSe4vrZSscIhjuCewVRkeu7b68Vb1vwJPqmpy3sd3Cri4+0xs6HcxzGRG5/uAx5GPbjjkA3J/CWkTi1DQyA20UkKMsrBijjDBjnLZwDk9+aLjwpptzLJI/ngyKFcLMwBwhTp9CazvDPg/+x9TfULxbKe58jyo5kiw0eZZpG2k9ARKBx/drM8UeFNQvr3Ub+JbS5WWNYxb4O5huU4bj2PXPHQCgDoh4R0xdQ+3qblbneGaRJ2UsNiJtODypEaZHTiqafD/REYsDeFihjJNy/wB0rtIxn0rlx8Pzc6ndQw29lEn2WJknVTiB/NncxRkD7uHVD0+Xt0AvXHw5mW2W3sTp8KrGhDbCCriMq6AAfccsWPuWyDngA6nWdK0oQzajevNCsduYppYnYFou4bbyayNX8C2uo6bBbadMttbm5F0yMGKn915YA2spACnp0NZP/CB6itkbSa50ybdA8aeeGLREliPLIAwCGweO3T06Pw3oVzoVzJAbWzFqfMZJYjhk3SbhGBgcYJP1oAx0sPCttqlzZ3F/eteRSwm5klWVYhKXEqZfbsBLHIGe+OmBW5a+DNKtEuli88faIfIZjKchM5wKztR8JX+pXuuxSS2yafq0kLSMGYyKiIFKhduMnHXPGehrV8NaJJoVl9m8u1Ad5JJXizlmZyR2GcKQM+1AGbpsfhvRdeW1iv7hb6J2tispfaXl/ehCxG3J5IGe9LP4T0KG4s7Kee5zM22CIsSDskM+M44wR3PQVBceDbx/GE/iCOaF2+2RTx28sjmNlEKxMSuMCQYyrAEjJFZcnw6vnWDzGsLjykjjdJWYCZlSVDcMdp/enzATxyVHzdMAHWx+FbCPRP7K33DwhlZHeUs6FSCuCfTAqvdeEdO1i0fz7uecXEcyyTK65lEsYjY8DH3AAMYrntM+HdxBc2yanLa38UUpeaWWaVnuhjguh+QEdOPTr2rqdC0260Twpb6ZDHZ/a7WHy41Eh8tiOhJ25Ge/H50AULPw94e16wNyhku4mN3F5rhkOZZD5oxgdG3Dpxzin3PhDTUsrkXFzeukyLHKzHexAPpg+v8AWsFPA2uQGxWK4snSGJw7NPIhLOZiwwFORmVecjO3kHC4tnwHcQWyrZ3EUZ+zxBo97BTOpXc+7BPIB7dTQBZh8L6fdaZcXGj3Bm+1QzW5+05MbLI/z7hgHj5scirR0bRtSSHSILmcSaXH9ndo88oygMhYjDEjBOOQcHg0zwZ4e1Pw/wDbk1CW2nSeTzI5I3Yugyfk5UDaOox3J+pzb3wVqc8t88MtnH9puLiRCHZTEZDGUmGF/wBYuxhj0bhuuQDr9I0qDRbAWdszmJXZl34yMnOOB05q9WT4b0ltG0dLaVlacu7yssjOGJYnq3PTFa1ABRRRQBBe2qX1jcWkjOqTxNEzIcMAwxkH15rntJ8H/wBm63Hqsl4stwEZHCw7FIKRoCBng4jBPqSegwK6aSRYonkbO1FLHAycD2rziK+8VaXJqsjpM8mqQLfWf7tpltpMhTERgY+TZx6qx70Abl54J+06u+ox3qxymYzAGDILcYDcjI46e9QWHw8t7K7SU3rum4ltqlHIMQQgMrDAyAf0rI1RvEDfbLSZru4kEk6JOLTBWPbHtKEDGD8wxzW5rtk1qnhOCzglWODUFL+XGWCJ5EoywHbeU/HHpQBHceAIptTN2LxCnntKI57cS4DJGDyx5YGJSG6jJ65pg+HypE0SajtjZp3wIBwZVw2OeORkelY0Gu+NWs7OeSGeS4EKyvEtpsVpHtS+xuCcLJxnPXg1bj1bxbNHMyXEhCJEY86YUMm+QAkgn+FST0HSgC4fh6ZobhLnUhI8sE8YdbcAo0rq+4ZJ4G3GO4JqTS/AI0vVIbyK+jCrOtzJDHaqi+YFZfkwflUhzxyc85607VP7bvfBtk0iTPMt3Cb+OOMpJLbiT94AvXleSB1GQOtZcD6xZ+ILiTRlex8P3Dq6pJanarJE7OVU48tWYRjpydxHJ5ANfVfA/wDamo3N296i+cWKqYM7cqBz83PT2qkvgi4/4SBgzxGw2LKJfKG4SC5aYIMNkYJAJxyPQ1l6R4v8SXa2TMs83mSI0q/YGGxGxnJA+pHA4xkmrtlrni77XZrcW800MksJlKWZjIVtoZckEYXJJyQcZOeMEAktPhtLbW6wHV0kRbBbEZtudoSFc/exn9wD07nrxUt18PJJYpo4NUWJJtwcG3zwWY8YYYxu/wA9KPGSRz+K/D0Swav5wnDvPZmXy0j5GxsHb8xPJPYfSqkWg3Gmx3ttps15YRXcrqokiluMoijBLsxKbjn60AXJ/h39o37tRQEkOrC3+YPsRDk7uVwn3fU5ycCtPQ/B8Wi6ff2azpILpdnmLAqPt+bG8jl2+bGT6dOucbTdAvZYdJnvLJ0vEu5LhV8+TZBCpZo4+eASxQYI6ZHarevDXJ7pDBFLBdvo14uyCVnjWbfD5fOAN2A+DjPWgCKH4d+RLBOuor58IXGLfCEqABld3TA555PpUCfC+GKCCFNUlxbXQvYWMYJ84FThjn5o8r9z368DEccF0s9o8EV8iQ3/AJ0MbLLn7PsAYZ6DnJwRzXReI7pr3wrHd2DXB8ye2kQxB1fb5yE5A5xtzkHtnNAFW98O3sHhSLTLMw3E4v1uCxhAQA3Hmv8AIWHABPGaon4chCVg1MLCwYlHtw3zNnJHPTngfrWbr+keIH1fUms5Z2tySzTgMQ29o9kbJjDqgVydvYkcFjnf8Ox3cd/YLdLdI66bh1dnKb9/vwOOgxkDAoAzNV8CXSR+dYSxTSm6jk8owgAL9rhmYnLDICxkY757Vp6F4JPh/VLi9s9Q2i4dnkiEOFYvIHbjOOxVe4BAJOBjraKAMq90drrX9P1RZ1T7GkieWUzu3gDrnjpXPR+AZYZ9Lli1GJfsLI5H2YgSMrMcnDjqGxznpxjnPbUUAcLp3w5/s+bT5E1If6EluqlINrN5SIhOd38W3nII59QDWprvhEa5NNcPeNFcqY2tJFU4gKHOcbsNk101FAHD/wDCv3a4knk1CEyu7SFha4IY3In/AL3tt+laPibwk3iO4VnvI4YwiBGEGZoWBJLRyBhtJBAOQR8o46109FAHDxfD5oNRhvo9UHmxJ5IVrcMrxf7QJwX/ANr9K7dRtUD0GKWigAooooAKKKKACiiigAooooAKKKKACiiigDN11r9NNLaejPKJE3qhG8x7hv254zjOK5SceMZJFSJrhF8za74Q/u+MEf7XXNdN4na5Xw9d/Y7r7LclQIpv7jE8GuKh8Zay2rLNNEsSrYgC1nYxq0wlEbuTg/Lk8cdKALaXPjWKDzJbeeU5jyqBQ2PLcEAZ/v7DmooLTxNa393fC3u1+0F5DHEV5kNrbKCRn++ko+v1rovEV/cHw/G1pqFlBeG4SJszlI3cHLReYOUJwQD1zx3rlYPiDcWVtzFlCgCrezqGSVriWNsy52tGuwAN3GMnmgCcr4weNJXtp5bkINiShTGGDPgn0ONmTU7S+MVvYmjS7Nqo37WVC7Hfbgq3PTBnP0AqGbxvqt65gigs7dhOiI6XRbkbCQx2/dO/AI64p9r8Sbi+EYg060WR/s6eXNdhWDytEAdoBYp+9+9jHyjrnAAN/wATPr6zQjR1Yr5TkFQCPN3LtD5/h27+nfFJ4eOvvFfx6m0gYqpt5JEAwSGz09PlrM1LX76+8N6RqVrJBDLK7tLZm68k3AQMGVJMcEEbgD1xg1Us/iIZIxDbQR3DCOPYbi5CSEsyqQ4weRuB4yPegC1ZWl9Y+G4FXSbr+24AFluV2lpCWAdgxPzZBJ5/pVH7d45McJ+yXODBGkzCNdyMGUOyrnkkE4+h9qtr49v2lig/syz8+bySmLwlMOJ8knZ1BgPGP4hzVWX4nyW1uktxpsCb7cXAxdZGGgEqLkqOTyKAN3xPa67e+Dvs2n/PeSQ4my3lufl7Y6Emra3V+nhm/khiuGv4I3EcZjGS4XgLk4YZ6E9arQeJ5/7Ilu5o7ZpPtxtY/Lk+RRuwpc84/wDris/QfEV9q41rVnBiS0gHk2pclMmJXJOBzznBHY9OlAFV7rxsYIHhhl3xmXcjxriT/ScICc/88Tk/StbwdHqgk1G41W3uI5p/KZvOAALBPmC4PTPSsBPH1/p8sl1eQxXdtLDCwEE2BG5tnlbbkY2koeSeM+1bdxr99e2mjY2WKX1y0U8sMyzBAAcBXHALUAcxbWXiKz0mzm0qxura/tYbr7SzqCJiQ3lqFz8x3FTnsAfWux0efWrbWby11ET3VsCqwXIjCjpzkZ+pzWIfHM+mwXKx2Ul7BZrdyzTXNyEfbDJsIAVSCMsOSRwCTSP8SJfNFsun2vnlJASl6JVSRUkdQSoIwRH0zkbuRxyAWPEljqb+JBdWFrLP/qkaOVAUIz95HzlCvcdDWeur+OJdPH+izQ3KoxbNupBZbYtgc9DKAPxq6vxBvJCIrfSLaaUPHDubUFQNIwUn5QrMF+brir+t3t4niq0tP7VbTbU6VcXUrrsKo6PEAxLDoA7elAGXPqPjBbl4ozJsjEjCQWoO8/uCo69PnmH/AACo5NV8bBp0ETDy1IicWobzPmIyeeOMVVs/iLqmpaNbPNp62F0j24uHadAxZvKZgIm+YKVc89v1rRn+Jgt7NrptJLRLJ5ZKTlv4QwP3O65P/AfTmgDb8OTa4dQv7fVi0sMap5M/lCMMcsDx68D26VgDWfF1zFMscUsDG4G1ntQSseyTI6/3lUZ96ty/EFk88DSlZ4rN7oKbnb93yiUOU4OJge/TkDIrT0fxNc6trF1psunLbG2BjkmW7STEoCllCHDY+fhsc46DIyAZXhqbXb7xKl5q9tNC32Qoy7MRqdwIwc8msDVYvEtr4q1G/wBItZ55Y76WSOI7grp9kwOSdpXzP4epNbun+JdXgS/S+3XE2lyNBKGCxi5dmzGQQv8AcP8ACOo6VRu/Ht3a30eoMX/s0xrKbXamcG2eTbuIyPmUck8c9qAJ01zxZ58TffhIjPNiVLbpHB78bVC0y11vxlKbeCWIKXRWaX7IfvFQSmM8YJPPtW7YeLZ7nVbXTbrSvstzchmQC5WVSEYh/mUY4AQ44PzgcGsqz8TalN481HRbi5MFok4FrIyJiUhATCDjg85559KANj7fqVp4LtLj99Nf/uUkZ4fmyXCsxUexJrnX8Q+Mvs1tcw2YdmtIjLAbYjExgkZ+faRVGP8AaqNPiJdtb217DbSSWlvbzNcJJIolndIFlxgIAPvcEYz6YxWqPH8sl61lDojyXUJdbhRcqqxkSPGuGIG4Foz0GRkcHNAGp4N+0nTLprkzMz3kjo0yFCVOMHB6CuirN0LV01zS47+KIxxSfcyc5GBnsOhyPwrSoAKz9b1WPRdJnv5UaQR4CovVmYhQPxJFaFQ3dpBfWz29zGJInxlT7HI/UUAV9KvxqelxXaFCzgggAgKwOCOeeCMVy/hvx8us6FNq11DHDBap/pQTJZXJ6gH+DH8R6846V11rZ2+n2Yt7dCkS5OBkkk8k+pJNc7odn4Uv4ozpUBkha0MSM0UipLBuOQCwAcZb3xkUATw+N9FnSJ45ZGSSTygwXgNnbg8+tSWvjHSLuG4kErReQobbMAhcHdjaCec7W49qlk8K6GVhT7GkSxvuRY2KDdwex5+6Pyq1aaJp1i7PBbKGZVQliW4Ukjr/ALx/OgDn4PGZhtNOvtUFtb2+oWzXMMMe95duAwHTBOGGfc1btvGlpd3iW8VlegtLHEC8ezBcMQSDyPumqdpa+DtSlgs7dGl82OeK3iZZQiIjBZRHkYTDAA4xzitK70bQdJtHv7iIwxWwSV5dzkjZnDHHJxk/nQAh1q/vNY1Sw0y3tydOCK5nYjzHZQ4Ax0GCOT3+lSeLNWm0TQHvIIIp282OIpKCVIdwp4HJ69KdHa6NrF9LdQgtOFRZ2jLpvGMqr9N3B+6emasvolnNp5sZvNlhMxn+aQ5DFy4weuATx6YFAHNaH420WKwjSS2SwdjIDHDFtTKEjpwQTjpirsXjW2bxBJpkttPG32RbmJGTEhG6UOSM42jy15/2xUjeDvDZvgp0/wDfMpY8vtfOQSx6EnJ680yPw/4Ym1aSzjt839rAm8guGSNt4X5vQ7pO/rQAsHjvSJxkJdoCu4b4sZ/diQd+pQg1Zg8YaVcXtraxmYtc4EbeX8uTkAE+vyn8qo6jp3hK2uDYXqiOUQ/aduZBhFURbgw9BtXGc9PWtO08M6RbtBNDbMGjIeMu7EqeSDgn/aP50AY2oeL7/T77XHezt307SZoI5CGIlZZFRiR2439O+KXwv4yuPEes6np32e3ifTbyeCc7jkojsiFQepJUk9h0rUm0nQ5dedZo999cBbp4mZij+XtUOV+6Svyj1HFI3hHRVJlWGSKQPNL5sczq26TmTkHoTzjpmgBNZ1fULXW9P02xgtpDdRSuTMzDGwA449c1m2XxG0WbSEvpEnhj2sr4jyqyKhdowR1O0E/QU261jwhdIr3d3Of7Pj8ppXinQqpABydozuGPrVy10PwrrltM1pbxvDzFJHGWj2ME2cpxtbYcZwDg+lAA/jzRo45Gb7TmFgk6iLmFi7Rqrc8EsjAfSpP+E30bETeZLslVnjbZwwC7jjnnjNVprTwnY6tcxzIVvE23MyFZG375GKE8Yc+YW2jnBzir8vg/Q5jETZ7BFH5aLG7IoXBHQHHQn86AIbnxXC/hLWNa0+JnfT7eWXyp12ZZI94B9iMfnWS/jbULKPTru+tLf7DPKkdxLGHUwBkB3EMOVBZQT9fStjT7HQNR0q+0+zV5bO8jxcAmQb1ZfLI3H2QggenvWlcaNY3dtFb3EJlhiiMQR2JDKRtIb+9x60AZ3hrxFJ4guNUzbrFBa3Hkwtk5kXGdx+vb2rOt/GFy2s6lBcRQLaWNxLG5jjkZyiR792cbc9BjNaNvp+hWN7dXVtciBrV/NugtwQiHZgbwTgDaOlVINF8Na619HH9qkFwwuLiF5Jo1cuCA+1sAg7Tgj+7x0oAdc+PtHgs3nQTzFYpZfLVRkiN3Ru/OGRume3qKkm8d6JbXclrcSyxTx7t8bpgjHXvVC80rwZY3o029LLM6E7JpJSoErOCdx+Ubmd+c9W9a3ZfDmiy3DSTWMEk8iFGeQZdxt2nJPJ470AZ0nj/QYFuGnmlhW1KC6Lx4+z7zhC/oGPTrS6f4nuNVtNbntrQR/Ytv2YTgr5gaJZAWA6fe7dqsnwZoDM5ewWQybfN3uzedtOV35Pz7TyM5x2pBpmh+GtMuFYyQW10yRSM0juSSBGig5JHG1Rj2oAr+HfFja5cx2slutrdxxbru2cnfG3GCPVT2NdPWFDp+jaxb+fZMQ8YFt9phJWQBGHy7jz1GDW6OBigAooooAKKKKACiiigAooooAKKKKACiiigDG8Vas2ieHbnUFhimMW35JThTlgOT+NZdl4x065OzULOSK8yVAS3eVXGcKVbb/F1A61reJzp66BcNqqyNZgqXEf3j8wx+uKqzRaTqN1NNdxS20uEBkmYJgqflIOetABb+MNDvUTyZZJYJpFhEgt3MZkZlXYTjAOXAIPv6GoD438NtCHMkhi8qNw32STbtcAqv3epHO3rweOKil8PeGtNgdYkkSN7iBSkExPlymRNjYzwSwTn/ABNO0nQfDl7oto1l5iwTxwTQ/vSsiYTKe4O08j0zQAy28R+FrOW5CGYedMJZZJLaQrvO0Z3EYA5X2GakXxt4XZogkpYOcKy2jlQFZBknbgKDInPTmrM3hjQ1VopjtWU8o8v3vmU9+vKimx+FdBlUQoWl8uIoF88ttRmRsdeBmJPyoAu2OqWWo6C1+LZ47RTJmOaLafkZgTt+q5FZcPiGIaVb65qNjbW2m3CB0kDF5Rn7mVC8kj0JxWhaXWj2LrpkE6ss0kxwXDKHDDehPY5fpVdvD2ifYvs32l0tkk/cotzgQMD/AAeh9qAK0njHw4qSGKKWZ4kDhI7NssNyL8uRg4MqZx03VKfFHhp7s2a4mlScQ7I7Vn+cbhxhecbHGR0waZa6HoOrpJJE0zOjSwktJ86kOgY/99wJz/s02ztPD1lrVtBb3cpn8+aaFfPzGkgysij0JMp496ALuvapBo/2aA2kDpeO3mmTKoFUZYthTk46ZHPrS2PiPRLnU1sLTd9rlB3ILZlIC8fPxx+PqPWreo6Vp+tbDcnzFh3rhX4G4YINZy2uh+HftOteezOsDGV/MDs6gjJx3IwB+FAE19feHtHuDHcQ28Tqiu5W3yI1IZVLED5QcMBn0Iqs/ivwwtq9tI6LbxZSWFrZgsRAztdcfLxyAetWNW0bRb+6kuL2UhpUW0lRZtolHJVGHcguxH1qkvhDQLiKeZvOBuvmuGeXBlOMbn9wKAILnxbotsbcWFpE6FZYpHeF4lhRYHm2k7DwQg+XrhgcGrMev+FY5njMdtHNbJghbU4XBUFVO3nBlXgf3h61NceEdIvp5SZp8uv72NJhhiYTDuIx18skZrP1rQPD1vGJbma7Z2lMIWGQF2ZzGSuMc/6pDg9gaAJ28ReG/M3xwW/lxiMtM8BVdmwupU7ecAZxxipZfEvha8ktZZmhmld/LiMlsWdTvVR1GV+Z1A92FVNQ8O+HLGy8m6urkRLFHGYvNBO0/ulOMZ/jxmmXngWCbXLK/s70xiEmTBO5sllJYcYI+ReD060Abur3Gh6bLFcanDbiW6IhV2gDM+0FgM4zgYJ9sZrNtfE3hCErFavaxCZhxHb7QewJwOnPU+taOrppd1qul217I32gPI8EangnynVt3ttZqzR4F0byUjFzeFRGI0/fjIQMGAHHbAoAkS48PazqsIi02xu2uBIks8kC7gUC4U5XJBDD8MVZvda0LR9YuPtKJBeGCOSacQcsjNsQFgOeRgCo9K8KaXo91HeW1xcMyGR8yTAqSyqrE8c8IP1qfVtE0y8u1v7ueSJmEUfyyBVfY+9Bjud386AILvxJ4ZltZlu57eWHcqyJJFuDE5I4I56H8qq/2p4LgTzFh08KW8oGO1B3Eo/AwvPyK4+gIpln4T0LUSdUhubuQXEhky0vU/MPTPG5qiTwLZJdWNzpV9Mggu/MmcyAlgsU0WBgY3Dzep7LigCbSdX8PJfh4ZIrdQTbWUUe0Q+WQr7owoAAbcv4jinnXfB91MAEs5jNIZGf7MGG5VzuY4646GlTwDo8T2/kyXUcdu6vFEJflTbsAAGOwQCobnwpolpcW8H2y9guLgGKMpLywCkY6elADLi88GyEFNN0ueRrdQGe1QL5Rk8nYWK8ckrt/CprvUPBqMZDLYW1yGcxXMcKCVGkDFnRip5baxLDrtPXFPHgrTLSy8v7ZcxwryxaRQDiUSjPHZs/nVKLwpoFwgkgubplsnNimMnysCSMJ06L5zc/T0oA6+yghtrKGG3OYlX5WzndnnP49fxqxVeytfsVssAmklC8AyEZAxjHFWKACiiigAOcHHWuDs/BOo2XhbStOjuU+0W8fl3MZu5WhfCOFZCQSCGYNjAGQPQGu5lj82F49zLvUruU4Iz3HvXA2Gra7pOkTz6kkkk+msNPBlztum3/AOu4HdDHz6lqAIo/AmvA2Ek2qwz3Nrw9w8r7p2+bEpGMBgCABznHWum8O6TqOi6DNBJ5Mt6SzoGuXeNmwMZYrlQSMkBeMnqeufoXivUdV1a1hmsYorW4i3blDbkby1cg546kj8Kzdc1bUbPx3cxPJcroggtRcSQ8mEs0gyBjoSEDEcgEetAFzTfCur6TfaXcwtZTfZY77zFeV0y1xOJcDCHIXGM8Z9K2dVs9T1vwrqenyQ29veXETwRkylozkYDZ25A56Yrn5PHGove3lta2kDBJ0jgd1cBlMskbZ47BVP8AwL0qtJ461tYIh9itFnkQOoYPh8x79g/2sjH40AOufB3iQeGG0G0vLPyot/2W6e4kWVd0TAFsIQzK7ZDHkgZ4YA1aufBOqS69c6lDqaJDKWYWhZ9oZgrH5xg481ARgDgsO9Z48f8AiCXTnuY9It0lVJXaB/MLx7IncqcD7xKBeP7wrovHdxqEHhuObSHb7Z9rtxGFbAcGRQQT6YJzQBB4X8O61pN8smoXMEkKxugWOd2xkgjgqBgc1cg0/VbXxLe6sbe2kF4YLUxpOf3cMZkPmZK8t84+X261xmr6zqtxb6YdIu71roxXH2pM7WjkXGflxztOcAdQK9H0rUbe+tlWG6W4kjRPMYDByVBBI96AOd8S+F9T1TxRY61p89tFJp9s6wCZiVeUupw67T8mF6g5BIIGQKzLrwb4iu9WkvmvIQ7TiUZvJGTbwdpj2YOOcHOfTFVJ5PFdh4ke2j+2XNpFcyweax4dLgboW6f8s23KT6YrSuvF2sWNyLKCxjk2SeTvuN+VA4DMR13YzxQBQfwH4iaNF+3WxEasuBcOHlQvGxRn2dwh+bHPGQck11Phjw9Po09/PdymaWd4xExuZJSsawxoVO/vvR2z33VneG/Gd3ruuize2hhg8nczZOd2yNgBng/efI7bKp+J7/Vodc8Qx2U8nlRaLHLGA+Nku+TJXj72AnHuPWgDQ1XwtqF/D4mjSS2X+1RCIcyMNoQc7vl4/DNT+HNH1Lw2zWflQXdtc3bSSXZnYzAFCcuCuGIKqgII4xwMYrnrDV9Rg8UNHf3F0NJYWwEw5xKY87TxwpPU+tdtf6nZP4cutQFzJ9k8h2MsAJcDGPlGM7vT3oA5/V/CurXPjpfEthcWqtBbQwxQTSNtk2tJv3gKcfLIdrDJBHoTVWfwfrRuxcwTQrK161y7G9lOFyuFGVI6BhwB161R0zXdY07SJdSgWXVLi8lDCyZy/wBkQqREpIHUsPm9M+1XZPHmpRyFX02ONjaNcKjhwQ23cqn60AQr4L19ZctcWklqUCPaC5kCyH9/8xO3gjzYzx3TPUCtvwfoGsaDDeJqd+l9JIF2TMxLuwLZLHA4OVxwSORkgLVnw9qep3mo6lbamturQeS0QhVgNrRgnk9ecj8DXK3+pawv9tBLiYRR+IoIY5N+GWIiHcqjH3fmfn6+lAFq68BajNNeyx3sIbU4MX285Hmq4ZCuFG4DG055xXVW02sRvarcababWcRSPDcFjGoViW5QZGQox759q4mz1fVEm01rm5lFqdWuFkk35LRruwCMdOBXTeEdRNwt7Fc3TySy3t1JbCTOWgWTapX/AGcFfzoAh1rwedc8ST3l06/Y3sEgRFlYHzVkLgso4KgkHr26VgL4E12O1R454vtwiMbzNeuxblScHZwGwcjHGec81LqGtahafEHU4Lma4TRFNqGkjPMTsrYAHZWO3J7cetQat4w1ifmCM2xSKeRdoP3gr4Rsjk5AIx60AWH8C6wLG5aK7AvGaP7P5l9LKqKI8FXDDDDcByAD3BBAFdT4k0y+1e3s7OBYBCLmGeaVnIK+XIj4Vcc52kdRjjr2zvB63kmoao11fTzrbvHFErPlcNDHIT05wzMAfqKw9Wv/ABVpXimWOFb28sobkT5UDa0M6hFj6clJAzfTrQBu6NbeINEs5oBp1pOjXUkuRdEMVd8jA29QCT+Fdb2rjVv7+28TwWgv2mit7FVuTKDsMxcDJwOuDxXZUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAZ2vaUut6NcaczqizAAsV3YGc9M1kax4Nh1N9sU0dvbhAoiEOQOG56j+9n8K0PEsepy6SU0nf8AafMU/IwXIByQTkEA9ODnnoelcpNaeM4GCWMdyCxfLPco6q28kMdxyV2kDHt0oAu2Hgye3u5mGswzDzIN6CAgqY5xOAcPgEg46dwfrLp3hm/025Mlo6LLa2MNrC8wzFPIi7fN2g5UhSU68+nArJsLbX7S7Ks81ldajfjdHPOrvLF9mjSSRcFuUZdwzgY471q+Lv7cm1qztdDup4p2s5pEVWURiRZIQpkB6rhnyB1oA0vEvhWHxJ9nZrue1kgJIkgOGPcfkQDUGh+G4NE125uEvYZBKpSONk/ernaxBbdyOMgYGM854rBe28bh1aM3flsqBkaWMlX2kSMDuGRu5C+nTaaim0vxVcIss0N2l1E4MUltLHvUm2253N1HmYznP4igDUvPBMl/HcLDqdsI2uLqVD9mLNG8rAnkOOVIYdB6dqif4fXMyXCzapbN5rMwxaMNhKkAgeZjPPbH4VX0Wy8Wafq/+kRz/YvPmnZLby9sjtLIzbtxzhlKFcDqD0r0JSWRSVKkjJU9RQBzfhnwtP4dvtRmbUFuY72Vpihh2sjF2bAbcflw3T1ye+KzL/4fy3jTbdShjVpbqWM/ZiWQzOr5zv6qVIB46j057iigDnNE8MSaTpF9YyXccz3IYCYRFWwQQC+WO489ePoKwp/hnvjdIb+CMPaeRlrZjsfYVZlG8AA5yQQTnPPNegUUAcUngm9F5d3DahauZp45kDWzYTZLK/TfjOJSMjHIzUUvw8d7Ixrqf73y0ABjIjLqeSQGzgjgjNd1RQBzPhXwtP4dnuma7ikimRFWKKIqqlS3I3Mx6EDGccE96o2ngee11W0vGvo5lt5Q2HjOZBvkYMxzy434B9j64HaUUAcv4i8KSa3ftcRzwIklukEiSxFshZVk6574x+NVdA8FXGj61HeyXsU0UaEImxwY+CNq/NgLgg8gnIrsqKAOH1jwNeanrE95HqcMaPO06boC0gzCsZjLbuU+XOMdyKqTfDi5kuJJ11GOORzkMsZ+QfNlV5+783869DooA8/T4dy+feXU9xBJNNGBCFDILZt5Y7DnIyD19c8EHFb134duLjw9pNgbiCS5sHt3MrxYVzHjOFHTIBroqKAPOpPh7qKKUs7y0ijaVZSuxuHBySD710Nr4cuLbwpqujiaESXf2nypEUgL5u4gn3Bbt6V0lFAHnr+Ab6OSR7OWyhLs+eGPyNHGNnT+8jt/wLoeagk+Hmry+XnUrbcq4WYhy6AAjaDn7p4z+Nek0UAcxJ4Xkl8DSaDugSRl4wXaMHfuA+Yk44x/TtWPN4G1F9QuLuOa1iM8zySBWYbsywuueOoEbj/gdd/RQBj+GdKudG0ZLK5nWZ1YlSvZewJwM/XH+NbFFFABRRRQAVztr4x0m6i1WSctBDp04jkaRSd6kDbIoGcqxyAe+01vXERntpYRLJEZEK+ZGcMuRjIPqKwJPBOkmYSQiW2H2dLd0twiK6o25Sw28kHv7n1oAr3PjjTIbOS6tInmCFl2NFJG7MCo4BTJHzDJ/Q1LD4tsW0t7i7FvFdgSb4UZ5EUoXGGfywVyY2HK9QcZxUlz4O0+7nkle4uwJJGk2Ky4UsVJx8ueqjqait/COlSG5uLO+vALoTJOYZxtk3s7HIxjKs74/I5HFAEsninTAkQtzDcTNPBC6Rk4XzJBHuVivzAMecemDg0moa1o1rr622pokElsnmwTuDt5ByM4wDgdzzVe18E6T9qN9FfXkrmVHLF0OWjkDgE7c8MuMZ4HHQAC7q/hPT9buWmu5LghgPkRgF4BAI4z39aAC38XeHLpd8GowupR3LBGwNoJYHjhgFY7TzgHiptM8SaVrUlwllJJKlvGkrO0DqpVt2MFgM/cPSs+TwNYzXS3M2oalLMqMgeSVGIDI0ZxlflGGPAwM84rWsNEttNumngkmJa2itmRyCrLHkKemc4Y+3tQBQPivRGjElrcQyuXVeUdfvY77Tzg/wBKj0/xZpVzqcEMUfkx30EU1vM0bKZS5cBSNvy8R8EnnPFNHgzw7YyO0MZtZbuZWZlk5kYPvA5z37DtUlt4MsLV7UpdXjLa+SIkZ0wBEzsg+7njzGHqRigCWXxXp1prV5pt9Kls0CqyyOSVcFC5ycYUgKxxnJAzUR8beGWG4agj5GTthdumeDhevB468Gnar4N03Wbua4vJbkmVgxRXACkRPHxxn7rt364preDbKSYzTXt/LKQMu8ikkhSoP3fRj7UAV7XVfDFrqF5eL9ljnXfI0sKO52Km5nbC/Lx+eOpp3/Cc6G2q29sJVMM8chNwyOvlurRDa6lcqCJkIY4GMeoqpdfDjTns7lYLm5a5eKRYnmZcIzRGLqqggYxkA84Gc4FSx+CdKvlZ57y4nufLNvcyLInzH91kHC8YEMY4A4HqSaALUvjbw2IZTFqEEjpuwmxsZUZ5IU4XH8WMY5qc+JtAtIDG11FGkYOVSNivAYttIGG27WJx02nOMVUg8GaVFE1ml7eui28kAjaVT5cbjaQBt4wOAfzzTLj4faZcWUlk19qQtHZmMAnHljcCG+Urg53E85wcFcUAadvr1itvqVxMq29vZXPkPIvzBvlRg3A6fOKgm8YeGop2im1GASqDlSjE8Ntx0654xTm0jSdK0i+tb66Jtb5v37XLqu4lFQ8gDHCD9aoW/hHQ74Gexvrg27CNWSCZWRmjIIYkgnPyjPOD6UAWx438PfvX+1sI0SJjL5D7W8wsEUccnKkY9eOtNk8W6WunzTgxSyqZSsSbiDsd1G5tvyEmNhg9wQM4pIfBVhBMkiXV78rxSFdyYdo5GkXPy56semOKRPA+nxS3TxXmoRi7837QiTALJvkeTJG3s0r49jg5FAEtt4u8O3U8Vql7CbpwCLdVLMCfoOgzgnoO9XLvWNGsL1o7m4iiuIIHkOUPyRgbm5A9BnHXAzWND4B0dCkS3d46QSiVITKhEbZByPlyOR1znk44q5qvg6y1fUZb24u71WkheAojJtCMhRgMqSMg5wDjPNAEN/400WGxW5tWW8d5Vj8sIykfOqkt8p2gbgRuwDkYPNTa54msdHvILQxRzTSMRIOQIhsZgWO0jnb06/Ws+98J6DbXjPPqlzbT3TBnHnIPNA2YUgr0BjHTB5PPNaWp+D7DVNQlvHuLqFpQPNSFkCuQpUE5UnOGPQ0ASQeKtEZ44xdxrNK4jCojEFs4ODjBAPBPQHrioz438NeV5v8Aa0GzJGcN2CnPTph1OehDA9DWZL8MtEuJWknnvZN5UuN6KG2ng8KMNj5dww23jOKlt/AWlixhgXUL+WGKJoIiZIztjO0bRhMHGwc9T3JoA2dO1uw1W7eOzkhlURiQsCQ3XHKkDHStWuVXwx4e06+nv7+WO5JbzAt8I2WFi2Qy/KMHPQ5zXUgggEHINAC0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAVHPcQ2sLTXE0cMS/eeRgqj6k1JWL4s0641bwvfWNooaeZQEBIHRge/HagDS+32Zs2u/tcH2ZQS03mDYAOuW6U0alYNbSXK3tsYI/vyiVdq/U5wK5FPDOpReAvEWiPGs99ew3Cxz7wBO0iEKxHRMZAIHHGRVu/0jUL7wjrmnpBN9ovISsRuGiDFigXHyfKAMA568nigDojqmniDzzfWwh3BfM85duT0Gc9aWTU7CKBJ5L22SF22JI0qhWb0Bzgng1zmt+H7ybw5aWlsZbidLqKZ2YoHAXrgnC5FRa5oOp6rouk2tt5ttPb6iszTSGJ3RAHG8jG0n5gcc0AdU99aRWy3Ml1Alu+NsrSAKc9MHpzR9vsysTfa4NszbYz5gw59B6muPn8Oaj/AMK+sNFjtQt3aXEBby5VYOI5VdnUv/ewSAe5xWjqOg/21odtYXdtMAtxvLs6CRMZw4K8BgSMY9KAOi+0wbZW86PbESJDuHyHGefTio01CykgedLy3aKP78iyqVX6nPFcpN4d1y48M3lndz29zeG+hnDLlFuoomjO1/QuqEHtk+lXdcsbnV/CWswWulNa3l1atDHG7Rh3ODjJUlQOeOfyoA3xf2ZhaYXcBiU4ZxINo+pzUkM8VxEJYJUljPR0YMD+IrkpdGu7rw21ncWuoPL5yOJDLBHMuB95dh2fL6Hrk1s+GbbULTQ4odT2fag7klVVSwLEgsF+UMRgnHGc0AbFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFXUknk0u7S1YrcNC4iIOMOVOOfriuJTSfGFs8EKTySxLcI7O9yCdm2DevTuwn/Ou+cEowDFCQfmGOPfmvOtL8fakvh/TWubWK8upNLt7ua5MwQF5UlYDYEx1hIODxkdaAE/sTxnFGsNvcSJFGihR54O4BjvBJGcsOh7V1vhPTrnS9CW2uo/Ll86Z9u/fgNIzDJ7nBFYMfxBml/dxaZbyzBo48C+Rd0jAE/LgsF+bg4rW8PeJ5ta1C5tJ7BLVokLqUn8zcBI8Zz8q45Q+vBoAwP7E8UyTJvmmWMNgqswClWnlLEgDr5bJUf8AYfiuPS2EMtytwsMUUcZuhtXbGQT05+YChPFerRaXp2rGfz7q5vpYLjSyFAiRS4IHG4FAoJJz345FWh8RJkuVguNIhiY26TsRe7gquAV/g9wMdc9AaAHalpPiww3Rtrt2MjgQKswBjDRksTxg4k2gD05qM6b4ta7aSVnltZWjaSIXISQfIwIDAYwGKt74x2qRviIwFu66SrRyQRSuRdgFTIZQFGVAPMJBJIxkVrT+IJbvwLe6zabbW4jhmIVwW8p4yykMGCnIKnIIoA5yXRvF0hUTAzfZ5/NhZrgZJAkwenH3lFanh/TPEY1K1fVpplt4BOdqzAhiXUxhuOcLuFVW1LXiND1JNaTyJ7Bbm5s2iijRsRBmLSkEoCxHPQVIvii81PxHe6b50+lW0NiZhcC1YgFXG91kdNjLjIBGQRz7AA2vElpq109oNPLGEbxKqTeWwYj5GzjkA54965k6X41W7gcTMYg0bSAXA5cH5yBj7pHapIvF2qWGpaDYahDqEnmwGS7f+zZHaVmjZ1RSibMrwDt7+gBput+NdRXV5rTT7e9hAgUwxzWMkZlcuucSOmwcHA9+tAGdp3/CWajHczwPeGYTNmOSTy1KNDOo+8vDB2iJxx8oq+uj+K4r4SQx+Wsl8txNtuANy7YFYEY5yFkGf8a2NF1+7uLjSzeXUYhm0p7mfegTa6ugLE9hhjntWtr19cWUenvbSBfNvoYXBAIZGbBHt1oA5NdE8Tx4hiaVYFiKkfaBuLZbawbHqQa0NBs/FFhqxm1B5LuKQOrgzDaMyrtYDHGELn3qgNY8Q3R1e3lvLixltMfvI4YXAlZiERSQwKkFScjI9q6jSr27l1vUrK5l3pbJAV+UAgsuW6e4oAn8QWJ1HQb22SFJZnhcRBgPvFSB16da5l9D1mK1gWzEsHlafFH5MUqorTAgMTxz8oPNdzRQB5u+leNWggc3Nys8cEcLBJ15Plyq74xjO4xGu20RL+HQ4E1HDXqq2/a2QeTj9MfStKigDzyTQfEllfX99Zu7SarDmcLIFMEob5dvr8vFa3hvT9es9WLX888lqUnB82UNj96DFjjrszmutooA47xTomqX2qfa9KTy7gW6xLKzgxy/MSUkQj7o4II55NZ/9l+MDqMMkszvaEMLiKO4Cs0mfldTjhQP4a9BooAoast82jzRWBxdyKI0cn/V7iAX99oJOO+K4yy8M65pwGhwXFwmkxX5lhuIZQreQ8bFkOcniQ8e30r0KigDzuLw5rbXWmw3McklpbzIz+ZKG3AF8k+uQw4r0QAAAAYAoooAKKKKACiiigAooooAKKKKACiiigAooooAp6pqC6Xpk988TyJCu5lTGcfjVmaVIIZJpWCxxqWZj2A5NV9T0+LVdOmspmZY5RhivWk1OG3nsTDdTiGFmUMxYKG5Hy8+vTHfNAGPb+NNOuNO0+/w8UF3cSWzebhWhkRHYhh6/uyPyq5J4p0aIfNeoW83yioyWDeYI8EdsMwB9M1nXvgLSrxpfmlhje7F6kcJCrFOIygdcdDzu+ozTX8B2DXc1yLu7WSSXzhhhhXMiSkjjuyA0Aa8XiTR5pRHHqEDOTgDd1OccfjxVbUfEFxYa5a6YulyzNdCQwusqANsUFup4+9jn0qgvgHT47mKeO6ukZJPMIVhhjuDYxjjkdqvX7aPN4k064n1a2ivbLzEjtzOgLGQAEEE5z93H/16AJfEXiK18N29rcXinyZ7hYC+4AJkE5OevTtzzTb3xNZ6dpz3F5iGcQtKts7gOwAJA9ASB0pL3w1Dq2lWdlqs73f2eUSszqP3hGcbh+NZkvw/sbiyNrcX13LGY/Lbe2SwAIXJ/wBkMaAJl8ZCXWItPg06WQyz+SjlwoJCB36+gI+vNLfeNrTTtabTbq3eJ1u4bfezqARKpKyDn7uVZfXIq5b+HrSyvbe7a5cvFKzpvIALOgTH5CjWPCWka7dNc31uXla2NsWDY+XcGB+oI4PbJ9aAG/8ACTwpdafDPbvEt7HJIrswwqoRyfqCCPrVfXPGdvoWp/ZJrSaVRbpcM8bLna0nl8KTknPOB2/Krd3o9pHqEepTXzW4gi8mAMyqkOcA4z6gAVLHpen3mtR69HIlxILYW6MpDLtDFsg+uSaAIz4v8PKFJ1i0AZtq/vBycA8fgQfxoh8XeH7jPlatavgbuH7cf4j86pab4IsdLS1jguJzHbI8USsF4Rl2heBzgdzULeBtOmCiO9nDQkLlGHGFVcH8FFAGqfFWgiSOM6rahpIxKv7wcoVZg302qx+gNNHi7w+zpGurWrSP91A+SeSvT6gj61jXHgXQ1sRZXt7J5P2cR7ZJFXMSJIh/ALMcntxSr4U0UWcV/PqhkgURv9oaREQ7JA4ORgdQKAN8eIdKOn2t8byNbe6GYWbjePpVC98aaPZS2m66je3mco86uNsX7oygt9VFLL4TsrrStOsmuZmhsmDROrDcR2G4e3HuKox/D6xjgMa395neCrbhlV8oxFRx/cJH60AaMvjDRFX91fwTMfM27XG0lAS3zdB0NSW3ivRblGIv4VZH8tlZsfN8owPXlgM+9ZEHw502ziMdpdXMCfMoRSNoUqVxt6dCOe+BUcng/RricWqavIs6zCUxJKu7ICZGOv8AApoA2V8YeHzEkj6rbRK+7b5j7SQpYE4Pb5W/I07UvEltZWtjNAv2n7dN5UO1woJCsxJJ4GAjVky/DzTpn3Nd3HKGNgQrZXezqOQehdvqDWmPC1qNLsNP86UwWhcgE5LBlZSM9hhzj04oAsQeJdFubmG2h1O2eeYkRxCQbmxzwKJPE2iRRNJJqdsirncWkAxgsDn6FG/75PpVTSPCdrpGpfb47iWSYxeUxfHzAAAfkBVHV/Bei6paairXbwRXEskl2UkGBujKsDnoPmZvYkmgDUtfFGmzzXcE9xFbTW87QlJZACwDBQw9iSBVix8Q6RqU4gstRt7iUgkLG4Y4HWsceFtEnuBLPdCeadp5oz5gG5ZFAbAH3gMA+xo0bwtpelTxanBfmVYI2XzAyKpGMfMVwDjHegDTn8U6DawtLPq1pGiuYyWlA+YLux9dvP0pIPEljdeIxo1s6zS/Z5J3kRgVTYyKVPv84/KsFfBOlSxmAatJJ9p3yqC6sXzA8BYevySHn6VoaB4Z0/T9R/tCxv3uFTz0CB1ZFaV0eTp3LIDjtmgDpqKKKACq97dfY7V5xBNOV/5ZwruY/QVYqK6hNzaTQCRozIjJvXquRjIoAq2upQajoi6isMn2eWEyeXIoDFcdCKytF1bQdW0+3vrSzhjtWhjkWV4kVULjKJn+9hs4HTdzjNbRtI49MNmjCOMQmMNj7oxjNcppHgKx0/RpNHttTd7F7VIXiQL/AK1QB5wx91jgZ7EjNAHQpJoTPHs+wFm2hMBcnHTH07U+C60hIJ722ktBHAhM0se3CKMsckduSa59fh9awfZFtr+eOO2l80Kyhyx3Zxk8468e9Saf4C0y2spLWWaS4glgSEhT5YICFCTtPOQe9AF6x1XTr5/tj6Y1tHc25lF1cRIvmR8AbjnIyCCA2OB7VUW28Iz675okt5bt2WMReYWQnb8oC9Pu1WvfAR1CK3S61WRzZ2/kWzCIAjDIwZ/7xGwD8T61asvBqWl7DdxX/wDq5Fk2LCoUkAg4x0Bz+FAFi5vNJivLqxt9H+2S2kayXCQW6HywclRzjJwScDJ59+XaVrWm6uz6fa2JNohliPyIYhsbaVKg5XPYEDIqZ9BePV7zUbG+e2e9VBcJ5YcMVG0MM9DtwPwFZ6eEZrbVRq1tqAF+FMbSeQF81Syk+Zj7xABAPvQBLrPiPStBme0ubF9iW4kOyNNnllgpAyRwCeR6VoQapptyZFbyowpMI8zb865CnHqu4hfrUOveGNP8RPbG+ViIN4wDgMGXBB9R3+orKu/ANvLb6ZFbX80H2GHySxQOZV82OXJz33RDn3NAGzqeu2Wl6laW17G6eertFOQNgZVyVznhiM49eamuLyyXRn1K/iEVsIPMkE6AlUxnBHP5VDr2iQ65BaRTSiMW93FcjKBtxRshefXpS3NimsWupWF5cRz2dwPLCR4DRjHIJHfPNAFX7bplzbO2oad9it5LbyxJcqih4m4Kgg5HX7pwaZF4i0a61FtNkhCC18xleVV8tfK8oZU5/wCmyY/GmzeHbm5t7PztYMj2TlonMK7fuNGdw6H5WNY8fw3gt4Ugt9WlVVjMcYeNWO39x37nFuvPX5jQB18N1prSi1hlti7fvBEhGTnndj9c1jx+K9KTxLPpptZYro3K2bTlFxJJ5fmKMg5xt7kY7VBo/gaHSb61u1vWlktwFGYlG4BNoGfpTj4JhHiWfX4710v5LkTK/lg7V2BGj9wQo56gigDd1fU4tG0i61KdHeG2jMjrHjdgdcZIpF1iwMDStdwoEA8wNIMoSOhqhqGi32r+Gxpd7qCrJKpjupI4h+8QgggDseRz6isc+AEF+90mrMkzPujBgUgDngjo3BIoA37/AMSaXp5i8y5jbfMkLbGB2Fs4Lc8DirP9r6aVZhfW5VQCSJBwD0/PNcsPh5bpJCyai3mWzmS23xKduZPMO4fxDd09Kisvhtaae6yWmpyr5bblXYCm7aVYke4Yjtjj0oA7KDULO5maGC6hlkUZKI4JAqhpPiK21mdktYpTGN+JTt25VgCCAcqeehA71n+H/BVroF6l1b3LSYVhgxgZBCjqPTb+tMj8JXFnrB1azv0W9ZRG7eQFEyF1ZjIB95tqkA+9AGnqHiOz03VotNmSZriW3aeMIoO8KyqVAzktll496kvtfsNPCieUeYXSNo1YFkLHAyM1m6/4Oi13WrbVWvZbe5tbdorZo1GYnLK28H1+XGOhBPrVO48Arc38V3LqcpeK4+0LiIffON2fUHaPpQBo6T4wsdZ1CK0tILhjJH5wkIXb5fOH65wSCPr1xTI/GunPqQsWiuI5TcT22XCgB4lDEde6kEeoqbQvDK6JPDIt20wisY7IBowOEZmDZHf5j+VU9W8BaRq2r3Gp3DSrLM0Lna2ArRnkj3ZQqn2UUAaUHiK1l1C2s3imhkuLUXSmTaAFJwAeeuT0rYrCfQHl1+TU5LxGkEYihiMIIjTcGP1OR17Vu0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZHifT5dU0GWzhRnd5Ij8rBSAJFYkHIxwDWvVPVrmWz0e9uoSglhgeRd4yuVBPIyPSgDhY7PxrESJ11CYhYlTyrqEJs+QPuBIZnyGOQVypI3A4qVdL8UXeniW+GoCeK3sh5CXaL5kit+/Iw+MkKOp7/WtG48Ra1Hr62MVrCyywu8AZGCsBCHDtJnCjzDsI9CDVPT/ABdqb6tpdjchD5v7u5cw7dknmSJg4YgA+XhSCQ2DnGRQBu+Gf7Yihmg1a3m3eYzpPJIrEqTwCAzY/Dj6dKgvNGeXx1ZagLAPZrp9xFLKNnEjSRMvBOc4RuceldNRQB5xBY+NLePR1I1CWT7HGb53u42AnKOJBjeOjbDxuGOmMHdc0Ox8WW2rWf2xrqS0XiXz7hWHKjJyHySGzwQR6Yru6KAOS8a6Nq2vW/kac/kNaR/a7eU4O+5U5jA+YYxt5yMfP7VnX1p4r1G6+0xw6jZeYQWhF4gWMfZj8o2v1EwUZ+vYmu+ooA5zxBYXWpeHbSF7W6luQ0bubWZElicD7y7iFJB7E4Oa5U6b8QF05UgZYr0NuR1dI4jFsfcjqCR5rNtO4AgE9cA16bRQBl6WLqDRSz292JvmdILmdZZVzyFLAkf+PH61xg0TxTp9xdxW63EsWptFcSzW0yRm3k3DzFyz5+73X0r0eigDzbUPD2vta3djBbX80Ukl1l3vEO9XkiZCCXyPlDjt39RXVeL9MuNR8HX+nWFv5s0kWyOMMFycjuSBW/RQB55eaV4pkvZZFF89u04kEIulGFDggAbwBxnjODRYaZ4uluLd7+XVUVBM0yrdxBWkCps2hTnYSG4PryFFeh0UAcz4OttbtrCeHWTc+YRCyNPMsjbjCnmYIJ6Sb+OnpxXNXfhrXzoaadaWskOoWlzNcpqSSx/vc7yoHzbtx3KDkADHWvS6KAPKZLrxDF4ml022udUneG22rF9pj3tI0O47gzcKCeHwRuIXI7WxaeOWFs7R6grxKFbbcxAN+/fJKmQ5PlFOpP1Jr0uigDB0uDWx4T8id1i1bY6rJM3mANk7WPJ+uMn61x3hnRPEuhW2opqelT6gWmuZo4YLqPyZyzoU3CRs5yCQSeBnPOBXp9FAHnN14a1K80fS7Wx0+5sZ7ZZmd7gw7fnEgK5R2YHLZABIAYZJxxo6fputWVnqMr6bDJZyYaPSSqtKzBVH3/MEYGR0x2612tFAHBW2h3itoJi0i+t/7PMrzB3g+dWjkXapWQkNlhgZCjd1441/CsE+kRLpTWd4ls3mTWzzlGaKMbAI5GBOWyzY6/KBk5BrpqKACiiigAooooAjngiuYHhnjWSJxtZGGQR6GvP9O0/VNK0uRrKzntnl1W+3yRwbpVhZ5GhIUj7pPl/QenOO51S8Gn6Te3rMFFvA8pJXdjapPQEZ6dM1zl945ghWSG3gla5jIOJIiFkAeJX289f3qY+vsaAMmwv/ABZBPaRXsN+zNPm7/wBHDxbSBlVIBOB26fjWlY2+t2/hrwpZW0lzaShljviIlYoghc87lOMuI1z1+Y/UTn4gaR5TSJFeyKoG4pAThiwXafQ5NSv4405J5bc2959oieJDF5XzEyOUXv8A3lI59j0NAHJRan40Z7K2ubu+ivp7eWQw/YYlUzII/kz837vcT83HB6+li1uPF1gi21rZXflIspKmJcEmQtlSR1wTjJ644rqNM8T6frC3N9HaSiKzt45lmdBuKyJvIUdRwAD05FVx8QNKKFvs96MIrcw4ALY2gnoCcjrxQBhTX3jPdeeQ2qRxqgNqJLGJmZDt+ZiCcODuG3HTBI6kLcXXjW2d1imvriIvKrSGyjZ40WfajKMKGJQ5PPToK2bnx9Yf2VLcW0cyzGFmhE8ZALeRJMuRnONsTfl71Y/4TO03m3S3mlukaFWjUAf6xwmRk9AT36jkUAYDSeMJJx5s+otB5qEqttGhChlz90d+cjJ9q19fv/EEHiC3TToLlrLyj5pWEMuTHLgjg8hxF+fTGaVfH2mw23mTieQLI0bPFCcBwzALjJOcKfbitKLxPZz6bBdxRTs89y9rFblQJGlTduXk4GNjnrjigDljD4mjuovtE2oXiy29jIxlt02q++UzDCqApUFO2fc4qtp0Gv6SbaG3tL9LaWOM3EsFtH53mkfxbgARngk9K6PS/GEeoxapqhKpo9nsVGMZ8x90MUoPX0kxjA6DnriWXxtp1vNJDcwXcMscTysjxc4QZOMHnjuOKAOSurnxXPZz6ebG9+zy2lzFIv2UAMWik2EFV67go69+mOTueJbfVgdFu9LS5F1bW0p/dxBstsXCNkHAJHsabqHj7ypozbWskdsI5zPLcQ8o6IrABQwPAPPrng8GtYeM9Oe6mtI4rl7qOYRLCI8NISHPGTjpE55wePcZAOYfV/GiSA+RfsftWGUWShEQOAQCMlgU5zx9c8VraP8A8JCdc0u51C4v5beaK7E0bQoiRNvj8oEBQQNocgnnPfnFamp+LtO0kE3Cz4VFdyqfc3AlQR6nBqpN4806EyN9mumhitbm6lkVR8qwiMtxnJ4kWgDIu9R8WyatfwW630NuZ0WKQWqtsUThXKkqQcxncPvfgcqG6CfEl34o0641m3vB5KyqGMSrEEKKFY4H3iQcj9K3E8daa08sDQXcc8UiRSRvHgq7OEA6+rKfowrWs7641TQ4ry1iW3nmQMiXHzBOe4U88e9AHDznxTJrc8ypqEF0XWAzJbxtGkJu0B2ZUg/uSzc56evFW44/FiSTRpLKbVnut7NbRhvkkJQ42fN5ikD8M9au6R4tu3s7W41OJJTeTyW8EdnA24NGX3E5J42pn8xzUx+IOj/Y/tKx3bqJWiYLFkqViWU5/wCAMD+nUYoA5e71rxZpdh5sj3SRtsijie1RApwnCnb1Pz9c9Olb7alrz+F9CurKWW8unkT7WUgAMo6MAduE57kAcdR1rZg17SdY0q9uWUSWlsWWUSqCDt68fh0NZWmeO7WbRYriezljuftclkbW3G8q6o0nbjBRC2aAMhNS8XXLRPb3L3Vul1JbF7aOMi4RX4l3hcKcMAV4GY25BxmGC98arBHCW1JCkEShvsKSFjkB2Zm/iHPGD6100fiaG58OXl1oFk8j2oQRW7RbNwZFdSq8ZBVwQOD24qnafEHTY9Nmur+5V1gJadooGT7OmQB5iMSVOTjHNAE/hibxA2pXEWqy3UsBhJjea3VMMJXX+FRyU2HBrEJ8eNHfxX674IkHkOkUbmZ1bZygXgNjzPbpxXZrr1sNJutSnjnt4LZSz+amCRtDAr65BGMd+OtYel+Pre80S1uriynF9JcyWclpbDzSk0YZmGRxjau4H0NAGHaR+I4tctLs/wBp+aheGcvbgrIpuDgE7egTBBH516ZXGDxpcXzWqWFsElupIkVJ48mMMGJLEMAfu9v1rshnAzjPfFAC0UUUAFFFFABRRRQAUUUUAFFFFABRRRQBT1PUYdKsmup0leNeoiTcfriotS1OyttDfUJ42ns2RSVVAxdWwBweucijWbG71GwNtaXUduWYeYZIjIGTuuAw6+uaj1fSG1Xw9JpZmjQyIis5iyvBB+7kcHHTNAEVhqOiaxbzMiwqXY280UwVXyG2bCPrwPrSNfaBBqdpbA2gmw6ROuzCFSMpns3z8D61z6fDdYpIXg1MxKJhLJEkWE4njmCoN3yDdH7/AHjUr+AZJNOhs5NUVxFA0CyG2UOVwoUkgjLALye+egoA6e71nTrK2mnlu4dsSsWVZFLHaMkAZ5PHSmahrlppvh6bXJ/M+xwwfaH2rltmM9PpXNw/D2KJjm7hYbJ0BFqAx8xSAWOfmK561t6r4fOqeDbnw+1yI/PtDbGcJnGRgnbn+tADJvFlpBdR2klreLdSbikBRdzBQpbHPP31461txSCWJJAGAdQwDDBGfUVyV74Je/ikgluLFbdhlYY7LaI5MAeYp37g/GM5xgDiui0+3vraxaC5uY5ZEJWGUKc7QAFLc8t6+tAFSbxTpMFtq87XIK6SSLoDqp25wPXrj68U2w8UWV9JcoVktzbsI384qP3m0MUHPJAIrFu/AJlS5FrqXlG9sjaXhkiMgmO7cJMbhgjLf99U++8CC91KW8N5FmS5lm2SWodQrrGuME/eHlAhvc8c0AbNv4n0y6nsIIpSZb5WeOM43KB/eGcinaj4jsdL1OLT7gTfaJrd54wiZDhWVSo9Wyy8e9YujeBn0jUrW6/tFZUgZn2GDDFmGDhs8DpxVnxJ4PHiDV7XUhfG2ns7aSO2dEy0UrMrCQHPbZjGOQSO9AHTI2+NX2su4A7W6j2NYNj4x0q+1GSyBmhdHkTfOoVGMZG7Bz2yK0tPj1KN5xqFxbzLlfKMMZQ/dG7IJPVske1cjL8N92oT3sWoRQyvNJKCtscneQdrndlgNvGMdaAOzfULJMb7u3XKeYMyAZX+916e9R32qW1hpE2qOTLaxRGUtDhty4zketcYfhoWsjbtqULk2gt/NezDOpCbMqS2QNuMgHqM5xkV1+raUupaDd6VEywJPC0IITIQEY6ZFADdG12z12KZ7USo0LBJI5V2spIBGfwNR3XiK0trq6tkhubmS0QPcfZ493l55APPXHOB2o0rSG0f7PbWaWsVisOJVSLazy8Dd+QqJdBmtNYv7/T7xYRqBRrhJIt/zqAu5DkYO0AcgjgHHXIBatNd067tVuBcxxKzOoWZgjfI5RuCemVNWG1KwQkPe2ylRkgyqMDOPX1rjo/hvH9pna4vo5oZ1kDg2w3oWaRh5bEnbxIQeOcdsmib4bxyTORexsjrGXaa2DyF1YMxD54DY5GO9AHZ2l/aX4kNpcxTiN9jmJwwVsZxx9RWS3i7T1Vz5V18mojTSBHz5xxjv93kc+9WtH0caQ98EeMw3NwZ0RI9uzIAI689PQViN4GRrl7n7TF57awupiTyOQBj9397/Z6+/SgDS0zxZp2p3EcEa3ELSvIkRnj2iRkJDBTk9MVd1rWLfQtON9dJM8QkjixEu5tzuEXjP95gPxrnofBt3bJbtHqMMktlNNcWitAVUSSMSS/zEkAEgYx+NbPiPRD4h0I6bJMkQeWGV2Me8Hy5FkxjI4JTH0NAFi21qznjLSSC1dc7orhlRwB3xnp70t7rVhY28s0lwj+UgdkjYM+3jnGfesLUvBEN1cXc1pLb23nQwRRqbfcIhHI7nGGB+bzCOMYwKzpfhxJLbeWdUiWQ24t2kW2IO0IEGPnyOmetAHcwTxXMQlhkWRD3Ug89xVXTNWttXjuHtt+Le4ktpN64O9DhvwzUGjaXdaR4fi037ZHNNDGY45/J2/7pZc8npnkZ9qraJo99o07R/aIJra4kuLm5IjKsZpJAw2jccLgsMc9BQBvUUUUAFFFFAFe/SCTTrlLqPzLdomEqf3lwcj8qx7bTPDd9YQanHBCbeeIXEcrMRlGCNu5PQ7EP/ARW3cxtNaTRIQGdGUE9MkVwKfDeYWVtA15bl4bCGyMnlnkJbyRE9e5dTj/ZoA6pfDWhbt62MIyAThjg87gcZ9ec08eG9G+1tcizTzjIJGO9vvBt4OM4+9z+NcvH8P55L1pbya0ljaaORhtckqo/1eC23A7cVseF/Cz+Hbu6l82IpPCiFI1IG5ZJW3fUiRR/wGgBNMl8MiQWtjEI4rxDbRuNwjnEeQVU55x831wcZqTU/CGialbNEIkify0TcpJ+RegIzg9MZ6+9Y8ngG5m0Gx0GS9hOn6aWNq2w+Y/ysqB+cfKG5I+9jtWV/wAIVqY16SO3tY4rVIo44ndR5QwBuYYbPJB4xx1oA7CLwhoaxxCe3FxIkZQSSSMSVKsp7/3XYfQ4pt3ovhnS7G51Ge2SK3VC8squ5AG4OTwf7wzkd654/Du6aGHfeW5mit47feFcEqsU0Z5ByM+ap4P8P5dDJ4fu38D3GhNdRvcSwyxCd1wAGJxnGMkAgE8ZIzxmgCgq+DX1O305LdWuLmEToqq5GxssGY9BnJOTzzWgR4cma50hlRfs7NeSI25NpyS0gbjuTkg9/esO6+H8lzdQXJ+wLcQWiwCUI+ZsJtKSDdgpnnsa0pPDWo39/O17dQQW/lpHA9ov7xFUhtvzgrgkZPBzwO1AFjTn8M3EK6dYRRPDqVsl0YkQ7XiKBUY+mVUAdPu1QnsvBdleXUM1usc0ERMu7zBuU/Kec/MeQO5pdM8FzWdro1vLeASaZZJai8gGyaQCMptPbYMgjqeB35Ny60K/ubud5xYXkBhEEcdyjEleM7iDjJPOcUAB0nwxqt9sks1e5ntvNKNvUmMgLkjgZOAD34p1x4e8M2PlrPaJH9pmVUy78yZZhg5+X7z+nU+tRwaDqGlyJPZSQzy22lm1hExb55A24Z/2e3WtLV9Nm1E6cVaNfs90k8gbPKgHIH50AZk0/hTUZfNlWGV48QKCrfODkAAfxdwPSqj6B4W1m1vNGsR5M5hniLoz7lV8RyEEn5uVAPUZAqnefDaKad7mCZUk3v5UTu7JCpBAK5OQwJ3DGBn061uaJ4Uj0nWJ9R852LRmKOIOxVdzbnfBOAzNgnGBx9SQC2/hXRJJYpXsEaSJt6vubJbIbJ55OQDznpV2x0yz05WW0iMatwRvYj9Tx1q3RQBmw+H9KgSBIrNVWB3kiG4nazghj17hj+dVI/Bvh+KAwppqCM5+XzHI5QR+v9wBfoBW7RQBmweH9KtraS3hs1SOV1dwGPzFTkEnOeKjn8M6Pc6i9/LZK107B2kDsMsEMYOAcZ2MV+hrWooAy4vDmkw2sltHZqsMnl7lDNz5ahU78YCqPwqM+FdDYsW02JixJctk78/3sn5ug65rYooAzYNB0y2sls4rULbrKswTex+dSCpyTnggcdOKZ/wjekHVX1P7Ev2x5BK0oduXCeXuxnGdpI6dK1aKAMeDwtottPHPDYhZI2DqwkbgjOO/ufzrYoooAKKKKACiiigAooooAKKKKACiiigAooooAKxPFMN1PpSJbCVo/tEZuEi+80WfmAxz6Zx2zW3WN4q1iXQPDd3qcMYkeDYdpBOQXCngd+aAOYOo6xZX7w6RpYtNPlvWCzLbSOHCrFj5B90NmQZG0ZTOeTmo1/4kguLXUZfOlup7NwfLsmCxAzRgKVyecBjk5PPQ101t4tgNjYXU0byrqDMbcWy79qKASX9CByaWPxvpMuzYLglw+B5Y/hdEPf1lQ/Q0Ac3e6jr2rWUazJdWtwJoWEa2LbUGAd4Y9TncCDnp2rf1eW/v/hdqMjxSf2lNpMpEaIVfzTGcADqDuxiodQ8cxW+lmaGwuvtLxSvGroCo8skHcQeOn60+L4g6SztA0N8LmGMvcRC3JMOASN2OBnacetAFfwlqE1jA1trkEyao8kaNOsTmKVWH7vYcYRQPl2noc5yTkzeIYJT4gWe9tpLvTVsXEEQQvH9oz/Eo7kcA0snxD0SJolnjvI3eLzgrQ8hcMwJGe4QkfUVpaZ4mttWvmtLe1vUkWPe5mh2BOuAcnOTigDmbTUPE0McYaN7azRreB4lti7wI0QZnBYkth/l5BwCSelZ9n4o8bsiNd6bN5pKFo4rYqOjAqNw4bOCQT06MOlW4/iDfJqzaXcwQLeGOeBVAbH2tXxEhPo6/N9BXT+L9cn8N+GJtTjRZJIWjDAqTkMwU4A+tAHOreeIdY8KTx6nbyKJsCSWC3cSQNkHb5RX94oIIJ4BGetZcF/4h0zm20aOMgOslxb2jhSnmxAyIhBKgqWOzBxgnkV1sPjO1itLW4vc4vQ0kAgXdhAQMMezfMMjt+FULfx20vlwtasLkXohkGw7WiMkiBk9TmOgDNtdb8XTXVuLoTrGs8e94bJlR02OCCrDcpLBTjngjkcil/t/xbaC1NwJJVuIVlZ1sSFi+VtwOOmCF6mt23+IGkXAQiG+jV0Do0kIAYGIyjv3QEj6U6Tx1ozLCrRXTx3CM2fJBXGWXB57lSKAJPBuo6pqdhLPqDiaNvLaGbyfK3ZQFhjuA2efw7VmaA0GnactxrltdjWbWWaS6uTC7k8tyGAwYypG0DgcAAEVpR+ITqPhfUbnw5Zn7VZJtitbiPywW2K6rgdirDH1q14c1xPEtpLfwBH05wggbHLEoGfP0LbfqpoAqeM0mutL042YLOb6BwwQsAueSQMcVzFveeI9L1u7gt4CIrjU5We4+yO6tjytqBRnaGBk5zjI68YPV2niXZFrlxqWyO3067MCmMElhhccepLAVW/4WBpZdEWy1Mu5ChTbYO7Y77cEjnbG5/CgDmoPEfjWTEbgjcFk8z7ARgbJyVxn1jiH/AG0+lOtfFesR67Z2TrHax3E++X/RmAwSB82emegPrXRyfELRoy5Ed68aruMiQ5XHlpL6/wByRT+NUfHGvv4dvo7k6bZzk27PbyyR7pC6sCyA9fukkfSgCfxpay3GueHzGiFVNx5jSwNLEAY8LvUEfxYxn04roNFvbW608QwBx9lVIZEkRlKnYpH3uTwRSaDqjazZPfLsNtI5+zsufmQADJ/HOPbFcbc/EqWztNVjfToxqlrqLW6Q5IWWAOUE2euMIw+oA70AZmiXmtaNaalLNp88tyHmbT38piiRmY7gwAzu2nI65AGPSmazJr2r2F7/AKNM1y0M4ie3t5IjKTYybTgnrv2gcDnHeuq1L4gWdnLbrBBPMpkPmlY+WjXcGZOecMpFGo/ECzihmWxt55biNkwJI8LIvmxI+055IEy/mKAMdfFPiuLUhbpbG9gE2IpvsTRi4jKj5upwQ5K9ugOTmkg1TXpta03UEa5kDxrHPG9i0YGWG5cE/wAJz82OnrXSL490VtuftCkxPLho8EbN25evUbW9uOtMuviBo1rJtKXcg53NHDlVw23k54+YgfjQAniyG7l13wu1kF8xL2Qu8iFkVTBJjdjHG7Zj321F4Dna3srjTrvcl817ezhfLZVMYnIUrn+HDJgZ6YrQvfEy23g8a4lviSWJTBbyuF3SNwqk9ByeT6ZrQ0XU7XXdHstXtMGK6hWRT3UHqp9weD7igDQooooAKwfGMl5F4dlawkMdzvUKxZlXr/EykMq+4Nb1FAHMyXOsH4bvc6esz6z/AGaXhEoDOZdnGR0JzWLJrv8AZNyraV9qvLWOziea5uruWUDdKqkMjcK+3LZyO+RxXbaldGx0u7u1UMYIXlCnvtBOP0rlNK+IllcIv9pRPa70jeKRUZo3DRhzzj+HOCelAGDqfi7VbqzvVgxarPACtziXhtpwqgONrHHUfiDSX3inWrqCN32R/Zppg1vA8yS4Fpc4WYjGcssRBBByQRjg11p8d6LNDIbS6VnQAtvRgFBYDnj3qFfiBpK3lyJ5PLtEjieCbaSZg4ckqO4ATOaAMS98b67ZzSiOCza23mKN3ik/dBfJzI5DEsMStwAPuZz1x0PhTxBqOsS3UOoQQo0IUrJbq3luD6FsH8CBx69akPjbSHmMFu8ssvni3AEZALGQxnk9QGBB+lWrTxBDJBdi5Xy7myjL3MafMExk9fpzQBzmrarfaf4ovp0m/doyQRvL5hhtwYS/zIHAbc6hQcAjOM9q2vCmrarrMF1c6lDBbKkvlpbqjB0IUFtxJ55OOAOlLaeILh7C11K8to4bK6QGNVYtIGYgIuOhJz26VEfHvh/cqi5lYt/dhY87S23p1wrcf7JoA5zxB4o1iy8UkxbFjtTLGLcrJgqVTEr4OGUZboM8Hmkfxn4ihMu46aWkkiWORopRAgMJbOQN5DMMA449+K6c+OdB+0eSLpy25V3CJtuSQBzj/aX86ZF450b7PvmuRvVVLiNSQC2MDnucj69qAMK58XeI4bBrsRWHMl4Ei+zyFtsDsq5+YcuFB6d+9JN4r1lNSkijFqZlbyfMMcpjxuPzbN+Onfr710i+L9KTzRPcqpjnaJyqkhP3jIu70JKkD3BpW8V2U/h+fVdPD3CRsihShUksVC8Ht8wNAHKDx1q97DcRxi3tXFqswl8hm8pg8YfIJ5G12PQYx3qdfF2rQ3FzFb28LKlw+wSCRzcAzuhKEsdoRQrEcjDDG0Ct4+NdKto4kvJWW5fCiOKNn8xskEJgcgEEVJrviuHRppYPIkklhWCSTCnGySTZx6ngnFAB4S1m/wBZsZJNRjhSZRG37pGQfMgbGCTyCcda57Wdf1i9uk01AIIZb1YZTGrrJCq3KJhmDD/WIxYEYwFPXOa6nT/FWkanex2lpdeZM6bwu08Y6g+hrGsPHaTORd2/lSCWOB7ZQfOid5Ai7lPVec7hxQBs+Ir+40fRBLZoGIkjiaSXc4iRmCmRuQW2g569utcHpvjbW7WyjgdrV9q4D3CTNLIS5xJ6bO3LDHHNdjc+NdJjt3MEjy3Pllo4Ah3OcyDGPYwyZ/3asaL4ostXtbdgTHPJCskkZHCZQOefTB60AchL4i1rU3tWS9jtGaeyeNBG21dyt5m/DAuuexIHA+tdr4b1c63oNjeSqsd1JbQyXEQBHlSPGrlefTdWfP4wglvtPstMjM893Ps/eAqFTYz7voQpx+PpUVx4ve38R3+mNDHstGhyRuLOrqWOMDAIAPB60Acz9u1i1+IV/KZ706bHd7cmeR0J8viLyz8qgn+Id+Kd/wAJ34jdIjEukvLJDcTJAIpt0jRmHEAyRiQmUjPIyBx2rfi8f2EjzBkeFfs0dxbtIjYYMhbDY6HirF14o8PQSjVLpnDW0boLoRsUVM5kw3TAMfP+6PagDEtPGHiHULiyt4IbKNroKZGe3kP2VjHKzQsN3LqY1GcjO8cDjPWeG7261Dw7bXF1Mkl06sJGWPaAwJH3c/1qjqPieWw0DWtS+zIx02d4wu7hwoU59vvfpVfT/HljM8kF/HJbXCOVGI2KSKCFDKcdCTge9AGboPi/WbyXSre4jhkkm8pZh5LK8m5WLuvOAEZQCMevTitzxXqF3YHTFguBBBcXDxXDlSTt8mRlAII2ksqgH1IqjN8QLCO7vYQrbYoQ0LlSA0n7wGNv7p3RkfWrEfj/AELyk865KzFY9yIjNh22jaCB1BYCgDnNF8Y68i6Tp9ytoxKQrJczrKDJlFyoxu/eckkng+1emVz1r410O9mihguXaSVgqKYyCcjOcHtXQ0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZ2uf2d/ZMv8Aa3/Hlld+QSM7ht6c9cfjitGsfxPpVxrXh+fT7Z0SSVozudyoAV1Y8gE54oAr6do/h2/je7sYkljd5Q4DNgOwKyAqeh6gjFO/4QzQCiKbBSEYsuXY8nbnv/sIfqBXPJ4K1eD7DbpcQS2ltPK7FrqWOSUs6OszlVy0g2sCMgMGPK5IqnH4A15LWO3N/DsWBc/6XMcziJ1L/d/vFD/wHOM0AdVPoPh22u4opoQkl3vjSMu22TOWYY6dyalPhDQmIJ09N2xkLZOWBz1OeepxnpXIz+BPEMxRzf27SpdGZ5JLuVhOuSdpXbheDt4zwOvarkPhDXJZ5DeSWgt5bmGaSGO7lKkK0m4fdB+ZWUck52+mBQBqT+BNNuNYa9lkkaFoUh+zYG3Yq7QpPUrjtVgy+HvC18sIWSG5uIs7Y4ZZSyL/ABHaDgDPJNce/gzWrVNHspX+1BhEk7LczFBItrKskrtjjLmMj1IHSurufDVzda3o9zNcb4LK1MUrrO8cjv8ALg/L1Bxzk/nQBevk0OzubW6u4IhNd3iGGTySxefYVU8A4O0EZPaj+ytL1G3v7CUSTxG78ydJCwCyfK4A6cfdPHHNVtV07U9Z06wmMMEF9Y363SwtISkgQsMbsZGVOenBxWTrXhXWNXn+2CWCCY+a4jS5kARyIlQghfmIEZPTgtgZ60AbUvg3QZ8+ZYqwMhlxvbAY4yevfA/KoNQ0Xw1otk2o3sYt4Lcq7TF3Ow7ywPHP3nJ/GuK0vwt4g1C5mklSSFVuWd1lu54RINx2k4QEuODlSQeBkV3Gi+GltvC8+kamqTm7EgucSvIHD5HV+fu4FADY/C/huffZJaBvswjVo9z4QCIogH/ACRx2NUIYfBc0n2OIjepkXbiUYMZJfnHYsT+NaWgaXqHh/T9PsZHGoySO3269dtrcJhGxjnhUTt0zzzWPqvw/kv8AxBLqUGotbxtMkohA4BI2y8dDvXA/CgDprC30zS7YS2cbJFdNHyqs247VRSe44VRk+nNR29ppUlytpZ/uW0ybzGhhBRVZ1J57EHeTx3rmbzwbrU2qXc9vfpEslxHJFP8Aa5Qyxh1bb5YG35QCByc5/h5zmx/D7XTHIGksIGaNQTBeTDzJBAY97fIOS+G7nqck9QDtpvCuj3DXHnWpkW4kMsqNIxVnxjcRnGfeki8J6LAUMdptKMHUh2yGCsmevXa7jPua5ceDvEMV/G8V3B9ljmZ1T7bNuCsuCvKnvk8Y+tVf+Ff68LUwrqEWVjdo2N7N8sxihUN05w8bt/wLOKAOjk0TwtZTnTpISsht3mMWZGzEEWJj9Aqov4L7VrO+k6jplvqMgjntI186GV0JwMY3DIzyD+NZms+HLnU/EkeoLIqwJps1qAtxJE5kdkIJ29V+T179KXSLPXNN8LDSUgsxeWdpHDbTtKxikcLgk/LkAH2OaALOkto11dImlysp0yM25t1VoxGHCkBlIHOFGPrUk/hrRZwyTWcbPKGUsSd7AuZCM9cbstXJXXg7xEumWtpZSWSSxyG5nuTdyeZPOSGLn5Mc4x0JAOBgVJdeB9TIa4hlR76Sa9LyvezZVJWYxbSQdpVSq4AHSgDpX8IaI7s7WfzNu58xuM5yBzwDknA7moIPDfh24lmihhLyWshSQea+UZvLkx1/2Im/AVz0vg/xDFeSNY3EKWvlKohe8lbzMEEqxIJwTuGc9+nWrvhzw1rOkeKbi9mFt/Z9wq4gS5kc27CKNMgsMvnZg7ugAxjJFAEtrpHg251SW3gjL3XmywuuZdvmYYuuT8u7DN+H4VUfTPCGl+Io4ZLoo4jMf2RvMYOxYMWY8hucdenWtLSPDU9ld61eTqzy3l9JLFGt5IsZjbZglRwG+TqB7Zq5q2k3t54i06+tnSOK3gnjaQn5lZwACB3xigC7FoumwQ2MCR/urQlrdGkJAJUjoTzwT16ZqrpukaVpOrvFYyyRzGOSZrXzWKYkkDM+09PmB6ep9a5L/hC/ESTi7jltmnS3mhRHvJQFd40UyBgMgkqSQMdc5zmtrwroGr6VfiXUnikVYJoldZi7Ya4aRF5UcBGC+ny8UAdfRRRQAUUUUAVtQjtZtNuor1lS0eF1mZn2AIQdxLdhjPNUn8PaVcWtnE0O+C2gaCEeYSPLZQpB5+bgDk1Y1qK6n0LUIbEsLyS2kWAq20iQqQvPbnHNYGhafr9v4kmur6W6azlWZfLkuA6qcQ7CFycciboP4hntQAv/AAi3hcRPLJcGRLUeXJJJesfLwQcMxbjoODTh4G8NpEtzGJ40jVSky3kgCIoYAKd3C4duBxg+wrndc8D6vez6+9phbXVHMkts0gzI6hRGQc4A4OQfQU660bxlJfSbnvZLEyMstvDeJGJYSrCMR8gqVJXdyudv8WaAOitvDXhu73TWk/m+XJ5peG7J2M0n2jOQeMl930YdjWrbaTpj38+qwqJZbuPy3k8zerJ6DnGK4fS9H8X2ogtp4rsWUcMcaJb3caNHIsEC7ic/MgZJgQc/eBweCGHSfHYiDwy3iSYCMjXUeCuBnABwGPIB/UdaAOzHhTTVtUtlNyIY2V4U+0ORCynKlOeMEflx04qha+GPDMoea0mDqk212juywEuxoyCc/eIkbPfJz1rS0ZtSt9G8u8trqS4hj+Uzyxs8xxkAlTjPYk8Z7nrXIXXhPXNU0e6sSDYi4vbnUgxYMVkL5iQ7XHP8eckAqOvNAG7F4N0BS9tHNKXjAZ0FySy8qQSM5H3F/Ko4vA/hm4hVlLzxvGYFb7UzAr3Uc/7PT2J65rHuvD3iPUdSOrCD7HdXNpHa3kZmUhk2neF2tjIbof8Aa9qgfwv4kfwxosNtF9mvNAtoZbWF3VhcXC8MpYPgDYCmT/z0agDpZPB3h2zSSSbdFHLIGcyXBVXbzC6g5POHZiPTNXYvDekwae2lxl1ik8ttnnHd+727SOc/wiszx7plzrvhQWkOgjULiYqPLeSJWt8j5nBY43AEgEZ5PpXFa14K8a3mrTXMJiS1ewW3VYbj544wy5iG7jdgHJ6GgD0KLwtof2qLUIS26GXzI3WclUO4kqOcAFicj/Cp9R0HStX1FpJpH+1LHGHSOcqdqvvTKg/3s81yEOkeJJvBt5ZavaTXF35dusMQMPlfLKSCirjawUKW7ZA21pP4av4fF11qsLzm0BklAjVBNJJIsalVYnBQCPOCB2Az2ANfSvDOi6bcPcWTyZ5jdftLMpYk5yM43c/WoU8I6DNM5Ek0s8IjTebt2eEI4kUZzkfMoNYw0OaRrm4g8PPZvJfwS+WPKC7UJG8BW+9gkk9aqHwp4jebxDFB5MUN9vCiZyAFMkjFFZSThtwJJGRuYDtgA3z4I8OpK17vuEaVtyyi8ddu5pDhTu4B86Tp/fNXNO0Kx0ee6uJJLcIYY7ZcgrshUYVWZmO4+/FYFzo2rDwRZaVqelW2pskEMCRQRAtb4j2u5LthiOcYx1/Gmat4d1C8j1ZLO0mtvPa1aKX5C6lEIZsZwzDIBz15oA6O08L6PZX1ncwmTzoCWh3TlvlCFAOTyoDHA9/elm8K6dLql5ftLdJLelPPRZ2VZNgwowPauV0ex8Q+HL+TUruzeaJYAssMAR8RLEmxIifm3b9+QTg8nriuq8QWEt5faLJHAXEF4XkdQMxqY3XP5sKAM9vBXh9oPKNxPsAWDm6P8KlQuc9gcYp8/wAPtBuraS1kF2YGL5hF3IEXepDgLnAzuOcetchdeBdajO+2XdGJdsYKqGdR3kBbGW6bhyMZxXeaBZT2eqa68tt5MdzdxyxEYwwEESE/99I1AD5fC+nz6RfaZIZ2t72UyzZlO4k4zz17U+98N6fqEzS3KyOzQrDneRgKwYEY6HcAc1r0UAc2/gbRJBJujnPmA+Z+/b942Wbe3PLBnYg+p9hTYvAeiQspjW5VVlSZU+0NtDrj5gM4ySoJ9fxNdNRQBzUXgbR4riKYC4YxlCFaYkZTO0/rXS0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZHiXVptG0d7q3i82bdtRNrMCcH0+la9U9Vvl03TJ7xojKIV3bAcZ5oA5MeKNbnvoGSC3isft8Nu5MblirwCQnpwNx259RWHb6/rXl2+rGG6ldLa022e5hgvbs7g8fM24Y5rrX8Wq2ryaXaWAmuQWRFMwTc4RH544Xa/3ueh46VV0/xzFdX9paTacIJJ2RWxMGxvMgjZeBvUiPOeMbhx1wAZV3421O1dporUXIaAMpWKQKeeRgjg1bk1PVpfCeqXUUsq3K6oqwEqeIzOgweM7dpI+ld1tX+6Pyo2rjGBj6UAedf8J9rCO6y6ZGpjVgfkkJlId13KAOnyDOfX6VOfF+u3Nqs0NpBCkaRNNujctzLtOBjpgZ/Gu+2L/dH5UbV/uj8qAOS8R+JtV0q/uEs7GKe2t7WGd3YPk+ZKUPQdFA3nviue1Xxnr8+n3sNtbwiRIF5t1fzAWjZt4yOmVHX1r04qDnIHPFQRWNtDdT3McKrNcbfNYD720YH6UAcQvjy/lubmFbIIiSlEnMMhUD5gMgDPJA/OoD47157aSSPSoFkUSkxOsm5CkUj4PHUlAOP71eihFHRR+VG1T/AAj8qAOAfxxrMV6LV9NgyJSvm4k2SDy4XAXj7371hz3Q+9SaV4v1e51KxXULaG3tpFZpTHE5x8gZRkjgjkV3Wxf7o/Kl2r/dH5UAcZ4u1bUdK1yzurAPNHHpl5O0BDbJHTyygbA6nL4/+tU+ieIdTvvEElnfQxxQxxzjKI2HeOYrkE9tuD+NdYVU9QD+FG0A5AH5UAcro+rTbfEGoM09xbLc/wCiKwI3DaBhcjpurL0/xF4ktbeXTbqCOXVV1BIlkmRghhlBZW+X+790/T3rvtqgYwMemKNq5zgZ9cUAebS+INcvUt7eQmKaS48qZogy7VF6sZGCP+eZzn0BrQ169v7bUdTga7uoRDYq2m+WM+dLg5zxy2QBj0NdxsXOdo/KlKqxBIBI6ZHSgDzeXxz4isNMgkvdOtFuJJ3gEY35BjB3M3opOOe2asjx9qE9xdQ2tjA3lzRrFKwcK6M0qk9Oo8tf++hXZX+j6fqbRNe2kU5izsLrnGcZH0OBn6VbEUajAjUD2FAHJaF4qn13Tb6S7i+wLHbrKJYwW2hlBPX+IHPHtWJ4Z8R3914fvojqklyRa3c8M8sTLOgUjZ/CFOA3PvXpIjQAgIoB6gCgRxgYCKBjGAKAOJl1jXG1Tw0iRXP2KaEG5mVAVlZrd2yT2CsFPvmriarft4GknDTNdfYJpVuxjAdQ238cgdq6vaAAABgdBRsULt2jb6Y4oA426v70a3aSf2mwsWsmEyxdYG8tm85xjDDoB7496veD9WS8sDBJqTXc5eSSLzRiTydw27uACQCucetdH5ac/IvIweO1NW3hWUSrEgkClQwUZweSP0FAElFFFABWR4kvLuw0aS5tMBkZTIeMhM/MQDwT7Vr0140kXa6hl9CM0AYmnX9/c+CkvrofZ757MyEuu3a20kEjt64rlfC/j2a88P217qbY1B4bVTaMAg/e4xPu/uNn8MY616DdS20FpLLdyRRWyoTK8rBUVe+SeAKyodS8LzmBYL/SJDMPJhCTRneAfurg84PYUAcTP431a8FxLZyLAiJcTKjgEjyo9wU+oJzz3FdffajcaX4EuL6a9T7Ytk8scsmBmTYWUD1/rVwXPh+RjtuNNZjlTiRD7Y6/hQur+H73baLqWmTkZxCJ42+6MnjPYc+woAfpd61xocMkk6SXaW6GfBGVcoGwR2POce9cNbeOr/T7LTbu4mTUVuonaaKNQrQEPtViegU57+lde2t6BZzTNb3NpLc3SG4ZIZkzMFxHnJYLxwvJHQ+hq7aLpM6zw2f2OQIdkyQlW2n0YDp9DQBxF38SJ7i3dbKyWGaC6to5PMnQ53Twqw/3Sshw/Tit678UXDeBptbtLXbOrPFsJ3KhWUxs+R1UYLZ7itAXnhx3njM+nBllFnIGKD95xiPnqenFPg1vRZ9PD2l3azQMJBHHG6/vNhIYKD1wQfagDmdS13Vbc3ttpl8L26tmhcbo12yBgWKgg8khTj0qfw34sn1zxRf+ZJHb6WtpbPaRyfK7tIzjJz6lOB7iui08aXJpFvqEFvDBazRrcguqrtBGQT2BwaqajqPhaC3W6v73TEjwk6yNKmWCNuQrzk4K8Y9KAMTx/wCIdV0K80xdMc/v47hnjWMOSUQMD9AevtS/8J6LXUUsZoRdTyJCwaGVBF8ygsVY9fp1rR1HxVpMF9DE9m91dfvdgjeElURlVmyzgAZcDGc9eODVuSbw/HcpDssWKMS7K0eICoz82TkflQBy9h8RbmOzto7zTjcXUibw8UyhWGyZ+f7pxA/HuKvx/Ea2a4it5LB45XuEhK+cp2h1hZW+mJ1/I1tW50O/1Geyis4JHSFLoyBFKSJLvQMpHXO1wf8A69QqfDja3caY9paRXlvGkuJFQb1IOCvOTgJg8cYFAD/DviVdfe4T7G9uYsEbpA24EkZ46fdNQaNrd3e+INXtXeGa0hukht3QgYUwLIef4uWxxWjZzaFbfNZz2Ee+PfmKRBuQHrweme9Jpk+h3MskOly2Ur2rBnW3ZW8tmHXjoSKAOe8Qa54ht/FrabpCJKiWUdz5bRjBJlKtufOQNo7A81TvfiNO1hcLb6Y1vc/ZHnjkkmRlXAJXIyCclT0rq9Tu7DS9Qs5ZrJpLm/lFossaKTyCcMSRxwfWqthPoGqQn/QYIRDJJaIlwiAnb94KATkUAY0Xj2SHEUlhJcyecI2ZXVApadYVAHf5nX8KU/EAq7uNPmkJWIC33qNjFrhW+bvzAR+XrW7Ivhi1t/tMh0yOEguJCyAEKdxIPfBGfqKk+xaKdO/tC306G4iaMTJ5EIZpBgkbR3J3H8zQBhp8RbaeRorbT5pZNsbRr5gAfeQOvsTW3pGvjVb+7sjaSQT2Z2zhmB2nPyj3yPm+hFZmjXPh2+eSWPRlsTHJ5RkuIo0HmKcbQQSMg4rYsv7M05Z5Vvoma4mLSSyTAlnAAxn2AAxQBz918QI4NUls1sGPkTSxylpAGwiyEEDvu8s4/wAaqXvxGW4RIdKgAuPNi3mVhgIzIDj1OH/CutTTdGuZpWS1s5ZVmLSFVViJOck+h5P5mscN4Wh1saI2mR29xGhliaS02RnkAlGIwTnFAGnoevJrf2jZbSQm3fypQ5ztkBIZfqMA/wDAhXOzeNp9SvdOsNKhNu97IjrPIAw8lvM529mzERg+talnq+j6NaSR27XNzuu2i3pGZHuJzuZ1XH3iArZxwNpHbFSmTw3Ba2WpxW9s63kizWjww7mmdgSpUAZzgk57DJOOaAJ9Q8RQadrVjpksTs92wVXBGFJzjI/A1s1iNJoOqeIntHhguNUsY1lYtGC0QJ4+b1rboAKKKKACiiigAooooAKKKKACiiigAooooAZLNFAm+WRY1zjLHAzVPWUs5dJnhvrn7PbygI0m4LjJ7E8VS8WafJqugTWEMHmyT/IrYB8s4+8c/l+NR+K9Mu9U8NrZ2yq8/nQMfQBXUk8+wNAFmLTdNudSOoxSiS7Ft5McqlSYo27rgdyvU56U5fD2nLdafP5IP9nRCK1QgERYG3I4znHHJ/WuOuPDGvaTcNb6LPcf2e7KzmN1WQu3msxGRgAMynFWW0rxWkaEXNzM8kt23Nwq+UTNmA9OVEfBHqaAO4uLmC1j8y4lSJMhdznAyegqD+1dP8vzPtsGzcybvMGMqMkfUAGuctdF1TU/A91p2rvL9vlQlXlZWKyAAgjHbcM1i2HgnVI7PVItVEd9DdL5qwRvsxNKFE209sbSV/3jQB6FbXlteIz208cqqdrFGzg9cU06hZi2e5N1CIEO1pN42g5xgmue8MJq2nXE1rqMMs6XErPFdOFEmxUQDzccE5yAfQCuX1TwZrU8dwlup+wT3iXkltu+cyiXk+m0qM/WgD1EEEAg5Bpa85u7bxPdy3baZfXEljFemMBCElaNkYtgsMfI5QD2U1ZttM8VRXsNw9zcyFtRZpYpJgY/IDDGMDI4LfXGKAOyudTsbNylzdwwsF3EO4BA6Zq0CCAQcg9DXB+KNC1XWtSvp4bMKiW0dvFucfvSJlkJ9hgHrXVWd/dSXq2s2nSwIY2ZZSwI+XaMHHQnccfQ0AWbTU7G/JFpdwzkdfLcNVqvMI/CniBdI0yOygisr6wa6ka4DjdKJDJiMY9dwOT0KipTpfjSOeSeK4uzGJMwQNOvEZDfKxxy2cc0AekuyojO5CqoySegFJHIksaSRsHRwGVlOQQehFee2lh4tl8qPUUnkhxKF2zqCv7xiN4x8wMZVceoPrUGm6Z4h04aZpbX1wh3RwiMnIEP2eMSMGAwCsgbGfU0AehXWo2VkwW6uoYSVLYkcDgdT9KWK+tZp/IiuI3l2CTYrAnaehx6VyHi7RdS1q8ujb2nyR6dPbxsWH7x5BgY9MU6wsdS0rxUb+S2uLmCXT7Sz3/KCjea278FDgn6GgDqzqVkL02Zu4RcjH7ouN3PTirVed674a1W78bXOrQwGS0jNkwiyAZjGZSSG6gqXU474IqK5sPHRkV7aeQPltyvINjPuOG9QuMce1AHpNMiljniWWJ1eNxlWU5BHtXnFppvjQXFpLNdX5VHieSN5E2n/SIvMHA5Hl+bj8KqWWgeNdOt7K0tri5isIokiliSRC4lXf8AMhIwI/uce1AHqtV5r+0tpkhmuYo5H+6jOATXmxl8R2GvaNa3F3qLiR2kuv4sZlIUDAxjbjPpWxqWi6qkuuCC0jubnULqGS3uZFDKkY2Aq2em0BiMdznrQB2s08NuoaaVI1JCgscZPpUlcp4kiu9b0WzaDTpi8OqRO8LYzsim5b6ELkfUVm6u3i+71aeWxguba0aFkjUSLndt4bHY5oA7qWaKBVaWRUDMEBY4yxOAPqTRFLHPEksTq8bgMrKcgg9xXm0mjeKbi6torw3VzaQX0E0JaRdwCXBdi/HPybMfQ1r+CLbxJbTBdZWUQizjQK5UBJFCggBeCD8xzxj8qAO1ooooAKKKKAMnxRYT6r4S1nTbUA3F3YzW8YY4G50KjJ9Mmuavfh3DqE088upCGW8ZZJRFAFBYPE3yjdwMQoO/JJzzXcyBTE4YEqVOQOuK8zGg6/PpHhcwtMLmPTrSO6WQkNA0QBkIbP3n5Q+vFAGjbfDqK1lsprfU7eNrcIh8uyRBKEIIztIy3HJOfoKH+GqnTvsiaoiYSNBJ9jVj8sUkXILEHIlJ5GPzrOsNH1hNBtbee3nN/FfRyo/IGwbdwODwcZ55zj3r06gDh1+H0gtJoDq+fOW4SRjAxO2WRZDglychgeSTweeeT0Og6I+iW7wNdC4XOIyYVRlXJIDEcseeta9FAHH6j4F/tC5v3bUdsN6k8UkZg3ERzbN+07uGBjBDY47g8Yq/8K8n+2W839sqY7eVnRDackGSR/mIcbj+9IyRgYyAMnPdUUAZDaI3/CKR6JHcqrR2yQLO0QYfKAASufb1+hrnoPh3s0+a3l1GKWVrUW8UptTmMiRpA3Lkn72CMjIHXmu4ooA4y58ByXZvGk1NA9ylwp223C+c8TMcb+xiGPrUE3w+uJIYIl1a3H2d28p208M20tuwx35Yg5549sHmu6ooA5zwz4Xk8PyM8l8lz/osVqu2FkIVHkYEku2T+8P5VR8Q+BP+Eg1K6un1BYVnVE2rb5dQscqfe3d/NJ6dq7GigDzuT4ZTyNIf7Ws0Ekbo6RabsTLLtJwJOfX5tx98V0+m+H5tJ1Caa0urdLaYxGSAWuOEj2YUhsDJCnocYPXPG7RQBieIvDsfiFtNWd4fs9pdi5khlgEqzAKRtOSAPvZzg9K5aX4X5V0hv7JI287bG2nBkjDtuGxS+0EdMkEEdhXolFAHB2vw3VY7hb2+t7kyW11AjfZDujMxBLAs7HIIP512lhbyWunW9vI8bvFGqFo02KcDHC5OB7ZqxRQByY8FBoI4ri7gnCahJffPaAjLA4XBY9PXvjpWFJ8LZp7G6t7jUrSTzlmCN9jI8tpLYQZX58DG0HAAHYYr0migDB8N+HpNCk1BnulmW7mMoRYyojJJLYJJOCWJxnAOcYzis/VfBsura9/a1xNYmWNfKiRrVmV4ywOJAXwxGODxzXXUUAcDYfDcaVqFvf2N5BFc2sm+LFuQkhImUtIA3zNtmxnj7o7cBZfhhaDSdOsIb6aZLOMRqt6TMgHlGPcik/I3O7juK72igDjtL8G3Ph7VnvtN1Oe68/ZHMl8Q3y5JYggA56YzmuxoooAKKKKACiiigAooooAKKKKACiiigAooooAKwvFmoXWm6VDLaTeTI91DEX2hvlZgD1BHet2s3W7zT7O1iOpxJJbyzLF+8QMoY5wTntxQBy1l4l1OXxPZac1wslmb+4tvtIRcXCJDv/NWypIwPlNdLqmqIPD2oXunXUUjwQsyvGyuFYLuHt0IP4iluDoMiCO5GnusCghZFQiNT0wD0B4pDLoVnJJabrON7p1R4cr+8YqFUbf90AY9BQBylj4t1/T7aKXVbBbiC4t/tMTtMiSKioC2VRSp5PHI461O3xAuPt72g0iMiJlWaRLzJw0ioDGNnzn514JHOR1xno9W1HTtF+yebbK0kpMMCoqL25UFiAB7ZqrbxaDLeQaoVhgnitjGsMoVfJX77fL/AAnB59jQBy2l/Em8n0C0ka0glu1tLYzyzXKxl5XiidiIgM7cSHBHGVI4HNdHrGrXieIYNPjuGtLY2b3RmjVGaVl/gXeCOnNaKzaAP3atp4zF90BOYxz/AN896fNfaJeCO3nnsZwxBSNyrA56YBoA5K48dzW9lol/DFLLppWKTU55IMNGkvCt8uVUgkMwz0IxXT6/qMsOhXE+mXdqtwrrEjySALvLAbd2CA3OOQcE81X8Qa1ouhaYtxd2yTxXjbFjiiVvO2oX78HCoTz6YHas7TPGPg+7ufsFnJD5V2DMXaPEUjeWjkHPcIyH9O2KAKNh49uftC2b2Uk8okKTG5lSNoW3BQnyKVfk9QRwfWoNY+It1/Y07WNkLO6WF5RJcyhQrRMiyoAVIZgXK49jyOK6a8v9Ft7PUP8AQiV05QsohtsMgI3Arx0HXIplhdaVLd2+ijTrh0Mb3MU11DuWTG3c25uScyDJ75NAGdpvj6XVdQgtbbSEH2i5aKMvfIW2qJCWZVBKkeWRtPfv1qz4o8VT6HqNoIYt9nE6nUJPLZvLjc7QcgYXBwee1aUuo6NazalNJDHG+nES3EhhwQWXOQcckjuPpUNjr2i6zeC0igEjXUCytviGHUqGAYdehHXigCG01y4uPGF/ZxTwT2EcNsY/nVQrOZQ+CAdxHlr8v1qDxL4pn0XWLJYoQ9hC6nUpdjHykf5V+YDAwfmOccAetbU82l6Xd2lq1vHE93I7RlIfl3qhYkkDAO0HmsNvGfhyWFne3Y/aQjsjwDMkZTcjkHqCo4HXjGOKAKsnxBuBem2i0aNy1y1vE5vMKSpwS3yfKPzpLX4hzXkCSx6LsWRikfm3W0FhCZmDHadvyjj1PoBmtKz8P+H7r7XZQQMfIvRPOGjA3SYyAcjlea6BrCzeNo2tIGjdg7KYwQzDoSPXgc+1AHE2nxRsr4L5FmF87Z5DTziNDuaRfnbBC4MZHG7kgHByBDF8Q7my86O8sVuJJJytqUuUUEHGFZiAoA/vZOeK7o6ZYFpGNlbFpTmQ+UuX5zzxzyAaG0ywfdusbZt2d2YlOc9c8UAYWieLxrllqMsVosU1pHvETThgwIbad6grg7eqlh17giq+ieOBqkmnRPZgPdGKJ2jk3bJXthccLj7m3I3Z6gjHGa6mG1t7YOILeKIOctsQLuPvjrTIdOsbaVJILO3ikRPLVkiVSqddoIHA9qAOMvfGl/a6sS1nC1tBPLDLHHKCxVdmG+7nPzfdrV0rxnDqWg3+sNaeRb20JnQNcxsZE2lhkA/IeCMNj61utpti8rytZWzSPy7mJSW+pxz0FOSxs44ZoUtYFimJMqLGAsmeu4d8980AcbcfEKf7BPPZ6P5jwQ3MsvmzlAvkybDwVyckgjIB55xUN/4r1L7e0cMzRQ28zibYUctgoNqkpjb8/Xg12kWk6bboyQ6faRqylWCQqAQeoOB04H5Ug0jTFGBp1oBjGBAvT06ewoA5Q+Po3FncrCqwTI0iItyhZhj5Q64yjZ4wO/A3HitHw74kl17VZCqtFbGzSQQsOUkEssbc4Bx+77/kK2X0bS5Qwk02zcMWZt0CnJYYYnjuOD60+10zT7Fy9pY21uxXaWhhVDjJOOB0ySfqaALdFFFABXL6j4iv7fU7nT4IrbzBc28EMkgYqPMVmJYAjONvYjrXUVRuNH0678/z7SOQ3G3zSRy23pz7dqAKFvrdxe+CzrMMccVwbRpwjgugYKT2IyOPWufXx5eQzPZanbRWWoWVrJNfwiMyD5XjVZIjuXdGwdj6jGOo57X7HarYGz8lFtRH5ZjAwoTGMfTFQXNjpl4m65gt5gI/L3uATsJBxnrglQfwoA5m5+IdvC9vcrZXg05xKXeS3Ks4UDDoS2NvPJPT2q1H4+sJ032unancI04t4njiQJNJkqQjMwU4KkHn9OavJ4b8NkBorC0UMTIDGduS3U8HvSxeGvDqXeYNPtY51ZZv3XysCMgNwfr9SKAKGr+K54tH0rVdKt2msr2EXDyeQ0rxRMgZXMasGIyy5IzjPSs+PxrqAgub5hYXFnbS28bCAMDIJQvzIxPOCeAR0rpW0PRpbW0tPs0XlWkfkwKrkGNMAbQQc4wAMegqOPw7oEVx9qSxtvM4I7qCowMLnAIHAwOKAG+KNYudD0yDUoRD9ljuYhetKpPlwMwVnGCMbcgnOeAa5vRfHd9qemCaZIIZ7dvJvQLZ/kkeULCApcEBkyxySRlfpXWWUGlPoo06IRy2XleW8Mx3ZRh0YN6g9DS3dlpMpe2nt4z9rlEkm0EbnRRhmI6EBFAz6AUAcvYfEBy8sWowIrsypA8SYTcd3DFm/wBkYA5PNWNO+IdjJp9o+oW88F1K0UbqFUKGfy8EfMcj94vHLYzxwa118LeHxIGWyj3H/pqx3Yz789TTW8IeHSwZrCPcihcmRsgDbgdf9hPxUegoAh0zxvpWq6ydJgWcXqlg8bhcoVZ1bOGOMGM5/wB5P7wqpp/ibV7vxdd6WdPSS0t7loWljjdfLXYGDFydpyTjaOa2pP7G07U7eQwwRXt7IyRyJH8zsyhmyR6iMdeu0VWuo9EiubrTSXjuL4iaYRFtzHIAbPboBQBHe6xqMviO40fTBaRPbWaXUkl0rMH3swVQAwwPkOW5xkcVg6R8UbG7tlutQt5LWGcI0HA+UGGN2DEkZOXOMDJAzjg111/o+l6l5b3kSyMimNXEhUsp6oSCNynHKnIPpVeXwzoMszTSWMJPy5UsdnAULlM7eAi44/hHpQBRtfHWn3V5bW32HU4XnKgGe38sLu6E5OcH1Gaq614q1LS73X5I4bSWy0a1iupI23LJKrBiwD5wCApx8pz0461pJoHhvSkV0tIojF864di3y8+uSRVqbQ9Gvbxr6e2WSaTy2fe7bWK8puTODjtkcUAcvYePbyfxNJp81mr2zXk9tEY4XVsJGJF+djsZjkjYCCMZ6VseIPEt1oOp2xNn5+mmIyXTxqTJAucb8Z+ZR3AGQOaJNL8MQeIGt3h/4mN1vuCDJIdpYEM45whIUjIwSBjtW49layXS3LpulSMxAlzjYeoIzg/jQBzNt8QNOXSlvbsvJHt3PNbR5jXKs6r1zkqufTkdMgVPN470ddMuJhdLbXUW7/RbgDzvlAYt5YbLDawOR2NXZPCXh6dAh06ER+X5QSNii7cMv3VIGQGYA9RnirB0DSTYXdg1vm2u23zoZW+c4A65yOFA49KAMo+P9HSZ4njvEKuU3NDhWI3Dg59VIHvSnx9oiyyxO08ckUyQsske0hn37ep4z5bDBwScYByM34vC+iRMcWasSQT5kjPyG3g/MTzu5qjd+FPC8KXE11anY8btKrXMpDoNzMNu7BX52+XGPmPFAFeD4haSsT/bHkWRWkPywkAoskq5Azk48lgffHqK1m8TWS6fb3fk3ZNwzLFB5BErFc5wp69O3XtmgeGdDktmh+wROjxSRncSW2StvcbicgFuev0p0vhvR7jTobGW2MkEL7490zlw3rv3bj75PNAGfJ490aMyJi8eZJ0t/JS2YyF3DFRt6jOxuDg8e4qhF8QIbnWvIhiP9nvFBNBOYmJmWRpRlQO2I8gkd+la9r4M8P2Vyk9vZMrpKsqA3EhVWUsVIUtgY3txjHNVZPBXhUTrC1kweb7qC5mxhdx2gBsKo3sQowPmPFAFnT/GWlaq8aWIuZ3Y4cRwlvK5xlsdBn610FYFp4N0GxuIpre1kWWIllY3UrE/72WO4cDg5Fb9ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWXr2kR6zZxW8s/lKkyyA7Q2SARjB+tZXjuz1u/0UQaPDHKC26ZTcNE5A6BcKc88kZGcVY8YabPq/h42UJeOaSRMPECTGwOQ30BAoAxf+Fb2wDRDUzlxlswIXPyhW567TgHA6VoW3gm3tFEn2wG5F1DcicwrnMcSRBfoQgP1Nc/a2vimHxDNqd3bTJNcWdrHcGEeYIlEriQR9iwQoxxnqcZIxUbr4x1LS3h1aK/julmheMwQxGMxh4yHOOfMGGLLjHtjFAHb6rov9s2Mdnc3Mbqv+tV4FdZMjglT09RiubuPhpBLBJb/wBr3AimtXtmDxqzHdB5O7J74AP1FVluvFnIb7bBLJJGrXEdkjEoN24sNhyeAB0GW7Cs6+ufHV1ZQH7DcS3tncxSIXgVQTtnVyMDBOCmM/LkjPGaANO98BXGp+JdQmkeCGwmG1BEi/J+6VcgdmJHI6Fasy+CraK0ureCaGa6u2iHmoqQtb7CTuTHf2rc8MveSNqr3Uc6o14rW7XEAid08iLJYADJ37xn29MVkNpNpp/jPUNUk0tzbQ2SypIkJOZAxZtv+1igDY13w1Y6zoCaVcssVtHgBwBuTAIyp/hOD1rn4vhjotvqQuLC4EKqrNBb7FkWMtGkRbB6jag69ya6DxZFLqPgTWorSKSSe506ZIIwp3l2jIUY7HJFcjPbeIrDVZbq2juJpDpVvBFLDa7Ah83LKQ2eQp54z7cUAddP4daVdTC3a41DaJFeEMoULtIx75qRfD1oybXmmkjNrHbLiQqVVWLZDA5yTjP+6K5C2uvGVxe2TXceoJAskDTmOJVK/KQ4K4+YZweCfpxWfcax4y0rRpruRri2jt7MrsezjEaP9mYhug/5ahR1xz0xQB3F34Stb6TUPPuJ/LvDEQqHaYzGuAc9T681m2fguLRJ4rqx1MpdxWy26vOAdyAKPm55GAcDsTWf4T1jxDqOs2zTT3FzpzeYsuYlVYTlyoL7B5ny+WDjBBI65bGn458O3utR2j6cqGc77aYv0EMgwzfVcAj3oA3L6xivdQ0y5e6VGspWkCDBEhaNkx+TE1z0nw4014WVZ5EdphLuA4TC7UCDPybRnGOhJ9azBo+rQ6VoNxqdm8mox6pC919nQybIo0ZA3y546HHq1dxp+qpqE08Itbq3eIKxE8WzcrFgCPrsJx1AIyBmgBtjp6aff3sxud7Xkgk2MACuBjj1rQBDDIII9RXn2s6TqU0+tw/Y55r+7uYpNOukB2xINvV+ibcNx3zxmsm1ufGulWq2dnaXf2RTh5FtAzwLvGWVGA8wnJxg5A3fLwpIB6xTTIiuEZ1DHoCeTXG6DceKX8SAalJdNYFWXbLbIijEMBDZUcEyNMPvEfLj3o8UaebnxLDPJptxeQDT5Y18qMn94T8oz0U+5xigDsg6FygZSw5K55FKSFBJIAHUmvIYdA8RW/iGzuriG4mmgnsXndYj+8VIsSkSnsO4/ixjvmvSru4XVfCktzapIy3dmZIkKEOQyZA29QeelAGorBlDKQQehBpa89Op61Y+HtDsNJ0/UY54IIkuWNmdgIC7l+YEn+LkDH+1RNN4/S/voxIFs0SQ29wYUcsQTtyirnBEiepHktxzggHoVFeZjU/Hc9tHiG8t52ZRIpt0cJFsTDg7MFy+4FcDAz8owDXb6LcXw0BJtTSV7tPM3jywHcKzbTtGBkqB09aANTIzjIz1xS15np+l6mviHS7yO0lgWS+1KcvNbOwSNyPL3gEFSQOAa2/hzLLa+F7DSb63uIL+OJ5pElhZAA0z469+nHoRQB2NFFFABRRRQBna5p8uq6PPZwT+TI+0q/b5WDbT/snGD7E1x58AaiLksmowLbzMGlhw2Ew8zbU9sTY57KK67xBqFxpeiT3ltCZZIymQELlULqHfaOW2qWbA67cVwdx4n1rTdXubyJxdW80USkGzlXnZOwdVLZH3EyO+e2RQA+HwFqU9xKryRWxt44UimTdiQqoBAGeFJAz3roPDXhe+0bV5L+7uLaZpbbyX2BsqRNJIMZ7Ykx/wEVhp4y8RXP2URixgDnZIZLWRsEuyg/eGOAD361mt4v8AE9jJLqFtZfaWuxDJLaG3lYQoYAXmUg/cVlwVAJJJ70AaQ+HOphF8vVIoZQIgZYy+4bXlLkZPVlkQf8AqVvh/qJvPtSahbo21QsS7wiEEZKjPcVEPF3iXyLifOnyJbpDlY7SYGXez5Ks5HO1ARkAHcOeRnd8Vzpf+Cru+gluY5YoiYyheJg/Axjg5oAyY/AOoxK+29tGMiKsgZXw5EBiyfocMPxpP+FeXseltbpqSvcvJcGS4kZ90iurKmeeo3Z4qWbWdS0Z5re0liNjbxWxBkgknkLzOckvvwAMHqMDI9MHNbx54ja3tbhbexQTW8O6F4ZFaOV7ZpTubdwA67cED73JoAltvCutWPi6yJUzWEDl1ZXbaASTjOeMZ6d60bzwZql5q99cvfwfZrmWJvKDSDKpcLLg4PUqGU/WpNf1TWL/w3Zx6P5kOpzxfaW3ARkKnJUgk/eIxwTx7VnyeNtYvLi3+wGyht5Qit59s7PEWgkkJbDjo0YXGByw/EAn0jwJqNhqun3NxfW9xHazibJDl0AjdAiZ/h+YH65pt14E1WXU5ruLULZSzMVkbfvIL7gGIPbpVfxHqd/dWmlanFId8mnLLNpu54jIXwT5Lr/y1GCApByD25pT421/7VBD9hW3hlVt8sltJIbR1YhY5Ap+YuADkY696AMzUPBviO2NlbITdwCeWZhHI+0Z8ohc5ypyjfNzgE+tbCeAdThuPNTUYnVixlhd5CspLzEE8/wAIlXHugq34w1nWLWSCfSlmePSwl5fxxADzUJwY8E5+55jAAE7tlV7zxLrkl409vcWI0oaibUbbdyzR+QXDF9+OWIXgDkde1AFS3+HOr29t5batHcShJEWaUvvBaMpuz1znBqzN4I1mYqTf2/mRz+Ys+6TdIMk4cZwQNxA/pgUzT57y88N69qE0sqXC6cqwojuPLbyd2Bljk7j161UufFuv2emXFvafZ9sFqVhkaF3k3Lbxy7yS2G5Z16dR7EUAdDrnhW91HxBPqVvPEqPbwQ+W2RvCO7ENjsd4/wC+aq6d4VvdE8Na7HLPJeXtxBIsLrK5YjZhVGTxz0xVJPGniC71SS0t00uEG8FtGZYJmZU3ECRxlVw64ZcN0PfBxNb+JfEWpaLrSxR2rX8Nu72wtomVuHZejM2Thcj6igCra+BNUCw3Md2YmISRYTPJiJw8DHvzkRyZ93NNXwF4git4turI9wqNFJI8sh80EKPMI7N8o4HFNn12/sdRtpfD94Lmze3t4bprzfLHHcSXEcYP3gd4V5GZcjAUZxxTZviLrFvc6jDKmmBrWV4EUqyl2SQqSAX5XAHPABYDLHGQC03gXWVuJbmLUP3zuzjdPIQCXJzjP904pk3gTW5bCSM3sP2jybyKKTzHzH50agEHPZlJ/Gorj4iaugklhi01oymY0IbcCFVjk7wD94gD5enWrPjLW1jvfC5XWr3T7q5uIpGhiV9jRA5cOgBJLHCAHufY0AbGnaDqGnx6m95MLkyRzCKRHfzHDsXCnnHy52gjsK5rT/BHiAWdhcQ3zQM8UBnglnkOwrtLd+pIOah8K6j4q0/U5o9W1aCayaWO2+1zGSWOeX94zGA4G35dgP8ACCCKadQ1uCXTki1Ka7iN4Q9zFM+25QsvzRhmIJGcFMlQMkdKANSLwRqtm32k30jyIImOLmQ5x5nmYBPVgyj/AIDWdp/grxBNotk/2ia3eWyRJoGu5MrJ5ahmJz94kc+mPc1teFtQ1y2vr1L+C6vrNTFE13HcI8SyjcZZAXZSIwCnC7sEMAM5rBnvvEQ08HT9UGps9xIkNzbXTgXUjqhR0UlhsT5gyA7R14wQAC3YaBrtn42svOW7extmO3bMxQqSxGSTyACBg16fXG6BrVkfEV/B/wAJCtyskgiS3lnDMJudwUdVHGAPbNdlQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVkeItQu9OsIZLIwiaW4jhzMhdQGOCcAj+da9ZXiB9ITT1/tt0S1MqAM7MoD5+XkdOaAMm08a263zadqMZju1vvsW+IExux27SPrvXjnBzngZpNP8dWl1Cu6Gd5CsWxkj2iZnjaQ7VJyMKhJyauHRvDk95BGLNWnt5BsK7/AJX4lBJHU8K2Tmkg8O+G/tMljDZIJbaOIsgZxsX5gnOf94fTigCHw54tj166u7ZQFZXY20ojOySPCkHk9fm5HFUtC8Y3mo3GnWF/BFaX9w5fbtJSeDY7B4zn1Cgg5x+RrobPw/pWn3Hn2lmkMnIypPGcA8Zx2H5UXOmaVb6YomhjitrOJyjknMKFSGIPUfKTQBR8W+J18MafDcCD7RI8gzGGwRGOXb8F/MkDvTLvxtpNnM8TefIRCJlMce4SKcY2+v3hTItV8OwJbebLKXECWcbTJIWkR1yB053BM59qTT/C3hO8tkuLGyikhI2ApI/GD0xngjA/KgBtz4+0q0CGeG7QO/lJ+6yWk3ohTGc7g0i9ff0NP1nxRJD4OXXdKjVy7xhUuEPALhWyARyOfyqTVdO8NWl3bvqNtGst7OqRsd2DIuJAeDgH90Dnvt5qaHTtBuNGtpFt82FuWmhVi+BySTgnJGcnnNADvDmr3Oqxag12IkNtfSWybFK5VcYJyTzzXP6/4xv9N8Yf2LDBbTxOLUJC8bbpfNd1Yb87V2qhbkc9Kkc+DpZykJmEt4yzboWlwzPhsjBxnGCfQVuazp2gwWl9qmqWyeULdRczMGJ8tDuB45G05ORyKAKs/jPSrI38Qhn/AOJeAZUSMDjcy5HPqh+vGM5FRy+PNOgleKW0vlkXb8nk5YlhnGAeoHOOtV49P8GXNxOqW4eUXKJKN0n+tdvNXv3J3Z981ZsfD3hbUoZmtbTzFjuGEhMkmRKvB5JzmgBD480tYIrhobsW0pHlTmL5XUnG7rxgjoefaovEPiq50fxTY6TH9mCXtq7xvMrYWUOijcwOAvz+mcgAcml1bw/4O09Yv7QsY4hdStFGFMnzMyklQFPGQpOBxxWm+laD4lhj1FoYr2K4tDCkodsPC+CR174B9ePagBIdVum8WvpLmFoUsluN6oQxcttPc8VS1XxU2jeJJbW5VWsUsVuMoh37zIVwTnGMDvj61dh8OaMNxtYyriRd0iTMzZU5Ckkk49qlufDOj3ks0txZLJJMyu7F2zlSSMHPHJPT1oAy38f6Sj5EN4bf93m48rEYMiK6DJ7kMPxNQWPjUT+J49KkTd56MYkERSRWVgGDZYjAB5Nblv4c0aztZLeKxiWB/LLoxLA+WAEPJ7BR+VVIfDnhy51I3sVij3UbiYThn6tzlTnH5UAYsXjXUG8fy+HxBbyRLeeQFVGVlj8kSGQvkqcFlXbgE5zU/g7xfd+Jru7t5RbRtYzzxTgKVLhZGRNgJPGFyW6ZOB3I3m8N6Q9zNctZL50063DybmyZFGA2c8HHHHbis/8A4Rzw2Lw6dDbCG7WKWYeW7qyrK3znOe7DOPWgClrfi6707xpbaBEtsourcPFJKpwr7sfMcgYx0HUmrMnj7R4r5rNjcNIs/wBn8wRERtICQwDHjgqeM56YzWneeGdH1BzJeWazyGEQF3ZslAcgdfUZz1qCTwb4fleRpNOR/Mbc4aRyCe/Gcc9/XvQBj/8ACxtONzayqHNlcQSlf3eZDIrwqFAz383oeQVOcYNbFh4gGvW90NIjkSWEqoku4GWPccEjsSQD0qrZ+GvCupWzS2tjG6JJJCXDOGDq6q/Oc53RKM9flFbdhpdlpkUkVnAIklbe4DE5bAGeT7CgDg5/HWsWmj6Vqd2dOit72aVHZYJHMYjjlcnaGyf9WBx/ePHHPdaNeT6holje3Vv9muJ4Elkh3bvLYgEjPeqkmg6JZWUDtZAQacXuIQNzeWSp3EDOTkFhjnrU2naJZaZMJbJZIovIWFId7FFUEkYUnjr+XFAGnRRRQAUUVAb21Acm5hAjYI/7wfKx6A+h5HFADrmY29rNMELmNGcKDjdgZxXJy+PoYjZH7C5W5trefHmAP++DFQox82CuCe2R15rq7sRGznE8gihMbB5CwXauOTk9K51bHwxPbWKvcxSxWMQtbcSSD5PlKj33FQcH8qAIrLxst5Y6deLZDyby6+zhhMOuM5XIBPoenSutrmbbRtCt7ay8q+ZraaUSRJ5ylJ34IPTkjA6elb1xfWlo6pcXMUTuMqHYAkblX+bKPqRQBYooqtc6hZ2bBbm6iiYjIDuAcev096ALNFU4NW0+5uGt4b2B5lYqUVxnI6jHtU9xcQ2sLTXEqRRr1ZzgCgCWimySJFG0kjqiKMszHAA9SapJrWmSFAt/bku6xoN4+Zj0A+uDj1oAv0VAL21NzLbC4jM0SB5I9wyinoSO3Q0211C0vt32W4jm2gE7GzgHpQBZooqKS5hinigeVVlmz5aE8tgZOPwoAlooqtdajZ2Tol1cxQtIGKB2wWCjLY+g5oAs0VVstSstSiMljdw3CDGTE4bGeR09afb3ltdPKkEySNC2yQKc7G9D70AT1RstG07Tp5ZrS0jhklLFiv8AtHc2PTJ5OOpq9RQAUVHLcQwNGssqI0rbEDHG5vQe9SUAFFR29xDdwJPbypLC4yrocgj2NV/7W07ymk+2wbFdo2beMBhyR9RQBcopFIZQynIIyCKak0UryIkis0TbXAPKnAOD+BB/GgAkhjlKGSNXKNuXcM7T6j3p9FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVDVtOXU7eK3kjilh80GWOXoy4II/Wr9YviTVbjSbSGS3CL5kmxppImkWPg4yqkE5PFAHP3HgS+SxeystWYRGSYxvMWLRxtEEWPIPzAFQMnnHvVdvAmqtcRul3aW6okQQRs7CMq8zHhs7gRNjkj7vGOMU08Ya1pMV6jrHdK01w1uXjcsmJpAFJLcggLj7uBxycCrF3491a3W5uRbWv2ZV/dAo27PkQy5JzhhmVlxxkr1oAdD8Pb2IWzG6tjNBtIlDSbiwdSXOSeSAc4x1ru9QgkutNureExLLLC6IZU3oGIIG5eMj1HevOm8f+IDDuig0tmCbsYkJk5PK4yvAHILDk4zXXa1qcyeDjqKRsJCsL7CXjPLrkfKQw6+v1yKAMG38EalZXEEtrPbpbwXkVzFYmVzFFtV1baSCRu3D5egx71v+H9JvdGnuIpGilhuXe6llUFcSsfuqufu4FVfC2v6nq19cxX6W4iEZkhaGJk4E0seDljnIjVuMfe/GsrXfGuqabNfJFHbiSGRkjt5LaQsQFyGLhguG6Dp+PSgDY8Z+F38V2+m2vneTDb3guZXVyr4EboNpA65fPPHy471mTeE9fvxFLf6jatdLFDGZYlZdpjdmJUY48wNtYe3HpUNp4g1wancfZLc3dvdXJVAwZvJbyonwOcBCom/4EB603Q/Get3+o6bFdW9kYLo/P8AZo5d8ZKqdrB8YKksCRu7ZAoAs6J4JudMubCWR7R/s8quzAHJxCseRx1yK7SeCK6t5bedBJFKhR0YcMpGCDXL+J9bvdK1W3SzWPfLEAGl3soJkCn5QwB4OfXjrWGvjbXm+yRSPplu1wYczyW8myPes+VI38kGFe44egDT8P8AgJ9Av0vU1OS5lW38txMMiR0ysTnn+GMlPfg9a1vD2hT6T5j3Bt5JpnklkeNTlSxztBP8NcdYeNtYtWj+02pWS7vEaaGfcfs6skG5VJIwFLucDPTsOam/4TbxAAkphtnCKzlI4GAkyhIXliQQR26+lAHWeJtBl15tIVJfLjs74XMpEjIzL5ciEKV5B/eZ/DHeubvvh1PjyNMuYba2il3wgFlYJhAIjjIKqU3DIIPAI6k1IPFet6nq+l29xJbQRi9hINqkwF0jCQEgnHyrgAqQwz36V1Hi/WNb0WC2m0jThfCRmSSMIWYHGQeowOGH1IoA59/AOppbzot9bYc78xRspVsqxdQP4jtK49DVDR/h7qjw6VfyTJaskKedYO8gQSAL++O0gmTK4weMfnVjVfEGthL1Q5tRJBISFD7gxhLIFO47GBx93qa67wpqV5qWlyfbjE00Epi8yNSocAAg4JPr60AczbfD6/tDpYhntESBc3IG4mVySGOcd1IHbpznjEtp8P7lBbrLdxRLEIkxDk5RVIYYPTd8p/OqqeMvERsVjSO1kvQACDbsC5aWRWKjdwIwqEg5yD26mOXxjqN/AbVZl3KluwnhVo3Z98e8Yz0wWyMY+tAHV+E9AudAtZ4bmaKVnYHzELkvgY3NuJ+Y8Zx6VU8SeFLrWdbhv7eeKF4o4kSUk702yh2xgd1BHXvU/jTxLP4b06G4too5ZHZvldSQwVSxA5GDx7+wNYl94p1kZnMlolg15dWyKkb72EaPsy+7gsQpGBQBWtPhxfRG2M81m4iVQy75WDNvBLfMTyVBGOnNDfDvWHtUg/tWJDHIsqygsWZFj2fZyOP3TEAnvyRjvVeDxDqlldSagWmufMkZFDPKY4owsfzbN2GxuY5xk4PNWV8c31neujrBMZLyIM4WVUaIrbhmQMflAEjnjP3M45YgAfb+Cr2OdLPCxxlbqSfywfIcSTNLEgJ5yjN2HT6ikj8B61azWv2a7tFhhcOULuOdoDY4PXk9q6TQp7ifwdLLPNM0wa6AkZjvwJZAvPXoBj8K5Cz8d6/ZafaQXUFmzx2qu9xMJczEIDtAUMd/JJ+h4oAsv8O9QWzdILi2W4ZChk8xxkNavEw6f89GV8/7PrXTeGtDvtJmunv5be4kkZiLhQ3myBnLgPnj5c7RgcgDp0rnIvGuuahZXP2KOyWaG0u5yxiZsmMjYAob+IMD1PStzwr4ludbv7y2m8l44IonjngU7ZMjkk5ODkH5cDAxgsOaAOqooooAK5S+0G9uLbWY44ow13eQTREvjKoyEk+h+U11dFAGN4q0ibXvDV3p1vKIppdjKWJCkq6vtbH8Lbdp9iazotCubvXb3WLy0ihElkltFahg5LKzNvJwAD82B7enStTxJqk+jaHLfW0cUkqSRIFlYquGkVCSR6Bifwrkh48v9PuLm2ubNLsveXCWsvniMbVn2AP8uFABGDk570AVLPwHremrpSxzRTxaaxa1i8wr5W6MhhnHPzngjoKWTw14oujbveQ+c0Jk27rgMQrXFrKBknPAhk7+ldV4n1a7tfBUup2TmC6Kwsuwo+CzqCATlTwTzWDL41vtL1rVPtsMj26TQwxQyMi+Vm2eUtlQc5KY5Pf8KAGQaZ4ngkt4bvUr37bNc7WKzvJE8WCsjjaoEeAVZQx6jA99+fSr238UXWpRWsN9b3dukGySTaYiufUHKnPOOfY1kSfEK5HnPDpMLxRqW3NdkEgQRTnjYf4Zcdeo/Gkb4jSSRzm10uOUxvhd1yVDLhjnOw8/J79etAAPDOrvPIn2WCGNdZ/tNZxN8xRTuEagDq2NpzgAE9as+JdL1vxBa2MsFtsSS0Jls5bkx+TMSjAtgEPgB1/H3q94t1e9tvh7qGrabIbe8W086FsK21uCBggg+nSuYtPiFqOm/wBrW2oWcl5LYSyOGZlDPCoiwqlF2SSZkJwMY4B5oA108O67e+GtSsb+7c3c0quhmufMRtrbsDCjajYxjmpdf8P3PiTTra2l09bGRJg4milVmiZY5Aj9vuuykDn6CqGm+Ob2SSa7mt0ltZ5YUgjjlB8gumVViEByTweuPWu5jmS6tC8UwAYEeZGwO09Dg9ODQByGheHtXstT1+91GKG4udSs7cO4fEckyiTco7hAHVRx0X88pfDvi2xRYtMZ47VWTy0luwZYwMZTcMbk4IG4k+1Ph8Za5pNrZprcJnlW0a7FxBGFivI9mRkn7jqSAR+I46aH/Cf3CX9rZzaMd9ywVHhuPNTBJAO5VxjIoAiXRvFMlw8VxNdfZzPFh4r9gxQTyM/GRjMbKvXPHtWQPDHjaWO0lmmZr+3T5blr7kKbdUKAYIDFwx3Y/iz1zXc+Kp9Rs/Dtxf6dcLDcWS/aWRlBWZE+Z4ySDjcARkcg4rFuPF91pWmxXtxbNdG6t2vxFvC+VFlAI1wp3uA4P1zzjFAFD/hH/FREsqXuoLMDF5Ik1EuuOd4cDaDnI5AB9M99fxFo2o6vf2jJboI7O2uCH8wHzXkhMYUA9OT1PFZ9n42vJPEmnQ3cMUFrf2jSInmhkjIcjJfYDuIHC9PeuyvbnGkXN1bzKMQM8cowQPlJB96AOM8F+F9U0S7Wa7jdY2trWBl+0gsrRRupJC4BT5hhTk55PSrK2HiG2XX4rGz8qW+u2mhuDOqhV2qO2SGO0gccZzULa/r6anoqDa8N7bwOCAmxsoxmd/4lx8pGOO3OeGw61q8cNol1rEMd6LsxyxssbRzJkZKvhflAPHGc9SaAKFxoHjdtOuI4b26W5Mcn2aVr/cyKYXUIxAALeaUbdjgDrxg3RpXi2HUVEUt09lHcOU33pLmIscBsnnAPGcnjtjnqtcv2g8K6lqFjOu+KzlmhlXDDIQkHng8iuPPjXUrG/tHu4JmhbSoZfKdoVEszyIm/cM7V+bnOMelAFe58K+Kn+xCOeaWaLZKs1xfs4gkEbhsg5zliCCM4raGl+I10WWMPKS19HJ9na7/efZwFEiCTsSwZhz0OMiqz/EO5jLBtHjyAQoF4Gy425GQpGPm6gnpW7pPiC6vtZuNLutPFvcWyCSUrKXXawUoQdoznLj22GgDnfCGieKNHvtPgu1K6dBEyOout45XIyPUNnt3zk5wL154Uvo9S1u6spVEN1bvJawqdrJdMm0tnoB0NQeIPEeo6P4gkklnlOlJLDGBaLHIVYgEpIjDf82RhlOBkcccwN47vRqFtcLBbyWUlurtDHcBiCzAKc7c7ucFaAGf2R4xS5a4jlunVpGaWCS+2hkEqFVQgnYdgfkfQ9a0rXTfEUOh6pCGmW4kuopLcSXfmOYRHEroJOCGJWTk4+8DVWP4jm4so5rbS1eRhuKPc7do+zmc5O088FfripIviIr3UVu+nbZHuEhYCfO1XWBlbp6TrnOACpGTxkAZomjeKLbXIrm+urt7bzOI2uyyrGQ3DLuwWHy8813dc54d8Vrrc8sE9slrIuDGvnB/MGSPQc/LXR0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZmu6zDommyXMis8m1vKiUZLsFJx+ladZWvWWlXlpGuqzrBGJAI5DP5JDN8uA2Ryc4x3oAoxeN9ExFHNdqly4AMQUn5iCSo9SMHjrUNz4p8P3UK2eoyo4lLEqqsQNruFORyDmJ8e6mll8A6FNG8TJdeVIctH9pfaSRgnGep6565GetVH+H1udaW8ivHS3EZTy/m3jLyO+G3YwxlbqpIHQigC3b+NPC1pbIkV8kUQBbBVgVGM5bPP4mtHQdcGt/b2WFo0trnyV3DBYbFbJH/AqzJvAvh2JJZrhZEiMeyYvcMqtGFAw/OCMDvV/w3BotvBcpo92LgNIHmJuDKwbaAM5JI+UDHtQBSTxnaR3eoC9At7e1meJWwSxEeBI5HZQWXn3ra0vV7PWbY3Nk7SQhiu8oVBIODjPUVm3Hg3SLppmmjlYzvM0n71huWXbvQ/7J2Lx7Vq6Zp1vpNhHZWoYQx52hmyRkk9fqaAMPS/HGmX0WJ2aC5EhQxFCef3mMHuD5T/981I/jnQEfb9rdiVDArCxBBQSDnH9xgfpVHVPDvhXSYVuNU1BbCNmVEmnvvJGQZGADEjn97J+B9qS18P+E5JbmytdQSSWyULPEl7uaACHyfnGcr8gxz35oA05fGmhQiUvdt+7YKQI2JJIJGBjpwfyq9dSadc2MGpzgSQW/wDpUUgBO07SNwA9ifzrnP8AhFvCen2C3734isywYXEt9+7J5A+YnH8RFbfkaNe2EvhpLyKQx26rJbx3A81IyPlJAOQDxz3oArSeONAiWBnu22TJ5gYRsQo3lOSBgfMCKpH4gaZNcRpaOGiZFZpJVZNu5lC8Y6ENwaoP4e8NwXlxF/btqttawmCa1lugTFK8hlBkJbPJyQpxV618C6Na6Zbte3DyvDbxxy3JlKq6ptIJ54UbR3oA018X6O0kKGd186VYomaJgrliqqQcYIJZQPrVe28a6ZcrHIGdEkRmSN0IkYiRk4X/AICTVFvC3hT7RaIdQYSIFltozqB4RXEi7Bu+6DGCMccH3oTQfCG62li1KMb5GS1Zb/8AjLlyqHPXLHgdjigDa0zxVpGsXhtbG6MsgXd9wgEcdyPcUvibVbrRNBvNUtraOdbOCS4lV32/KiFiB7nFV7LwbpWnTia0+0ROOm2dh6Z7/wCyP1rV1TToNX0q70263fZ7qJoZQjbSUYYIz7gmgDGXxdbWgEOrYguvKWcpCrOojY4Uk4wMkEfhT28b6AkgVr3AMayb9h24IBHOMdxUt74V06/DiczkvDDCSJSDtiYsvT3Jz61UHgPRhEIx9p2gBRmYngDGOfbigDoobiKe2S4Rv3TqHBIxx+Nc7pvjrSb7Tbm9lZ4Fgu/sxVlLM27BjYAdmVlI+vtWx/Y9qNC/sdPMS08j7ONrncExj73Xp3rOn8HaTNfveLHJDI4i3rE+1GMZJQlRxkZPPpxQBoaVren61G72E/mKm0tlSpAYZBwR3FYsHjS3OrXdpdBLX7PIyNHLkSn5gqMo/iDEjGPUCtfSNCs9F8z7J5nzoiHe5bhBhf0NULrwVpF7cLNci4leJmaHdMx8liwfKnqCGVSPTHFAFvT/ABNpWqXAgs52lk3NGwCH5HGco391htPB/qKZ4g8SWvh0WbXKsy3Eyxkr/Ap43H2BI/Om6Z4T0zSNQkvrT7Qs0zNJPmZis0hzmRlzgt8x5+noMWNT0Cw1fzxfRGVZoDAVJ4Cn09D70AVpfF2kxarHpvmyvcPcfZzshYqr+W0mM4x91SeKj0HxK2vXrJBAn2ZLWCZpgxwzSoHXb6jB61JH4UsIxEVlufMiuxdpJ5p3CQRmLr6FCQR71Y0Tw9ZaBCYrLzQhiihAdy2FjQIgH4AUAatFFFABRRRQBm+IdRttI8PX+o3kHn21tC0sseAdygZIwevFQSX3h8yz20z2JljB86IqrEHIyCMcnJXj1IqzrukQ6/oV7pFxLLFDeRNDI8WNwU8HGQR+lYt34Fs7q+e9F/dxXRna4WRBH8jnyuQCvOPJXg+pzmgDolFpf2aELFPbOAVBUMpHbikfTrGQuZLK3cyEF90SncR0zxzjtRZWr2kHlPdS3HPDSKoI/wC+QKs0AVf7NsQMfYrb0/1S+mPT04+lCaZYRklLK2UnrtiUZ/SrVFAEbwQywmGSJHiIwUZQVI+lRiwswkSC0gCwndGPLGEPqOOKsUUAUX0iyeeGUQqhicyBYxtVm9WA61PBZ21tbm3hgRISWJQDg7jk8e+TU9FAEf2eHyRD5MflKu0JtGAMYxj0xRHbwQoiRwxoiDCqqgBR7elSUUANkjSaNo5EV0YYZWGQR6EVEbK1ZIka2hKQ/wCrUxjCfT0qeigCq2mWDoEaytioG0AxLwPTpUkVrBDaLaRwotuqbBHj5dvTGPSpqKAIVtbdRhYIgNgj4QfdHRfp7VE2lac4iDWFqREMR5hX5B7ccVbooAgjsrWKyWyS3jFsq7BFtyu30xTW06xf71lbnEflcxL9z+706e1WaKAKv9mWBOfsNtn/AK5L/h7Ci1sIbSe4mTeZJ23OztnA7AegGTx71aooAgaytXuBcNbQtOOkhjBb8+tRjS9PUqRY2wKnIxCvBzn09at0UAUxpOmrnGn2oznOIV5yCD29CR+NDaRprOHbTrQsOhMK56AensPyq5RQBTGk6cJ4ZlsrdZYTmNljAK/TFXKKKACiiigAooooAKKKKACiiigAooooAKKKKACsPxVp91qWmW8NpF5ki3cMjDcBhVYEnn2rcooA84HhzxQLm1nE12XjuBNme+MgRjHcpuALHgeZCSvcKevNPi8NeIprMLLc6rFItnOBv1dmPnt5YQ5QrkDEpGc43Dp0HolFAHHt4e1S78H3ulTXEnnm43wG4nMpZFZWCsxJODgjk96o6h4c1jVvEEeq7brT4nFvazW9veeU7Ro0jO7NGw4+cAAEnvxXfUUAeRWdv4t1SG9NrNqvmyyMVZ7poxEuZdvBcYf5kyAABsHy9QdO60HxhJcXM8NxfK00jOqHUDsUZG1cB+B1ztwf5V6VRQBxXjfwxeeIYNNFqs8d7aq7QXMVyFSCYhcGRGB8xMjnqcZ45rnNf8IeIdd1PWpE0a2s1lSKGK4iulVriJJQ7KVUfKXJZiSeyj1J9YooA4C10DXpNDNrqq3U9+Nhhu47/AicZ2vtyANuQGxnd6Gta20bVYtYu7qyuHsElx54nPnpcSAj94ibvkyowenbjiupooA4O88KX10byWzF1ZF5/OtoZLhZFjmYSrLJ8xYBGWT7o75OAevQ2dtOnhmbTPs8ga2gNpEXI/fBYwA341t0UAefXXgq+vVsdu2LZbIbmGcq8UsiROiLwNwGX+Yg4IGB1NZ9t4F1qCGaEsZEnhe3SWaRTNCC0Tb5GBw5+RhkZOFT3x6jRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf//Z']"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "base64_list = encode_image(path)\n",
    "base64_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "65e2dabc",
   "metadata": {},
   "outputs": [],
   "source": [
    "def pdf_to_text(pdf_path, txt_output_path=None):\n",
    "    doc = pymupdf.open(pdf_path)\n",
    "    text = \"\"\n",
    "    for page in doc:\n",
    "        text += page.get_text()\n",
    "    doc.close()\n",
    "    \n",
    "    if txt_output_path:\n",
    "        with open(txt_output_path, \"w\", encoding=\"utf-8\") as f:\n",
    "            f.write(text)\n",
    "    \n",
    "    return text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "cf40999e",
   "metadata": {},
   "outputs": [],
   "source": [
    "text = pdf_to_text(\"data/pdf/PIIS0022522319384089.pdf\", \"data/txt/PIIS0022522319384089.txt\")\n",
    "text1 = pdf_to_text(\"data/pdf/TAH2015.pdf\", \"data/txt/TAH2015.txt\")\n",
    "text2 = pdf_to_text(\"data/pdf/Living_With_a_Total_Artificial_Heart.pdf\",\"data/txt/Living_With_a_Total_Artificial_Heart.txt\")\n",
    "text3 = pdf_to_text(\"data/pdf/Artificial_hearts.pdf\", \"data/txt/Artificial_hearts.txt\")\n",
    "text4 = pdf_to_text(\"data/pdf/16877accepted_Version.pdf\", \"data/txt/16877accepted_Version.txt\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "7306095c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " \n",
      "The ongoing quest for the first total artificial heart as\n",
      "destination therapy\n",
      "Citation for published version (APA):\n",
      "Vis, A., Arfaee, M., Khambati, H., Slaughter, M. S., Gummert, J. F., Overvelde, J. T. B., & Kluin, J. (2022). The\n",
      "ongoing quest for the first total artificial heart as destination therapy. Nature Reviews. Cardiology, 19(12), 813-\n",
      "828. https://doi.org/10.1038/s41569-022-00723-8\n",
      "DOI:\n",
      "10.1038/s41569-022-00723-8\n",
      "Document status and date:\n",
      "Published: 01/12/2022\n",
      "Document Version:\n",
      "Accepted manuscript including changes made at the peer-review stage\n",
      "Please check the document version of this publication:\n",
      "• A submitted manuscript is the version of the article upon submission and before peer-review. There can be\n",
      "important differences between the submitted version and the official published version of record. People\n",
      "interested in the research are advised to contact the author for the final version of the publication, or visit the\n",
      "DOI to the publisher's website.\n",
      "• The final author version and the galley proof are versions of the publication after peer review.\n",
      "• The final published version features the final layout of the paper including the volume, issue and page\n",
      "numbers.\n",
      "Link to publication\n",
      "General rights\n",
      "Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners\n",
      "and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.\n",
      "            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.\n",
      "            • You may not further distribute the material or use it for any profit-making activity or commercial gain\n",
      "            • You may freely distribute the URL identifying the publication in the public portal.\n",
      "If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above, please\n",
      "follow below link for the End User Agreement:\n",
      "www.tue.nl/taverne\n",
      "Take down policy\n",
      "If you believe that this document breaches copyright please contact us at:\n",
      "openaccess@tue.nl\n",
      "providing details and we will investigate your claim.\n",
      "Download date: 24. Jul. 2025\n",
      "The ongoing quest for the first total artificial heart \n",
      "as destination therapy \n",
      "Annemijn Vis1,2, Maziar Arfaee1,2, Husain Khambati1,2, Mark S. Slaughter3, Jan F. Gummert4, \n",
      "Johannes T. B. Overvelde5,6 and Jolanda Kluin1,2  \n",
      " \n",
      "Affiliations: \n",
      "1. Cardiothoracic Surgery,Amsterdam UMC location University of Amsterdam, Amsterdam, The \n",
      "Netherlands. \n",
      "2. Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences,Amsterdam, The Netherlands. \n",
      "3. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY, USA. \n",
      "4. Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University \n",
      "Bochum, Bad Oeynhausen, Germany. \n",
      "5. Autonomous Matter Department, AMOLF, Amsterdam, The Netherlands. \n",
      "6. Institute for ComplexMolecular Systems and Department of MechanicalEngineering, Eindhoven \n",
      "University of Technology, Eindhoven, The Netherlands. \n",
      "e-mail: j.kluin@amsterdamumc.nl \n",
      " \n",
      " \n",
      "Abstract \n",
      "Many patients with end-stage heart disease die because of the scarcity of donor hearts. \n",
      "A total artificial heart (TAH), an implantable machine that replaces the heart, has so far been successfully \n",
      "used in over 1,700 patients as a temporary life-saving technology for bridging to heart transplantation. \n",
      "However, after more than six decades of research on TAHs, a TAH that is suitable for destination therapy \n",
      "is not yet available. High complication rates, bulky devices, poor durability, poor biocompatibility and low \n",
      "patient quality of life are some of the major drawbacks of current TAH devices that must be addressed \n",
      "before TAHs can be used as a destination therapy. Quickly emerging innovations in battery technology, \n",
      "wireless energy transmission, biocompatible materials and soft robotics are providing a promising \n",
      "opportunity for TAH development and might help to solve the drawbacks of current TAHs. In this Review, \n",
      "we describe the milestones in the history of TAH research and reflect on lessons learned during TAH \n",
      "development. We summarize the differences in the working mechanisms of these devices, discuss the \n",
      "next generation of TAHs and highlight emerging technologies that will promote TAH development in the \n",
      "coming decade. Finally, we present current challenges and future perspectives for the field. \n",
      " \n",
      "Introduction \n",
      "Cardiovascular disease is the leading cause of death globally, and heart failure, one of the end points of \n",
      "cardiovascular disease, affects approximately 2% of the adult population worldwide1. The estimated \n",
      "prevalence of heart failure will increase markedly owing to the ageing global population. It is predicted \n",
      "that by 2030, more than 8 million people in the USA (1 in every 33) will have heart failure2. Heart \n",
      "transplantation is currently considered the gold standard treatment for end-stage heart failure. However, \n",
      "a tremendous shortage of donor hearts exists worldwide. In 2018, more than 2,500 patients were actively \n",
      "awaiting heart transplantation in the USA alone3. To compensate for this shortage, mechanical devices to \n",
      "support the failing heart, such as left ventricular assist devices (LVADs), have been widely implanted over \n",
      "the past two decades as an alternative therapy for end-stage heart failure. At present, over 3,000 LVADs \n",
      "are implanted in North America every year, either as a bridge to heart transplantation or as destination \n",
      "therapy4. LVADs are a treatment option for patients with left ventricular failure but are not suitable for \n",
      "patients with severe biventricular failure or other conditions that preclude the use of LVADs5. \n",
      "Furthermore, LVAD support is associated with poor quality of life and a risk of complications, such as \n",
      "thromboembolic events, bleeding and driveline infections6,7,8,9. A total artificial heart (TAH) is a surgically \n",
      "implanted pump that provides blood circulation and replaces cardiac ventricles that are diseased or \n",
      "damaged10. The TAH is implanted in an orthotopic position and replaces both the left and right ventricle \n",
      "of the native heart. In 1969, a TAH was implanted in a patient for the first time11. However, TAHs have so \n",
      "far primarily been implanted as a temporary bridging therapy for patients with advanced heart failure \n",
      "who are awaiting heart transplantation. The SynCardia TAH (SynCardia Systems, Tucson, AZ, USA) is the \n",
      "TAH that is most frequently implanted as a bridge to heart transplantation therapy and is under \n",
      "investigation in a clinical trial to assess its applicability as destination therapy12. However, the limitations \n",
      "of the SynCardia device, which include bulkiness, short durability, high complication rates and low patient \n",
      "quality of life owing to the need for percutaneous hoses and frequent hospitalizations, have so far \n",
      "precluded its approval for this indication. An urgent need for destination therapies for (biventricular) end-\n",
      "stage heart disease exists because the majority of patients have no prospect of recovery with currently \n",
      "available therapies. The rapidly emerging technologies in wireless energy transmission, biocompatible \n",
      "materials and soft robotics provide a promising outlook for TAH development. Many teams across the \n",
      "world have tried different approaches to develop various types of TAHs, of which only a few are still under \n",
      "development. In this Review, we describe the historical milestones and lessons learned during TAH \n",
      "development and discuss the current generation of TAHs and the differences in their working \n",
      "mechanisms. We also highlight new technologies that will promote TAH development in the coming \n",
      "decade. \n",
      "History of TAH development \n",
      "Animal experiments \n",
      "The development of TAHs dates back to the previous century. One of the first experiments with a TAH \n",
      "was reported in 1958, when pioneers Willem Kolff and Tetsuzo Akutsu at the Cleveland Clinic (Cleveland, \n",
      "OH, USA) implanted a TAH in a dog after removing its native heart13. The TAH sustained blood circulation \n",
      "in the dog for 90 min13. More experiments in dogs were conducted at the Cleveland Clinic in the 1960s, \n",
      "including implantation of a mechanical TAH with two blood chambers that were alternately emptied by a \n",
      "motor pendulum14 and implantation of two different pneumatically driven TAHs15. In the same period, \n",
      "Domingo Liotta (School of Medicine, Cordoba, Argentina) implanted a pneumatic TAH, named the Liotta \n",
      "Heart, in dogs16. These experiments inspired more researchers across the world to start developing TAHs. \n",
      "In Japan in 1963, Kazuhiko Atsumi (Tokyo University School of Medicine, Tokyo, Japan) developed several \n",
      "types of pneumatic and mechanical TAH and tested them in 56 dogs17. In 1964, a national artificial heart \n",
      "programme was initiated in the USA, sponsored by the National Heart, Lung and Blood Institute. This big \n",
      "nationwide project, led by Frank Hastings, aimed to develop novel technical advances (similar to the aims \n",
      "of the USA space programme) for generating TAHs. Boosted by the national artificial heart programme, \n",
      "TAH experiments were conducted in numerous research centres in the USA, such as at the Penn State \n",
      "Milton S. Hershey Medical Center18 and the Cleveland Clinic19. \n",
      "First TAH implantation in humans \n",
      "In 1969, Denton Cooley (Texas Heart Institute, Houston, TX, USA) performed the first TAH implantation in \n",
      "humans, implanting the Liotta–Cooley TAH in a patient aged 47 years11 (Fig. 1). The Liotta–Cooley device \n",
      "was a rigid pneumatic TAH with two ventricles implanted orthotopically. An external pump moved \n",
      "compressed air into a pneumatic chamber inside the ventricle, which pushed a diaphragm and caused the \n",
      "ejection of blood from the blood chamber on the other side of the membrane. The Liotta–Cooley TAH \n",
      "supported the patient for 64 h, after which the patient underwent heart transplantation11. The patient \n",
      "died owing to sepsis 32 h after the heart transplantation. Furthermore, the poor biocompatibility of the \n",
      "valves and the surfaces that were in contact with the blood might have contributed to haemolysis and \n",
      "renal impairment11. Therefore, although the first TAH implantation was ground-breaking, it was not \n",
      "considered a success20. However, this first implantation of a TAH in humans proved the concept that such \n",
      "technology could support a patient as a bridge to heart transplantation. However, the procedure sparked \n",
      "ethical and legal controversy regarding improper consent and experimentation21. In the years after the \n",
      "first implantation in humans, further research on TAH prototypes was conducted solely in large animal \n",
      "models by researchers from the University of Alberta (Edmonton, Alberta, Canada)22; the University of \n",
      "Utah College of Medicine (Salt Lake City, UT, USA)23,24,25,26; the University of Mississippi Medical Centre \n",
      "(Jackson, MS, USA)27,28; the Cleveland Clinic29,30; the Baylor College of Medicine (Houston, TX, USA)31; and \n",
      "the US Atomic Energy Commission (University of Utah, Salt Lake City, UT, USA)32,33,34. It took 12 years from \n",
      "the first TAH implantation in humans until the next human TAH implantation in 1981, again at the Texas \n",
      "Heart Institute, when the pneumatic Akutsu III TAH was implanted as a bridge to transplantation in a man \n",
      "aged 36 years35. The Akutsu III TAH worked similarly to the Liotta–Cooley TAH, with two inflatable air sacs \n",
      "to displace blood. The Akutsu III TAH supported the patient for 55 h, after which the patient received \n",
      "heart transplantation. However, in the last 27 h before the transplantation surgery, the patient could not \n",
      "be fully supported by the TAH and died 7 days after the heart transplantation owing to multiorgan \n",
      "failure35. The third TAH implantation in humans occurred in 1982 at the University of Utah, where William \n",
      "DeVries and Willem Kolff implanted the Jarvik-7 TAH as destination therapy in a patient aged 61 years \n",
      "with congestive heart failure36. The Jarvik-7 was a pneumatic device with a similar working mechanism to \n",
      "the Liotta–Cooley TAH. After implantation of the Jarvik-7 TAH, the patient was conscious and able to \n",
      "communicate with his family. Progressive circulatory shock led to his death 112 days after TAH \n",
      "implantation36. This first successful clinical outcome with the Jarvik-7 TAH encouraged many teams across \n",
      "the world to continue developing TAHs (Fig. 1). Most TAHs developed by the first pioneers were \n",
      "pneumatically or hydraulically driven; later, researchers developed TAHs with different working \n",
      "mechanisms. Currently available TAHs can be classified into three types on the basis of their working \n",
      "mechanism: fluid-driven TAHs, mechanical TAHs and continuous-flow TAHs (Fig. 2), which are discussed \n",
      "below. \n",
      "Working mechanisms of TAHs \n",
      "Fluid-driven TAHs \n",
      "Fluid-driven TAHs are the oldest type of TAH, with a working mechanism similar to that of the Liotta–\n",
      "Cooley and Jarvik-7 TAHs. Fluid-driven devices have blood chambers separated by a membrane from a \n",
      "chamber filled with fluid (air or liquid). A pressure rise in the fluid chamber moves the flexible membrane \n",
      "so that the blood chamber empties and the blood is ejected (Fig. 2a). A pump is required to increase the \n",
      "pressure in the pneumatic or hydraulic chamber. Often, these pumps are placed outside the body, which \n",
      "requires percutaneous hoses to move the pressurized fluid from the pump to the TAH. Depending on the \n",
      "type of pump used in these pneumatic and hydraulic devices, the left and right chamber eject blood either \n",
      "simultaneously or alternatingly. More recently developed TAHs (such as the Carmat TAH (Aeson; Carmat, \n",
      "Vélizy-villacoublay, France)) are designed to have the pump implanted in the body, avoiding the need for \n",
      "percutaneous pneumatic or hydraulic pressure hoses. However, percutaneous cables to supply power to \n",
      "the TAH are often still needed. \n",
      "Historical devices \n",
      "Several pneumatic TAHs were developed in the 1980s, such as the Brno TAH (Vacord Bioengineering \n",
      "Research Company, Brno, Czech Republic)37, Penn State pneumatic TAH (Pennsylvania State University, \n",
      "Hershey, Pennsylvania)38, Phoenix (Southern Taiwan University, Tainan, Taiwan)39,40, Poisk TAH (Institute \n",
      "of Organ and Tissue Transplantation, Moscow, Russia)41,42, POLTAH (Artificial Heart Laboratory, Zabrze, \n",
      "Poland)43 and Vienna TAH (University of Vienna, Vienna, Austria)44. In the same period, the \n",
      "electrohydraulic TAH (EHTAH) was developed in Japan (Artificial Organs Department, Osaka, Japan)45. \n",
      "Development of the hydraulically driven AbioCor (Abiomed, Danvers, MA, USA) started in the 1990s46,47,48. \n",
      "AbioCor was the first fully implantable system designed without any percutaneous cables; it consisted of \n",
      "four internal components and a transcutaneous energy transfer (TET) system. The characteristics of all the \n",
      "TAHs discussed in this Review are summarized in Table 1. \n",
      "Current devices \n",
      "Two fluid-driven devices, SynCardia49 and the Carmat TAH, are currently in use as a bridge to \n",
      "transplantation and are undergoing further evaluation as destination therapy. Another fluid-driven TAH, \n",
      "SoftHeart (ETH Zurich, Zurich, Switzerland)50, is currently under development51,52. The working mechanism \n",
      "of these three prototypes is very similar to the earliest devices, such as the Liotta–Cooley and Akutsu III \n",
      "TAHs. The history of the development of SynCardia dates back 40 years to 1982, when Kolff and DeVries \n",
      "performed the first successful implantation of a TAH in a patient36. This TAH, the Jarvik-7, is now known as \n",
      "SynCardia. SynCardia is a pneumatically driven TAH consisting of two independent ventricles that collect \n",
      "and eject blood simultaneously in a pulsatile manner. A four-layer polyurethane membrane separates the \n",
      "blood in the ventricle from the pneumatic chamber. The pressures in the pneumatic chamber are \n",
      "generated by a pump placed outside the body and connected via percutaneous drivelines. SynCardia is \n",
      "the first TAH that received CE approval (in 1999) and FDA approval (in 2004) for temporary use as a bridge \n",
      "to heart transplantation in eligible candidates who are at risk of imminent death from end-stage \n",
      "biventricular failure53,54. This TAH has been implanted in over 1,700 patients worldwide55. The Carmat \n",
      "system is a hydraulic TAH developed in France that received CE approval as a bridge to transplantation \n",
      "therapy in 2020. The Carmat TAH consists of left and right blood chambers separated from the hydraulic \n",
      "pressure chamber by a two-layer biocompatible membrane made from bovine pericardium. The pumps \n",
      "that pressurize the hydraulic pressure chambers of the Carmat TAH are built within the TAH itself, making \n",
      "this device larger than SynCardia. Furthermore, the Carmat TAH ejects blood from the left and right blood \n",
      "chambers alternatingly. Although percutaneous pressure hoses are not required to pressurize the \n",
      "hydraulic chamber, the Carmat system requires percutaneous cables to deliver the required electrical \n",
      "power to the TAH. The Carmat TAH has been implanted as a bridge to transplantation in 24 patients in \n",
      "clinical trials (as of February 2022)56. SoftHeart is a pneumatically driven TAH entirely made of silicone \n",
      "rubber (except for its mechanical heart valves), and is the only completely soft TAH developed so far. \n",
      "SoftHeart has been tested only in vitro50,57. Although the durability of SoftHeart has been improved \n",
      "compared with earlier iterations, it is still limited to only 110,000 cycles (approximately 30 h)50,57. \n",
      "Mechanical TAHs \n",
      "The functionality and clinical applicability of fluid-driven TAHs were demonstrated in the early 1990s, but \n",
      "some of their disadvantages also became apparent. These TAHs were bulky, had poor durability and \n",
      "required percutaneous air pressure hoses and external drivers, which led scientists to explore alternative \n",
      "working mechanisms and shift the focus to mechanically actuated TAHs58. Mechanically actuated TAHs \n",
      "have many similarities to fluid-driven TAHs: both have two chambers to collect and eject blood, and inlet \n",
      "and outlet valves to direct the flow (Fig. 2b). Like fluid-driven TAHs, mechanical TAHs have a moving \n",
      "membrane to empty the blood chambers. However, instead of emptying the blood chambers with the use \n",
      "of pressurized gas or liquid (as in fluid-driven devices), mechanically actuated TAHs have an electric motor \n",
      "that drives a pusher plate against the blood chambers. Compared with fluid-driven TAHs, mechanical \n",
      "TAHs are less bulky and, most importantly, do not require large external drivers. \n",
      "Historical devices \n",
      "Multiple mechanical TAHs were developed in the 1990s by different teams and institutions: AnyHeart \n",
      "(Seoul University, Seoul, South Korea)59,60,61, Baylor TAH (Baylor College of Medicine)62,63, Cleveland \n",
      "Nimbus (Cleveland Clinic)64,65, eccentric roller TAH (Hiroshima University, Hiroshima, Japan)66, Linear TAH \n",
      "(Shinshu University, Nagano, Japan)67,68, MagScrew (Cleveland Clinic)69, Milwaukee Heart (Milwaukee \n",
      "Heart Project, Milwaukee, WI, USA)70, Ovalis (Humboldt University, Hamburg, Germany)71 and Penn State \n",
      "electric TAH (Pennsylvania State University)72. These TAHs can be classified on the basis of their working \n",
      "mechanism as TAHs with mechanical actuation parts with either linear or rotary motion. \n",
      "Current devices \n",
      "We have identified three mechanically actuated devices that are still under development: Realheart TAH \n",
      "(Linköping University, Linköping, Sweden)73,74, ReinHeart (Helmholtz Institute, Aachen, Germany)75 and \n",
      "RollingHeart (University of Lausanne, Lausanne, Switzerland)76. None of these devices has been assessed \n",
      "in clinical trials. Realheart and ReinHeart are fully implantable systems, including a TET system and \n",
      "internal battery packs. Both TAHs are actuated with magnets and are being assessed in animal studies. \n",
      "The RollingHeart is a mechanically actuated TAH developed in Switzerland and has only been tested in \n",
      "vitro. This TAH has a spherical shape, and two moving disks divide the spherical cavity into four chambers. \n",
      "An electrical motor moves the disks and thereby changes the volume of the chamber over time, which \n",
      "enables the filling and ejection of the blood. The design is unique because it does not require any valves. \n",
      "However, issues in the design of this TAH related to the recirculation and mixing of oxygenated with \n",
      "deoxygenated blood need to be addressed76. \n",
      "Continuous-flow TAHs \n",
      "A major disadvantage of the above-mentioned fluid-driven and mechanical devices is that they require \n",
      "several indispensable components, such as blood collecting chambers, flexible membranes and valves. As \n",
      "a result, these devices are often bulky and usually do not fit inside petite patients, such as children and \n",
      "some women. The flexible membranes present in these devices are often prone to wear and tear because \n",
      "they deform with every heartbeat (about 35 million times a year). Continuous-flow pumps were \n",
      "introduced as an alternative to traditional pulsatile devices. Because blood is pumped continuously in \n",
      "these devices, they do not require valves, membranes or blood collecting chambers. Therefore, \n",
      "continuous-flow TAHs are smaller and lighter than other types of TAHs. In addition, their lifetime is longer \n",
      "owing to the absence of flexible membranes and the continuous rotation of their motors in a single \n",
      "direction. In the past two decades, substantial progress has been achieved in the field of continuous-flow \n",
      "LVADs, whose efficacy has been proved in clinical trials77. The longest reported duration of LVAD support \n",
      "without mechanical failure is 13 years77,78. These positive results inspired many TAH researchers to use \n",
      "continuous-flow pumps for TAH development, mainly because of their superior power-to-size ratio and \n",
      "durability compared with fluid-driven and mechanical TAHs. After implantation of a regular continuous-\n",
      "flow LVAD, some blood flow pulsatility remains because the native heart is left in place. By contrast, \n",
      "continuous-flow TAHs eject blood continuously and generate a true continuous blood flow. Given that the \n",
      "physiological response to long-term continuous blood flow is unclear79,80,81, most of the investigators \n",
      "developing continuous-flow TAHs are exploring the possibility of modulating the flow to provide some \n",
      "level of pulsatilily79. So far, achieving the same pulsatility index as with the native heart or the pulsatile \n",
      "TAHs has not been possible. \n",
      "Historical devices \n",
      "The first continuous-flow TAHs were developed in the 1990s. We have identified three continuous-flow \n",
      "TAH devices, which are no longer in use: the flow-transformed pulsatile TAH (University of Tokyo, Tokyo, \n",
      "Japan)82, the undulation pump TAH (UPTAH) (University of Tokyo, Tokyo, Japan)83 and the Impeller TAH \n",
      "(Jiangsu University, Zhenjiang, China)84. \n",
      "Current devices \n",
      "Although LVADs were developed to assist the native left ventricle, these devices are powerful enough to \n",
      "take over the function of the native ventricle completely. Therefore, several research groups have \n",
      "investigated the efficacy of two commercially available LVADs (such as HeartMate II, Heartmate III, \n",
      "HeartWare HVAD, Jarvik 2000 and HeartAssist 5) combined into a TAH configuration after removing the \n",
      "native heart85,86,87,88,89,90,91,92,93,94. The configuration of two LVADs functioning as a TAH has been tested in \n",
      "animal studies and clinical trials85,86,87,88,89,90,91,92,93,94. In this Review, we refer to the configuration of two \n",
      "commercially available LVADs functioning as a TAH as ‘LVAD–TAH’. Many TAH developers have used \n",
      "continuous-flow pump technology to develop custom-built TAH devices. Several continuous-flow TAHs \n",
      "are currently under development: BiVACOR (BiVACOR, Houston, TX, USA)95, Cleveland continuous-flow \n",
      "TAH (CFTAH)96,97 and helical-flow TAH (HFTAH) (University of Tokyo, Tokyo, Japan)98 are being assessed in \n",
      "chronic animal experiments, and Hybrid CFTAH (Drexel University, Philadelphia, PA, USA)99 and \n",
      "OregonHeart (OregonHeart, Portland, OR, USA)100,101 are undergoing in vitro testing. \n",
      "Balancing right and left cardiac outputs of TAHs \n",
      "A major issue that must be addressed for successful TAH implantation is the balancing of the right and left \n",
      "cardiac outputs20. In a physiological setting, the cardiac output of the left ventricle is slightly greater than \n",
      "the cardiac output of the right ventricle102, because part of the oxygen-rich blood from the aorta goes into \n",
      "the bronchial arteries that supply the lung parenchyma, which then drains back to the left atrium103,104. \n",
      "Therefore, part of the blood ejected by the left ventricle returns to the left atrium without passing \n",
      "through the right circulation, resulting in a larger systemic flow than pulmonary flow. In healthy \n",
      "individuals, the bronchial shunt flow is approximately 1% of the cardiac output103. However, various \n",
      "pulmonary diseases increase the bronchial shunt flow to up to one-third of the left ventricular output103. \n",
      "A study showed that three out of five patients with an implanted AbioCor TAH had increases in bronchial \n",
      "flow of up to 1.4 l/min, which is 28% of a cardiac output of 5 l/min105. The native heart continuously \n",
      "balances the systemic and pulmonary flows by ventricular interdependence, via the Frank–Starling \n",
      "mechanism102, but this balancing mechanism is difficult to implement in TAHs. If a TAH cannot \n",
      "compensate for flow differences in venous return, severe complications such as lung oedema and \n",
      "respiratory failure will arise20. Therefore, balancing the outputs to the systemic and pulmonary \n",
      "circulations during TAH support is one of the biggest challenges in TAH design20,106. Pulsatile TAHs can \n",
      "alter the stroke volume of one of the blood chambers if a sudden change in atrial pressure occurs. The \n",
      "stroke volume can be adjusted in two ways: by adjusting the filling volume inside the chamber or by \n",
      "adjusting the ejection fraction. This adjustment is an active process that requires either manual control or \n",
      "automatic control by feedback from incorporated sensors. In the Carmat system, many internal \n",
      "electronics, microprocessors and sensors are needed to constantly monitor different internal pressures, \n",
      "as well as an ultrasound transducer to monitor the position of the membrane107. In SynCardia, the system \n",
      "parameters are manually set to fill the ventricles to 70–85% of their capacity, to create a buffer that \n",
      "passively enables the augmentation of venous return108. As a result, SynCardia is sensitive to preload, \n",
      "demonstrating Frank–Starling-like behaviour under normal conditions108. Therefore, Syncardia can \n",
      "provide increased output in response to increased preload. However, the shape of the Syncardia Frank–\n",
      "Starling curve differs from that of the human heart, because this TAH is inelastic108,109. ReinHeart’s design \n",
      "uses the concept of passive and active limitation of the right-sided filling, in combination with the right \n",
      "ventricle having a fixed volume that is 10% smaller than that of the left ventricle110. A balancing \n",
      "mechanism is also required for continuous-flow TAHs, because a sudden drop in atrial pressure quickly \n",
      "results in negative atrial pressures (suction event). Continuous-flow TAHs that have two separate pumps \n",
      "for the left and right circulation (such as in the LVAD–TAH, Hybrid CFTAH and HFTAH) have some inherent \n",
      "flow-balancing capacity98,99,106. However, a study testing the performance of several types of continuous-\n",
      "flow TAHs made from two separate pumps in an in vitro set-up in which systemic and pulmonary \n",
      "resistance were changed to mimic the human cardiovascular system during daily activities showed that, \n",
      "although all the devices had some flow-balancing capacity, none was able to accommodate all resistance \n",
      "settings106. Cleveland CFTAH, BiVACOR and OregonHeart use a single moving rotor to perfuse the \n",
      "pulmonary and systemic circulations. The rotor of the OregonHeart is typically set to pump 60% of each \n",
      "beat time to the left circulation and 40% to the right circulation, but this ratio can be adjusted manually to \n",
      "meet the needs of a wide range of physiological conditions101. BiVACOR incorporates an axial magnetic \n",
      "levitation system, which enables active control of the position of the single moving rotor95. A leftward \n",
      "shift of the rotor causes an increase in left-sided flow95. The Cleveland CFTAH uses a similar mechanism, \n",
      "but in this TAH, the rotor can have passive axial movements inside the stator, enabling the TAH to balance \n",
      "the left and right outputs passively, without any sensors111. The axial position of the rotor is determined \n",
      "by the pressure gradient between the left and right blood chambers. When the pressure drops in one of \n",
      "the blood chambers, the rotor passively moves to that side, which helps to prevent atrium wall suction \n",
      "and balances the cardiac outputs111. This low-complexity passive feedback mechanism inherently reduces \n",
      "the risk of device failure compared with the complex active feedback mechanisms in other TAHs. \n",
      "Chronic animal trials \n",
      "Chronic animal trials are an important step in the preclinical testing of new TAHs. Chronic animal trials \n",
      "have been conducted for AbioCor, AnyHeart, Baylor TAH, BiVACOR, Brno TAH, Carmat TAH, Cleveland \n",
      "CFTAH, Cleveland Nimbus, EHTAH, HFTAH, LVAD–TAH, MagScrew, Penn State electric TAH, Penn State \n",
      "pneumatic TAH, Phoenix, ReinHeart, SynCardia, UPTAH and Vienna TAH (Table 2). Calves are the most \n",
      "frequently used animal model for TAH implantation, followed by goats and sheep. In most of the older \n",
      "chronic animal trials, the animal was implanted with a TAH and was followed up until death. In \n",
      "contemporary studies, researchers often terminate the experiments after a given follow-up period \n",
      "(usually 30–90 days, according to FDA regulations), by taking out the TAH. For the latter studies, elective \n",
      "termination is assigned as the cause of death in Table 2. Nevertheless, the follow-up time in chronic \n",
      "animal trials is often short. Only ten TAH devices were associated with a maximum survival time \n",
      "exceeding 100 days (AbioCor112, Brno TAH37, Cleveland Nimbus113, EHTAH114, HFTAH98, Penn State electric \n",
      "TAH115, Penn State pneumatic TAH38, SynCardia25, UPTAH83 and Vienna TAH44) and only one device was \n",
      "associated with a maximum survival time of over a year (Penn State electric TAH)115. Overall, the most \n",
      "frequently reported cause of death in chronic animal trials is mechanical failure of the device. Examples of \n",
      "mechanical failure that occurred in chronic animal trials include an electrical short circuit caused by fluid \n",
      "entering the electronics, dislocation of TET coils, obstruction of the inflow or outflow grafts of the TAH, \n",
      "membrane ruptures, air leakage in pneumatic devices, failure of the implantable battery and a defect or \n",
      "lock in pump bearings26,69,83,93,98,114,116,117,118,119. The second- and third-most frequently reported reasons \n",
      "of death are thromboembolic complications and respiratory failure, respectively. \n",
      "Clinical trials \n",
      "Since the first successful implantation of a TAH in humans in 1982, a total of nine different TAH devices \n",
      "have been assessed in patients in clinical trials: AbioCor, Brno TAH, Carmat TAH, LVAD–TAH, Penn State \n",
      "pneumatic TAH, Phoenix, Poisk TAH, SynCardia and Vienna TAH (Table 3). These TAHs are pneumatic or \n",
      "hydraulic pulsatile devices, except the continuous-flow LVAD–TAH. \n",
      "Early studies in humans \n",
      "Several fluid-driven TAHs were tested in humans in the 1980s and 1990s. Overall, the outcomes were \n",
      "poor, and many patients died within the first days after receiving a TAH or could not successfully receive a \n",
      "heart transplant120,121,122. The Brno TAH, developed in the Czech Republic, was implanted in six patients120. \n",
      "All patients died of serious complications related to poor device biocompatibility, with a maximum \n",
      "survival of 10 days120. The Phoenix TAH was implanted in two patients121,123. One patient received a heart \n",
      "transplant on the same day as TAH implantation but died 1 day after receiving the heart transplant121. The \n",
      "other patient was successfully bridged to heart transplantation after 15 days of support with the Phoenix \n",
      "TAH123. The Poisk TAH was developed in Russia and has been implanted in 13 patients122. Of these \n",
      "patients, 12 died during support with the Poisk TAH, for unknown reasons. The maximum period of \n",
      "support was 15 days122. The Vienna TAH was implanted in five patients, and three of these patients were \n",
      "successfully bridged to heart transplantation44,124. The maximum duration of support was 22 days44,124. \n",
      "The Penn State pneumatic TAH was implanted in three patients38. Two of the patients were bridged to \n",
      "heart transplantation, and the third patient did not receive a heart transplant because a suitable donor \n",
      "was not found. After 70 days of support, the patient had a cerebrovascular accident, manifested by \n",
      "aphasia. The TAH support stopped on day 379 when this patient had a respiratory arrest and could not be \n",
      "resuscitated38. \n",
      "Latest clinical trials \n",
      "AbioCor, the first fully implantable TAH that used a TET system, was implanted in 14 patients between \n",
      "2001 and 200348. The maximum duration of support was 512 days, which occurred in a patient who died \n",
      "owing to a membrane rupture in the device125. The most frequently observed causes of death were \n",
      "thromboembolic complications and multiorgan failure125. The development of AbioCor stopped in 2007 \n",
      "owing to concerns related to the high number of patients who died because of complications of stroke \n",
      "(caused by an ineffective anticoagulation regimen), the low quality of life of the patients and the poor \n",
      "commercial viability20,79. Since 2011, several teams worldwide have studied the use of a combination of \n",
      "two commercially available rotary LVADs (HeartMate II, HeartMate III or HeartWare HVAD) adapted to a \n",
      "TAH configuration to replace the native heart completely86,87,89,90,91,94. These LVAD–TAHs have been \n",
      "implanted in nine patients86,87,89,90,91,94, with a maximum reported duration of support of 6 months89. The \n",
      "most frequently reported complications were related to thromboembolic and haemorrhagic \n",
      "events86,87,89,90,91,94. The pneumatically actuated SynCardia, the first TAH that became commercially \n",
      "available as a bridge to transplantation therapy, is currently available in two sizes (70 cm3 or 50 cm3 \n",
      "ventricles), which enables its implantation in patients of various body sizes. The youngest recipient of a \n",
      "50 cm3 SynCardia is a boy aged 10 years126. So far, Syncardia has been implanted in over 1,700 patients \n",
      "worldwide, with a maximum reported duration of support of 4.5 years receiving permanent SynCardia \n",
      "support55,127. Despite the poor prognosis that the SynCardia recipients have before TAH implantation, the \n",
      "long-term survival of recipients of a heart transplant after temporary support with SynCardia is \n",
      "encouraging and comparable with the long-term survival of recipients of a heart transplant who did not \n",
      "receive SynCardia support128. Twelve months after the SynCardia implantation, 55% of the patients had \n",
      "received heart transplantation, 14% were still supported by the SynCardia device and 31% died before \n",
      "undergoing a heart transplantation129. SynCardia is currently being evaluated in an approved \n",
      "investigational device exemption clinical trial for use as destination therapy12. \n",
      " \n",
      "The care of patients receiving SynCardia support remains challenging128. The percutaneous hoses are \n",
      "frequently associated with driveline infections, and the TAH material itself often causes mediastinitis and \n",
      "constrictive pericarditis128. The period after heart transplantation is associated with a high risk of \n",
      "(temporary) haemodialysis owing to impaired renal perfusion and postoperative compression of the \n",
      "donor heart128. The risk of post-transplantation complications increases with prolonged TAH support128. \n",
      "The most frequently reported causes of death during support with a SynCardia device are multiorgan \n",
      "failure (40%), thromboembolic complications (13%) and infection (10%)129,130,131,132,133,134,135,136. Although \n",
      "minor device malfunctions are frequently described in the literature, severe device malfunctions that lead \n",
      "to death are rare (<2% of the deaths during SynCardia support)129,130,131,132,133,134,135,136. The hydraulic TAH \n",
      "developed by Carmat received CE approval as bridge to transplantation therapy in 2020, but the company \n",
      "is continuing clinical research with the aim of ultimately using the Carmat TAH as destination therapy56. \n",
      "The Carmat TAH has been implanted as a bridge to transplantation in 24 patients (as of February \n",
      "2022)107,137,138. Patient enrollment for the second clinical trial on the Carmat TAH is ongoing56. Although \n",
      "the Carmat TAH was designed to promote biocompatibility, given that its diaphragms and valves are made \n",
      "from bovine pericardium, all patients must receive a strict anticoagulation regimen138. Thus far, the \n",
      "clinical outcomes of 11 recipients of the Carmat TAH have been described in the literature107,138, with a \n",
      "maximum support duration of 308 days138. Of these patients, six died during TAH support, and the other \n",
      "five were successfully bridged to heart transplantation107,138. The causes of death were multiorgan failure \n",
      "(50%), mechanical failure (33%) and respiratory failure (17%). No thromboembolic complications were \n",
      "observed107,138. To date, no TAH has been approved as destination therapy. Only the SynCardia and \n",
      "Carmat TAH are approved as temporary therapy to bridge a severely ill patient to heart transplantation. \n",
      "The percutaneous drivelines of both TAHs are associated with low quality of life and a high risk of \n",
      "infection128. Long-term support with the SynCardia TAH is associated with serious risks such as stroke and \n",
      "multiorgan failure128,129,130,131,132,133,134,135,136. \n",
      "Technological advances and future perspectives \n",
      "TET systems to improve quality of life \n",
      "The TAHs currently available for clinical use (SynCardia and Carmat TAH) have percutaneous cables to \n",
      "supply power to the devices. Percutaneous drivelines are associated with a high risk of infection and \n",
      "reduce the patient’s quality of life owing to the limited freedom of movement of the patient. Therefore, \n",
      "TAH devices intended for approval as destination therapy should ideally omit these percutaneous cables. \n",
      "Percutaneous cables can be avoided when all TAH components are implanted inside the body and the \n",
      "electrical power is wirelessly transferred via a TET system.A TET system transfers all the electrical power \n",
      "required by the TAH across the patient’s skin via an internal and external coil. Part of this energy is stored \n",
      "in internal battery packs, enabling the patient to have free-from-charging periods. In the past decade, \n",
      "batteries have become smaller and have longer battery life, enabling implantation in the body. In addition \n",
      "to small and high-capacity batteries, high efficiency of the TAH is also essential when energy is provided \n",
      "through a TET system. Figure 3 shows the efficiencies of all types of TAH. The methodology we used to \n",
      "calculate the efficiencies is described in Box 1. Generally, fluid-driven TAHs are slow systems because they \n",
      "first have to move fluid or air to empty the blood-containing chambers. Therefore, emptying the \n",
      "chambers in fluid-driven systems is easier and more efficient at low beat rates than at high beat rates. \n",
      "Fluid-driven TAHs generally show a decline in efficiency at high beat rates. For example, the efficiency of \n",
      "the hydraulic EHTAH declines at cardiac outputs exceeding 6 l/min (Fig. 3a). Like fluid-driven TAHs, \n",
      "mechanical TAHs also have blood chambers, and higher cardiac output can be achieved by maximizing \n",
      "stroke volume and, if needed, by increasing the beat rate. In general, mechanical TAHs become more \n",
      "efficient at higher beat rates and, therefore, at higher cardiac outputs (Fig. 3b). The highest efficiency \n",
      "reported for mechanical TAHs is often reached at a cardiac output of approximately 10 l/min60,63,64,66,69,70. \n",
      "Compared with pulsatile devices, continuous-flow devices do not have blood-collecting chambers because \n",
      "they pump blood continuously. In general, the efficiency of continuous-flow pumps increases with higher \n",
      "cardiac outputs. The optimal efficiency of most continuous-flow TAHs is at a much higher cardiac output \n",
      "than the average cardiac output of 5 l/min (Fig. 3c). \n",
      "Prolonging the free-from-charging periods during support with TAHs using TET \n",
      "systems \n",
      "Efficient TAHs prolong the period that the patient can engage in activities without charging the TAH, \n",
      "which will improve the quality of life of TAH recipients in the future. The most up-to-date battery \n",
      "technology used for TET systems in TAHs has been described by the team developing ReinHeart139. The \n",
      "ReinHeart system has implantable 12 volt lithium–iron–phosphate batteries with 1.1 Ah capacity139. We \n",
      "have used this battery as a standard to compare the running time (defined as the maximum time in which \n",
      "the TAH recipient can engage in activities without charging the TAH) of current TAHs if they hypothetically \n",
      "had TET systems with this specific internal battery capacity (Fig. 3d). The running time was calculated for a \n",
      "cardiac output of at least 5 l/min against a physiological mean left afterload (≥90 mmHg). The data show \n",
      "that current TAH devices can hypothetically support the patients with a physiological cardiac output for \n",
      "approximately 1 h with the current battery technology (Fig. 3c; Table 4). For reference, the AbioCor \n",
      "(implanted for the first time in 2001) had the capacity to support the patient for up to 20 min without \n",
      "connection to a power source47. Our comparison results suggest that continuous-flow devices (Cleveland \n",
      "CFTAH and OregonHeart) are better than mechanically actuated devices in terms of their working time \n",
      "with internal batteries alone because continuous-flow TAHs require less input power than other TAH \n",
      "types to generate a higher cardiac output (Fig. 3d). Among continuous-flow devices, OregonHeart \n",
      "performs slightly better than the Cleveland CFTAH with regards to efficiency and the required input power \n",
      "(Fig. 3d). The mechanical ReinHeart has a relatively high power consumption (12.5 W) and provides less \n",
      "cardiac output than the other four TAHs analysed, resulting in the lowest efficiency (10.8%). Overall, we \n",
      "can conclude that for most TAHs, either the power consumption or the efficiency does not yet reach the \n",
      "levels required to use a TET system. To date, the AbioCor is the only fully implantable TAH that used a TET \n",
      "system that has been implanted in patients. The latest technological advances in TET systems are \n",
      "promising for future TAH development. Battery technology is rapidly evolving, resulting in more powerful \n",
      "and compact batteries. Powerful implantable batteries will prolong the time frame in which the patient \n",
      "can be free from having to use an electrical power source for the TAH. Furthermore, improving the overall \n",
      "efficiency of the TAH itself will help to use the stored energy of the internal battery packs more \n",
      "effectively. Therefore, we expect that transcutaneous charging of a fully implantable TAH with charging-\n",
      "free periods of >1 h will be feasible in the near future. \n",
      "Bioinspired TAHs aim to improve biocompatibility \n",
      "Since the beginning of TAH development in the 1960s, TAHs have been associated with limited \n",
      "biocompatibility resulting in frequently occurring pannus and thrombus formation. Although many \n",
      "attempts have been made to improve the design of TAHs, the biocompatibility issues could not be \n",
      "resolved. By the 1970s, the realization came that no implanted artificial material will ever come close to \n",
      "the anti-thrombogenic properties of the patient’s endothelium. Current TAH devices are still associated \n",
      "with numerous complications related to biocompatibility. A high number of thromboembolic events have \n",
      "been reported in clinical trials and animal studies. All TAH recipients require a strict anticoagulation \n",
      "regimen that results in a high risk of haemorrhagic events. Devices such as the Carmat TAH improved \n",
      "biocompatibility by using membranes and heart valves containing sheep pericardial tissue. The available \n",
      "data on the Carmat TAH suggest that patients receiving a Carmat TAH need less anticoagulation \n",
      "medication than patients receiving a SynCardia device138. Upcoming solutions to address biocompatibility \n",
      "issues can be found in new developments in biomaterials science. If growing endothelium derived from \n",
      "the patient on the blood-contacting surfaces of the TAH becomes possible, this strategy would probably \n",
      "resolve many biocompatibility issues. The developers of the HybridHeart aim to grow a layer of patient-\n",
      "derived endothelium on the inside of the soft ventricles with the use of biofunctionalization and in situ \n",
      "tissue-engineering techniques140. However, owing to the large surface area and the continuous movement \n",
      "of the TAH ventricles, applying tissue engineering techniques on TAH devices remains challenging. Even \n",
      "after five decades of research, we are still far from being able to create a living endothelium inside the \n",
      "ventricles of a TAH141. The interaction of rigid components with the blood is associated with many adverse \n",
      "effects. These effects have been most widely studied for the rotors in LVAD devices and include risks of \n",
      "thrombus formation and non-surgical bleeding caused by the device-altered haemostatic function9,142. \n",
      "The artificial surface of the rotary blood pumps can induce platelet adhesion, which increases the risk of \n",
      "thrombosis, and the rotating parts can induce loss of haemostasis-related receptors on platelets, which \n",
      "increases the risk of bleeding142. Haemolysis is the second-most common LVAD-related complication, \n",
      "presumably caused by the destruction of erythrocytes in the rotating LVAD devices143. Problems related to \n",
      "the incompatibility between hard machines and soft human tissue might be solved if the machine is as \n",
      "soft as the human tissue. Soft robotics is an emerging research field that focuses on developing robots \n",
      "made of soft materials. In the past year, a few research groups have shifted their focus to developing \n",
      "TAHs that are completely soft on the inside and outside, such as SoftHeart and HybridHeart50,144,145. The \n",
      "primary benefit of developing soft TAHs is that they mimic the natural movement of the heart, potentially \n",
      "reducing the stress on the blood and thereby resulting in fewer adverse effects57. The second benefit of \n",
      "soft robotic cardiac devices is that they are compliant because they can stretch, contract or bend. As a \n",
      "result, soft robotic cardiac devices can promote both the contraction and the relaxation phases of the \n",
      "heart146. Owing to its elastic behaviour, the ventricle of a soft TAH has higher passive filling and contracts \n",
      "more forcefully at high filling pressures than at low filling pressures. Therefore, the soft robotic cardiac \n",
      "device passively ejects higher cardiac outputs at larger end-diastolic volumes, like the Frank–Starling \n",
      "mechanism of the native heart. This compliance is inherent to soft robotic cardiac devices147 and works \n",
      "without the need for any sensors or manual control. A soft robotic cardiac sleeve developed in 2017, the \n",
      "first soft robotic cardiac assist device under development, shows Frank–Starling behaviour146. This Frank–\n",
      "Starling mechanism could mean that the expansible volume capabilities of future soft robotic TAHs can \n",
      "balance the left and right outputs to achieve Frank–Starling curve behaviour that resembles human \n",
      "physiology. Given that TAHs need to work for a high number of cycles (one cycle for every heartbeat), \n",
      "achieving high durability and reliability remains a major challenge for TAH development. The SoftHeart \n",
      "had a maximum working duration of 110,000 cycles (approximately 30 h), after which a fatigue crack \n",
      "caused device failure57. Although current soft TAHs are at early development stages, with future \n",
      "optimization their benefits might outweigh those of traditionally rigid TAH devices. \n",
      "Conclusions \n",
      "After more than six decades of TAH research, TAHs have been successfully used in over 1,700 patients as a \n",
      "bridge to heart transplantation, but a TAH suitable for destination therapy has not yet been developed. \n",
      "Some of the major drawbacks of current TAHs are high complication rates, bulkiness, short durability, \n",
      "poor biocompatibility and low quality of life for the patients. These issues need to be resolved before the \n",
      "potential of TAHs as destination therapy can be realized. Nevertheless, the field of TAH research is rapidly \n",
      "evolving, and various approaches are emerging that could potentially improve the quality of life of TAH \n",
      "recipients. With the development of TET systems and improved TAH efficiency, percutaneous cables will \n",
      "no longer be necessary to provide electrical power to the implanted TAH. The field of battery technology \n",
      "is continuously improving, delivering more compact batteries that are easier to implant internally and that \n",
      "prolong the period during which the patient can engage in activities without charging the TAH. New \n",
      "insights into soft robotics might result in the development of completely soft TAHs that reduce the \n",
      "occurrence of adverse effects associated with traditionally rigid TAHs. Meanwhile, smart biomaterials \n",
      "might solve current biocompatibility issues. In the future, these new technologies have the potential to \n",
      "enable the development of the first TAH approved for destination therapy. \n",
      "Key points \n",
      "• \n",
      "After decades of research on total artificial hearts, only two devices are clinically available as a \n",
      "bridge to transplantation therapy; a total artificial heart suitable for destination therapy has not \n",
      "yet been developed. \n",
      "• \n",
      "Currently available total artificial hearts have major drawbacks, including bulkiness, limited \n",
      "durability, poor biocompatibility, high complication rates and low quality of life for the recipients. \n",
      "• \n",
      "We are on the verge of an era in total artificial heart development in which rapidly evolving \n",
      "technologies from different fields will lead to new approaches in total artificial heart design and \n",
      "development. \n",
      "• \n",
      "More powerful and more compact batteries and transcutaneous energy transfer systems will \n",
      "omit the need for percutaneous cables and will improve the quality of life of the recipients of a \n",
      "total artificial heart. \n",
      "• \n",
      "With the rise of soft robotic technologies and smart biomaterials, completely soft total artificial \n",
      "hearts might soon be developed and are likely to have fewer biocompatibility issues than current \n",
      "devices. \n",
      " \n",
      "Figures \n",
      " \n",
      "Figure 1. Timeline of the milestones in the development of total artificial hearts \n",
      "All current TAH devices and the most historically important TAH devices are shown. The red bars \n",
      "represent the period of development and/or reporting of testing results in literature for each TAH. CFTAH, \n",
      "continuous-flow total artificial heart; EHTAH, electrohydraulic total artificial heart; ERTAH, eccentric roller \n",
      "total artificial heart; FTPTAH, flow-transformed pulsatile total artificial heart; HFTAH, helical flow total \n",
      "artificial heart; LVAD–TAH, total artificial heart made with two left ventricular assist devices; UPTAH, \n",
      "undulation pump total artificial heart. Images reproduced with permission from ref.171, Springer Nature \n",
      "(AbioCor); ref.48, Science Museum Group/Academic (Akutsu III); ref.172, Wiley (BiVACOR); ref.173, \n",
      "Carmat/OUP (Carmat TAH); ref.96, Springer Nature (Cleveland CFTAH); ref.98, Wiley (HFTAH); The Board \n",
      "of Trustees of the Science Museum (Jarvik-7); ref.11, Elsevier (Liotta–Cooley TAH); ref.100, Wiley \n",
      "(OregonHeart); ref.174, Wiley (Realheart TAH); and ref.108, Elsevier (SynCardia). \n",
      " \n",
      " \n",
      "Figure 2. Working mechanism for different types of total artificial hearts \n",
      "a. Fluid-driven total artificial hearts (TAHs) are composed of blood chambers and pneumatic or hydraulic \n",
      "chambers, which are separated by a membrane. A pump moves pressurized air or liquid into the \n",
      "pneumatic or hydraulic chambers, which moves the membrane and causes the ejection of the blood in a \n",
      "pulsatile manner. In the example shown in the figure, blood is ejected from both blood chambers \n",
      "alternately; however, some devices eject blood simultaneously from both chambers. The pump that \n",
      "moves the air or fluid can be implanted in the body or can be placed externally. For the latter, \n",
      "percutaneous hoses are required. Phase 1 shows the filling of the right blood chamber and the ejection of \n",
      "the left blood chamber. In phase 2, the pump rotates in the opposite direction, resulting in the filling of \n",
      "the left blood chamber and the ejection of the right blood chamber. B. Mechanical TAHs have two blood \n",
      "chambers and a mechanical motor, separated by a membrane. A motor pushes a mechanical part (pusher \n",
      "plate) against the membrane so that blood is ejected from that blood chamber. In the example, blood is \n",
      "ejected from the blood chambers alternately; however, some devices eject blood simultaneously from \n",
      "both chambers. In phase 1, the mechanical motor moves the pusher plate against the membrane of the \n",
      "left chamber, which ejects blood while the right chamber fills. In phase 2, the mechanical motor moves \n",
      "the pusher plate against the membrane of the right chamber, which ejects blood while the left ventricle \n",
      "fills. c .Continuous-flow TAHs have two continuous-flow pumps that pump blood continuously in one \n",
      "direction. Valves are usually not required. There is no filling or ejection phase because the blood is \n",
      "continuously being pumped. CFTAH, continuous-flow total artificial heart; EHTAH, electrohydraulic total \n",
      "artificial heart; ERTAH, eccentric roller total artificial heart; FTPTAH, flow-transformed pulsatile total \n",
      "artificial heart; HFTAH, helical flow total artificial heart; LVAD–TAH, total artificial heart made with two \n",
      "left ventricular assist devices; UPTAH, undulation pump total artificial heart. \n",
      " \n",
      " \n",
      "Figure 3. Efficiency of total artificial hearts \n",
      "Overall efficiencies of total artificial hearts (TAHs) are depicted against the cardiac output. The method of \n",
      "calculation for the overall efficiencies of the TAHs is explained in Box 1. All values are measured under \n",
      "physiological mean left afterload conditions (≥90 mmHg). If right afterload was not reported when tested \n",
      "in a double-sided mock loop, we assumed it to be 20 mmHg. For some TAH devices, we were not able to \n",
      "obtain data to calculate efficiencies. Data for ReinHeart were shared by the authors upon request. a. \n",
      "Overall efficiencies for fluid-driven TAHs45,175. b. Overall efficiencies for mechanical \n",
      "TAHs60,63,64,66,67,69,70,71,76,176. c. Overall efficiencies for continuous-flow TAHs84,95,98,157,168,170. d .Running time \n",
      "(defined as the maximum time in which the TAH recipient can engage in activities without charging the \n",
      "TAH) of TAHs developed since 201576,157,170, calculated as though these TAHs hypothetically had \n",
      "transcutaneous energy transfer systems with the internal battery capacity of the most recently available \n",
      "battery technology (from the ReinHeart system). CFTAH, continuous-flow total artificial heart; EHTAH, \n",
      "electrohydraulic total artificial heart; ERTAH, eccentric roller total artificial heart; HFTAH, helical flow total \n",
      "artificial heart; UPTAH, undulation pump total artificial heart. \n",
      " \n",
      "Tables \n",
      "TAH \n",
      "Region \n",
      "Type \n",
      "Dimensions \n",
      "(mm) \n",
      "Weight \n",
      "(g) \n",
      "Volume \n",
      "(ml) \n",
      "Power \n",
      "supply \n",
      "Valve \n",
      "types \n",
      "Development \n",
      "stage \n",
      "Refs \n",
      "AbioCor \n",
      "USA \n",
      "Fluid-\n",
      "driven \n",
      "85 × 85 × 100 \n",
      "907 \n",
      "723a \n",
      "TET \n",
      "Mechanical \n",
      "Stopped \n",
      "46,47,48 \n",
      "AnyHeart \n",
      "South \n",
      "Korea \n",
      "Mechanical \n",
      "60 × 100 × 100 \n",
      "650 \n",
      "600 \n",
      "TET \n",
      "Mechanical \n",
      "Stopped \n",
      "59,60,61 \n",
      "Baylor TAH \n",
      "USA and \n",
      "Japan \n",
      "Mechanical \n",
      "97 × 97 × 83 \n",
      "620 \n",
      "510 \n",
      "TET \n",
      "Biological \n",
      "Stopped \n",
      "62,63 \n",
      "BiVACOR \n",
      "USA \n",
      "Continuous \n",
      "flow \n",
      "NR \n",
      "650 \n",
      "NR \n",
      "Percutaneous \n",
      "No valves \n",
      "Animal \n",
      "models \n",
      "95,148 \n",
      "Brno TAH \n",
      "Czech \n",
      "Republic \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "NR \n",
      "NR \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "37 \n",
      "Carmat TAH \n",
      "(Aeson) \n",
      "France \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "900 \n",
      "750 \n",
      "Percutaneous \n",
      "Biological \n",
      "Approved \n",
      "51,52 \n",
      "Cleveland \n",
      "continuous-\n",
      "flow TAH \n",
      "USA \n",
      "Continuous \n",
      "flow \n",
      "60 × 60 × 100 \n",
      "486 \n",
      "160 \n",
      "Percutaneous \n",
      "No valves \n",
      "Animal \n",
      "models \n",
      "96,97 \n",
      "Cleveland \n",
      "Nimbus \n",
      "USA \n",
      "Mechanical \n",
      "90 × 97 × 134 \n",
      "NR \n",
      "700 \n",
      "TET \n",
      "Biological \n",
      "Stopped \n",
      "64,65 \n",
      "Eccentric roller \n",
      "TAH \n",
      "Japan \n",
      "Mechanical \n",
      "100 × 100 × 80 \n",
      "1,800 \n",
      "800a \n",
      "Percutaneous \n",
      "No valves \n",
      "Stopped \n",
      "66 \n",
      "Electrohydraulic \n",
      "TAH \n",
      "Japan \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "2,492 \n",
      "872 \n",
      "TET \n",
      "Mechanical \n",
      "Stopped \n",
      "45 \n",
      "Flow-\n",
      "transformed \n",
      "pulsatile TAH \n",
      "Japan \n",
      "Continuous \n",
      "flow \n",
      "NR \n",
      "2,000 \n",
      "550 \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "82 \n",
      "Helical flow \n",
      "TAH \n",
      "Japan \n",
      "Continuous \n",
      "flow \n",
      "80 × 80 × 77 \n",
      "565 \n",
      "493a \n",
      "Percutaneous \n",
      "No valves \n",
      "Animal \n",
      "models \n",
      "98 \n",
      "Hybrid \n",
      "continuous-\n",
      "flow TAH \n",
      "USA \n",
      "Continuous \n",
      "flow \n",
      "50 × 50 × 50b \n",
      "NR \n",
      "125a,b \n",
      "Percutaneous \n",
      "No valves \n",
      "In vitro \n",
      "99 \n",
      "Impeller TAH \n",
      "China \n",
      "Continuous \n",
      "flow \n",
      "40 × 40 × 80 \n",
      "250 \n",
      "128a \n",
      "TET \n",
      "No valves \n",
      "Stopped \n",
      "84 \n",
      "Linear TAH \n",
      "Japan \n",
      "Mechanical \n",
      "85 × 85 × 94 \n",
      "1,900 \n",
      "560 \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "67,68 \n",
      "LVAD–TAH \n",
      "Various \n",
      "Continuous \n",
      "flow \n",
      "Various \n",
      "Various \n",
      "Various \n",
      "Percutaneous \n",
      "No valves \n",
      "Clinical trials \n",
      "  \n",
      "MagScrew \n",
      "USA \n",
      "Mechanical \n",
      "NR \n",
      "890 \n",
      "506 \n",
      "TET \n",
      "Biological \n",
      "Stopped \n",
      "69 \n",
      "Milwaukee \n",
      "Heart \n",
      "USA \n",
      "Mechanical \n",
      "83 × 83 × 62 \n",
      "600 \n",
      "490 \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "70 \n",
      "OregonHeart \n",
      "USA \n",
      "Continuous \n",
      "flow \n",
      "85 × 75 × 60b \n",
      "NR \n",
      "130 \n",
      "Percutaneous \n",
      "No valves \n",
      "In vitro \n",
      "100,101 \n",
      "Ovalis \n",
      "Germany \n",
      "Mechanical \n",
      "75 × 75 × 95 \n",
      "950 \n",
      "560 \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "71 \n",
      "Penn State \n",
      "electric TAH \n",
      "USA \n",
      "Mechanical \n",
      "91 × 91 × 94 \n",
      "700 \n",
      "778a \n",
      "TET \n",
      "Mechanical \n",
      "Stopped \n",
      "72 \n",
      "Penn State \n",
      "pneumatic TAH \n",
      "USA \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "NR \n",
      "NR \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "38 \n",
      "Phoenix \n",
      "Taiwan \n",
      "Fluid-\n",
      "driven \n",
      "70 × 70 × 130 \n",
      "NR \n",
      "NR \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "39,40 \n",
      "Poisk TAH \n",
      "Russia \n",
      "Fluid-\n",
      "driven \n",
      "125 × 100 × 70 \n",
      "220 \n",
      "NR \n",
      "Percutaneous \n",
      "NR \n",
      "Stopped \n",
      "41,42 \n",
      "POLTAH \n",
      "Poland \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "NR \n",
      "NR \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "43 \n",
      "Realheart TAH \n",
      "Sweden \n",
      "Mechanical \n",
      "148 × 126 × 96 \n",
      "800 \n",
      "1,790a \n",
      "TET \n",
      "Mechanical \n",
      "Animal \n",
      "models \n",
      "73,74 \n",
      "ReinHeart \n",
      "Germany \n",
      "Mechanical \n",
      "87 × 87 × 90 \n",
      "940 \n",
      "550 \n",
      "TET \n",
      "Mechanical \n",
      "Animal \n",
      "models \n",
      "75 \n",
      "RollingHeart \n",
      "Switzerland \n",
      "Mechanical \n",
      "80 × 80 × 110 \n",
      "NR \n",
      "704a \n",
      "Percutaneous \n",
      "No valves \n",
      "In vitro \n",
      "76 \n",
      "SoftHeart \n",
      "Switzerland \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "136 \n",
      "447 \n",
      "Percutaneous \n",
      "Mechanical \n",
      "In vitro \n",
      "57 \n",
      "Table 1. Baseline characteristics of total artificial hearts. \n",
      "LVAD–TAH, total artificial heart made with two left ventricular assist devices; NR, not reported, TAH, total \n",
      "artificial heart; TET, transcutaneous energy transfer. aCalculated with the reported dimensions. bReported \n",
      "target size (not the current prototype). \n",
      " \n",
      " \n",
      "TAH \n",
      "Type \n",
      "Study \n",
      "period \n",
      "Number of \n",
      "animals \n",
      "Maximum \n",
      "survival \n",
      "(days) \n",
      "Most reported causes of death (n) \n",
      "Refs \n",
      "AbioCora \n",
      "Fluid-driven \n",
      "1990–\n",
      "2001 \n",
      "120 \n",
      "108 \n",
      "Elective termination (16), \n",
      "mechanical failure (5) \n",
      "20,112,117,149,150 \n",
      "AnyHeart \n",
      "Mechanical \n",
      "1990 \n",
      "1 \n",
      "4 \n",
      "Respiratory failure (1) \n",
      "59 \n",
      "Baylor TAHa \n",
      "Mechanical \n",
      "1993–\n",
      "1994 \n",
      "8 \n",
      "7 \n",
      "NR \n",
      "151,152 \n",
      "BiVACORa \n",
      "Continuous flow \n",
      "2017 \n",
      "15 \n",
      "90 \n",
      "NR \n",
      "148,153 \n",
      "Brno TAHa \n",
      "Fluid-driven \n",
      "1983–\n",
      "1995 \n",
      "168 \n",
      "314 \n",
      "Thromboembolic complications (6), \n",
      "mechanical failure (5) \n",
      "37,119,154,155 \n",
      "Carmat TAH \n",
      "(Aeson) \n",
      "Fluid-driven \n",
      "2014–\n",
      "2017 \n",
      "12 \n",
      "10 \n",
      "Thromboembolic complications (4), \n",
      "bleeding (2), respiratory failure (2) \n",
      "118,156 \n",
      "Cleveland \n",
      "continuous-\n",
      "flow TAH \n",
      "Continuous flow \n",
      "2015 \n",
      "17 \n",
      "90 \n",
      "Elective termination (4), bleeding (3) \n",
      "157 \n",
      "Cleveland \n",
      "Nimbus \n",
      "Mechanical \n",
      "1992–\n",
      "1994 \n",
      "12 \n",
      "120 \n",
      "Mechanical failure (10), \n",
      "thromboembolic complications (1), \n",
      "infection (1) \n",
      "64,113 \n",
      "Electrohydraulic \n",
      "TAHa \n",
      "Fluid-driven \n",
      "1990–\n",
      "2003 \n",
      "57 \n",
      "159 \n",
      "Mechanical failure (14), \n",
      "thromboembolic complications (7), \n",
      "respiratory failure (7) \n",
      "114,158,159,160,161,162 \n",
      "Helical flow \n",
      "TAH \n",
      "Continuous flow \n",
      "2015 \n",
      "13 \n",
      "100 \n",
      "Mechanical failure (7) \n",
      "98 \n",
      "LVAD–TAH \n",
      "Continuous flow \n",
      "2009–\n",
      "2021 \n",
      "40 \n",
      "92 \n",
      "Thromboembolic complications (23), \n",
      "elective termination (8) \n",
      "85,88,92,93 \n",
      "MagScrew \n",
      "Mechanical \n",
      "2001-2005 \n",
      "12 \n",
      "92 \n",
      "Mechanical failure (5), respiratory \n",
      "failure (3) \n",
      "69,163 \n",
      "Penn State \n",
      "electric TAH \n",
      "Mechanical \n",
      "1990–\n",
      "2000 \n",
      "54 \n",
      "388 \n",
      "Mechanical failure (17), respiratory \n",
      "failure (13) \n",
      "72,115,164,165,166 \n",
      "Penn State \n",
      "pneumatic TAHa \n",
      "Fluid-driven \n",
      "1979–\n",
      "1989 \n",
      "47 \n",
      "353 \n",
      "Mechanical failure (22), \n",
      "thromboembolic complications (6) \n",
      "38,167 \n",
      "Phoenix \n",
      "Fluid-driven \n",
      "2001 \n",
      "41 \n",
      "60 \n",
      "Respiratory failure (22), \n",
      "thromboembolic (6), multiorgan \n",
      "failure (6) \n",
      "40 \n",
      "Reinhearta \n",
      "Mechanical \n",
      "2015 \n",
      "12 \n",
      "2 \n",
      "NR \n",
      "75 \n",
      "SynCardia \n",
      "Fluid-driven \n",
      "1979–\n",
      "1981 \n",
      "31 \n",
      "268 \n",
      "Thromboembolic complications (8), \n",
      "bleeding (5) \n",
      "25,26 \n",
      "Undulation \n",
      "pump TAH \n",
      "Continuous flow \n",
      "2000–\n",
      "2011 \n",
      "68 \n",
      "153 \n",
      "Mechanical failure (30), bleeding \n",
      "(15) \n",
      "83,116,168,169 \n",
      "Vienna TAHa \n",
      "Fluid-driven \n",
      "1991 \n",
      "15 \n",
      "180 \n",
      "Mechanical failure (3) \n",
      "44 \n",
      "Table 2. Total artificial hearts assessed in chronic animal trials \n",
      "All devices that have been assessed in published chronic animal trials are listed. The cause of death of the \n",
      "animals was not always reported in the literature, especially for AbioCor, Baylor TAH, BiVACOR, Brno TAH, \n",
      "electrohydraulic TAH, ReinHeart, Penn State pneumatic TAH and Vienna TAH. LVAD–TAH, total artificial heart \n",
      "made with two left ventricular assist devices; NR, not reported; TAH, total artificial heart. aDevices with high \n",
      "numbers of missing animal data. \n",
      " \n",
      " \n",
      "SynCardia 70cc \n",
      "USA \n",
      "Fluid-\n",
      "driven \n",
      "NR \n",
      "240 \n",
      "400 \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Approved \n",
      "49 \n",
      "Undulation \n",
      "pump TAH \n",
      "Japan \n",
      "Continuous \n",
      "flow \n",
      "77 × 77 × 79 \n",
      "660 \n",
      "310 \n",
      "Percutaneous \n",
      "No valves \n",
      "Stopped \n",
      "83 \n",
      "Vienna TAH \n",
      "Austria \n",
      "Fluid-\n",
      "driven \n",
      "72 × 72 × 120 \n",
      "NR \n",
      "622a \n",
      "Percutaneous \n",
      "Mechanical \n",
      "Stopped \n",
      "44 \n",
      " \n",
      "TAH \n",
      "Type \n",
      "Number \n",
      "of \n",
      "implanted \n",
      "devices \n",
      "TAH support \n",
      "duration (days) \n",
      "Number \n",
      "implanted as \n",
      "bridge to \n",
      "transplantation \n",
      "(%) \n",
      "Number of \n",
      "deaths \n",
      "during TAH \n",
      "support (%) \n",
      "Most reported causes of \n",
      "death during TAH support \n",
      "(%) \n",
      "Refs \n",
      "Mean \n",
      "Maximum \n",
      "AbioCor \n",
      "Fluid-driven \n",
      "11 \n",
      "142 \n",
      "512 \n",
      "0 (0) \n",
      "10 (100) \n",
      "Thromboembolic \n",
      "complications (50), \n",
      "multiorgan failure (33) \n",
      "125 \n",
      "Brno TAH \n",
      "Fluid-driven \n",
      "6 \n",
      "5 \n",
      "10 \n",
      "0 (0) \n",
      "6 (100) \n",
      "Thromboembolic \n",
      "complications (50), \n",
      "bleeding (33) \n",
      "120 \n",
      "Carmat \n",
      "TAH \n",
      "(Aeson)a \n",
      "Fluid-driven \n",
      "24 \n",
      "166 \n",
      "308 \n",
      "(45) \n",
      "(55) \n",
      "Multiorgan failure (50), \n",
      "mechanical failure (33) \n",
      "107,138 \n",
      "LVAD–\n",
      "TAH \n",
      "Continuous \n",
      "flow \n",
      "9 \n",
      "92 \n",
      "180 \n",
      "4 (44) \n",
      "4 (44) \n",
      "Multiorgan failure (50), \n",
      "bleeding (50) \n",
      "86,87,89,90 \n",
      ",91,94 \n",
      "Penn \n",
      "State \n",
      "pneumatic \n",
      "TAH \n",
      "Fluid-driven \n",
      "3 \n",
      "135 \n",
      "379 \n",
      "2 (67) \n",
      "1 (33) \n",
      "Aspiration pneumonia \n",
      "(100) \n",
      "38 \n",
      "Phoenix \n",
      "Fluid-driven \n",
      "2 \n",
      "8 \n",
      "15 \n",
      "2 (100) \n",
      "0 (0) \n",
      "– \n",
      "121,123 \n",
      "Poisk TAH \n",
      "Fluid-driven \n",
      "13 \n",
      "5 \n",
      "15 \n",
      "1 (8) \n",
      "12 (92) \n",
      "Unknown \n",
      "122 \n",
      "SynCardiab \n",
      "Fluid-driven \n",
      ">1,700 \n",
      "94 \n",
      "4.5 years \n",
      "(65) \n",
      "(33) \n",
      "Multiorgan failure (40), \n",
      "thromboembolic \n",
      "complications (13), \n",
      "infection (10) \n",
      "127,129,130,131 \n",
      ",132,133,134, \n",
      "135,136 \n",
      "Vienna \n",
      "TAH \n",
      "Fluid-driven \n",
      "5 \n",
      "12 \n",
      "22 \n",
      "3 (60) \n",
      "2 (40) \n",
      "Infection (50), multiorgan \n",
      "failure (50) \n",
      "44,124 \n",
      "Table 3. Total artificial hearts assessed in clinical trials.  \n",
      "All TAH devices that were implanted in patients are listed. LVAD–TAH, total artificial heart made with two left \n",
      "ventricular assist devices; TAH, total artificial heart. aThe trial on the Carmat TAH is currently enrolling \n",
      "patients56; a total of 24 patients received the Carmat TAH (as of February 2022), of which data from only 11 \n",
      "patients are described in the literature; the mean duration of support, bridge to transplantation, death during \n",
      "TAH support and most reported causes of death are based on data from these 11 patients. bSynCardia TAHs \n",
      "have been implanted in over 1,700 patients, of which only a fraction has been reported in the literature; we \n",
      "used data from eight clinical trials describing 574 patients implanted with a SynCardia TAH to calculate the \n",
      "mean duration of support, bridge to transplantation, death during TAH support and most reported causes of \n",
      "death116,117,118,119,120,121,122,123. \n",
      " \n",
      "TAH \n",
      "Type \n",
      "Cardiac output \n",
      "(l/min) \n",
      "Input \n",
      "power (W) \n",
      "Output \n",
      "power (W) \n",
      "Efficiency \n",
      "(%) \n",
      "Running time without \n",
      "charging (min) \n",
      "References \n",
      "Cleveland \n",
      "continuous-flow \n",
      "TAH \n",
      "Continuous \n",
      "flow \n",
      "7.4 \n",
      "12.9 \n",
      "1.7 \n",
      "13.3 \n",
      "61 \n",
      "157 \n",
      "OregonHeart \n",
      "Continuous \n",
      "flow \n",
      "7.5 \n",
      "10.0 \n",
      "1.7 \n",
      "17.5 \n",
      "79 \n",
      "170 \n",
      "ReinHeart \n",
      "Mechanical \n",
      "5.5 \n",
      "12.5 \n",
      "1.3 \n",
      "10.8 \n",
      "63 \n",
      "Unpublished dataa \n",
      "RollingHeart \n",
      "Mechanical \n",
      "5.3 \n",
      "14.0 \n",
      "2.0 \n",
      "14.1 \n",
      "57 \n",
      "76 \n",
      "Table 4. Power requirements and efficiency of total artificial hearts. \n",
      "All TAHs currently being investigated with published power requirements are listed. For the TAHs not \n",
      "listed in the table, no power requirements have been reported in the literature. All parameters were \n",
      "measured at a physiological mean left afterload (≥90 mmHg). TAH, total artificial heart. aData for \n",
      "ReinHeart was shared by the authors upon request. \n",
      "Glossary \n",
      "Driveline: Percutaneous cable that transmits electrical power from an external driver to the \n",
      "internally implanted device such as a TAH or LVAD. \n",
      "Transcutaneous energy transfer (TET) system: A wireless power delivery system that uses magnetic \n",
      "fields to transfer power across the skin without the need for direct electrical connectivity. \n",
      "Bronchial shunt: The physiological passage of oxygenated blood from the aorta to the bronchial \n",
      "circulation. This blood returns directly to the left atrium, thereby bypassing the right side of the \n",
      "heart. \n",
      "Frank–Starling mechanism: This law states that the stroke volume of the heart increases in response \n",
      "to an increase in the volume of blood in the ventricles before contraction (the end diastolic volume), \n",
      "when all other factors remain constant. \n",
      "Preload: The filling pressure of the ventricle at the end of diastole, which is determined by the atrial \n",
      "pressure. \n",
      "Stator: The stationary part of a rotary machine or device. \n",
      "Investigational device exemption: Type of FDA approval that allows the investigational device to be \n",
      "used in a clinical study in order to collect safety and efficacy data. \n",
      "Afterload: The amount of pressure that the ventricle needs to exert to eject the blood during \n",
      "ventricular contraction. \n",
      "Box 1 Calculation of TAH efficiencies \n",
      "To compare the efficiency of the different types of total artificial heart (TAH) shown in Fig. 3, we used \n",
      "a consistent measure of the power consumed by the TAH (input power) and the amount of work \n",
      "(output power) performed by the TAH to pump blood against physiological pressures. The numerical \n",
      "value of the output power is the product of the difference in outlet and inlet pressure (pressure \n",
      "head) and the flow of blood generated by the heart (cardiac output). For pulsatile TAHs, we \n",
      "calculated the pressure head as the difference between the mean afterload and the intraventricular \n",
      "pressure. We assume that during diastole, the pressure inside the TAH ventricle drops to near \n",
      "0 mmHg, as in the native heart177. For continuous-flow TAHs, we calculated the pressure head as \n",
      "the difference between the mean afterload and the mean preload. We have used the following \n",
      "equation to calculate the output power of the TAHs: \n",
      " \n",
      "where the output power is in watt, Qsys and Qpul are the resulting cardiac output (in m3/s) for the \n",
      "systemic and pulmonary circulations, respectively, and Hsys and Hpul are the pressure heads (in \n",
      "N/m2) for systemic and pulmonary circulations, respectively, against which the TAH must pump. The \n",
      "input power to the TAH is an individual number unique to the device. Therefore, we analysed only \n",
      "the TAHs that have the corresponding input power reported in the literature. We have used the \n",
      "following equation for calculating the efficiency (η) of a TAH on the basis of input power and output \n",
      "power: \n",
      " \n",
      "Acknowledgements \n",
      "The authors are grateful to L. C. van Laake (AMOLF, Netherlands), D. Zrinscak (Scuola Superiore \n",
      "Sant’Anna, Italy) and A. Henseler (evos GmbH, Germany) for their contributions and discussions; D. \n",
      "van Urk (Amsterdam UMC, The Netherlands) for assisting with screening and selecting articles; T. \n",
      "Azami (Amsterdam UMC, The Netherlands) and C. M. van de Beek (Amsterdam UMC, The \n",
      "Netherlands) for assistance with data extraction; C. E. J. M. Limpens (Amsterdam UMC, The \n",
      "Netherlands) and A. Malekzadeh (Amsterdam UMC, The Netherlands) for their help with the \n",
      "literature search; and ReinHeart TAH GmbH, Germany for providing additional data upon request. \n",
      "The authors’ work is part of the HybridHeart project and is funded by the European Union Horizon \n",
      "2020 research and innovation programme under grant agreement no. 767195. \n",
      "Contributions \n",
      "A.V. and M.A. did the major literature search and wrote the first draft. All of the authors contributed \n",
      "to the discussion of content and reviewed and edited the manuscript before submission. \n",
      "Corresponding author \n",
      "Correspondence to Jolanda Kluin. \n",
      "Competing interests \n",
      "A.V., M.A., H.K., J.T.B.O. and J.K. are part of the HybridHeart consortium. The other authors declare \n",
      "no competing interests. \n",
      "References \n",
      "1. \n",
      "Metra, M. & Teerlink, J. R. Heart failure. Lancet 390, 1981–1995 (2017). \n",
      "2. \n",
      "Heidenreich, P. A. et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart \n",
      "Association. Circ. Heart Fail. 6, 606–619 (2013). \n",
      "3. \n",
      "Colvin, M. et al. OPTN/SRTR 2018 annual data report: heart. Am. J. Transpl. 20, 340–426 (2020). \n",
      "4. \n",
      "Molina, E. J. et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann. Thorac. Surg. 111, 778–792 (2021). \n",
      "5. \n",
      "Han, J. J., Acker, M. A. & Atluri, P. Left ventricular assist devices. Circulation 138, 2841–2851 (2018). \n",
      "6. \n",
      "Gurvits, G. E. & Fradkov, E. Bleeding with the artificial heart: gastrointestinal hemorrhage in CF-LVAD patients. World J. \n",
      "Gastroenterol. 23, 3945–3953 (2017). \n",
      "7. \n",
      "Galand, V. et al. Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular \n",
      "assist devices. JACC Clin. Electrophysiol. 4, 1166–1175 (2018). \n",
      "8. \n",
      "Ross, D. W. et al. Left ventricular assist devices and the kidney. Clin. J. Am. Soc. Nephrol. 13, 348–355 (2018).  \n",
      "9. \n",
      "Aissaoui, N. et al. Understanding left ventricular assist devices. Blood Purif. 46, 292–300 (2018). \n",
      "10. National Heart Lung and Blood Institute. What Is Total Artificial Heart? Total Artificial Heart https://www.nhlbi.nih.gov/health-\n",
      "topics/total-artificial-heart (NIH, 2020). \n",
      "11. Cooley, D. A. et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am. J. Cardiol. 24, 723–730 (1969). \n",
      "12. US National Library of Medicine. SynCardia 70cc TAH-t for Destination Therapy (DT) (RA-540). ClinicalTrials.gov \n",
      "https://ClinicalTrials.gov/show/NCT02232659 (2021). \n",
      "13. Akutsu, T. & Kolff, W. J. Permanent substitutes for valves and hearts. ASAIO J. 4, 230–234 (1958). \n",
      "14. Houston, C. S., Akutsu, T. & Kolff, W. J. Pendulum type of artificial heart within the chest: preliminiary report. Am. Heart J. 59, \n",
      "723–730 (1960).  \n",
      "15. 15. Seidel, W., Akutsu, T., Mirkovitch, V., Brown, F. & Kolff, W. J. Air-driven artificial hearts inside the chest. Trans. Am. Soc. Artif. \n",
      "Intern. Organs 7, 378–387 (1961). \n",
      "16. Liotta, D. et al. Artificial heart in the chest: preliminary report. Trans. Am. Soc. Artif. Intern. Organs 7,318–322 (1961). \n",
      "17. Atsumi, K. et al. Artificial heart incorporated in the chest. Trans. Am. Soc. Artif. Intern. Organs 9, 292–298 (1963). \n",
      "18. Pierce, W. S. et al. Total heart replacement by a single intrathoracic blood pump. J. Surg. Res. 5, 387–394 (1965). \n",
      "19. Nosé, Y., Tretbar, L. L., SenGupta, A., Topaz, S. R. & Kolff, W. J. An artificial heart inside the chest. J. Thorac. Cardiovasc. Surg. 50, \n",
      "792–799 (1965). \n",
      "20. Cohn, W. E., Timms, D. L. & Frazier, O. H. Total artificial hearts: past, present, and future. Nat. Rev. Cardiol. 12, 609–617 (2015).  \n",
      "21. Curran, W. J. Law-medicine notes. The first mechanical heart transplant: informed consent and experimentation. N. Engl. J. \n",
      "Med. 291, 1015–1016 (1974). \n",
      "22. Morris, D. T. & Couves, C. M. Experiences with a sac-type artificial heart. Can. Med. Assoc. J. 105, 483–487 (1971). \n",
      "23. Kwan-Gett, C. S., Van Kampen, K. R., Kawai, J., Eastwood, N. & Kolff, W. J. Results of total artificial heart implantation in calves. J. \n",
      "Thorac. Cardiovasc. Surg. 62, 880–889 (1971). \n",
      "24. Kawai, J. et al. Implantation of a total artificial heart in calves under hypothermia with 10 day survival. J. Thorac. Cardiovasc. \n",
      "Surg. 64, 45–60 (1972). \n",
      "25. Hastings, W. L. et al. A retrospective study of nine calves surviving five months on the pneumatic total artificial heart. Trans. Am. \n",
      "Soc. Artif. Intern. Organs 27, 71–76 (1981). \n",
      "26. Fukumasu, H., Iwaya, F., Olsen, D. B., Lawson, J. H. & Kolff, W. J. Surgical implantation of the Jarvik-5 total artificial heart in a \n",
      "calf. Trans. Am. Soc. Artif. Intern. Organs 25, 232–238 (1979). \n",
      "27. Akutsu, T., Takagi, H. & Takano, H. Total artificial hearts with built-in valves. Trans. Am. Soc. Artif. Intern. Organs 16, 392–397 \n",
      "(1970). \n",
      "28. Honda, T. et al. One 25 day survivor with total artificial heart. J. Thorac. Cardiovasc. Surg. 69, 92–101 (1975). \n",
      "29. Nakazono, M. et al. A case report of 17 days survival with an implanted artificial heart in a calf. Jpn Heart J. 15, 485–497 (1974). \n",
      "30. Kasai, S. et al. Survival for 145 days with a total artificial heart. J. Thorac. Cardiovasc. Surg. 73, 637–646 (1977). \n",
      "31. Kennedy, J. H. et al. Development of an orthotopic cardiac prosthesis. J. Thorac. Cardiovasc. Surg. 65, 673–683 (1973).  \n",
      "32. Backman, D. K., Donovan, F. M., Sandquist, G., Kessler, T. & Kolff, W. J. The design and evaluation of ventricles for the aec \n",
      "artificial heart nuclear power source. ASAIO J. 19, 542–552 (1973). \n",
      "33. Smith, L. et al. Development on the implantation of a total nuclear-powered artificial heart system. ASAIO J. 20, 732–735 (1974). \n",
      "34. Urzua, J., Sudilovsky, O., Panke, T., Kiraly, R. J. & Nosé, Y. Preliminary report: anatomic constraints for the implantation of an \n",
      "artificial heart. J. Surg. Res. 17, 262–268 (1974). \n",
      "35. Cooley, D. A., Akutsu, T., Norman, J. C., Serrato, M. A. & Frazier, O. H. Total artificial heart in two-staged cardiac transplantation. \n",
      "Cardiovasc. Dis. 8, 305–319 (1981). \n",
      "36. DeVries, W. C. et al. Clinical use of the total artificial heart. N. Engl. J. Med. 310, 273–278 (1984). \n",
      "37. Vasků, J. & Urbánek, P. Constructional and functional characteristics of recent total artificial heart models TNS Brno VII, VIII, and \n",
      "IX. Artif. Organs 19, 535–543 (1995). \n",
      "38. Davis, P. K., Pae, W. E. Jr & Pierce, W. S. Toward an implantable artificial heart. Experimental and clinical experience at The \n",
      "Pennsylvania State University. Invest. Radiol. 24, 81–87 (1989). \n",
      "39. Hsu, C. H. Fuzzy logic automatic control of the Phoenix-7 total artificial heart. J. Artif. Organs 7, 69–76 (2004). \n",
      "40. Hsu, C. H. In vivo and clinical study of Phoenix-7 total artificial heart. Biomed. Eng. Appl. Basis Commun. 13, 133–139 (2001). \n",
      "41. Shumakov, V. I. et al. Use of an ellipsoid artificial heart. Artif. Organs 11, 16–19 (1987). \n",
      "42. Shumakov, V. I. et al. New design of an orthotopic fluorosiloxane rubber heart prosthesis. Biomed. Eng. 10, 223–224 (1976). \n",
      "43. Nawrat, Z. & Malota, Z. The analysis of driving mode influence on energy dissipation in pneumatic artificial heart chambers. \n",
      "Artif. Organs 22, 898–904 (1998). \n",
      "44. Rokitansky, A. et al. The new small Viennese total artificial heart: experimental and first clinical experiences. Artif. Organs 15, \n",
      "129–135 (1991). \n",
      "45. Homma, A. et al. Development of an electrohydraulic total artificial heart system: improvement of pump unit. Electron. \n",
      "Commun. Jpn. 93, 34–46 (2010). \n",
      "46. Ford, B. J. A new generation of cardiology: the AbioCor implantable replacement heart. Air Med. J. 22, 26–30 (2003). \n",
      "47. Dowling, R. D. et al. The AbioCor implantable replacement heart. Ann. Thorac. Surg. 75, S93–S99 (2003). \n",
      "48. Smith, P. A., Cohn, W. E. & Frazier, O. H. in Mechanical Circulatory and Respiratory Support (eds Gregory, S. D., Stevens, M. C. & \n",
      "Fraser, J. F.) Ch. 7, 221–244 (Academic, 2018). \n",
      "49. Spiliopoulos, S., Dimitriou, A. M., Guersoy, D., Koerfer, R. & Tenderich, G. Expanding applicability of total artificial heart therapy: \n",
      "the 50-cc SynCardia total artificial heart. Ann. Thorac. Surg. 100, e55–e57 (2015). \n",
      "50. Cohrs, N. H. et al. A soft total artificial heart-first concept evaluation on a hybrid mock circulation. Artif. Organs 41, 948–958 \n",
      "(2017). \n",
      "51. Stepanenko, A. & Kaufmann, F. A novel total artificial heart: search for haemocompatibility. Lancet 386, 1517–1519 (2015). \n",
      "52. CARMAT. Artificial hearts: devices from France’s Carmat to go on sale in Europe. YouTube https:// \n",
      "www.youtube.com/watch?v=j9T2HnSfVME (2021). \n",
      "53. US Food and Drug Administration. SynCardia Temporary Cardio West Total Artificial Heart (TAH-T). AccessData \n",
      "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P030011 (2004). \n",
      "54. EC Design-Examination Certificate. SynCardia temporary Total Artificial Heart (TAH-t) and external drivers. SynCardia \n",
      "http://syncardia.com/wp-content/uploads/2018/02/CE-665479-Design-Examination-26-May-2017.pdf (2017). \n",
      "55. SynCardia. SynCardia 70cc total artificial heart. SynCardia https://syncardia.com/clinicians/our-products/see-all-our-products/ \n",
      "(2021). \n",
      "56. US National Library of Medicine. Carmat TAH early feasibility study. ClinicalTrials.gov \n",
      "https://clinicaltrials.gov/ct2/show/NCT04117295 (2022). \n",
      "57. Guex, L. G. et al. Increased longevity and pumping performance of an injection molded soft total artificial heart. Soft Robot. 23, \n",
      "23 (2020). \n",
      "58. Mihaylov, D., Verkerke, G. J. & Rakhorst, G. Mechanical circulatory support systems — a review. Technol. Health Care 8, 251–\n",
      "266 (2000). \n",
      "59. Min, B. G. et al. A moving-actuator type electromechanical total artificial heart — Part II: circular type and animal experiment. \n",
      "IEEE Trans. Biomed. Eng. 37, 1195–1200 (1990). \n",
      "60. Min, B. G. et al. A moving-actuator type electromechanical total artificial heart — Part I: linear type and mock circulation \n",
      "experiments. IEEE Trans. Biomed. Eng. 37, 1186–1194 (1990). \n",
      "61. Ahn, J. M., Kang, D. W., Kim, H. C. & Min, B. G. In vivo performance evaluation of a transcutaneous energy and information \n",
      "transmission system for the total artificial heart. ASAIO J. 39, M208–M212 (1993). \n",
      "62. Ohashi, Y., de Andrade, A. & Nosé, Y. Hemolysis in an electromechanical driven pulsatile total artificial heart. Artif. Organs 27, \n",
      "1089–1093 (2003). \n",
      "63. Takatani, S. et al. One piece ultracompact totally implantable electromechanical total artificial heart for permanent use. ASAIO J. \n",
      "48, 538–545 (2002). \n",
      "64. Irié, H. et al. Initial in vivo tests of an electrohydraulic actuated total artificial heart. ASAIO J. 38, M497–M500 (1992). \n",
      "65. Fukamachi, K. et al. Anatomic fitting studies of a total artificial heart in heart transplant recipients. Critical dimensions and \n",
      "prediction of fit. ASAIO J. 42, M337–M342 (1996). \n",
      "66. Sueshiro, M., Fukunaga, S., Hirai, S., Sueda, T. & Matsuura, Y. Eccentric roller type total artificial heart designed for implantation. \n",
      "Artif. Organs 22, 451–457 (1998). \n",
      "67. Kobayashi, M. et al. In vitro evaluation of linear motor-driven total artificial heart. Artif. Organs 20, 1320–1324 (1996). \n",
      "68. Yamada, H., Yamaguchi, M., Kobayashi, K., Matsuura, Y. & Takano, H. Development and test of a linear motor-driven total \n",
      "artificial heart. IEEE Eng. Med. Biol. Mag. 14, 84–90 (1995). \n",
      "69. Weber, S. et al. MagScrew TAH: an update. ASAIO J. 51, xxxvi–xlvi (2005). \n",
      "70. Gao, H. et al. In vitro assessment of the Milwaukee heart and right to left balance. ASAIO J. 38, M722–M725 (1992). \n",
      "71. Sauer, I. M., Frank, J., Spiegelberg, A. & Bücherl, E. S. Ovalis TAH: development and in vitro testing of a new electromechanical \n",
      "energy converter for a total artificial heart. ASAIO J. 46, 744–748 (2000). \n",
      "72. Mehta, S. M. et al. Testing of a 50 cc stroke volume completely implantable artificial heart: expanding chronic mechanical \n",
      "circulatory support to women, adolescents, and small stature men. ASAIO J. 46, 779–782 (2000). \n",
      "73. Szabó, Z. et al. Scandinavian real heart (SRH) 11 implantation as total artificial heart (TAH)-experimental update. J. Clin. Exp. \n",
      "Cardiol. 9, 2 (2018). \n",
      "74. Sonntag, S. J. et al. Virtual implantations to transition from porcine to bovine animal models for a total artificial heart. Artif. \n",
      "Organs 44, 384–393 (2020). \n",
      "75. Pelletier, B. et al. System overview of the fully implantable destination therapy — ReinHeart total artificial heart. Eur. J. \n",
      "Cardiothorac. Surg. 47, 80–86 (2015). \n",
      "76. Tozzi, P. et al. An original valveless artificial heart providing pulsatile flow tested in mock circulatory loops. Int. J. Artif. Organs \n",
      "40, 683–689 (2017). \n",
      "77. Kirklin, J. K. et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J. Heart Lung Transpl. \n",
      "36, 1080–1086 (2017). \n",
      "78. Potapov, E. V., Kaufmann, F., Müller, M., Mulzer, J. & Falk, V. Longest ongoing support (13 years) with magnetically levitated left \n",
      "ventricular assist device. ASAIO J. 66, e121–e122 (2020). \n",
      "79. Yang, M. in Technology and Therapy Management 99–100 (Springer, 2020). \n",
      "80. Healy, A. H. et al. Physiologic effects of continuousflow left ventricular assist devices. J. Surg. Res. 202, 363–371 (2016). \n",
      "81. Bhimaraj, A., Uribe, C. & Suarez, E. E. Physiological impact of continuous flow on end-organ function: clinical implications in the \n",
      "current era of left ventricular assist devices. Methodist. Debakey Cardiovasc. J. 11, 12–17 (2015). \n",
      "82. Isoyama, T. et al. New version of flow-transformed pulsatile total artificial heart with no electrical switching valve. Artif. Organs \n",
      "19, 694–696 (1995). \n",
      "83. Abe, Y. et al. Results of animal experiments with the fourth model of the undulation pump total artificial heart. Artif. Organs 35, \n",
      "781–790 (2011). \n",
      "84. Qian, K. X., Ru, W. M., Zeng, P. & Yuan, H. Y. A novel impeller TAH using magnetic bearings for load reduction. J. Med. Eng. \n",
      "Technol. 26, 214–216 (2002). \n",
      "85. Feng, J. et al. New continuous-flow total artificial  heart and vascular permeability. J. Surg. Res. 199, 296–305 (2015). \n",
      "86. Lebreton, G., Mastroianni, C., Amour, J. & Leprince, P. Implantation of two HVADs used as a total artificial heart: a new \n",
      "approach. Ann. Thorac. Surg. 107, e165–e167 (2019). \n",
      "87. Mulvihill, M. S. et al. Usefulness of two centrifugal ventricular assist devices in a total artificial heart configuration: a preliminary \n",
      "report. J. Heart Lung Transpl. 36, 1266–1268 (2017). \n",
      "88. Cohn, W. E. et al. Eight-year experience with a continuous-flow total artificial heart in calves. ASAIO J. 60, 25–30 (2014). \n",
      "89. Pirk, J. et al. Total artificial heart support with two continuous-flow ventricular assist devices in a patient with an infiltrating \n",
      "cardiac sarcoma. ASAIO J. 59, 178–180 (2013). \n",
      "90. Frazier, O. H. & Cohn, W. E. Continuous-flow total heart replacement device implanted in a 55-year-old man with end-stage \n",
      "heart failure and severe amyloidosis. Tex. Heart Inst. J. 39, 542–546 (2012). \n",
      "91. Strueber, M., Schmitto, J. D., Kutschka, I. & Haverich, A. Placement of two implantable centrifugal pumps to serve as a total \n",
      "artificial heart after cardiectomy. J. Thorac. Cardiovasc. Surg. 143, 507–509 (2012). \n",
      "92. Frazier, O. H., Cohn, W. E., Tuzun, E., Winkler, J. A. & Gregoric, I. D. Continuous-flow total artificial heart supports long-term \n",
      "survival of a calf. Tex. Heart Inst. J. 36, 568–574 (2009). \n",
      "93. Baldwin, A. C., Gemmato, C. J., Cohn, W. E. & Frazier, O. H. Feasibility of long-term continuous flow total heart replacement in \n",
      "calves. Int. J. Artif. Organs 45, 44–51 (2021). \n",
      "94. Daneshmand, M. A., Bishawi, M., Milano, C. A. & Schroder, J. N. The HeartMate 6. ASAIO J. 66, e46–e49 (2020). \n",
      "95. Kleinheyer, M. et al. Rapid speed modulation of a rotary total artificial heart impeller. Artif. Organs 40, 824–833 (2016). \n",
      "96. Fukamachi, K. et al. Generating pulsatility by pump speed modulation with continuous-flow total artificial heart in awake calves. \n",
      "J. Artif. Organs 20, 381–385 (2017). \n",
      "97. Miyamoto, T. et al. Analysis of Cleveland clinic continuous-flow total artificial heart performance using the virtual mock loop: \n",
      "comparison with an in vivo study. Artif. Organs 44, 375–383 (2020). \n",
      "98. Abe, Y. et al. Animal experiments of the helical flow total artificial heart. Artif. Organs 39, 670–680 (2015). \n",
      "99. Fox, C. et al. Hybrid continuous-flow total artificial heart. Artif. Organs 42, 500–509 (2018). \n",
      "100. Glynn, J. et al. The OregonHeart total artificial heart: design and performance on a mock circulatory loop. Artif. Organs 41, 904–\n",
      "910 (2017). \n",
      "101. Jurney, P. L. et al. Characterization of a pulsatile rotary total artificial heart. Artif. Organs 45, 135–142 (2021). \n",
      "102. Franklin, D. L., Van Citters, R. L. & Rushmer, R. F. Balance between right and left ventricular output. Circ. Res. 10, 17–26 (1962). \n",
      "103. Ley, S., Kreitner, K. F., Morgenstern, I., Thelen, M. & Kauczor, H. U. Bronchopulmonary shunts in patients with chronic \n",
      "thromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. Am. J. Roentgenol. 179, 1209–1215 \n",
      "(2002). \n",
      "104. Baile, E. M., Ling, H., Heyworth, J. R., Hogg, J. C. & Pare, P. D. Bronchopulmonary anastomotic and noncoronary collateral blood \n",
      "flow in humans during cardiopulmonary bypass. Chest 87, 749–754 (1985). \n",
      "105. Bhunia, S. K. & Kung, R. T. Indirect bronchial shunt flow measurements in AbioCor implantable replacement heart recipients. \n",
      "ASAIO J. 50, 211–214 (2004). \n",
      "106. Nestler, F. et al. Investigation of the inherent left-right flow balancing of rotary total artificial hearts by means of a resistance \n",
      "box. Artif. Organs 44, 584–593 (2020). \n",
      "107. Latrémouille, C. et al. A bioprosthetic total artificial heart for end-stage heart failure: results from a pilot study. J. Heart Lung \n",
      "Transpl. 37, 33–37 (2018). \n",
      "108. Slepian, M. J. et al. The Syncardia™ total artificial heart: in vivo, in vitro, and computational modelling studies. J. Biomech. 46, \n",
      "266–275 (2013). \n",
      "109. Crosby, J. R. et al. Physiological characterization of the SynCardia total artificial heart in a mock  circulation system. ASAIO J. 61, \n",
      "274–281 (2015). \n",
      "110. Diedrich, M. et al. Experimental investigation of right–left flow balance concepts for a total artificial heart. Artif. Organs 45, 364–\n",
      "372 (2021). \n",
      "111. Horvath, D. et al. Mechanism of self-regulation and in vivo performance of the cleveland clinic continuous-flow total artificial \n",
      "heart. Artif. Organs 41, 411–417 (2017). \n",
      "112. Kung, R. T. et al. Progress in the development of the ABIOMED total artificial heart. ASAIO J. 41, M245–M248 (1995).  \n",
      "113. Harasaki, H. et al. Progress in Cleveland Clinic — Nimbus total artificial heart development. ASAIO J. 40, M494–M498 (1994). \n",
      "114. Kim, H. C., Khanwilkar, P. S., Bearnson, G. B. & Olsen, D. B. Development of a microcontroller-based automatic control system \n",
      "for the electrohydraulic total artificial heart. IEEE Trans. Biomed. Eng. 44, 77–89 (1997). \n",
      "115. Snyder, A. J. et al. An electrically powered total artificial heart. Over 1 year survival in the calf. ASAIO J. 38, M707–M712 (1992). \n",
      "116. Abe, Y. et al. Third model of the undulation pump total artificial heart. ASAIO J. 49, 123–127 (2003). \n",
      "117. Dowling, R. D. et al. Initial experience with the AbioCor implantable replacement heart at the University of Louisville. ASAIO J. \n",
      "46, 579–581 (2000). \n",
      "118. Latrémouille, C. et al. Animal studies with the Carmat bioprosthetic total artificial heart. Eur. J.  Cardiothorac. Surg. 47, e172–\n",
      "e179 (2015). \n",
      "119. Vasků, J. et al. A comparative study of a group of eight calves, surviving longer than 1 month with the total artificial heart. Artif. \n",
      "Organs 7, 470–478 (1983). \n",
      "120. Vasků, J., Urbánek, P., Dostál, M. & Vasků, J. The applicability of experimental experience with the total artificial heart to its \n",
      "clinical use. Int. J. Artif. Organs 15, 307–311 (1992). \n",
      "121. Copeland, J. G. et al. The total artificial heart as a bridge to transplantation. A report of two cases. JAMA 256, 2991–2995 (1986). \n",
      "122. Shumakov, V. et al. Clinical indications for the use of the “Poisk-IOM” total artificial heart: the experience of 13 implantations in \n",
      "humans. Artif. Organs 15, 372–375 (1991). \n",
      "123. Wei, J. et al. Successful use of Phoenix-7 total artificial heart. Transpl. Proc. 30, 3403–3404 (1998). \n",
      "124. Trubel, W. et al. Clinical total artificial heart bridging: Viennese strategy and experiences. Artif. Organs 13, 470–475 (1989). \n",
      "125. Frazier, O. H. et al. The total artificial heart: where we stand. Cardiology 101, 117–121 (2004). \n",
      "126. Alaeddine, M., Ploutz, M., Arabia, F. A. & Velez, D. A. Implantation of total artificial heart in a 10-year-old after support with a \n",
      "temporary perventricular assist device. J. Thorac. Cardiovasc. Surg. 159, e227–e229 (2020). \n",
      "127. SynCardia. Turkish man becomes world’s longest supported syncardia temporary total artificial heart patient. SynCardia \n",
      "https://syncardia.com/news/ turkish-man-becomes-worlds-longest-supported-syncardia-temporary-total-artificial-heart-\n",
      "patient/ (2017). \n",
      "128. David, C. H. et al. A heart transplant after total artificial heart support: initial and long-term results. Eur. J. Cardiothorac. Surg. \n",
      "58, 1175–1181 (2020). \n",
      "129. Carrier, M. et al. Outcomes after heart transplantation and total artificial heart implantation: a multicentre study. J. Heart Lung \n",
      "Transplant. 28, 28 (2020). \n",
      "130. Hulman, M., Artemiou, P., Hudec, V., Olejarova, I. & Goncalvesova, E. SynCardia, total artificial heart, as a bridge to transplant. \n",
      "Bratisl. Lek. Listy 120, 325–330 (2019). \n",
      "131. Nguyen, A. et al. Experience with the SynCardia total artificial heart in a Canadian centre. Can. J. Surg. 60, 375–379 (2017). \n",
      "132. Kirsch, M. E. et al. SynCardia temporary total artificial heart as bridge to transplantation: current results at La Pitié hospital. Ann. \n",
      "Thorac. Surg. 95, 1640–1646 (2013). \n",
      "133. Copeland, J. G. et al. Experience with more than 100 total artificial heart implants. J. Thorac. Cardiovasc. Surg. 143, 727–734 \n",
      "(2012). \n",
      "134. Roussel, J. C. et al. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann. Thorac. Surg. 87, \n",
      "124–130 (2009). \n",
      "135. El-Banayosy, A. et al. CardioWest total artificial heart: bad Oeynhausen experience. Ann. Thorac. Surg. 80, 548–552 (2005). \n",
      "136. Thanavaro, K. L., Tang, D. G., Kasirajan, V. & Shah, K. B. Clinical indications for implantation of the total artificial heart. ASAIO J. \n",
      "60, 594–596 (2014).  \n",
      "137. Carmat. Carmat outlines commercial and development plan for its total artificial heart. Carmat \n",
      "https://www.carmatsa.com/carmat-content/uploads/2021/01/pr_carmat_conference_06-01-21.pdf (2021). \n",
      "138. Netuka, I. et al. Initial bridge to transplant experience with a bioprosthetic autoregulated artificial heart. J. Heart Lung Transpl. \n",
      "39, 1491–1493 (2020). \n",
      "139. Unthan, K. et al. Design and evaluation of a fully implantable control unit for blood pumps. Biomed. Res. Int. 2015, 257848 \n",
      "(2015). \n",
      "140. Kluin, J. et al. In situ heart valve tissue engineering using a bioresorbable elastomeric implant — from material design to 12 \n",
      "months follow-up in sheep. Biomaterials 125, 101–117 (2017). \n",
      "141. Zilla, P., Deutsch, M., Bezuidenhout, D., Davies, N. H. & Pennel, T. Progressive reinvention or destination lost? Half a century of \n",
      "cardiovascular tissue engineering. Front. Cardiovasc. Med. 7, 159 (2020). \n",
      "142. Chen, Z. et al. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and \n",
      "bleeding. Artif. Organs 43, 745–755 (2019). \n",
      "143. Zaiser, A. S. et al. Adverse events of percutaneous microaxial left ventricular assist devices-a retrospective, single-centre cohort \n",
      "study. J. Clin. Med. 10, 3710 (2021). \n",
      "144. HybridHeart. The development of a soft biocompatible artificial heart. HybridHeart https://www.hybridheart.eu/(2021). \n",
      "145. Kohll, A. X. et al. Long-term performance of a pneumatically actuated soft pump manufactured byrubber compression molding. \n",
      "Soft Robot. 6, 206–213 (2019). \n",
      "146. Roche, E. T. et al. Soft robotic sleeve supports heart function. Sci. Transl. Med. 9, eaaf3925 (2017). \n",
      "147. Banerjee, H., Tse, Z. T. H. & Ren, H. Soft robotics with compliance and adaptation for biomedical applications and forthcoming \n",
      "challenges. Int. J. Robot. Autom. 33, 69–80 (2018). \n",
      "148. Greatrex, N., Kleinheyer, M., Nestler, F. & Timms, D. The Maglev heart. IEEE Spectr. 56, 22–29 (2019). \n",
      "149. Parnis, S. M. et al. Chronic in vivo evaluation of an electrohydraulic total artificial heart. ASAIO J. 40, M489–M493 (1994). \n",
      "150. Dowling, R. D., Etoch, S. W., Stevens, K. A., Johnson, A. C. & Gray, L. A. Jr Current status of the AbioCor implantable replacement \n",
      "heart. Ann. Thorac. Surg. 71, S147–S149 (2001). \n",
      "151. Takatani, S. et al. Totally implantable total artificial heart and ventricular assist device with multipurpose miniature \n",
      "electromechanical energy system. Artif. Organs 18, 80–92 (1994). \n",
      "152. Takatani, S. et al. Left and right pump output control in one-piece electromechanical total artificial heart. Artif. Organs 17, 176–\n",
      "184 (1993). \n",
      "153. Cohn, W. E. et al. Pulsatile outflow in cows supported long-term with the BiVACOR rotary TAH. J. Heart Lung Transplant. 36, S14 \n",
      "(2017). \n",
      "154. Dostál, M. et al. Hematological and biochemical studies in calves living over 100 days with the polymethylmethacrylate total \n",
      "artificial heart TNS Brno II. Int. J. Artif. Organs 9, 39–48 (1986). \n",
      "155. Vasků, J. et al. Recent efforts in artificial heart research in Czechoslovakia. ASAIO Trans. 35, 805–811 (1989). \n",
      "156. Smadja, D. M. et al. The Carmat bioprosthetic total artificial heart is associated with early hemostatic recovery and no acquired \n",
      "von Willebrand syndrome in calves. J. Cardiothorac. Vasc. Anesth. 31, 1595–1602 (2017). \n",
      "157. Karimov, J. H. et al. First report of 90-day support of two calves with a continuous-flow total artificial heart. J. Thorac. \n",
      "Cardiovasc. Surg. 150, 687–693. e681 (2015). \n",
      "158. Taenaka, Y. et al. Development and evaluation of components for a totally implantable artificial heart system. ASAIO J. 40, \n",
      "M314–M318 (1994). \n",
      "159. Taenaka, Y. et al. An electrohydraulic total artificial heart with a separately placed actuator. ASAIO Trans. 36, M242–M245 \n",
      "(1990). \n",
      "160. Tatsumi, E. et al. A blood pump with an interatrial shunt for use as an electrohydraulic total artificial heart. ASAIO J. 38, M425–\n",
      "M430 (1992). \n",
      "161. Tatsumi, E. et al. The National Cardiovascular Center electrohydraulic total artificial heart and ventricular assist device systems: \n",
      "current status of development. ASAIO J. 49, 243–249 (2003). \n",
      "162. Tatsumi, E. et al. Current status of development and in vivo evaluation of the National Cardiovascular Center electrohydraulic \n",
      "total artificial heart system. J. Artif. Organs 3, 62–69 (2000). \n",
      "163. Doi, K. et al. In vivo studies of the MagScrew total artificial heart in calves. ASAIO J. 48, 222–225 (2002). \n",
      "164. Kuroda, H. et al. Postoperative pulmonary complications in calves after implantation of an electric total artificial heart. ASAIO J. \n",
      "44, M613–M618 (1998). \n",
      "165. Pierce, W. S. et al. An electric artificial heart for clinical use. Ann. Surg. 212, 339–343 (1990). 166.  \n",
      "166. Snyder, A. J. et al. In vivo testing of a completely implanted total artificial heart system. ASAIO J. 39, M177–M184 (1993). \n",
      "167. Shaffer, L. J. et al. Total artificial heart implantation in calves with pump on an angled port design. Trans. Am. Soc. Artif. Intern. \n",
      "Organs 25, 254–259 (1979). \n",
      "168. Abe, Y. et al. Development of mechanical circulatory support devices at the University of Tokyo. J. Artif. Organs 10, 60–70 \n",
      "(2007). \n",
      "169. Mochizuki, S. et al. Results of animal experiments using an undulation pump total artificial heart: analysis of 10 day and 19 day \n",
      "survival. ASAIO J. 46, 500–504 (2000). \n",
      "170. Wampler, R. et al. Performance of a novel shuttling total artificial heart on a on a mock circulatory loop. J. Heart Lung \n",
      "Transplant. 36, S56–S57 (2017). \n",
      "171. Cooley, D. The total artificial heart. Nat. Med. 9, 108–111 (2003). \n",
      "172. Emmanuel, S. et al. Anatomical human fitting of the BiVACOR total artificial heart. Artif. Organs 46, 50–56 (2022). \n",
      "173. Mohacsi, P. & Leprince, P. The Carmat total artificial heart. Eur. J. Cardiothorac. Surg. 46, 933–934 (2014). \n",
      "174. Pieper, I. L. et al. Evaluation of the novel total artificial heart Realheart in a pilot human fitting study. Artif. Organs 44, 174–177 \n",
      "(2020). \n",
      "175. Yu, L. S. et al. A compact and noise free electrohydraulic total artificial heart. ASAIO J. 39, M386–M391 (1993). \n",
      "176. Rosenberg, G. et al. Dynamic in vitro and in vivo performance of a permanent total artificial heart. Artif. Organs 22, 87–94 \n",
      "(1998). \n",
      "177. Marieb, E. N. & Hoehn, K. in The Heart 679–681 (Pearson, 2013). \n",
      " \n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(text4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c72cc6cf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content=\"The ongoing quest for the first total artificial heart as\\n\\ndestination therapy\\n\\nCitation for published version (APA):\\n\\nVis, A., Arfaee, M., Khambati, H., Slaughter, M. S., Gummert, J. F., Overvelde, J. T. B., & Kluin, J. (2022). The\\n\\nongoing quest for the first total artificial heart as destination therapy. Nature Reviews. Cardiology, 19(12), 813-\\n\\n828. https://doi.org/10.1038/s41569-022-00723-8\\n\\nDOI:\\n\\n10.1038/s41569-022-00723-8\\n\\nDocument status and date:\\n\\nPublished: 01/12/2022\\n\\nDocument Version:\\n\\nAccepted manuscript including changes made at the peer-review stage\\n\\nPlease check the document version of this publication:\\n\\nA submitted manuscript is the version of the article upon submission and before peer-review. There can be\\n\\nimportant differences between the submitted version and the official published version of record. People\\n\\ninterested in the research are advised to contact the author for the final version of the publication, or visit the\\n\\nDOI to the publisher's website.\\n\\nThe final author version and the galley proof are versions of the publication after peer review.\\n\\nThe final published version features the final layout of the paper including the volume, issue and page\\n\\nnumbers.\\n\\nLink to publication\\n\\nGeneral rights\\n\\nCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners\\n\\nand it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.\\n\\nUsers may download and print one copy of any publication from the public portal for the purpose of private study or research.\\n\\nYou may not further distribute the material or use it for any profit-making activity or commercial gain\\n\\nYou may freely distribute the URL identifying the publication in the public portal.\\n\\nIf the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above, please\\n\\nfollow below link for the End User Agreement:\\n\\nwww.tue.nl/taverne\\n\\nTake down policy\\n\\nIf you believe that this document breaches copyright please contact us at:\\n\\nopenaccess@tue.nl\\n\\nproviding details and we will investigate your claim.\\n\\nDownload date: 24. Jul. 2025\\n\\nThe ongoing quest for the first total artificial heart\\n\\nas destination therapy\\n\\nAnnemijn Vis1,2, Maziar Arfaee1,2, Husain Khambati1,2, Mark S. Slaughter3, Jan F. Gummert4,\\n\\nJohannes T. B. Overvelde5,6 and Jolanda Kluin1,2\\n\\nAffiliations:\\n\\n1. Cardiothoracic Surgery,Amsterdam UMC location University of Amsterdam, Amsterdam, The\\n\\nNetherlands.\\n\\n2. Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences,Amsterdam, The Netherlands.\\n\\n3. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY, USA.\\n\\n4. Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University\\n\\nBochum, Bad Oeynhausen, Germany.\\n\\n5. Autonomous Matter Department, AMOLF, Amsterdam, The Netherlands.\\n\\n6. Institute for ComplexMolecular Systems and Department of MechanicalEngineering, Eindhoven\\n\\nUniversity of Technology, Eindhoven, The Netherlands.\\n\\ne-mail: j.kluin@amsterdamumc.nl\\n\\nAbstract\\n\\nMany patients with end-stage heart disease die because of the scarcity of donor hearts.\\n\\nA total artificial heart (TAH), an implantable machine that replaces the heart, has so far been successfully\\n\\nused in over 1,700 patients as a temporary life-saving technology for bridging to heart transplantation.\\n\\nHowever, after more than six decades of research on TAHs, a TAH that is suitable for destination therapy\\n\\nis not yet available. High complication rates, bulky devices, poor durability, poor biocompatibility and low\\n\\npatient quality of life are some of the major drawbacks of current TAH devices that must be addressed\\n\\nbefore TAHs can be used as a destination therapy. Quickly emerging innovations in battery technology,\\n\\nwireless energy transmission, biocompatible materials and soft robotics are providing a promising\\n\\nopportunity for TAH development and might help to solve the drawbacks of current TAHs. In this Review,\\n\\nwe describe the milestones in the history of TAH research and reflect on lessons learned during TAH\\n\\ndevelopment. We summarize the differences in the working mechanisms of these devices, discuss the\\n\\nnext generation of TAHs and highlight emerging technologies that will promote TAH development in the\\n\\ncoming decade. Finally, we present current challenges and future perspectives for the field.\\n\\nIntroduction\\n\\nCardiovascular disease is the leading cause of death globally, and heart failure, one of the end points of\\n\\ncardiovascular disease, affects approximately 2% of the adult population worldwide1. The estimated\\n\\nprevalence of heart failure will increase markedly owing to the ageing global population. It is predicted\\n\\nthat by 2030, more than 8 million people in the USA (1 in every 33) will have heart failure2. Heart\\n\\ntransplantation is currently considered the gold standard treatment for end-stage heart failure. However,\\n\\na tremendous shortage of donor hearts exists worldwide. In 2018, more than 2,500 patients were actively\\n\\nawaiting heart transplantation in the USA alone3. To compensate for this shortage, mechanical devices to\\n\\nsupport the failing heart, such as left ventricular assist devices (LVADs), have been widely implanted over\\n\\nthe past two decades as an alternative therapy for end-stage heart failure. At present, over 3,000 LVADs\\n\\nare implanted in North America every year, either as a bridge to heart transplantation or as destination\\n\\ntherapy4. LVADs are a treatment option for patients with left ventricular failure but are not suitable for\\n\\npatients with severe biventricular failure or other conditions that preclude the use of LVADs5.\\n\\nFurthermore, LVAD support is associated with poor quality of life and a risk of complications, such as\\n\\nthromboembolic events, bleeding and driveline infections6,7,8,9. A total artificial heart (TAH) is a surgically\\n\\nimplanted pump that provides blood circulation and replaces cardiac ventricles that are diseased or\\n\\ndamaged10. The TAH is implanted in an orthotopic position and replaces both the left and right ventricle\\n\\nof the native heart. In 1969, a TAH was implanted in a patient for the first time11. However, TAHs have so\\n\\nfar primarily been implanted as a temporary bridging therapy for patients with advanced heart failure\\n\\nwho are awaiting heart transplantation. The SynCardia TAH (SynCardia Systems, Tucson, AZ, USA) is the\\n\\nTAH that is most frequently implanted as a bridge to heart transplantation therapy and is under\\n\\ninvestigation in a clinical trial to assess its applicability as destination therapy12. However, the limitations\\n\\nof the SynCardia device, which include bulkiness, short durability, high complication rates and low patient\\n\\nquality of life owing to the need for percutaneous hoses and frequent hospitalizations, have so far\\n\\nprecluded its approval for this indication. An urgent need for destination therapies for (biventricular) end-\\n\\nstage heart disease exists because the majority of patients have no prospect of recovery with currently\\n\\navailable therapies. The rapidly emerging technologies in wireless energy transmission, biocompatible\\n\\nmaterials and soft robotics provide a promising outlook for TAH development. Many teams across the\\n\\nworld have tried different approaches to develop various types of TAHs, of which only a few are still under\\n\\ndevelopment. In this Review, we describe the historical milestones and lessons learned during TAH\\n\\ndevelopment and discuss the current generation of TAHs and the differences in their working\\n\\nmechanisms. We also highlight new technologies that will promote TAH development in the coming\\n\\ndecade.\\n\\nHistory of TAH development\\n\\nAnimal experiments\\n\\nThe development of TAHs dates back to the previous century. One of the first experiments with a TAH\\n\\nwas reported in 1958, when pioneers Willem Kolff and Tetsuzo Akutsu at the Cleveland Clinic (Cleveland,\\n\\nOH, USA) implanted a TAH in a dog after removing its native heart13. The TAH sustained blood circulation\\n\\nin the dog for 90\\u2009min13. More experiments in dogs were conducted at the Cleveland Clinic in the 1960s,\\n\\nincluding implantation of a mechanical TAH with two blood chambers that were alternately emptied by a\\n\\nmotor pendulum14 and implantation of two different pneumatically driven TAHs15. In the same period,\\n\\nDomingo Liotta (School of Medicine, Cordoba, Argentina) implanted a pneumatic TAH, named the Liotta\\n\\nHeart, in dogs16. These experiments inspired more researchers across the world to start developing TAHs.\\n\\nIn Japan in 1963, Kazuhiko Atsumi (Tokyo University School of Medicine, Tokyo, Japan) developed several\\n\\ntypes of pneumatic and mechanical TAH and tested them in 56 dogs17. In 1964, a national artificial heart\\n\\nprogramme was initiated in the USA, sponsored by the National Heart, Lung and Blood Institute. This big\\n\\nnationwide project, led by Frank Hastings, aimed to develop novel technical advances (similar to the aims\\n\\nof the USA space programme) for generating TAHs. Boosted by the national artificial heart programme,\\n\\nTAH experiments were conducted in numerous research centres in the USA, such as at the Penn State\\n\\nMilton S. Hershey Medical Center18 and the Cleveland Clinic19.\\n\\nFirst TAH implantation in humans\\n\\nIn 1969, Denton Cooley (Texas Heart Institute, Houston, TX, USA) performed the first TAH implantation in\\n\\nhumans, implanting the Liotta–Cooley TAH in a patient aged 47\\u2009years11 (Fig. 1). The Liotta–Cooley device\\n\\nwas a rigid pneumatic TAH with two ventricles implanted orthotopically. An external pump moved\\n\\ncompressed air into a pneumatic chamber inside the ventricle, which pushed a diaphragm and caused the\\n\\nejection of blood from the blood chamber on the other side of the membrane. The Liotta–Cooley TAH\\n\\nsupported the patient for 64\\u2009h, after which the patient underwent heart transplantation11. The patient\\n\\ndied owing to sepsis 32\\u2009h after the heart transplantation. Furthermore, the poor biocompatibility of the\\n\\nvalves and the surfaces that were in contact with the blood might have contributed to haemolysis and\\n\\nrenal impairment11. Therefore, although the first TAH implantation was ground-breaking, it was not\\n\\nconsidered a success20. However, this first implantation of a TAH in humans proved the concept that such\\n\\ntechnology could support a patient as a bridge to heart transplantation. However, the procedure sparked\\n\\nethical and legal controversy regarding improper consent and experimentation21. In the years after the\\n\\nfirst implantation in humans, further research on TAH prototypes was conducted solely in large animal\\n\\nmodels by researchers from the University of Alberta (Edmonton, Alberta, Canada)22; the University of\\n\\nUtah College of Medicine (Salt Lake City, UT, USA)23,24,25,26; the University of Mississippi Medical Centre\\n\\n(Jackson, MS, USA)27,28; the Cleveland Clinic29,30; the Baylor College of Medicine (Houston, TX, USA)31; and\\n\\nthe US Atomic Energy Commission (University of Utah, Salt Lake City, UT, USA)32,33,34. It took 12 years from\\n\\nthe first TAH implantation in humans until the next human TAH implantation in 1981, again at the Texas\\n\\nHeart Institute, when the pneumatic Akutsu III TAH was implanted as a bridge to transplantation in a man\\n\\naged 36\\u2009years35. The Akutsu III TAH worked similarly to the Liotta–Cooley TAH, with two inflatable air sacs\\n\\nto displace blood. The Akutsu III TAH supported the patient for 55\\u2009h, after which the patient received\\n\\nheart transplantation. However, in the last 27\\u2009h before the transplantation surgery, the patient could not\\n\\nbe fully supported by the TAH and died 7\\u2009days after the heart transplantation owing to multiorgan\\n\\nfailure35. The third TAH implantation in humans occurred in 1982 at the University of Utah, where William\\n\\nDeVries and Willem Kolff implanted the Jarvik-7 TAH as destination therapy in a patient aged 61\\u2009years\\n\\nwith congestive heart failure36. The Jarvik-7 was a pneumatic device with a similar working mechanism to\\n\\nthe Liotta–Cooley TAH. After implantation of the Jarvik-7 TAH, the patient was conscious and able to\\n\\ncommunicate with his family. Progressive circulatory shock led to his death 112\\u2009days after TAH\\n\\nimplantation36. This first successful clinical outcome with the Jarvik-7 TAH encouraged many teams across\\n\\nthe world to continue developing TAHs (Fig. 1). Most TAHs developed by the first pioneers were\\n\\npneumatically or hydraulically driven; later, researchers developed TAHs with different working\\n\\nmechanisms. Currently available TAHs can be classified into three types on the basis of their working\\n\\nmechanism: fluid-driven TAHs, mechanical TAHs and continuous-flow TAHs (Fig. 2), which are discussed\\n\\nbelow.\\n\\nWorking mechanisms of TAHs\\n\\nFluid-driven TAHs\\n\\nFluid-driven TAHs are the oldest type of TAH, with a working mechanism similar to that of the Liotta–\\n\\nCooley and Jarvik-7 TAHs. Fluid-driven devices have blood chambers separated by a membrane from a\\n\\nchamber filled with fluid (air or liquid). A pressure rise in the fluid chamber moves the flexible membrane\\n\\nso that the blood chamber empties and the blood is ejected (Fig. 2a). A pump is required to increase the\\n\\npressure in the pneumatic or hydraulic chamber. Often, these pumps are placed outside the body, which\\n\\nrequires percutaneous hoses to move the pressurized fluid from the pump to the TAH. Depending on the\\n\\ntype of pump used in these pneumatic and hydraulic devices, the left and right chamber eject blood either\\n\\nsimultaneously or alternatingly. More recently developed TAHs (such as the Carmat TAH (Aeson; Carmat,\\n\\nVélizy-villacoublay, France)) are designed to have the pump implanted in the body, avoiding the need for\\n\\npercutaneous pneumatic or hydraulic pressure hoses. However, percutaneous cables to supply power to\\n\\nthe TAH are often still needed.\\n\\nHistorical devices\\n\\nSeveral pneumatic TAHs were developed in the 1980s, such as the Brno TAH (Vacord Bioengineering\\n\\nResearch Company, Brno, Czech Republic)37, Penn State pneumatic TAH (Pennsylvania State University,\\n\\nHershey, Pennsylvania)38, Phoenix (Southern Taiwan University, Tainan, Taiwan)39,40, Poisk TAH (Institute\\n\\nof Organ and Tissue Transplantation, Moscow, Russia)41,42, POLTAH (Artificial Heart Laboratory, Zabrze,\\n\\nPoland)43 and Vienna TAH (University of Vienna, Vienna, Austria)44. In the same period, the\\n\\nelectrohydraulic TAH (EHTAH) was developed in Japan (Artificial Organs Department, Osaka, Japan)45.\\n\\nDevelopment of the hydraulically driven AbioCor (Abiomed, Danvers, MA, USA) started in the 1990s46,47,48.\\n\\nAbioCor was the first fully implantable system designed without any percutaneous cables; it consisted of\\n\\nfour internal components and a transcutaneous energy transfer (TET) system. The characteristics of all the\\n\\nTAHs discussed in this Review are summarized in Table 1.\\n\\nCurrent devices\\n\\nTwo fluid-driven devices, SynCardia49 and the Carmat TAH, are currently in use as a bridge to\\n\\ntransplantation and are undergoing further evaluation as destination therapy. Another fluid-driven TAH,\\n\\nSoftHeart (ETH Zurich, Zurich, Switzerland)50, is currently under development51,52. The working mechanism\\n\\nof these three prototypes is very similar to the earliest devices, such as the Liotta–Cooley and Akutsu III\\n\\nTAHs. The history of the development of SynCardia dates back 40\\u2009years to 1982, when Kolff and DeVries\\n\\nperformed the first successful implantation of a TAH in a patient36. This TAH, the Jarvik-7, is now known as\\n\\nSynCardia. SynCardia is a pneumatically driven TAH consisting of two independent ventricles that collect\\n\\nand eject blood simultaneously in a pulsatile manner. A four-layer polyurethane membrane separates the\\n\\nblood in the ventricle from the pneumatic chamber. The pressures in the pneumatic chamber are\\n\\ngenerated by a pump placed outside the body and connected via percutaneous drivelines. SynCardia is\\n\\nthe first TAH that received CE approval (in 1999) and FDA approval (in 2004) for temporary use as a bridge\\n\\nto heart transplantation in eligible candidates who are at risk of imminent death from end-stage\\n\\nbiventricular failure53,54. This TAH has been implanted in over 1,700 patients worldwide55. The Carmat\\n\\nsystem is a hydraulic TAH developed in France that received CE approval as a bridge to transplantation\\n\\ntherapy in 2020. The Carmat TAH consists of left and right blood chambers separated from the hydraulic\\n\\npressure chamber by a two-layer biocompatible membrane made from bovine pericardium. The pumps\\n\\nthat pressurize the hydraulic pressure chambers of the Carmat TAH are built within the TAH itself, making\\n\\nthis device larger than SynCardia. Furthermore, the Carmat TAH ejects blood from the left and right blood\\n\\nchambers alternatingly. Although percutaneous pressure hoses are not required to pressurize the\\n\\nhydraulic chamber, the Carmat system requires percutaneous cables to deliver the required electrical\\n\\npower to the TAH. The Carmat TAH has been implanted as a bridge to transplantation in 24 patients in\\n\\nclinical trials (as of February 2022)56. SoftHeart is a pneumatically driven TAH entirely made of silicone\\n\\nrubber (except for its mechanical heart valves), and is the only completely soft TAH developed so far.\\n\\nSoftHeart has been tested only in vitro50,57. Although the durability of SoftHeart has been improved\\n\\ncompared with earlier iterations, it is still limited to only 110,000 cycles (approximately 30\\u2009h)50,57.\\n\\nMechanical TAHs\\n\\nThe functionality and clinical applicability of fluid-driven TAHs were demonstrated in the early 1990s, but\\n\\nsome of their disadvantages also became apparent. These TAHs were bulky, had poor durability and\\n\\nrequired percutaneous air pressure hoses and external drivers, which led scientists to explore alternative\\n\\nworking mechanisms and shift the focus to mechanically actuated TAHs58. Mechanically actuated TAHs\\n\\nhave many similarities to fluid-driven TAHs: both have two chambers to collect and eject blood, and inlet\\n\\nand outlet valves to direct the flow (Fig. 2b). Like fluid-driven TAHs, mechanical TAHs have a moving\\n\\nmembrane to empty the blood chambers. However, instead of emptying the blood chambers with the use\\n\\nof pressurized gas or liquid (as in fluid-driven devices), mechanically actuated TAHs have an electric motor\\n\\nthat drives a pusher plate against the blood chambers. Compared with fluid-driven TAHs, mechanical\\n\\nTAHs are less bulky and, most importantly, do not require large external drivers.\\n\\nHistorical devices\\n\\nMultiple mechanical TAHs were developed in the 1990s by different teams and institutions: AnyHeart\\n\\n(Seoul University, Seoul, South Korea)59,60,61, Baylor TAH (Baylor College of Medicine)62,63, Cleveland\\n\\nNimbus (Cleveland Clinic)64,65, eccentric roller TAH (Hiroshima University, Hiroshima, Japan)66, Linear TAH\\n\\n(Shinshu University, Nagano, Japan)67,68, MagScrew (Cleveland Clinic)69, Milwaukee Heart (Milwaukee\\n\\nHeart Project, Milwaukee, WI, USA)70, Ovalis (Humboldt University, Hamburg, Germany)71 and Penn State\\n\\nelectric TAH (Pennsylvania State University)72. These TAHs can be classified on the basis of their working\\n\\nmechanism as TAHs with mechanical actuation parts with either linear or rotary motion.\\n\\nCurrent devices\\n\\nWe have identified three mechanically actuated devices that are still under development: Realheart TAH\\n\\n(Linköping University, Linköping, Sweden)73,74, ReinHeart (Helmholtz Institute, Aachen, Germany)75 and\\n\\nRollingHeart (University of Lausanne, Lausanne, Switzerland)76. None of these devices has been assessed\\n\\nin clinical trials. Realheart and ReinHeart are fully implantable systems, including a TET system and\\n\\ninternal battery packs. Both TAHs are actuated with magnets and are being assessed in animal studies.\\n\\nThe RollingHeart is a mechanically actuated TAH developed in Switzerland and has only been tested in\\n\\nvitro. This TAH has a spherical shape, and two moving disks divide the spherical cavity into four chambers.\\n\\nAn electrical motor moves the disks and thereby changes the volume of the chamber over time, which\\n\\nenables the filling and ejection of the blood. The design is unique because it does not require any valves.\\n\\nHowever, issues in the design of this TAH related to the recirculation and mixing of oxygenated with\\n\\ndeoxygenated blood need to be addressed76.\\n\\nContinuous-flow TAHs\\n\\nA major disadvantage of the above-mentioned fluid-driven and mechanical devices is that they require\\n\\nseveral indispensable components, such as blood collecting chambers, flexible membranes and valves. As\\n\\na result, these devices are often bulky and usually do not fit inside petite patients, such as children and\\n\\nsome women. The flexible membranes present in these devices are often prone to wear and tear because\\n\\nthey deform with every heartbeat (about 35 million times a year). Continuous-flow pumps were\\n\\nintroduced as an alternative to traditional pulsatile devices. Because blood is pumped continuously in\\n\\nthese devices, they do not require valves, membranes or blood collecting chambers. Therefore,\\n\\ncontinuous-flow TAHs are smaller and lighter than other types of TAHs. In addition, their lifetime is longer\\n\\nowing to the absence of flexible membranes and the continuous rotation of their motors in a single\\n\\ndirection. In the past two decades, substantial progress has been achieved in the field of continuous-flow\\n\\nLVADs, whose efficacy has been proved in clinical trials77. The longest reported duration of LVAD support\\n\\nwithout mechanical failure is 13\\u2009years77,78. These positive results inspired many TAH researchers to use\\n\\ncontinuous-flow pumps for TAH development, mainly because of their superior power-to-size ratio and\\n\\ndurability compared with fluid-driven and mechanical TAHs. After implantation of a regular continuous-\\n\\nflow LVAD, some blood flow pulsatility remains because the native heart is left in place. By contrast,\\n\\ncontinuous-flow TAHs eject blood continuously and generate a true continuous blood flow. Given that the\\n\\nphysiological response to long-term continuous blood flow is unclear79,80,81, most of the investigators\\n\\ndeveloping continuous-flow TAHs are exploring the possibility of modulating the flow to provide some\\n\\nlevel of pulsatilily79. So far, achieving the same pulsatility index as with the native heart or the pulsatile\\n\\nTAHs has not been possible.\\n\\nHistorical devices\\n\\nThe first continuous-flow TAHs were developed in the 1990s. We have identified three continuous-flow\\n\\nTAH devices, which are no longer in use: the flow-transformed pulsatile TAH (University of Tokyo, Tokyo,\\n\\nJapan)82, the undulation pump TAH (UPTAH) (University of Tokyo, Tokyo, Japan)83 and the Impeller TAH\\n\\n(Jiangsu University, Zhenjiang, China)84.\\n\\nCurrent devices\\n\\nAlthough LVADs were developed to assist the native left ventricle, these devices are powerful enough to\\n\\ntake over the function of the native ventricle completely. Therefore, several research groups have\\n\\ninvestigated the efficacy of two commercially available LVADs (such as HeartMate II, Heartmate III,\\n\\nHeartWare HVAD, Jarvik 2000 and HeartAssist 5) combined into a TAH configuration after removing the\\n\\nnative heart85,86,87,88,89,90,91,92,93,94. The configuration of two LVADs functioning as a TAH has been tested in\\n\\nanimal studies and clinical trials85,86,87,88,89,90,91,92,93,94. In this Review, we refer to the configuration of two\\n\\ncommercially available LVADs functioning as a TAH as ‘LVAD–TAH’. Many TAH developers have used\\n\\ncontinuous-flow pump technology to develop custom-built TAH devices. Several continuous-flow TAHs\\n\\nare currently under development: BiVACOR (BiVACOR, Houston, TX, USA)95, Cleveland continuous-flow\\n\\nTAH (CFTAH)96,97 and helical-flow TAH (HFTAH) (University of Tokyo, Tokyo, Japan)98 are being assessed in\\n\\nchronic animal experiments, and Hybrid CFTAH (Drexel University, Philadelphia, PA, USA)99 and\\n\\nOregonHeart (OregonHeart, Portland, OR, USA)100,101 are undergoing in vitro testing.\\n\\nBalancing right and left cardiac outputs of TAHs\\n\\nA major issue that must be addressed for successful TAH implantation is the balancing of the right and left\\n\\ncardiac outputs20. In a physiological setting, the cardiac output of the left ventricle is slightly greater than\\n\\nthe cardiac output of the right ventricle102, because part of the oxygen-rich blood from the aorta goes into\\n\\nthe bronchial arteries that supply the lung parenchyma, which then drains back to the left atrium103,104.\\n\\nTherefore, part of the blood ejected by the left ventricle returns to the left atrium without passing\\n\\nthrough the right circulation, resulting in a larger systemic flow than pulmonary flow. In healthy\\n\\nindividuals, the bronchial shunt flow is approximately 1% of the cardiac output103. However, various\\n\\npulmonary diseases increase the bronchial shunt flow to up to one-third of the left ventricular output103.\\n\\nA study showed that three out of five patients with an implanted AbioCor TAH had increases in bronchial\\n\\nflow of up to 1.4\\u2009l/min, which is 28% of a cardiac output of 5\\u2009l/min105. The native heart continuously\\n\\nbalances the systemic and pulmonary flows by ventricular interdependence, via the Frank–Starling\\n\\nmechanism102, but this balancing mechanism is difficult to implement in TAHs. If a TAH cannot\\n\\ncompensate for flow differences in venous return, severe complications such as lung oedema and\\n\\nrespiratory failure will arise20. Therefore, balancing the outputs to the systemic and pulmonary\\n\\ncirculations during TAH support is one of the biggest challenges in TAH design20,106. Pulsatile TAHs can\\n\\nalter the stroke volume of one of the blood chambers if a sudden change in atrial pressure occurs. The\\n\\nstroke volume can be adjusted in two ways: by adjusting the filling volume inside the chamber or by\\n\\nadjusting the ejection fraction. This adjustment is an active process that requires either manual control or\\n\\nautomatic control by feedback from incorporated sensors. In the Carmat system, many internal\\n\\nelectronics, microprocessors and sensors are needed to constantly monitor different internal pressures,\\n\\nas well as an ultrasound transducer to monitor the position of the membrane107. In SynCardia, the system\\n\\nparameters are manually set to fill the ventricles to 70–85% of their capacity, to create a buffer that\\n\\npassively enables the augmentation of venous return108. As a result, SynCardia is sensitive to preload,\\n\\ndemonstrating Frank–Starling-like behaviour under normal conditions108. Therefore, Syncardia can\\n\\nprovide increased output in response to increased preload. However, the shape of the Syncardia Frank–\\n\\nStarling curve differs from that of the human heart, because this TAH is inelastic108,109. ReinHeart’s design\\n\\nuses the concept of passive and active limitation of the right-sided filling, in combination with the right\\n\\nventricle having a fixed volume that is 10% smaller than that of the left ventricle110. A balancing\\n\\nmechanism is also required for continuous-flow TAHs, because a sudden drop in atrial pressure quickly\\n\\nresults in negative atrial pressures (suction event). Continuous-flow TAHs that have two separate pumps\\n\\nfor the left and right circulation (such as in the LVAD–TAH, Hybrid CFTAH and HFTAH) have some inherent\\n\\nflow-balancing capacity98,99,106. However, a study testing the performance of several types of continuous-\\n\\nflow TAHs made from two separate pumps in an in vitro set-up in which systemic and pulmonary\\n\\nresistance were changed to mimic the human cardiovascular system during daily activities showed that,\\n\\nalthough all the devices had some flow-balancing capacity, none was able to accommodate all resistance\\n\\nsettings106. Cleveland CFTAH, BiVACOR and OregonHeart use a single moving rotor to perfuse the\\n\\npulmonary and systemic circulations. The rotor of the OregonHeart is typically set to pump 60% of each\\n\\nbeat time to the left circulation and 40% to the right circulation, but this ratio can be adjusted manually to\\n\\nmeet the needs of a wide range of physiological conditions101. BiVACOR incorporates an axial magnetic\\n\\nlevitation system, which enables active control of the position of the single moving rotor95. A leftward\\n\\nshift of the rotor causes an increase in left-sided flow95. The Cleveland CFTAH uses a similar mechanism,\\n\\nbut in this TAH, the rotor can have passive axial movements inside the stator, enabling the TAH to balance\\n\\nthe left and right outputs passively, without any sensors111. The axial position of the rotor is determined\\n\\nby the pressure gradient between the left and right blood chambers. When the pressure drops in one of\\n\\nthe blood chambers, the rotor passively moves to that side, which helps to prevent atrium wall suction\\n\\nand balances the cardiac outputs111. This low-complexity passive feedback mechanism inherently reduces\\n\\nthe risk of device failure compared with the complex active feedback mechanisms in other TAHs.\\n\\nChronic animal trials\\n\\nChronic animal trials are an important step in the preclinical testing of new TAHs. Chronic animal trials\\n\\nhave been conducted for AbioCor, AnyHeart, Baylor TAH, BiVACOR, Brno TAH, Carmat TAH, Cleveland\\n\\nCFTAH, Cleveland Nimbus, EHTAH, HFTAH, LVAD–TAH, MagScrew, Penn State electric TAH, Penn State\\n\\npneumatic TAH, Phoenix, ReinHeart, SynCardia, UPTAH and Vienna TAH (Table 2). Calves are the most\\n\\nfrequently used animal model for TAH implantation, followed by goats and sheep. In most of the older\\n\\nchronic animal trials, the animal was implanted with a TAH and was followed up until death. In\\n\\ncontemporary studies, researchers often terminate the experiments after a given follow-up period\\n\\n(usually 30–90\\u2009days, according to FDA regulations), by taking out the TAH. For the latter studies, elective\\n\\ntermination is assigned as the cause of death in Table 2. Nevertheless, the follow-up time in chronic\\n\\nanimal trials is often short. Only ten TAH devices were associated with a maximum survival time\\n\\nexceeding 100\\u2009days (AbioCor112, Brno TAH37, Cleveland Nimbus113, EHTAH114, HFTAH98, Penn State electric\\n\\nTAH115, Penn State pneumatic TAH38, SynCardia25, UPTAH83 and Vienna TAH44) and only one device was\\n\\nassociated with a maximum survival time of over a year (Penn State electric TAH)115. Overall, the most\\n\\nfrequently reported cause of death in chronic animal trials is mechanical failure of the device. Examples of\\n\\nmechanical failure that occurred in chronic animal trials include an electrical short circuit caused by fluid\\n\\nentering the electronics, dislocation of TET coils, obstruction of the inflow or outflow grafts of the TAH,\\n\\nmembrane ruptures, air leakage in pneumatic devices, failure of the implantable battery and a defect or\\n\\nlock in pump bearings26,69,83,93,98,114,116,117,118,119. The second- and third-most frequently reported reasons\\n\\nof death are thromboembolic complications and respiratory failure, respectively.\\n\\nClinical trials\\n\\nSince the first successful implantation of a TAH in humans in 1982, a total of nine different TAH devices\\n\\nhave been assessed in patients in clinical trials: AbioCor, Brno TAH, Carmat TAH, LVAD–TAH, Penn State\\n\\npneumatic TAH, Phoenix, Poisk TAH, SynCardia and Vienna TAH (Table 3). These TAHs are pneumatic or\\n\\nhydraulic pulsatile devices, except the continuous-flow LVAD–TAH.\\n\\nEarly studies in humans\\n\\nSeveral fluid-driven TAHs were tested in humans in the 1980s and 1990s. Overall, the outcomes were\\n\\npoor, and many patients died within the first days after receiving a TAH or could not successfully receive a\\n\\nheart transplant120,121,122. The Brno TAH, developed in the Czech Republic, was implanted in six patients120.\\n\\nAll patients died of serious complications related to poor device biocompatibility, with a maximum\\n\\nsurvival of 10\\u2009days120. The Phoenix TAH was implanted in two patients121,123. One patient received a heart\\n\\ntransplant on the same day as TAH implantation but died 1\\u2009day after receiving the heart transplant121. The\\n\\nother patient was successfully bridged to heart transplantation after 15\\u2009days of support with the Phoenix\\n\\nTAH123. The Poisk TAH was developed in Russia and has been implanted in 13 patients122. Of these\\n\\npatients, 12 died during support with the Poisk TAH, for unknown reasons. The maximum period of\\n\\nsupport was 15\\u2009days122. The Vienna TAH was implanted in five patients, and three of these patients were\\n\\nsuccessfully bridged to heart transplantation44,124. The maximum duration of support was 22 days44,124.\\n\\nThe Penn State pneumatic TAH was implanted in three patients38. Two of the patients were bridged to\\n\\nheart transplantation, and the third patient did not receive a heart transplant because a suitable donor\\n\\nwas not found. After 70\\u2009days of support, the patient had a cerebrovascular accident, manifested by\\n\\naphasia. The TAH support stopped on day 379 when this patient had a respiratory arrest and could not be\\n\\nresuscitated38.\\n\\nLatest clinical trials\\n\\nAbioCor, the first fully implantable TAH that used a TET system, was implanted in 14 patients between\\n\\n2001 and 200348. The maximum duration of support was 512\\u2009days, which occurred in a patient who died\\n\\nowing to a membrane rupture in the device125. The most frequently observed causes of death were\\n\\nthromboembolic complications and multiorgan failure125. The development of AbioCor stopped in 2007\\n\\nowing to concerns related to the high number of patients who died because of complications of stroke\\n\\n(caused by an ineffective anticoagulation regimen), the low quality of life of the patients and the poor\\n\\ncommercial viability20,79. Since 2011, several teams worldwide have studied the use of a combination of\\n\\ntwo commercially available rotary LVADs (HeartMate II, HeartMate III or HeartWare HVAD) adapted to a\\n\\nTAH configuration to replace the native heart completely86,87,89,90,91,94. These LVAD–TAHs have been\\n\\nimplanted in nine patients86,87,89,90,91,94, with a maximum reported duration of support of 6\\u2009months89. The\\n\\nmost frequently reported complications were related to thromboembolic and haemorrhagic\\n\\nevents86,87,89,90,91,94. The pneumatically actuated SynCardia, the first TAH that became commercially\\n\\navailable as a bridge to transplantation therapy, is currently available in two sizes (70\\u2009cm3 or 50\\u2009cm3\\n\\nventricles), which enables its implantation in patients of various body sizes. The youngest recipient of a\\n\\n50\\u2009cm3 SynCardia is a boy aged 10\\u2009years126. So far, Syncardia has been implanted in over 1,700 patients\\n\\nworldwide, with a maximum reported duration of support of 4.5\\u2009years receiving permanent SynCardia\\n\\nsupport55,127. Despite the poor prognosis that the SynCardia recipients have before TAH implantation, the\\n\\nlong-term survival of recipients of a heart transplant after temporary support with SynCardia is\\n\\nencouraging and comparable with the long-term survival of recipients of a heart transplant who did not\\n\\nreceive SynCardia support128. Twelve\\u2009months after the SynCardia implantation, 55% of the patients had\\n\\nreceived heart transplantation, 14% were still supported by the SynCardia device and 31% died before\\n\\nundergoing a heart transplantation129. SynCardia is currently being evaluated in an approved\\n\\ninvestigational device exemption clinical trial for use as destination therapy12.\\n\\nThe care of patients receiving SynCardia support remains challenging128. The percutaneous hoses are\\n\\nfrequently associated with driveline infections, and the TAH material itself often causes mediastinitis and\\n\\nconstrictive pericarditis128. The period after heart transplantation is associated with a high risk of\\n\\n(temporary) haemodialysis owing to impaired renal perfusion and postoperative compression of the\\n\\ndonor heart128. The risk of post-transplantation complications increases with prolonged TAH support128.\\n\\nThe most frequently reported causes of death during support with a SynCardia device are multiorgan\\n\\nfailure (40%), thromboembolic complications (13%) and infection (10%)129,130,131,132,133,134,135,136. Although\\n\\nminor device malfunctions are frequently described in the literature, severe device malfunctions that lead\\n\\nto death are rare (<2% of the deaths during SynCardia support)129,130,131,132,133,134,135,136. The hydraulic TAH\\n\\ndeveloped by Carmat received CE approval as bridge to transplantation therapy in 2020, but the company\\n\\nis continuing clinical research with the aim of ultimately using the Carmat TAH as destination therapy56.\\n\\nThe Carmat TAH has been implanted as a bridge to transplantation in 24 patients (as of February\\n\\n2022)107,137,138. Patient enrollment for the second clinical trial on the Carmat TAH is ongoing56. Although\\n\\nthe Carmat TAH was designed to promote biocompatibility, given that its diaphragms and valves are made\\n\\nfrom bovine pericardium, all patients must receive a strict anticoagulation regimen138. Thus far, the\\n\\nclinical outcomes of 11 recipients of the Carmat TAH have been described in the literature107,138, with a\\n\\nmaximum support duration of 308\\u2009days138. Of these patients, six died during TAH support, and the other\\n\\nfive were successfully bridged to heart transplantation107,138. The causes of death were multiorgan failure\\n\\n(50%), mechanical failure (33%) and respiratory failure (17%). No thromboembolic complications were\\n\\nobserved107,138. To date, no TAH has been approved as destination therapy. Only the SynCardia and\\n\\nCarmat TAH are approved as temporary therapy to bridge a severely ill patient to heart transplantation.\\n\\nThe percutaneous drivelines of both TAHs are associated with low quality of life and a high risk of\\n\\ninfection128. Long-term support with the SynCardia TAH is associated with serious risks such as stroke and\\n\\nmultiorgan failure128,129,130,131,132,133,134,135,136.\\n\\nTechnological advances and future perspectives\\n\\nTET systems to improve quality of life\\n\\nThe TAHs currently available for clinical use (SynCardia and Carmat TAH) have percutaneous cables to\\n\\nsupply power to the devices. Percutaneous drivelines are associated with a high risk of infection and\\n\\nreduce the patient’s quality of life owing to the limited freedom of movement of the patient. Therefore,\\n\\nTAH devices intended for approval as destination therapy should ideally omit these percutaneous cables.\\n\\nPercutaneous cables can be avoided when all TAH components are implanted inside the body and the\\n\\nelectrical power is wirelessly transferred via a TET system.A TET system transfers all the electrical power\\n\\nrequired by the TAH across the patient’s skin via an internal and external coil. Part of this energy is stored\\n\\nin internal battery packs, enabling the patient to have free-from-charging periods. In the past decade,\\n\\nbatteries have become smaller and have longer battery life, enabling implantation in the body. In addition\\n\\nto small and high-capacity batteries, high efficiency of the TAH is also essential when energy is provided\\n\\nthrough a TET system. Figure 3 shows the efficiencies of all types of TAH. The methodology we used to\\n\\ncalculate the efficiencies is described in Box 1. Generally, fluid-driven TAHs are slow systems because they\\n\\nfirst have to move fluid or air to empty the blood-containing chambers. Therefore, emptying the\\n\\nchambers in fluid-driven systems is easier and more efficient at low beat rates than at high beat rates.\\n\\nFluid-driven TAHs generally show a decline in efficiency at high beat rates. For example, the efficiency of\\n\\nthe hydraulic EHTAH declines at cardiac outputs exceeding 6\\u2009l/min (Fig. 3a). Like fluid-driven TAHs,\\n\\nmechanical TAHs also have blood chambers, and higher cardiac output can be achieved by maximizing\\n\\nstroke volume and, if needed, by increasing the beat rate. In general, mechanical TAHs become more\\n\\nefficient at higher beat rates and, therefore, at higher cardiac outputs (Fig. 3b). The highest efficiency\\n\\nreported for mechanical TAHs is often reached at a cardiac output of approximately 10\\u2009l/min60,63,64,66,69,70.\\n\\nCompared with pulsatile devices, continuous-flow devices do not have blood-collecting chambers because\\n\\nthey pump blood continuously. In general, the efficiency of continuous-flow pumps increases with higher\\n\\ncardiac outputs. The optimal efficiency of most continuous-flow TAHs is at a much higher cardiac output\\n\\nthan the average cardiac output of 5\\u2009l/min (Fig. 3c).\\n\\nProlonging the free-from-charging periods during support with TAHs using TET\\n\\nsystems\\n\\nEfficient TAHs prolong the period that the patient can engage in activities without charging the TAH,\\n\\nwhich will improve the quality of life of TAH recipients in the future. The most up-to-date battery\\n\\ntechnology used for TET systems in TAHs has been described by the team developing ReinHeart139. The\\n\\nReinHeart system has implantable 12\\u2009volt lithium–iron–phosphate batteries with 1.1\\u2009Ah capacity139. We\\n\\nhave used this battery as a standard to compare the running time (defined as the maximum time in which\\n\\nthe TAH recipient can engage in activities without charging the TAH) of current TAHs if they hypothetically\\n\\nhad TET systems with this specific internal battery capacity (Fig. 3d). The running time was calculated for a\\n\\ncardiac output of at least 5\\u2009l/min against a physiological mean left afterload (≥90\\u2009mmHg). The data show\\n\\nthat current TAH devices can hypothetically support the patients with a physiological cardiac output for\\n\\napproximately 1\\u2009h with the current battery technology (Fig. 3c; Table 4). For reference, the AbioCor\\n\\n(implanted for the first time in 2001) had the capacity to support the patient for up to 20\\u2009min without\\n\\nconnection to a power source47. Our comparison results suggest that continuous-flow devices (Cleveland\\n\\nCFTAH and OregonHeart) are better than mechanically actuated devices in terms of their working time\\n\\nwith internal batteries alone because continuous-flow TAHs require less input power than other TAH\\n\\ntypes to generate a higher cardiac output (Fig. 3d). Among continuous-flow devices, OregonHeart\\n\\nperforms slightly better than the Cleveland CFTAH with regards to efficiency and the required input power\\n\\n(Fig. 3d). The mechanical ReinHeart has a relatively high power consumption (12.5\\u2009W) and provides less\\n\\ncardiac output than the other four TAHs analysed, resulting in the lowest efficiency (10.8%). Overall, we\\n\\ncan conclude that for most TAHs, either the power consumption or the efficiency does not yet reach the\\n\\nlevels required to use a TET system. To date, the AbioCor is the only fully implantable TAH that used a TET\\n\\nsystem that has been implanted in patients. The latest technological advances in TET systems are\\n\\npromising for future TAH development. Battery technology is rapidly evolving, resulting in more powerful\\n\\nand compact batteries. Powerful implantable batteries will prolong the time frame in which the patient\\n\\ncan be free from having to use an electrical power source for the TAH. Furthermore, improving the overall\\n\\nefficiency of the TAH itself will help to use the stored energy of the internal battery packs more\\n\\neffectively. Therefore, we expect that transcutaneous charging of a fully implantable TAH with charging-\\n\\nfree periods of >1\\u2009h will be feasible in the near future.\\n\\nBioinspired TAHs aim to improve biocompatibility\\n\\nSince the beginning of TAH development in the 1960s, TAHs have been associated with limited\\n\\nbiocompatibility resulting in frequently occurring pannus and thrombus formation. Although many\\n\\nattempts have been made to improve the design of TAHs, the biocompatibility issues could not be\\n\\nresolved. By the 1970s, the realization came that no implanted artificial material will ever come close to\\n\\nthe anti-thrombogenic properties of the patient’s endothelium. Current TAH devices are still associated\\n\\nwith numerous complications related to biocompatibility. A high number of thromboembolic events have\\n\\nbeen reported in clinical trials and animal studies. All TAH recipients require a strict anticoagulation\\n\\nregimen that results in a high risk of haemorrhagic events. Devices such as the Carmat TAH improved\\n\\nbiocompatibility by using membranes and heart valves containing sheep pericardial tissue. The available\\n\\ndata on the Carmat TAH suggest that patients receiving a Carmat TAH need less anticoagulation\\n\\nmedication than patients receiving a SynCardia device138. Upcoming solutions to address biocompatibility\\n\\nissues can be found in new developments in biomaterials science. If growing endothelium derived from\\n\\nthe patient on the blood-contacting surfaces of the TAH becomes possible, this strategy would probably\\n\\nresolve many biocompatibility issues. The developers of the HybridHeart aim to grow a layer of patient-\\n\\nderived endothelium on the inside of the soft ventricles with the use of biofunctionalization and in situ\\n\\ntissue-engineering techniques140. However, owing to the large surface area and the continuous movement\\n\\nof the TAH ventricles, applying tissue engineering techniques on TAH devices remains challenging. Even\\n\\nafter five decades of research, we are still far from being able to create a living endothelium inside the\\n\\nventricles of a TAH141. The interaction of rigid components with the blood is associated with many adverse\\n\\neffects. These effects have been most widely studied for the rotors in LVAD devices and include risks of\\n\\nthrombus formation and non-surgical bleeding caused by the device-altered haemostatic function9,142.\\n\\nThe artificial surface of the rotary blood pumps can induce platelet adhesion, which increases the risk of\\n\\nthrombosis, and the rotating parts can induce loss of haemostasis-related receptors on platelets, which\\n\\nincreases the risk of bleeding142. Haemolysis is the second-most common LVAD-related complication,\\n\\npresumably caused by the destruction of erythrocytes in the rotating LVAD devices143. Problems related to\\n\\nthe incompatibility between hard machines and soft human tissue might be solved if the machine is as\\n\\nsoft as the human tissue. Soft robotics is an emerging research field that focuses on developing robots\\n\\nmade of soft materials. In the past year, a few research groups have shifted their focus to developing\\n\\nTAHs that are completely soft on the inside and outside, such as SoftHeart and HybridHeart50,144,145. The\\n\\nprimary benefit of developing soft TAHs is that they mimic the natural movement of the heart, potentially\\n\\nreducing the stress on the blood and thereby resulting in fewer adverse effects57. The second benefit of\\n\\nsoft robotic cardiac devices is that they are compliant because they can stretch, contract or bend. As a\\n\\nresult, soft robotic cardiac devices can promote both the contraction and the relaxation phases of the\\n\\nheart146. Owing to its elastic behaviour, the ventricle of a soft TAH has higher passive filling and contracts\\n\\nmore forcefully at high filling pressures than at low filling pressures. Therefore, the soft robotic cardiac\\n\\ndevice passively ejects higher cardiac outputs at larger end-diastolic volumes, like the Frank–Starling\\n\\nmechanism of the native heart. This compliance is inherent to soft robotic cardiac devices147 and works\\n\\nwithout the need for any sensors or manual control. A soft robotic cardiac sleeve developed in 2017, the\\n\\nfirst soft robotic cardiac assist device under development, shows Frank–Starling behaviour146. This Frank–\\n\\nStarling mechanism could mean that the expansible volume capabilities of future soft robotic TAHs can\\n\\nbalance the left and right outputs to achieve Frank–Starling curve behaviour that resembles human\\n\\nphysiology. Given that TAHs need to work for a high number of cycles (one cycle for every heartbeat),\\n\\nachieving high durability and reliability remains a major challenge for TAH development. The SoftHeart\\n\\nhad a maximum working duration of 110,000\\u2009cycles (approximately 30\\u2009h), after which a fatigue crack\\n\\ncaused device failure57. Although current soft TAHs are at early development stages, with future\\n\\noptimization their benefits might outweigh those of traditionally rigid TAH devices.\\n\\nConclusions\\n\\nAfter more than six decades of TAH research, TAHs have been successfully used in over 1,700 patients as a\\n\\nbridge to heart transplantation, but a TAH suitable for destination therapy has not yet been developed.\\n\\nSome of the major drawbacks of current TAHs are high complication rates, bulkiness, short durability,\\n\\npoor biocompatibility and low quality of life for the patients. These issues need to be resolved before the\\n\\npotential of TAHs as destination therapy can be realized. Nevertheless, the field of TAH research is rapidly\\n\\nevolving, and various approaches are emerging that could potentially improve the quality of life of TAH\\n\\nrecipients. With the development of TET systems and improved TAH efficiency, percutaneous cables will\\n\\nno longer be necessary to provide electrical power to the implanted TAH. The field of battery technology\\n\\nis continuously improving, delivering more compact batteries that are easier to implant internally and that\\n\\nprolong the period during which the patient can engage in activities without charging the TAH. New\\n\\ninsights into soft robotics might result in the development of completely soft TAHs that reduce the\\n\\noccurrence of adverse effects associated with traditionally rigid TAHs. Meanwhile, smart biomaterials\\n\\nmight solve current biocompatibility issues. In the future, these new technologies have the potential to\\n\\nenable the development of the first TAH approved for destination therapy.\\n\\nKey points\\n\\nAfter decades of research on total artificial hearts, only two devices are clinically available as a\\n\\nbridge to transplantation therapy; a total artificial heart suitable for destination therapy has not\\n\\nyet been developed.\\n\\nCurrently available total artificial hearts have major drawbacks, including bulkiness, limited\\n\\ndurability, poor biocompatibility, high complication rates and low quality of life for the recipients.\\n\\nWe are on the verge of an era in total artificial heart development in which rapidly evolving\\n\\ntechnologies from different fields will lead to new approaches in total artificial heart design and\\n\\ndevelopment.\\n\\nMore powerful and more compact batteries and transcutaneous energy transfer systems will\\n\\nomit the need for percutaneous cables and will improve the quality of life of the recipients of a\\n\\ntotal artificial heart.\\n\\nWith the rise of soft robotic technologies and smart biomaterials, completely soft total artificial\\n\\nhearts might soon be developed and are likely to have fewer biocompatibility issues than current\\n\\ndevices.\\n\\nFigures\\n\\nFigure 1. Timeline of the milestones in the development of total artificial hearts\\n\\nAll current TAH devices and the most historically important TAH devices are shown. The red bars\\n\\nrepresent the period of development and/or reporting of testing results in literature for each TAH. CFTAH,\\n\\ncontinuous-flow total artificial heart; EHTAH, electrohydraulic total artificial heart; ERTAH, eccentric roller\\n\\ntotal artificial heart; FTPTAH, flow-transformed pulsatile total artificial heart; HFTAH, helical flow total\\n\\nartificial heart; LVAD–TAH, total artificial heart made with two left ventricular assist devices; UPTAH,\\n\\nundulation pump total artificial heart. Images reproduced with permission from ref.171, Springer Nature\\n\\n(AbioCor); ref.48, Science Museum Group/Academic (Akutsu III); ref.172, Wiley (BiVACOR); ref.173,\\n\\nCarmat/OUP (Carmat TAH); ref.96, Springer Nature (Cleveland CFTAH); ref.98, Wiley (HFTAH); The Board\\n\\nof Trustees of the Science Museum (Jarvik-7); ref.11, Elsevier (Liotta–Cooley TAH); ref.100, Wiley\\n\\n(OregonHeart); ref.174, Wiley (Realheart TAH); and ref.108, Elsevier (SynCardia).\\n\\nFigure 2. Working mechanism for different types of total artificial hearts\\n\\na. Fluid-driven total artificial hearts (TAHs) are composed of blood chambers and pneumatic or hydraulic\\n\\nchambers, which are separated by a membrane. A pump moves pressurized air or liquid into the\\n\\npneumatic or hydraulic chambers, which moves the membrane and causes the ejection of the blood in a\\n\\npulsatile manner. In the example shown in the figure, blood is ejected from both blood chambers\\n\\nalternately; however, some devices eject blood simultaneously from both chambers. The pump that\\n\\nmoves the air or fluid can be implanted in the body or can be placed externally. For the latter,\\n\\npercutaneous hoses are required. Phase 1 shows the filling of the right blood chamber and the ejection of\\n\\nthe left blood chamber. In phase 2, the pump rotates in the opposite direction, resulting in the filling of\\n\\nthe left blood chamber and the ejection of the right blood chamber. B. Mechanical TAHs have two blood\\n\\nchambers and a mechanical motor, separated by a membrane. A motor pushes a mechanical part (pusher\\n\\nplate) against the membrane so that blood is ejected from that blood chamber. In the example, blood is\\n\\nejected from the blood chambers alternately; however, some devices eject blood simultaneously from\\n\\nboth chambers. In phase 1, the mechanical motor moves the pusher plate against the membrane of the\\n\\nleft chamber, which ejects blood while the right chamber fills. In phase 2, the mechanical motor moves\\n\\nthe pusher plate against the membrane of the right chamber, which ejects blood while the left ventricle\\n\\nfills. c .Continuous-flow TAHs have two continuous-flow pumps that pump blood continuously in one\\n\\ndirection. Valves are usually not required. There is no filling or ejection phase because the blood is\\n\\ncontinuously being pumped. CFTAH, continuous-flow total artificial heart; EHTAH, electrohydraulic total\\n\\nartificial heart; ERTAH, eccentric roller total artificial heart; FTPTAH, flow-transformed pulsatile total\\n\\nartificial heart; HFTAH, helical flow total artificial heart; LVAD–TAH, total artificial heart made with two\\n\\nleft ventricular assist devices; UPTAH, undulation pump total artificial heart.\\n\\nFigure 3. Efficiency of total artificial hearts\\n\\nOverall efficiencies of total artificial hearts (TAHs) are depicted against the cardiac output. The method of\\n\\ncalculation for the overall efficiencies of the TAHs is explained in Box 1. All values are measured under\\n\\nphysiological mean left afterload conditions (≥90\\u2009mmHg). If right afterload was not reported when tested\\n\\nin a double-sided mock loop, we assumed it to be 20\\u2009mmHg. For some TAH devices, we were not able to\\n\\nobtain data to calculate efficiencies. Data for ReinHeart were shared by the authors upon request. a.\\n\\nOverall efficiencies for fluid-driven TAHs45,175. b. Overall efficiencies for mechanical\\n\\nTAHs60,63,64,66,67,69,70,71,76,176. c. Overall efficiencies for continuous-flow TAHs84,95,98,157,168,170. d .Running time\\n\\n(defined as the maximum time in which the TAH recipient can engage in activities without charging the\\n\\nTAH) of TAHs developed since 201576,157,170, calculated as though these TAHs hypothetically had\\n\\ntranscutaneous energy transfer systems with the internal battery capacity of the most recently available\\n\\nbattery technology (from the ReinHeart system). CFTAH, continuous-flow total artificial heart; EHTAH,\\n\\nelectrohydraulic total artificial heart; ERTAH, eccentric roller total artificial heart; HFTAH, helical flow total\\n\\nartificial heart; UPTAH, undulation pump total artificial heart.\\n\\nTables\\n\\nTAH\\n\\nRegion\\n\\nType\\n\\nDimensions\\n\\n(mm)\\n\\nWeight\\n\\n(g)\\n\\nVolume\\n\\n(ml)\\n\\nPower\\n\\nsupply\\n\\nValve\\n\\ntypes\\n\\nDevelopment\\n\\nstage\\n\\nRefs\\n\\nAbioCor\\n\\nUSA\\n\\nFluid-\\n\\ndriven\\n\\n85\\u2009×\\u200985\\u2009×\\u2009100\\n\\n907\\n\\n723a\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n46,47,48\\n\\nAnyHeart\\n\\nSouth\\n\\nKorea\\n\\nMechanical\\n\\n60\\u2009×\\u2009100\\u2009×\\u2009100\\n\\n650\\n\\n600\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n59,60,61\\n\\nBaylor TAH\\n\\nUSA and\\n\\nJapan\\n\\nMechanical\\n\\n97\\u2009×\\u200997\\u2009×\\u200983\\n\\n620\\n\\n510\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n62,63\\n\\nBiVACOR\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\nNR\\n\\n650\\n\\nNR\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels\\n\\n95,148\\n\\nBrno TAH\\n\\nCzech\\n\\nRepublic\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n37\\n\\nCarmat TAH\\n\\n(Aeson)\\n\\nFrance\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n900\\n\\n750\\n\\nPercutaneous\\n\\nBiological\\n\\nApproved\\n\\n51,52\\n\\nCleveland\\n\\ncontinuous-\\n\\nflow TAH\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n60\\u2009×\\u200960\\u2009×\\u2009100\\n\\n486\\n\\n160\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels\\n\\n96,97\\n\\nCleveland\\n\\nNimbus\\n\\nUSA\\n\\nMechanical\\n\\n90\\u2009×\\u200997\\u2009×\\u2009134\\n\\nNR\\n\\n700\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n64,65\\n\\nEccentric roller\\n\\nTAH\\n\\nJapan\\n\\nMechanical\\n\\n100\\u2009×\\u2009100\\u2009×\\u200980\\n\\n1,800\\n\\n800a\\n\\nPercutaneous\\n\\nNo valves\\n\\nStopped\\n\\n66\\n\\nElectrohydraulic\\n\\nTAH\\n\\nJapan\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n2,492\\n\\n872\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n45\\n\\nFlow-\\n\\ntransformed\\n\\npulsatile TAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\nNR\\n\\n2,000\\n\\n550\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n82\\n\\nHelical flow\\n\\nTAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\n80\\u2009×\\u200980\\u2009×\\u200977\\n\\n565\\n\\n493a\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels\\n\\n98\\n\\nHybrid\\n\\ncontinuous-\\n\\nflow TAH\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n50\\u2009×\\u200950\\u2009×\\u200950b\\n\\nNR\\n\\n125a,b\\n\\nPercutaneous\\n\\nNo valves\\n\\nIn vitro\\n\\n99\\n\\nImpeller TAH\\n\\nChina\\n\\nContinuous\\n\\nflow\\n\\n40\\u2009×\\u200940\\u2009×\\u200980\\n\\n250\\n\\n128a\\n\\nTET\\n\\nNo valves\\n\\nStopped\\n\\n84\\n\\nLinear TAH\\n\\nJapan\\n\\nMechanical\\n\\n85\\u2009×\\u200985\\u2009×\\u200994\\n\\n1,900\\n\\n560\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n67,68\\n\\nLVAD–TAH\\n\\nVarious\\n\\nContinuous\\n\\nflow\\n\\nVarious\\n\\nVarious\\n\\nVarious\\n\\nPercutaneous\\n\\nNo valves\\n\\nClinical trials\\n\\nMagScrew\\n\\nUSA\\n\\nMechanical\\n\\nNR\\n\\n890\\n\\n506\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n69\\n\\nMilwaukee\\n\\nHeart\\n\\nUSA\\n\\nMechanical\\n\\n83\\u2009×\\u200983\\u2009×\\u200962\\n\\n600\\n\\n490\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n70\\n\\nOregonHeart\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n85\\u2009×\\u200975\\u2009×\\u200960b\\n\\nNR\\n\\n130\\n\\nPercutaneous\\n\\nNo valves\\n\\nIn vitro\\n\\n100,101\\n\\nOvalis\\n\\nGermany\\n\\nMechanical\\n\\n75\\u2009×\\u200975\\u2009×\\u200995\\n\\n950\\n\\n560\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n71\\n\\nPenn State\\n\\nelectric TAH\\n\\nUSA\\n\\nMechanical\\n\\n91\\u2009×\\u200991\\u2009×\\u200994\\n\\n700\\n\\n778a\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n72\\n\\nPenn State\\n\\npneumatic TAH\\n\\nUSA\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n38\\n\\nPhoenix\\n\\nTaiwan\\n\\nFluid-\\n\\ndriven\\n\\n70\\u2009×\\u200970\\u2009×\\u2009130\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n39,40\\n\\nPoisk TAH\\n\\nRussia\\n\\nFluid-\\n\\ndriven\\n\\n125\\u2009×\\u2009100\\u2009×\\u200970\\n\\n220\\n\\nNR\\n\\nPercutaneous\\n\\nNR\\n\\nStopped\\n\\n41,42\\n\\nPOLTAH\\n\\nPoland\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n43\\n\\nRealheart TAH\\n\\nSweden\\n\\nMechanical\\n\\n148\\u2009×\\u2009126\\u2009×\\u200996\\n\\n800\\n\\n1,790a\\n\\nTET\\n\\nMechanical\\n\\nAnimal\\n\\nmodels\\n\\n73,74\\n\\nReinHeart\\n\\nGermany\\n\\nMechanical\\n\\n87\\u2009×\\u200987\\u2009×\\u200990\\n\\n940\\n\\n550\\n\\nTET\\n\\nMechanical\\n\\nAnimal\\n\\nmodels\\n\\n75\\n\\nRollingHeart\\n\\nSwitzerland\\n\\nMechanical\\n\\n80\\u2009×\\u200980\\u2009×\\u2009110\\n\\nNR\\n\\n704a\\n\\nPercutaneous\\n\\nNo valves\\n\\nIn vitro\\n\\n76\\n\\nSoftHeart\\n\\nSwitzerland\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n136\\n\\n447\\n\\nPercutaneous\\n\\nMechanical\\n\\nIn vitro\\n\\n57\\n\\nTable 1. Baseline characteristics of total artificial hearts.\\n\\nLVAD–TAH, total artificial heart made with two left ventricular assist devices; NR, not reported, TAH, total\\n\\nartificial heart; TET, transcutaneous energy transfer. aCalculated with the reported dimensions. bReported\\n\\ntarget size (not the current prototype).\\n\\nTAH\\n\\nType\\n\\nStudy\\n\\nperiod\\n\\nNumber of\\n\\nanimals\\n\\nMaximum\\n\\nsurvival\\n\\n(days)\\n\\nMost reported causes of death (n)\\n\\nRefs\\n\\nAbioCora\\n\\nFluid-driven\\n\\n1990–\\n\\n2001\\n\\n120\\n\\n108\\n\\nElective termination (16),\\n\\nmechanical failure (5)\\n\\n20,112,117,149,150\\n\\nAnyHeart\\n\\nMechanical\\n\\n1990\\n\\n1\\n\\n4\\n\\nRespiratory failure (1)\\n\\n59\\n\\nBaylor TAHa\\n\\nMechanical\\n\\n1993–\\n\\n1994\\n\\n8\\n\\n7\\n\\nNR\\n\\n151,152\\n\\nBiVACORa\\n\\nContinuous flow\\n\\n2017\\n\\n15\\n\\n90\\n\\nNR\\n\\n148,153\\n\\nBrno TAHa\\n\\nFluid-driven\\n\\n1983–\\n\\n1995\\n\\n168\\n\\n314\\n\\nThromboembolic complications (6),\\n\\nmechanical failure (5)\\n\\n37,119,154,155\\n\\nCarmat TAH\\n\\n(Aeson)\\n\\nFluid-driven\\n\\n2014–\\n\\n2017\\n\\n12\\n\\n10\\n\\nThromboembolic complications (4),\\n\\nbleeding (2), respiratory failure (2)\\n\\n118,156\\n\\nCleveland\\n\\ncontinuous-\\n\\nflow TAH\\n\\nContinuous flow\\n\\n2015\\n\\n17\\n\\n90\\n\\nElective termination (4), bleeding (3)\\n\\n157\\n\\nCleveland\\n\\nNimbus\\n\\nMechanical\\n\\n1992–\\n\\n1994\\n\\n12\\n\\n120\\n\\nMechanical failure (10),\\n\\nthromboembolic complications (1),\\n\\ninfection (1)\\n\\n64,113\\n\\nElectrohydraulic\\n\\nTAHa\\n\\nFluid-driven\\n\\n1990–\\n\\n2003\\n\\n57\\n\\n159\\n\\nMechanical failure (14),\\n\\nthromboembolic complications (7),\\n\\nrespiratory failure (7)\\n\\n114,158,159,160,161,162\\n\\nHelical flow\\n\\nTAH\\n\\nContinuous flow\\n\\n2015\\n\\n13\\n\\n100\\n\\nMechanical failure (7)\\n\\n98\\n\\nLVAD–TAH\\n\\nContinuous flow\\n\\n2009–\\n\\n2021\\n\\n40\\n\\n92\\n\\nThromboembolic complications (23),\\n\\nelective termination (8)\\n\\n85,88,92,93\\n\\nMagScrew\\n\\nMechanical\\n\\n2001-2005\\n\\n12\\n\\n92\\n\\nMechanical failure (5), respiratory\\n\\nfailure (3)\\n\\n69,163\\n\\nPenn State\\n\\nelectric TAH\\n\\nMechanical\\n\\n1990–\\n\\n2000\\n\\n54\\n\\n388\\n\\nMechanical failure (17), respiratory\\n\\nfailure (13)\\n\\n72,115,164,165,166\\n\\nPenn State\\n\\npneumatic TAHa\\n\\nFluid-driven\\n\\n1979–\\n\\n1989\\n\\n47\\n\\n353\\n\\nMechanical failure (22),\\n\\nthromboembolic complications (6)\\n\\n38,167\\n\\nPhoenix\\n\\nFluid-driven\\n\\n2001\\n\\n41\\n\\n60\\n\\nRespiratory failure (22),\\n\\nthromboembolic (6), multiorgan\\n\\nfailure (6)\\n\\n40\\n\\nReinhearta\\n\\nMechanical\\n\\n2015\\n\\n12\\n\\n2\\n\\nNR\\n\\n75\\n\\nSynCardia\\n\\nFluid-driven\\n\\n1979–\\n\\n1981\\n\\n31\\n\\n268\\n\\nThromboembolic complications (8),\\n\\nbleeding (5)\\n\\n25,26\\n\\nUndulation\\n\\npump TAH\\n\\nContinuous flow\\n\\n2000–\\n\\n2011\\n\\n68\\n\\n153\\n\\nMechanical failure (30), bleeding\\n\\n(15)\\n\\n83,116,168,169\\n\\nVienna TAHa\\n\\nFluid-driven\\n\\n1991\\n\\n15\\n\\n180\\n\\nMechanical failure (3)\\n\\n44\\n\\nTable 2. Total artificial hearts assessed in chronic animal trials\\n\\nAll devices that have been assessed in published chronic animal trials are listed. The cause of death of the\\n\\nanimals was not always reported in the literature, especially for AbioCor, Baylor TAH, BiVACOR, Brno TAH,\\n\\nelectrohydraulic TAH, ReinHeart, Penn State pneumatic TAH and Vienna TAH. LVAD–TAH, total artificial heart\\n\\nmade with two left ventricular assist devices; NR, not reported; TAH, total artificial heart. aDevices with high\\n\\nnumbers of missing animal data.\\n\\nSynCardia 70cc\\n\\nUSA\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n240\\n\\n400\\n\\nPercutaneous\\n\\nMechanical\\n\\nApproved\\n\\n49\\n\\nUndulation\\n\\npump TAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\n77\\u2009×\\u200977\\u2009×\\u200979\\n\\n660\\n\\n310\\n\\nPercutaneous\\n\\nNo valves\\n\\nStopped\\n\\n83\\n\\nVienna TAH\\n\\nAustria\\n\\nFluid-\\n\\ndriven\\n\\n72\\u2009×\\u200972\\u2009×\\u2009120\\n\\nNR\\n\\n622a\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n44\\n\\nTAH\\n\\nType\\n\\nNumber\\n\\nof\\n\\nimplanted\\n\\ndevices\\n\\nTAH support\\n\\nduration (days)\\n\\nNumber\\n\\nimplanted as\\n\\nbridge to\\n\\ntransplantation\\n\\n(%)\\n\\nNumber of\\n\\ndeaths\\n\\nduring TAH\\n\\nsupport (%)\\n\\nMost reported causes of\\n\\ndeath during TAH support\\n\\n(%)\\n\\nRefs\\n\\nMean\\n\\nMaximum\\n\\nAbioCor\\n\\nFluid-driven\\n\\n11\\n\\n142\\n\\n512\\n\\n0 (0)\\n\\n10 (100)\\n\\nThromboembolic\\n\\ncomplications (50),\\n\\nmultiorgan failure (33)\\n\\n125\\n\\nBrno TAH\\n\\nFluid-driven\\n\\n6\\n\\n5\\n\\n10\\n\\n0 (0)\\n\\n6 (100)\\n\\nThromboembolic\\n\\ncomplications (50),\\n\\nbleeding (33)\\n\\n120\\n\\nCarmat\\n\\nTAH\\n\\n(Aeson)a\\n\\nFluid-driven\\n\\n24\\n\\n166\\n\\n308\\n\\n(45)\\n\\n(55)\\n\\nMultiorgan failure (50),\\n\\nmechanical failure (33)\\n\\n107,138\\n\\nLVAD–\\n\\nTAH\\n\\nContinuous\\n\\nflow\\n\\n9\\n\\n92\\n\\n180\\n\\n4 (44)\\n\\n4 (44)\\n\\nMultiorgan failure (50),\\n\\nbleeding (50)\\n\\n86,87,89,90\\n\\n,91,94\\n\\nPenn\\n\\nState\\n\\npneumatic\\n\\nTAH\\n\\nFluid-driven\\n\\n3\\n\\n135\\n\\n379\\n\\n2 (67)\\n\\n1 (33)\\n\\nAspiration pneumonia\\n\\n(100)\\n\\n38\\n\\nPhoenix\\n\\nFluid-driven\\n\\n2\\n\\n8\\n\\n15\\n\\n2 (100)\\n\\n0 (0)\\n\\n–\\n\\n121,123\\n\\nPoisk TAH\\n\\nFluid-driven\\n\\n13\\n\\n5\\n\\n15\\n\\n1 (8)\\n\\n12 (92)\\n\\nUnknown\\n\\n122\\n\\nSynCardiab\\n\\nFluid-driven\\n\\n>1,700\\n\\n94\\n\\n4.5 years\\n\\n(65)\\n\\n(33)\\n\\nMultiorgan failure (40),\\n\\nthromboembolic\\n\\ncomplications (13),\\n\\ninfection (10)\\n\\n127,129,130,131\\n\\n,132,133,134,\\n\\n135,136\\n\\nVienna\\n\\nTAH\\n\\nFluid-driven\\n\\n5\\n\\n12\\n\\n22\\n\\n3 (60)\\n\\n2 (40)\\n\\nInfection (50), multiorgan\\n\\nfailure (50)\\n\\n44,124\\n\\nTable 3. Total artificial hearts assessed in clinical trials.\\n\\nAll TAH devices that were implanted in patients are listed. LVAD–TAH, total artificial heart made with two left\\n\\nventricular assist devices; TAH, total artificial heart. aThe trial on the Carmat TAH is currently enrolling\\n\\npatients56; a total of 24 patients received the Carmat TAH (as of February 2022), of which data from only 11\\n\\npatients are described in the literature; the mean duration of support, bridge to transplantation, death during\\n\\nTAH support and most reported causes of death are based on data from these 11 patients. bSynCardia TAHs\\n\\nhave been implanted in over 1,700 patients, of which only a fraction has been reported in the literature; we\\n\\nused data from eight clinical trials describing 574 patients implanted with a SynCardia TAH to calculate the\\n\\nmean duration of support, bridge to transplantation, death during TAH support and most reported causes of\\n\\ndeath116,117,118,119,120,121,122,123.\\n\\nTAH\\n\\nType\\n\\nCardiac output\\n\\n(l/min)\\n\\nInput\\n\\npower (W)\\n\\nOutput\\n\\npower (W)\\n\\nEfficiency\\n\\n(%)\\n\\nRunning time without\\n\\ncharging (min)\\n\\nReferences\\n\\nCleveland\\n\\ncontinuous-flow\\n\\nTAH\\n\\nContinuous\\n\\nflow\\n\\n7.4\\n\\n12.9\\n\\n1.7\\n\\n13.3\\n\\n61\\n\\n157\\n\\nOregonHeart\\n\\nContinuous\\n\\nflow\\n\\n7.5\\n\\n10.0\\n\\n1.7\\n\\n17.5\\n\\n79\\n\\n170\\n\\nReinHeart\\n\\nMechanical\\n\\n5.5\\n\\n12.5\\n\\n1.3\\n\\n10.8\\n\\n63\\n\\nUnpublished dataa\\n\\nRollingHeart\\n\\nMechanical\\n\\n5.3\\n\\n14.0\\n\\n2.0\\n\\n14.1\\n\\n57\\n\\n76\\n\\nTable 4. Power requirements and efficiency of total artificial hearts.\\n\\nAll TAHs currently being investigated with published power requirements are listed. For the TAHs not\\n\\nlisted in the table, no power requirements have been reported in the literature. All parameters were\\n\\nmeasured at a physiological mean left afterload (≥90\\u2009mmHg). TAH, total artificial heart. aData for\\n\\nReinHeart was shared by the authors upon request.\\n\\nGlossary\\n\\nDriveline: Percutaneous cable that transmits electrical power from an external driver to the\\n\\ninternally implanted device such as a TAH or LVAD.\\n\\nTranscutaneous energy transfer (TET) system: A wireless power delivery system that uses magnetic\\n\\nfields to transfer power across the skin without the need for direct electrical connectivity.\\n\\nBronchial shunt: The physiological passage of oxygenated blood from the aorta to the bronchial\\n\\ncirculation. This blood returns directly to the left atrium, thereby bypassing the right side of the\\n\\nheart.\\n\\nFrank–Starling mechanism: This law states that the stroke volume of the heart increases in response\\n\\nto an increase in the volume of blood in the ventricles before contraction (the end diastolic volume),\\n\\nwhen all other factors remain constant.\\n\\nPreload: The filling pressure of the ventricle at the end of diastole, which is determined by the atrial\\n\\npressure.\\n\\nStator: The stationary part of a rotary machine or device.\\n\\nInvestigational device exemption: Type of FDA approval that allows the investigational device to be\\n\\nused in a clinical study in order to collect safety and efficacy data.\\n\\nAfterload: The amount of pressure that the ventricle needs to exert to eject the blood during\\n\\nventricular contraction.\\n\\nBox 1 Calculation of TAH efficiencies\\n\\nTo compare the efficiency of the different types of total artificial heart (TAH) shown in Fig. 3, we used\\n\\na consistent measure of the power consumed by the TAH (input power) and the amount of work\\n\\n(output power) performed by the TAH to pump blood against physiological pressures. The numerical\\n\\nvalue of the output power is the product of the difference in outlet and inlet pressure (pressure\\n\\nhead) and the flow of blood generated by the heart (cardiac output). For pulsatile TAHs, we\\n\\ncalculated the pressure head as the difference between the mean afterload and the intraventricular\\n\\npressure. We assume that during diastole, the pressure inside the TAH ventricle drops to near\\n\\n0\\u2009mmHg, as in the native heart177. For continuous-flow TAHs, we calculated the pressure head as\\n\\nthe difference between the mean afterload and the mean preload. We have used the following\\n\\nequation to calculate the output power of the TAHs:\\n\\nwhere the output power is in watt, Qsys and Qpul are the resulting cardiac output (in m3/s) for the\\n\\nsystemic and pulmonary circulations, respectively, and Hsys and Hpul are the pressure heads (in\\n\\nN/m2) for systemic and pulmonary circulations, respectively, against which the TAH must pump. The\\n\\ninput power to the TAH is an individual number unique to the device. Therefore, we analysed only\\n\\nthe TAHs that have the corresponding input power reported in the literature. We have used the\\n\\nfollowing equation for calculating the efficiency (η) of a TAH on the basis of input power and output\\n\\npower:\\n\\nAcknowledgements\\n\\nThe authors are grateful to L. C. van Laake (AMOLF, Netherlands), D. Zrinscak (Scuola Superiore\\n\\nSant’Anna, Italy) and A. Henseler (evos GmbH, Germany) for their contributions and discussions; D.\\n\\nvan Urk (Amsterdam UMC, The Netherlands) for assisting with screening and selecting articles; T.\\n\\nAzami (Amsterdam UMC, The Netherlands) and C. M. van de Beek (Amsterdam UMC, The\\n\\nNetherlands) for assistance with data extraction; C. E. J. M. Limpens (Amsterdam UMC, The\\n\\nNetherlands) and A. Malekzadeh (Amsterdam UMC, The Netherlands) for their help with the\\n\\nliterature search; and ReinHeart TAH GmbH, Germany for providing additional data upon request.\\n\\nThe authors’ work is part of the HybridHeart project and is funded by the European Union Horizon\\n\\n2020 research and innovation programme under grant agreement no. 767195.\\n\\nContributions\\n\\nA.V. and M.A. did the major literature search and wrote the first draft. All of the authors contributed\\n\\nto the discussion of content and reviewed and edited the manuscript before submission.\\n\\nCorresponding author\\n\\nCorrespondence to Jolanda Kluin.\\n\\nCompeting interests\\n\\nA.V., M.A., H.K., J.T.B.O. and J.K. are part of the HybridHeart consortium. The other authors declare\\n\\nno competing interests.\\n\\nReferences\\n\\n1.\\n\\nMetra, M. & Teerlink, J. R. Heart failure. Lancet 390, 1981–1995 (2017).\\n\\n2.\\n\\nHeidenreich, P. A. et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart\\n\\nAssociation. Circ. Heart Fail. 6, 606–619 (2013).\\n\\n3.\\n\\nColvin, M. et al. OPTN/SRTR 2018 annual data report: heart. Am. J. Transpl. 20, 340–426 (2020).\\n\\n4.\\n\\nMolina, E. J. et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann. Thorac. Surg. 111, 778–792 (2021).\\n\\n5.\\n\\nHan, J. J., Acker, M. A. & Atluri, P. Left ventricular assist devices. Circulation 138, 2841–2851 (2018).\\n\\n6.\\n\\nGurvits, G. E. & Fradkov, E. Bleeding with the artificial heart: gastrointestinal hemorrhage in CF-LVAD patients. World J.\\n\\nGastroenterol. 23, 3945–3953 (2017).\\n\\n7.\\n\\nGaland, V. et al. Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular\\n\\nassist devices. JACC Clin. Electrophysiol. 4, 1166–1175 (2018).\\n\\n8.\\n\\nRoss, D. W. et al. Left ventricular assist devices and the kidney. Clin. J. Am. Soc. Nephrol. 13, 348–355 (2018).\\n\\n9.\\n\\nAissaoui, N. et al. Understanding left ventricular assist devices. Blood Purif. 46, 292–300 (2018).\\n\\n10. National Heart Lung and Blood Institute. What Is Total Artificial Heart? Total Artificial Heart https://www.nhlbi.nih.gov/health-\\n\\ntopics/total-artificial-heart (NIH, 2020).\\n\\n11. Cooley, D. A. et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am. J. Cardiol. 24, 723–730 (1969).\\n\\n12. US National Library of Medicine. SynCardia 70cc TAH-t for Destination Therapy (DT) (RA-540). ClinicalTrials.gov\\n\\nhttps://ClinicalTrials.gov/show/NCT02232659 (2021).\\n\\n13. Akutsu, T. & Kolff, W. J. Permanent substitutes for valves and hearts. ASAIO J. 4, 230–234 (1958).\\n\\n14. Houston, C. S., Akutsu, T. & Kolff, W. J. Pendulum type of artificial heart within the chest: preliminiary report. Am. Heart J. 59,\\n\\n723–730 (1960).\\n\\n15. 15. Seidel, W., Akutsu, T., Mirkovitch, V., Brown, F. & Kolff, W. J. Air-driven artificial hearts inside the chest. Trans. Am. Soc. Artif.\\n\\nIntern. Organs 7, 378–387 (1961).\\n\\n16. Liotta, D. et al. Artificial heart in the chest: preliminary report. Trans. Am. Soc. Artif. Intern. Organs 7,318–322 (1961).\\n\\n17. Atsumi, K. et al. Artificial heart incorporated in the chest. Trans. Am. Soc. Artif. Intern. Organs 9, 292–298 (1963).\\n\\n18. Pierce, W. S. et al. Total heart replacement by a single intrathoracic blood pump. J. Surg. Res. 5, 387–394 (1965).\\n\\n19. Nosé, Y., Tretbar, L. L., SenGupta, A., Topaz, S. R. & Kolff, W. J. An artificial heart inside the chest. J. Thorac. Cardiovasc. Surg. 50,\\n\\n792–799 (1965).\\n\\n20. Cohn, W. E., Timms, D. L. & Frazier, O. H. Total artificial hearts: past, present, and future. Nat. Rev. Cardiol. 12, 609–617 (2015).\\n\\n21. Curran, W. J. Law-medicine notes. The first mechanical heart transplant: informed consent and experimentation. N. Engl. J.\\n\\nMed. 291, 1015–1016 (1974).\\n\\n22. Morris, D. T. & Couves, C. M. Experiences with a sac-type artificial heart. Can. Med. Assoc. J. 105, 483–487 (1971).\\n\\n23. Kwan-Gett, C. S., Van Kampen, K. R., Kawai, J., Eastwood, N. & Kolff, W. J. Results of total artificial heart implantation in calves. J.\\n\\nThorac. Cardiovasc. Surg. 62, 880–889 (1971).\\n\\n24. Kawai, J. et al. Implantation of a total artificial heart in calves under hypothermia with 10 day survival. J. Thorac. Cardiovasc.\\n\\nSurg. 64, 45–60 (1972).\\n\\n25. Hastings, W. L. et al. A retrospective study of nine calves surviving five months on the pneumatic total artificial heart. Trans. Am.\\n\\nSoc. Artif. Intern. Organs 27, 71–76 (1981).\\n\\n26. Fukumasu, H., Iwaya, F., Olsen, D. B., Lawson, J. H. & Kolff, W. J. Surgical implantation of the Jarvik-5 total artificial heart in a\\n\\ncalf. Trans. Am. Soc. Artif. Intern. Organs 25, 232–238 (1979).\\n\\n27. Akutsu, T., Takagi, H. & Takano, H. Total artificial hearts with built-in valves. Trans. Am. Soc. Artif. Intern. Organs 16, 392–397\\n\\n(1970).\\n\\n28. Honda, T. et al. One 25 day survivor with total artificial heart. J. Thorac. Cardiovasc. Surg. 69, 92–101 (1975).\\n\\n29. Nakazono, M. et al. A case report of 17 days survival with an implanted artificial heart in a calf. Jpn Heart J. 15, 485–497 (1974).\\n\\n30. Kasai, S. et al. Survival for 145 days with a total artificial heart. J. Thorac. Cardiovasc. Surg. 73, 637–646 (1977).\\n\\n31. Kennedy, J. H. et al. Development of an orthotopic cardiac prosthesis. J. Thorac. Cardiovasc. Surg. 65, 673–683 (1973).\\n\\n32. Backman, D. K., Donovan, F. M., Sandquist, G., Kessler, T. & Kolff, W. J. The design and evaluation of ventricles for the aec\\n\\nartificial heart nuclear power source. ASAIO J. 19, 542–552 (1973).\\n\\n33. Smith, L. et al. Development on the implantation of a total nuclear-powered artificial heart system. ASAIO J. 20, 732–735 (1974).\\n\\n34. Urzua, J., Sudilovsky, O., Panke, T., Kiraly, R. J. & Nosé, Y. Preliminary report: anatomic constraints for the implantation of an\\n\\nartificial heart. J. Surg. Res. 17, 262–268 (1974).\\n\\n35. Cooley, D. A., Akutsu, T., Norman, J. C., Serrato, M. A. & Frazier, O. H. Total artificial heart in two-staged cardiac transplantation.\\n\\nCardiovasc. Dis. 8, 305–319 (1981).\\n\\n36. DeVries, W. C. et al. Clinical use of the total artificial heart. N. Engl. J. Med. 310, 273–278 (1984).\\n\\n37. Vasků, J. & Urbánek, P. Constructional and functional characteristics of recent total artificial heart models TNS Brno VII, VIII, and\\n\\nIX. Artif. Organs 19, 535–543 (1995).\\n\\n38. Davis, P. K., Pae, W. E. Jr & Pierce, W. S. Toward an implantable artificial heart. Experimental and clinical experience at The\\n\\nPennsylvania State University. Invest. Radiol. 24, 81–87 (1989).\\n\\n39. Hsu, C. H. Fuzzy logic automatic control of the Phoenix-7 total artificial heart. J. Artif. Organs 7, 69–76 (2004).\\n\\n40. Hsu, C. H. In vivo and clinical study of Phoenix-7 total artificial heart. Biomed. Eng. Appl. Basis Commun. 13, 133–139 (2001).\\n\\n41. Shumakov, V. I. et al. Use of an ellipsoid artificial heart. Artif. Organs 11, 16–19 (1987).\\n\\n42. Shumakov, V. I. et al. New design of an orthotopic fluorosiloxane rubber heart prosthesis. Biomed. Eng. 10, 223–224 (1976).\\n\\n43. Nawrat, Z. & Malota, Z. The analysis of driving mode influence on energy dissipation in pneumatic artificial heart chambers.\\n\\nArtif. Organs 22, 898–904 (1998).\\n\\n44. Rokitansky, A. et al. The new small Viennese total artificial heart: experimental and first clinical experiences. Artif. Organs 15,\\n\\n129–135 (1991).\\n\\n45. Homma, A. et al. Development of an electrohydraulic total artificial heart system: improvement of pump unit. Electron.\\n\\nCommun. Jpn. 93, 34–46 (2010).\\n\\n46. Ford, B. J. A new generation of cardiology: the AbioCor implantable replacement heart. Air Med. J. 22, 26–30 (2003).\\n\\n47. Dowling, R. D. et al. The AbioCor implantable replacement heart. Ann. Thorac. Surg. 75, S93–S99 (2003).\\n\\n48. Smith, P. A., Cohn, W. E. & Frazier, O. H. in Mechanical Circulatory and Respiratory Support (eds Gregory, S. D., Stevens, M. C. &\\n\\nFraser, J. F.) Ch. 7, 221–244 (Academic, 2018).\\n\\n49. Spiliopoulos, S., Dimitriou, A. M., Guersoy, D., Koerfer, R. & Tenderich, G. Expanding applicability of total artificial heart therapy:\\n\\nthe 50-cc SynCardia total artificial heart. Ann. Thorac. Surg. 100, e55–e57 (2015).\\n\\n50. Cohrs, N. H. et al. A soft total artificial heart-first concept evaluation on a hybrid mock circulation. Artif. Organs 41, 948–958\\n\\n(2017).\\n\\n51. Stepanenko, A. & Kaufmann, F. A novel total artificial heart: search for haemocompatibility. Lancet 386, 1517–1519 (2015).\\n\\n52. CARMAT. Artificial hearts: devices from France’s Carmat to go on sale in Europe. YouTube https://\\n\\nwww.youtube.com/watch?v=j9T2HnSfVME (2021).\\n\\n53. US Food and Drug Administration. SynCardia Temporary Cardio West Total Artificial Heart (TAH-T). AccessData\\n\\nhttps://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P030011 (2004).\\n\\n54. EC Design-Examination Certificate. SynCardia temporary Total Artificial Heart (TAH-t) and external drivers. SynCardia\\n\\nhttp://syncardia.com/wp-content/uploads/2018/02/CE-665479-Design-Examination-26-May-2017.pdf (2017).\\n\\n55. SynCardia. SynCardia 70cc total artificial heart. SynCardia https://syncardia.com/clinicians/our-products/see-all-our-products/\\n\\n(2021).\\n\\n56. US National Library of Medicine. Carmat TAH early feasibility study. ClinicalTrials.gov\\n\\nhttps://clinicaltrials.gov/ct2/show/NCT04117295 (2022).\\n\\n57. Guex, L. G. et al. Increased longevity and pumping performance of an injection molded soft total artificial heart. Soft Robot. 23,\\n\\n23 (2020).\\n\\n58. Mihaylov, D., Verkerke, G. J. & Rakhorst, G. Mechanical circulatory support systems — a review. Technol. Health Care 8, 251–\\n\\n266 (2000).\\n\\n59. Min, B. G. et al. A moving-actuator type electromechanical total artificial heart — Part II: circular type and animal experiment.\\n\\nIEEE Trans. Biomed. Eng. 37, 1195–1200 (1990).\\n\\n60. Min, B. G. et al. A moving-actuator type electromechanical total artificial heart — Part I: linear type and mock circulation\\n\\nexperiments. IEEE Trans. Biomed. Eng. 37, 1186–1194 (1990).\\n\\n61. Ahn, J. M., Kang, D. W., Kim, H. C. & Min, B. G. In vivo performance evaluation of a transcutaneous energy and information\\n\\ntransmission system for the total artificial heart. ASAIO J. 39, M208–M212 (1993).\\n\\n62. Ohashi, Y., de Andrade, A. & Nosé, Y. Hemolysis in an electromechanical driven pulsatile total artificial heart. Artif. Organs 27,\\n\\n1089–1093 (2003).\\n\\n63. Takatani, S. et al. One piece ultracompact totally implantable electromechanical total artificial heart for permanent use. ASAIO J.\\n\\n48, 538–545 (2002).\\n\\n64. Irié, H. et al. Initial in vivo tests of an electrohydraulic actuated total artificial heart. ASAIO J. 38, M497–M500 (1992).\\n\\n65. Fukamachi, K. et al. Anatomic fitting studies of a total artificial heart in heart transplant recipients. Critical dimensions and\\n\\nprediction of fit. ASAIO J. 42, M337–M342 (1996).\\n\\n66. Sueshiro, M., Fukunaga, S., Hirai, S., Sueda, T. & Matsuura, Y. Eccentric roller type total artificial heart designed for implantation.\\n\\nArtif. Organs 22, 451–457 (1998).\\n\\n67. Kobayashi, M. et al. In vitro evaluation of linear motor-driven total artificial heart. Artif. Organs 20, 1320–1324 (1996).\\n\\n68. Yamada, H., Yamaguchi, M., Kobayashi, K., Matsuura, Y. & Takano, H. Development and test of a linear motor-driven total\\n\\nartificial heart. IEEE Eng. Med. Biol. Mag. 14, 84–90 (1995).\\n\\n69. Weber, S. et al. MagScrew TAH: an update. ASAIO J. 51, xxxvi–xlvi (2005).\\n\\n70. Gao, H. et al. In vitro assessment of the Milwaukee heart and right to left balance. ASAIO J. 38, M722–M725 (1992).\\n\\n71. Sauer, I. M., Frank, J., Spiegelberg, A. & Bücherl, E. S. Ovalis TAH: development and in vitro testing of a new electromechanical\\n\\nenergy converter for a total artificial heart. ASAIO J. 46, 744–748 (2000).\\n\\n72. Mehta, S. M. et al. Testing of a 50 cc stroke volume completely implantable artificial heart: expanding chronic mechanical\\n\\ncirculatory support to women, adolescents, and small stature men. ASAIO J. 46, 779–782 (2000).\\n\\n73. Szabó, Z. et al. Scandinavian real heart (SRH) 11 implantation as total artificial heart (TAH)-experimental update. J. Clin. Exp.\\n\\nCardiol. 9, 2 (2018).\\n\\n74. Sonntag, S. J. et al. Virtual implantations to transition from porcine to bovine animal models for a total artificial heart. Artif.\\n\\nOrgans 44, 384–393 (2020).\\n\\n75. Pelletier, B. et al. System overview of the fully implantable destination therapy — ReinHeart total artificial heart. Eur. J.\\n\\nCardiothorac. Surg. 47, 80–86 (2015).\\n\\n76. Tozzi, P. et al. An original valveless artificial heart providing pulsatile flow tested in mock circulatory loops. Int. J. Artif. Organs\\n\\n40, 683–689 (2017).\\n\\n77. Kirklin, J. K. et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J. Heart Lung Transpl.\\n\\n36, 1080–1086 (2017).\\n\\n78. Potapov, E. V., Kaufmann, F., Müller, M., Mulzer, J. & Falk, V. Longest ongoing support (13 years) with magnetically levitated left\\n\\nventricular assist device. ASAIO J. 66, e121–e122 (2020).\\n\\n79. Yang, M. in Technology and Therapy Management 99–100 (Springer, 2020).\\n\\n80. Healy, A. H. et al. Physiologic effects of continuousflow left ventricular assist devices. J. Surg. Res. 202, 363–371 (2016).\\n\\n81. Bhimaraj, A., Uribe, C. & Suarez, E. E. Physiological impact of continuous flow on end-organ function: clinical implications in the\\n\\ncurrent era of left ventricular assist devices. Methodist. Debakey Cardiovasc. J. 11, 12–17 (2015).\\n\\n82. Isoyama, T. et al. New version of flow-transformed pulsatile total artificial heart with no electrical switching valve. Artif. Organs\\n\\n19, 694–696 (1995).\\n\\n83. Abe, Y. et al. Results of animal experiments with the fourth model of the undulation pump total artificial heart. Artif. Organs 35,\\n\\n781–790 (2011).\\n\\n84. Qian, K. X., Ru, W. M., Zeng, P. & Yuan, H. Y. A novel impeller TAH using magnetic bearings for load reduction. J. Med. Eng.\\n\\nTechnol. 26, 214–216 (2002).\\n\\n85. Feng, J. et al. New continuous-flow total artificial  heart and vascular permeability. J. Surg. Res. 199, 296–305 (2015).\\n\\n86. Lebreton, G., Mastroianni, C., Amour, J. & Leprince, P. Implantation of two HVADs used as a total artificial heart: a new\\n\\napproach. Ann. Thorac. Surg. 107, e165–e167 (2019).\\n\\n87. Mulvihill, M. S. et al. Usefulness of two centrifugal ventricular assist devices in a total artificial heart configuration: a preliminary\\n\\nreport. J. Heart Lung Transpl. 36, 1266–1268 (2017).\\n\\n88. Cohn, W. E. et al. Eight-year experience with a continuous-flow total artificial heart in calves. ASAIO J. 60, 25–30 (2014).\\n\\n89. Pirk, J. et al. Total artificial heart support with two continuous-flow ventricular assist devices in a patient with an infiltrating\\n\\ncardiac sarcoma. ASAIO J. 59, 178–180 (2013).\\n\\n90. Frazier, O. H. & Cohn, W. E. Continuous-flow total heart replacement device implanted in a 55-year-old man with end-stage\\n\\nheart failure and severe amyloidosis. Tex. Heart Inst. J. 39, 542–546 (2012).\\n\\n91. Strueber, M., Schmitto, J. D., Kutschka, I. & Haverich, A. Placement of two implantable centrifugal pumps to serve as a total\\n\\nartificial heart after cardiectomy. J. Thorac. Cardiovasc. Surg. 143, 507–509 (2012).\\n\\n92. Frazier, O. H., Cohn, W. E., Tuzun, E., Winkler, J. A. & Gregoric, I. D. Continuous-flow total artificial heart supports long-term\\n\\nsurvival of a calf. Tex. Heart Inst. J. 36, 568–574 (2009).\\n\\n93. Baldwin, A. C., Gemmato, C. J., Cohn, W. E. & Frazier, O. H. Feasibility of long-term continuous flow total heart replacement in\\n\\ncalves. Int. J. Artif. Organs 45, 44–51 (2021).\\n\\n94. Daneshmand, M. A., Bishawi, M., Milano, C. A. & Schroder, J. N. The HeartMate 6. ASAIO J. 66, e46–e49 (2020).\\n\\n95. Kleinheyer, M. et al. Rapid speed modulation of a rotary total artificial heart impeller. Artif. Organs 40, 824–833 (2016).\\n\\n96. Fukamachi, K. et al. Generating pulsatility by pump speed modulation with continuous-flow total artificial heart in awake calves.\\n\\nJ. Artif. Organs 20, 381–385 (2017).\\n\\n97. Miyamoto, T. et al. Analysis of Cleveland clinic continuous-flow total artificial heart performance using the virtual mock loop:\\n\\ncomparison with an in vivo study. Artif. Organs 44, 375–383 (2020).\\n\\n98. Abe, Y. et al. Animal experiments of the helical flow total artificial heart. Artif. Organs 39, 670–680 (2015).\\n\\n99. Fox, C. et al. Hybrid continuous-flow total artificial heart. Artif. Organs 42, 500–509 (2018).\\n\\n100. Glynn, J. et al. The OregonHeart total artificial heart: design and performance on a mock circulatory loop. Artif. Organs 41, 904–\\n\\n910 (2017).\\n\\n101. Jurney, P. L. et al. Characterization of a pulsatile rotary total artificial heart. Artif. Organs 45, 135–142 (2021).\\n\\n102. Franklin, D. L., Van Citters, R. L. & Rushmer, R. F. Balance between right and left ventricular output. Circ. Res. 10, 17–26 (1962).\\n\\n103. Ley, S., Kreitner, K. F., Morgenstern, I., Thelen, M. & Kauczor, H. U. Bronchopulmonary shunts in patients with chronic\\n\\nthromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. Am. J. Roentgenol. 179, 1209–1215\\n\\n(2002).\\n\\n104. Baile, E. M., Ling, H., Heyworth, J. R., Hogg, J. C. & Pare, P. D. Bronchopulmonary anastomotic and noncoronary collateral blood\\n\\nflow in humans during cardiopulmonary bypass. Chest 87, 749–754 (1985).\\n\\n105. Bhunia, S. K. & Kung, R. T. Indirect bronchial shunt flow measurements in AbioCor implantable replacement heart recipients.\\n\\nASAIO J. 50, 211–214 (2004).\\n\\n106. Nestler, F. et al. Investigation of the inherent left-right flow balancing of rotary total artificial hearts by means of a resistance\\n\\nbox. Artif. Organs 44, 584–593 (2020).\\n\\n107. Latrémouille, C. et al. A bioprosthetic total artificial heart for end-stage heart failure: results from a pilot study. J. Heart Lung\\n\\nTranspl. 37, 33–37 (2018).\\n\\n108. Slepian, M. J. et al. The Syncardia™ total artificial heart: in vivo, in vitro, and computational modelling studies. J. Biomech. 46,\\n\\n266–275 (2013).\\n\\n109. Crosby, J. R. et al. Physiological characterization of the SynCardia total artificial heart in a mock  circulation system. ASAIO J. 61,\\n\\n274–281 (2015).\\n\\n110. Diedrich, M. et al. Experimental investigation of right–left flow balance concepts for a total artificial heart. Artif. Organs 45, 364–\\n\\n372 (2021).\\n\\n111. Horvath, D. et al. Mechanism of self-regulation and in vivo performance of the cleveland clinic continuous-flow total artificial\\n\\nheart. Artif. Organs 41, 411–417 (2017).\\n\\n112. Kung, R. T. et al. Progress in the development of the ABIOMED total artificial heart. ASAIO J. 41, M245–M248 (1995).\\n\\n113. Harasaki, H. et al. Progress in Cleveland Clinic — Nimbus total artificial heart development. ASAIO J. 40, M494–M498 (1994).\\n\\n114. Kim, H. C., Khanwilkar, P. S., Bearnson, G. B. & Olsen, D. B. Development of a microcontroller-based automatic control system\\n\\nfor the electrohydraulic total artificial heart. IEEE Trans. Biomed. Eng. 44, 77–89 (1997).\\n\\n115. Snyder, A. J. et al. An electrically powered total artificial heart. Over 1 year survival in the calf. ASAIO J. 38, M707–M712 (1992).\\n\\n116. Abe, Y. et al. Third model of the undulation pump total artificial heart. ASAIO J. 49, 123–127 (2003).\\n\\n117. Dowling, R. D. et al. Initial experience with the AbioCor implantable replacement heart at the University of Louisville. ASAIO J.\\n\\n46, 579–581 (2000).\\n\\n118. Latrémouille, C. et al. Animal studies with the Carmat bioprosthetic total artificial heart. Eur. J.  Cardiothorac. Surg. 47, e172–\\n\\ne179 (2015).\\n\\n119. Vasků, J. et al. A comparative study of a group of eight calves, surviving longer than 1 month with the total artificial heart. Artif.\\n\\nOrgans 7, 470–478 (1983).\\n\\n120. Vasků, J., Urbánek, P., Dostál, M. & Vasků, J. The applicability of experimental experience with the total artificial heart to its\\n\\nclinical use. Int. J. Artif. Organs 15, 307–311 (1992).\\n\\n121. Copeland, J. G. et al. The total artificial heart as a bridge to transplantation. A report of two cases. JAMA 256, 2991–2995 (1986).\\n\\n122. Shumakov, V. et al. Clinical indications for the use of the “Poisk-IOM” total artificial heart: the experience of 13 implantations in\\n\\nhumans. Artif. Organs 15, 372–375 (1991).\\n\\n123. Wei, J. et al. Successful use of Phoenix-7 total artificial heart. Transpl. Proc. 30, 3403–3404 (1998).\\n\\n124. Trubel, W. et al. Clinical total artificial heart bridging: Viennese strategy and experiences. Artif. Organs 13, 470–475 (1989).\\n\\n125. Frazier, O. H. et al. The total artificial heart: where we stand. Cardiology 101, 117–121 (2004).\\n\\n126. Alaeddine, M., Ploutz, M., Arabia, F. A. & Velez, D. A. Implantation of total artificial heart in a 10-year-old after support with a\\n\\ntemporary perventricular assist device. J. Thorac. Cardiovasc. Surg. 159, e227–e229 (2020).\\n\\n127. SynCardia. Turkish man becomes world’s longest supported syncardia temporary total artificial heart patient. SynCardia\\n\\nhttps://syncardia.com/news/ turkish-man-becomes-worlds-longest-supported-syncardia-temporary-total-artificial-heart-\\n\\npatient/ (2017).\\n\\n128. David, C. H. et al. A heart transplant after total artificial heart support: initial and long-term results. Eur. J. Cardiothorac. Surg.\\n\\n58, 1175–1181 (2020).\\n\\n129. Carrier, M. et al. Outcomes after heart transplantation and total artificial heart implantation: a multicentre study. J. Heart Lung\\n\\nTransplant. 28, 28 (2020).\\n\\n130. Hulman, M., Artemiou, P., Hudec, V., Olejarova, I. & Goncalvesova, E. SynCardia, total artificial heart, as a bridge to transplant.\\n\\nBratisl. Lek. Listy 120, 325–330 (2019).\\n\\n131. Nguyen, A. et al. Experience with the SynCardia total artificial heart in a Canadian centre. Can. J. Surg. 60, 375–379 (2017).\\n\\n132. Kirsch, M. E. et al. SynCardia temporary total artificial heart as bridge to transplantation: current results at La Pitié hospital. Ann.\\n\\nThorac. Surg. 95, 1640–1646 (2013).\\n\\n133. Copeland, J. G. et al. Experience with more than 100 total artificial heart implants. J. Thorac. Cardiovasc. Surg. 143, 727–734\\n\\n(2012).\\n\\n134. Roussel, J. C. et al. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann. Thorac. Surg. 87,\\n\\n124–130 (2009).\\n\\n135. El-Banayosy, A. et al. CardioWest total artificial heart: bad Oeynhausen experience. Ann. Thorac. Surg. 80, 548–552 (2005).\\n\\n136. Thanavaro, K. L., Tang, D. G., Kasirajan, V. & Shah, K. B. Clinical indications for implantation of the total artificial heart. ASAIO J.\\n\\n60, 594–596 (2014).\\n\\n137. Carmat. Carmat outlines commercial and development plan for its total artificial heart. Carmat\\n\\nhttps://www.carmatsa.com/carmat-content/uploads/2021/01/pr_carmat_conference_06-01-21.pdf (2021).\\n\\n138. Netuka, I. et al. Initial bridge to transplant experience with a bioprosthetic autoregulated artificial heart. J. Heart Lung Transpl.\\n\\n39, 1491–1493 (2020).\\n\\n139. Unthan, K. et al. Design and evaluation of a fully implantable control unit for blood pumps. Biomed. Res. Int. 2015, 257848\\n\\n(2015).\\n\\n140. Kluin, J. et al. In situ heart valve tissue engineering using a bioresorbable elastomeric implant — from material design to 12\\n\\nmonths follow-up in sheep. Biomaterials 125, 101–117 (2017).\\n\\n141. Zilla, P., Deutsch, M., Bezuidenhout, D., Davies, N. H. & Pennel, T. Progressive reinvention or destination lost? Half a century of\\n\\ncardiovascular tissue engineering. Front. Cardiovasc. Med. 7, 159 (2020).\\n\\n142. Chen, Z. et al. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and\\n\\nbleeding. Artif. Organs 43, 745–755 (2019).\\n\\n143. Zaiser, A. S. et al. Adverse events of percutaneous microaxial left ventricular assist devices-a retrospective, single-centre cohort\\n\\nstudy. J. Clin. Med. 10, 3710 (2021).\\n\\n144. HybridHeart. The development of a soft biocompatible artificial heart. HybridHeart https://www.hybridheart.eu/(2021).\\n\\n145. Kohll, A. X. et al. Long-term performance of a pneumatically actuated soft pump manufactured byrubber compression molding.\\n\\nSoft Robot. 6, 206–213 (2019).\\n\\n146. Roche, E. T. et al. Soft robotic sleeve supports heart function. Sci. Transl. Med. 9, eaaf3925 (2017).\\n\\n147. Banerjee, H., Tse, Z. T. H. & Ren, H. Soft robotics with compliance and adaptation for biomedical applications and forthcoming\\n\\nchallenges. Int. J. Robot. Autom. 33, 69–80 (2018).\\n\\n148. Greatrex, N., Kleinheyer, M., Nestler, F. & Timms, D. The Maglev heart. IEEE Spectr. 56, 22–29 (2019).\\n\\n149. Parnis, S. M. et al. Chronic in vivo evaluation of an electrohydraulic total artificial heart. ASAIO J. 40, M489–M493 (1994).\\n\\n150. Dowling, R. D., Etoch, S. W., Stevens, K. A., Johnson, A. C. & Gray, L. A. Jr Current status of the AbioCor implantable replacement\\n\\nheart. Ann. Thorac. Surg. 71, S147–S149 (2001).\\n\\n151. Takatani, S. et al. Totally implantable total artificial heart and ventricular assist device with multipurpose miniature\\n\\nelectromechanical energy system. Artif. Organs 18, 80–92 (1994).\\n\\n152. Takatani, S. et al. Left and right pump output control in one-piece electromechanical total artificial heart. Artif. Organs 17, 176–\\n\\n184 (1993).\\n\\n153. Cohn, W. E. et al. Pulsatile outflow in cows supported long-term with the BiVACOR rotary TAH. J. Heart Lung Transplant. 36, S14\\n\\n(2017).\\n\\n154. Dostál, M. et al. Hematological and biochemical studies in calves living over 100 days with the polymethylmethacrylate total\\n\\nartificial heart TNS Brno II. Int. J. Artif. Organs 9, 39–48 (1986).\\n\\n155. Vasků, J. et al. Recent efforts in artificial heart research in Czechoslovakia. ASAIO Trans. 35, 805–811 (1989).\\n\\n156. Smadja, D. M. et al. The Carmat bioprosthetic total artificial heart is associated with early hemostatic recovery and no acquired\\n\\nvon Willebrand syndrome in calves. J. Cardiothorac. Vasc. Anesth. 31, 1595–1602 (2017).\\n\\n157. Karimov, J. H. et al. First report of 90-day support of two calves with a continuous-flow total artificial heart. J. Thorac.\\n\\nCardiovasc. Surg. 150, 687–693. e681 (2015).\\n\\n158. Taenaka, Y. et al. Development and evaluation of components for a totally implantable artificial heart system. ASAIO J. 40,\\n\\nM314–M318 (1994).\\n\\n159. Taenaka, Y. et al. An electrohydraulic total artificial heart with a separately placed actuator. ASAIO Trans. 36, M242–M245\\n\\n(1990).\\n\\n160. Tatsumi, E. et al. A blood pump with an interatrial shunt for use as an electrohydraulic total artificial heart. ASAIO J. 38, M425–\\n\\nM430 (1992).\\n\\n161. Tatsumi, E. et al. The National Cardiovascular Center electrohydraulic total artificial heart and ventricular assist device systems:\\n\\ncurrent status of development. ASAIO J. 49, 243–249 (2003).\\n\\n162. Tatsumi, E. et al. Current status of development and in vivo evaluation of the National Cardiovascular Center electrohydraulic\\n\\ntotal artificial heart system. J. Artif. Organs 3, 62–69 (2000).\\n\\n163. Doi, K. et al. In vivo studies of the MagScrew total artificial heart in calves. ASAIO J. 48, 222–225 (2002).\\n\\n164. Kuroda, H. et al. Postoperative pulmonary complications in calves after implantation of an electric total artificial heart. ASAIO J.\\n\\n44, M613–M618 (1998).\\n\\n165. Pierce, W. S. et al. An electric artificial heart for clinical use. Ann. Surg. 212, 339–343 (1990). 166.\\n\\n166. Snyder, A. J. et al. In vivo testing of a completely implanted total artificial heart system. ASAIO J. 39, M177–M184 (1993).\\n\\n167. Shaffer, L. J. et al. Total artificial heart implantation in calves with pump on an angled port design. Trans. Am. Soc. Artif. Intern.\\n\\nOrgans 25, 254–259 (1979).\\n\\n168. Abe, Y. et al. Development of mechanical circulatory support devices at the University of Tokyo. J. Artif. Organs 10, 60–70\\n\\n(2007).\\n\\n169. Mochizuki, S. et al. Results of animal experiments using an undulation pump total artificial heart: analysis of 10 day and 19 day\\n\\nsurvival. ASAIO J. 46, 500–504 (2000).\\n\\n170. Wampler, R. et al. Performance of a novel shuttling total artificial heart on a on a mock circulatory loop. J. Heart Lung\\n\\nTransplant. 36, S56–S57 (2017).\\n\\n171. Cooley, D. The total artificial heart. Nat. Med. 9, 108–111 (2003).\\n\\n172. Emmanuel, S. et al. Anatomical human fitting of the BiVACOR total artificial heart. Artif. Organs 46, 50–56 (2022).\\n\\n173. Mohacsi, P. & Leprince, P. The Carmat total artificial heart. Eur. J. Cardiothorac. Surg. 46, 933–934 (2014).\\n\\n174. Pieper, I. L. et al. Evaluation of the novel total artificial heart Realheart in a pilot human fitting study. Artif. Organs 44, 174–177\\n\\n(2020).\\n\\n175. Yu, L. S. et al. A compact and noise free electrohydraulic total artificial heart. ASAIO J. 39, M386–M391 (1993).\\n\\n176. Rosenberg, G. et al. Dynamic in vitro and in vivo performance of a permanent total artificial heart. Artif. Organs 22, 87–94\\n\\n(1998).\\n\\n177. Marieb, E. N. & Hoehn, K. in The Heart 679–681 (Pearson, 2013).\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='Artificial Hearts\\n\\nRuba Hadidi\\n\\nAn artificial heart is a prosthetic device that is implanted into the body to replace the biological heart.\\n\\n2 types of artificial heart: \\uf0a7 TAH(Total Artificial Heart) \\uf0a7 Cardiac Assist device\\n\\nBenefit of a functional artificial heart would be to lower the need for heart transplants.\\n\\nThe first artificial heart implanted in a living being was placed in a dog at the Cleveland Clinic in 1957; it survived about 90 minutes.\\n\\nApril 4, 1969 Liotta and Cooley replaced a dying man’s heart with a mechanical heart inside the chest.  The patient woke up and recovered well. After 64 hours the artificial heart was removed and replaced by a donor heart. However; thirty\\n\\ntwo hours after transplantation the patient died of what was later proved to be an acute pulmonary infection, most likely caused by an immunosuppressive drugs complication. If they left the artificial heart in place the patient may have lived longer.\\n\\nModifications: \\uf0fc A ventricle with hemispherical diaphragms that did not crush red blood cells \\uf0fc An external heart driver that inherently regulated blood flow without needing complex control systems. \\uf0fc An ovoid shape to fit inside the human chest. \\uf0fc A more blood\\n\\ncompatible polyurethane that made the inside of the ventricles smooth and seamless to reduce dangerous stroke\\n\\ncausing blood clots.\\n\\nIn 1982,  Dr. DeVries implanted the artificial heart into retired dentist who survived 112 days with the device. Bill Schroeder became the second recipient, and lived for a record 620 days.\\n\\nAbioCor is the first fully implantable total artificial heart which unlike previous total artificial hearts does not require wires to external devices. The internal battery lasts for half an hour and a wearable external battery pack lasts for 4 hours. It is intended for critically ill patients who cannot receive a heart transplant. Some limitations of the current AbioCor is that because of its size it is implantable in only 50% of the male population and has a life span of 1 to 2 years.\\n\\nIn 2006, an artificial heart was implanted into a 15\\n\\nyear old girl in Canada. It was intended to act as a temporary fixture until a donor heart could be found. Instead, the artificial heart (called a Berlin Heart) allowed for natural processes to occur and her heart healed on its own. After 146 days the Berlin Heart was removed.\\n\\nDisadvantages of artificial hearts : \\uf0d8 Even though they should be permanent they are only functioning less than two years \\uf0d8 An artificial Heart costs around $250,000 without the cost of surgery.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Journal of Cardiovascular Nursing\\n\\nVol. 29, No. 1, pp E1YE8 x Copyright B 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins\\n\\nLiving With a Total Artificial Heart\\n\\nPatients’ Perspectives\\n\\nLaura S. Savage, RN, MSN, PCCN; Jeanne Salyer, PhD, RN; Maureen P. Flattery, RN, MS, ANP;\\n\\nLucy Alburger, RN; Kenna Joyce, RN, BSN, PCCN; Barbara Mann, RN;\\n\\nMalliga Ravindar, RN, MSN; Maranatha Gonzalez, RN, MS\\n\\nBackground: Advances in mechanical circulatory support have reduced morbidity and mortality in end-stage\\n\\nheart failure. To date, there have been no published studies examining the psychosocial impact on patients who\\n\\nare supported with a total artificial heart (TAH-t). Purpose: The purpose of this study was to describe the lived\\n\\nexperience of patients currently supported by the TAH-t awaiting transplant. Methods: A qualitative method using\\n\\nGiorgi’s modification of phenomenologic inquiry guided the investigation, which was conducted at a transplant\\n\\ncenter located in the mid-Atlantic region of the United States. A purposive sample was selected to reflect\\n\\nparticipants currently supported by the TAH-t. All participants (9 men, 1 woman; mean age, 48.2 years; nonischemic\\n\\netiology, 80%) were in-patients on the progressive care unit at the time of the interview and had been supported for\\n\\nat least 30 days. The mean length of device therapy was 84.7 days (range, 33Y245 days). Findings: Hope for the\\n\\nfuture was the overarching theme. Subthemes included reflections, for better or for worse, the secret club, and\\n\\ncoping and adaptation. The patients reflected on severity of illness, progress, and expressed optimism. For better\\n\\nor for worse described how symptoms improved but were offset by restrictions imposed by the technology. The\\n\\nsecret club described the support provided to help deal with their life situation. Coping and adaptation suggested\\n\\nthat the patients came to terms with and accepted their circumstances. Conclusions: The findings will help clinicians\\n\\nunderstand patients experiencing a life-changing situation and implications for psychosocial interventions.\\n\\nKEY WORDS: heart transplantation, lived experience, total artificial heart\\n\\nH\\n\\neart failure (HF) is a common health problem\\n\\ncausing approximately 250,000 deaths per year\\n\\nin the United States. From 1979 to 2001, deaths caused\\n\\nby HF increased dramaticallyVmaking it the only ma-\\n\\njor cardiovascular health problem that is increasing in\\n\\nincidence and prevalence.1 Although advances in medical\\n\\ntherapy have resulted in improved survival in patients\\n\\nwith moderate and severe HF, the gold standard therapy in\\n\\nend-stage HF remains to be cardiac transplantation. Ad-\\n\\nvances in mechanical support, such as the development of\\n\\nthe left ventricular assist device (LVAD) and the total\\n\\nartificial heart (TAH-t), have reduced morbidity and mor-\\n\\ntality in this population with end-stage HF and offers a\\n\\nbridge to transplantation for many patients with severe\\n\\nillness as they wait for a donor heart. Our understanding\\n\\nof the psychosocial impact of this experience is, how-\\n\\never, limited. Thus, the purpose of this study was to\\n\\ndescribe the lived experience of patients currently sup-\\n\\nported by the TAH-t and ‘‘bridged to transplant’’ with\\n\\nE1\\n\\nLaura S. Savage, RN, MSN, PCCN\\n\\nTransplant Coordinator, Heart Failure/Heart Transplant Program, Pauley\\n\\nHeart Center, Virginia Commonwealth University Health System, Richmond.\\n\\nJeanne Salyer, PhD, RN\\n\\nAssociate Professor, School of Nursing, Virginia Commonwealth\\n\\nUniversity, Richmond.\\n\\nMaureen P. Flattery, RN, MS, ANP\\n\\nTransplant Coordinator, Heart Failure/Heart Transplant Program,\\n\\nPauley Heart Center, Virginia Commonwealth University Health\\n\\nSystem, Richmond.\\n\\nLucy Alburger, RN\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nKenna Joyce, RN, BSN, PCCN\\n\\nClinical Coordinator, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nBarbara Mann, RN\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nMalliga Ravindar, RN, MSN\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nMaranatha Gonzalez, RN, MS\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nMaureen P. Flattery, RN, MS, ANP, is a member of the Speaker’s\\n\\nBureau of Xdx, Inc., Brisbane, California. All other authors have\\n\\nno funding or conflicts of interest to disclose.\\n\\nCorrespondence\\n\\nLaura S. Savage, RN, MSN, PCCN, Heart Failure/Heart Transplant\\n\\nProgram, Pauley Heart Center, Virginia Commonwealth University\\n\\nHealth System, 1200 E Broad St, West Hospital, 5th Fl, Richmond,\\n\\nVA 23298 (lsavage@mcvh-vcu.edu).\\n\\nDOI: 10.1097/JCN.0b013e318272391e\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nthis device. Understanding patients’ experiences with\\n\\nthis new technology will sensitize healthcare profes-\\n\\nsionals to better address both physical and psycho-\\n\\nsocial needs during the wait for a donor heart.\\n\\nBecause medical management has improved, patients\\n\\nwith end-stage heart disease are living longer. Moreover,\\n\\nmechanical circulatory support devices (MCSDs) are\\n\\nbecoming more commonplace because there is a short-\\n\\nage of donor organs and the wait for a donor heart is\\n\\noften long. Research has shown that the TAH-t offers\\n\\nsignificant physiologic benefit. For example, Platis and\\n\\nLarson2 found that 79% of patients survive to trans-\\n\\nplant when bridged with the TAH-t as compared with\\n\\n46% of matched controls in the control group who did\\n\\nnot receive any type of MCSD (P G 0.0001). In addi-\\n\\ntion, these researchers reported a 70% 1-year survival of\\n\\npatients after transplant as compared with 31% in the\\n\\ncontrol group (P G 0.001). Although these survival sta-\\n\\ntistics are impressive, there is little research related to\\n\\nthe psychological impact of living with this life-sustaining\\n\\ndevice. There is, however, evidence that patients with HF\\n\\nbridged to transplant with a ventricular assist device ex-\\n\\nperience physical as well as psychosocial concerns. For ex-\\n\\nample,Zambroski and colleagues3 identified facing the\\n\\nunknown, feeling confined, living with fear, as well as\\n\\nhope for the future as key issues for patients living with\\n\\nan LVAD. Savage and Canody4 reported adaptive behav-\\n\\niors and improved quality of life for patients, and Casida\\n\\nand colleagues5 provided further insight regarding early\\n\\nversus late adjustment. There is, however, no literature\\n\\nthat addresses the lived experience of patients with the\\n\\nTAH-t. This study, therefore, adds to the body of knowl-\\n\\nedge related to providing care to patients with this MCSD.\\n\\nMethods\\n\\nDesign, Sample, and Setting\\n\\nA descriptive, phenomenologic qualitative inquiry was\\n\\nused to allow participants to freely describe their ex-\\n\\nperiences while being supported by the TAH-t. The inves-\\n\\ntigation was conducted at a transplant center located in\\n\\nthe mid Atlantic region of the United States. This center\\n\\nhas been implanting the TAH-t (SynCardia Systems, Inc;\\n\\nTucson, Arizona) as a bridge to heart transplant for the\\n\\nlast 6 years. One of 67 centers worldwide, this center\\n\\nhas performed 65 of these procedures since 2006.\\n\\nA purposive sample was selected to reflect partic-\\n\\nipants currently supported by the TAH-t. All partic-\\n\\nipants (9 men, 1 woman; mean age, 48.2 years [range,\\n\\n32Y60 years]; nonischemic etiology, 80%) were in-\\n\\npatients at the time of the interview. On average, the\\n\\nlength of device therapy was 84.7 days (range, 33Y245;\\n\\nsee Table). Giorgi’s modification of phenomenologic\\n\\ninquiry, which preserves the meaning of the phenom-\\n\\nenon within the context of each participant’s experience\\n\\nand allows free expression of their lived experience,\\n\\nguided the investigation.6\\n\\nData Collection Procedures\\n\\nAfter informed consent was obtained, pertinent\\n\\ndemographic and clinical information was extracted\\n\\nfrom the medical record. Unstructured interviews were\\n\\nconducted and audiotape recorded in the participant’s\\n\\nhospital room. The interviews were conducted in the\\n\\nparticipant’s hospital room by 2 researchers trained in\\n\\nqualitative interviewing. The interviews lasted from 15\\n\\nto 45 minutes. Some participants were more descrip-\\n\\ntive than were others. Each subject was interviewed\\n\\nonce. The participants were allowed to direct the pace of\\n\\nthe interview. The interviewers started by prompting the\\n\\nparticipants to describe their lives before they became ill\\n\\nby saying ‘‘Tell me about your life before you got sick.’’\\n\\nFollow-up questions included queries as to what it was\\n\\nlike living with t TAH-t. Data collection, which occurred\\n\\nbetween June 2010 and January 2011, was continued\\n\\nuntilredundancyorsaturationoccurred.De-identifiedin-\\n\\nterviews were transcribed for analysis. In addition, an\\n\\nindependent author (J.S.), with no previous knowledge\\n\\nof the participants, reviewed all transcripts for meaning.\\n\\nData Analysis\\n\\nData analysis occurred in accordance with Colaizzi’s\\n\\nphenomenologic method. This process includes (1) read-\\n\\ning all of the participants’ descriptions, (2) extracting\\n\\nsignificant statements, (3) creating meaning by coding\\n\\nTABLE\\n\\nDemographic and Clinical\\n\\nCharacteristics of Participants (n = 10)\\n\\nVariable\\n\\nFrequency\\n\\nMean (SD)\\n\\nRange\\n\\nAge, y\\n\\n48.2 (11.5)\\n\\n32Y60\\n\\nGender\\n\\nFemale\\n\\n1\\n\\nMale\\n\\n9\\n\\nMarital Status\\n\\nNever married\\n\\n1\\n\\nPreviously married\\n\\n2\\n\\nMarried\\n\\n7\\n\\nEducation\\n\\nLower than high school\\n\\n1\\n\\nHigh school\\n\\n0\\n\\nHigher than high school\\n\\n9\\n\\nEthnicity\\n\\nWhite\\n\\n7\\n\\nAfrican American\\n\\n2\\n\\nIndian\\n\\n1\\n\\nDiagnosis\\n\\nNICM\\n\\n8\\n\\nICM\\n\\n2\\n\\nLength of device therapy\\n\\n(at time of interview)\\n\\n84.7 (65.1)\\n\\n33Y245\\n\\nAbbreviations: ICM, ischemic cardiomyopathy; NICM, nonischemic\\n\\ncardiomyopathy.\\n\\nE2 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nrepetitive issues, (4) aggregating issues into clusters of\\n\\nthemes, (5) writing an exhaustive description, (6) deter-\\n\\nmining similar concepts, and (7) returning to the partic-\\n\\nipants for validation, as necessary.7 Verbatim transcripts\\n\\nof the interviews were distributed to the investigators. The\\n\\ninvestigators were staff nurses from the cardiothoracic\\n\\nstep-down unit. The investigators were blinded to the\\n\\nidentity of the participants. Each investigator indepen-\\n\\ndently reviewed the transcripts for meaning. The group\\n\\nmet multiple times to discuss content and phrases and\\n\\nto come to agreement on identified themes. Once the\\n\\nthemes were agreed upon, each investigator was as-\\n\\nsigned a theme to validate with the statements from\\n\\nthe verbatim transcripts.\\n\\nFindings\\n\\nOne overarching theme and 4 subthemes were gen-\\n\\nerated from the analysis of the transcripts. The overarch-\\n\\ning theme was hope for the future. The 4 subthemes\\n\\nincluded reflections, for better or for worse, the secret\\n\\nclub, and coping and adaptation. Reflections were char-\\n\\nacterized by looking back at how serious their illness\\n\\nhad becomeVand yet, they also described their pro-\\n\\ngress and expressed that they were looking forward to\\n\\ngoing home after transplant. For better or for worse\\n\\ndescribed specifically how symptoms and function-\\n\\ning improved after TAH-t implantation but were offset\\n\\nby awareness of the restrictions imposed by the tech-\\n\\nnology. The secret club described a ‘‘club’’ of which\\n\\nneither the patients nor the family members wanted to\\n\\nbe members. However, what emerged was a type of\\n\\nsupport provided by the staff and other patients to help\\n\\nthe patients deal with the isolation posed by friends’\\n\\nand family members’ need to travel long distances to\\n\\nvisit. The final subtheme, coping and adaptation, sug-\\n\\ngested that the patients eventually came to terms with\\n\\nand accepted their life situation.\\n\\nHope for the future was characterized by state-\\n\\nments such as:\\n\\nIt was very I. I can say uplifting or eye opening. You\\n\\nknow I realized that I could, you know, live longer. And\\n\\nthey had put this in me for that reason, you know. They\\n\\nwould work with me to go through the rehab and all the\\n\\nother things until I got to the point of receiving a\\n\\nheartVand that gave I it made me feel good. And my\\n\\nconfidence is very high now. And ever since they put it in,\\n\\nI’ve had no adjustment at all and see the light in the\\n\\ntunnel I you know it was psychologicalVthe physical\\n\\nside that improved with my body and the psychological\\n\\nside from my mind I.\\n\\nThe participants consistently discussed feeling that\\n\\nlife had become ‘‘very difficult’’ before the TAH-t. Their\\n\\nsymptoms limited their ability to not only perform ac-\\n\\ntivities of daily living but also to ‘‘enjoy’’ life. The TAH-t\\n\\ngave them hope for the future because they found that\\n\\nthey were able to perform simple activities without\\n\\nbecoming fatigued or short-breathed. One stated: ‘‘I\\n\\nwasn’t in the same place that I was I And the bridge\\n\\nwas gone behind me but, you know, the bridge went\\n\\nall the way across and I could see the end of it.’’ Another\\n\\nparticipant stated: ‘‘I It’s a step towards where you need\\n\\nto go. I You want to see the finish line.’’\\n\\nReflections\\n\\nThe participants reflected on their experiences before\\n\\nand after receiving the TAH-t. Some of these descriptions\\n\\nwere very general and reflected their HF symptoms.\\n\\n‘‘Tired all the time,’’ ‘‘lethargic,’’ ‘‘unable to do anything,’’\\n\\nand ‘‘exhausted by it’’ were recurring comments. One\\n\\nparticipant was more descriptiveVcommenting that\\n\\n‘‘My heart just went to pot. You know, I just went\\n\\ndownhill.’’ Requiring an internal cardiac defibrillator\\n\\nwas described by several participants. One com-\\n\\nmented: ‘‘Every minute of the day I was scared about\\n\\nthe shock.’’ Another participantVreflecting on how\\n\\nhe had deterioratedVcommented:\\n\\nThey couldn’t control my fluid build-up with IV lasix, so\\n\\nthey started some other drugs. I by the time I got to four\\n\\nIV bags hanging off four pumps they said ‘‘we’re gonna\\n\\nhave to send you down to Richmond.’’ I spent three days\\n\\nin what a lot of people say is ICU psychosis. I think it’s a\\n\\nvision questVsome people say a near death experience. I\\n\\ndon’t care what it was, it scared the hell out of me. I\\n\\nthey started running testsVGod, so many testsVand\\n\\ncome to find out, an LVAD wouldn’t have done it. So\\n\\nthey started a balloon pump which actually didn’t make\\n\\nme feel better. Ok, I’m fine with that. And then they took\\n\\nme in, split me open, basically rendered me heartless and\\n\\nconnected me to ‘‘big blue’’ as it’s called.\\n\\nIn addition to reflecting about the severity of their\\n\\nHF, some shared their thoughts about dependence on\\n\\nthe TAH-t technology. One participant commented:\\n\\n‘‘I was kinda scared because it kept me alive.’’ An-\\n\\nother commented: ‘‘I know that I am married to this\\n\\nmachine now.’’ Another, reflecting on how he got to\\n\\nthe point of needing a transplant, commented: ‘‘I need\\n\\na whole new heartVit was that bad. And like now,\\n\\nit’s like I don’t have one. You know I have this I\\n\\nthing in there I you know how fragile your life is.\\n\\nA machine is keeping me alive.’’\\n\\nFor Better or for Worse\\n\\nMost participants indicated that symptoms and func-\\n\\ntioning had improved since receiving the TAH-t, but\\n\\nthere were trade-offs that included restrictions imposed\\n\\nby the technology. Comments like ‘‘I feel I like I\\n\\ncompletely normal. That’s the hardest part I like, I feel\\n\\nlike I could just go home, you know, but I have this 400\\n\\npound thing hooked up to me’’ were representative.\\n\\nEven though the participants noted that their symp-\\n\\ntoms had improved after insertion of the TAH-t, they\\n\\nfelt that, in some ways, things had gotten worse for\\n\\nLiving With a Total Artificial Heart E3\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nthem. Nearly all of them felt that, in some way, they\\n\\nhad lost some of their freedom. The drive lines are\\n\\n‘‘only so long,’’ the console is ‘‘big and cumbersome,’’\\n\\nand they needed nurses to help them walk around in\\n\\nthe hallways. They could no longer independently do\\n\\nthings they had been accustomed to doing, for ex-\\n\\nample, playing with their pets or just getting up and\\n\\ndoing what they wanted to do. Some participants felt\\n\\nas if they were ‘‘in jail’’ or a ‘‘prisoner.’’ One thing\\n\\nthey discussed was the fact that they could not get out\\n\\nof their rooms without someone to pull the console.\\n\\n‘‘You can’t walk as freely as you want to.’’ This made\\n\\ninteractions with people other than staff members\\n\\ndifficult. ‘‘I am married to this machine now.’’ ‘‘I am\\n\\nlocked in this room. I don’t have the freedom to do\\n\\nwhat I normally would be doing.’’ ‘‘I just lay and look\\n\\nat the pictures and wonder at all the fun I used to\\n\\nhave. I feel a little deprived.’’ ‘‘I am very protective\\n\\nwith that machine. I’m an emotional mess.’’ In addition\\n\\nto feeling like they had lost their freedom, many com-\\n\\nmented on how the wait for a donor was so impersonal.\\n\\n‘‘I have been turned into 12 hour shiftsVgo to bed\\n\\nwith one nurse, wake up with another. But this is\\n\\nwhat waiting for a heart is like.’’ One participant\\n\\nsummed it up by saying: ‘‘It’s like you got a place\\n\\nthat’s called ‘wait.’ You have to wait on this and wait\\n\\non that. Now I’m waiting on a heart.’’\\n\\nSecret Club\\n\\nThe secret club was a source of support for the par-\\n\\nticipants. Some described their cardiac rehabilitation\\n\\nsessions as a ‘‘social hour.’’ One participant stated:\\n\\n‘‘You gotta keep your hope. After ‘R’ talked with\\n\\nme I felt better. I get a lot of support from the others.’’\\n\\nThe participants also described the support provided\\n\\nby the staff. Although most of the support these par-\\n\\nticipants described was technical, it made them feel\\n\\nsecure about their dependence on the technology. One\\n\\ncommented: ‘‘The staff knows what to do, and are\\n\\nvery well educated, the ones I’ve had know the machine\\n\\nand they’re very well trained on it. And when you see\\n\\nthat, it gives you confidence.’’ Other sources of support\\n\\nfor the participants included social work, chaplains, oc-\\n\\ncupational and physical therapists, as well as family\\n\\nand friends.\\n\\nThe participants also felt that their need to be\\n\\nwith family when they could come to the hospital\\n\\nwas supported. One expressed appreciation about\\n\\n‘‘my family being able to come to the room, come\\n\\nhere to the room. We have barbecue, couple friends\\n\\nover, have barbeque here with my wife and a lot of\\n\\nfamily members. You have conversations with them.\\n\\nNot only about how you are, or your family, but\\n\\nwhat are we gonna do to try to get better and get to\\n\\nthe next step. Supportive type roles. That’s a very\\n\\ngood feeling, you know.’’ One comment character-\\n\\nized the bond between and among the participants:\\n\\nI’ve met a lot of other people going through this I you\\n\\nknow, it’s kind of like a secret club I you don’t really\\n\\nwant to be in but it just reminds you that there I there is\\n\\nso much I too many other things going on in life that\\n\\nwhen you’re out in the regular world living you forget\\n\\nabout what’s happening to other people in a way I you\\n\\nknow, meeting people going through the same, it’s like a\\n\\nweird kind of community that you suddenly become a\\n\\npart ofVand I can’t imagine ever not feeling a part of it\\n\\nfor the rest of our lives ’cause it’s something that we’ll\\n\\nalways be dealing with and I it’s kind of a special\\n\\nexperience even though it’s scary. It just makes you look\\n\\nat life differently and what’s important.\\n\\nCoping and Adaptation\\n\\nThe participants described a variety of strategies they\\n\\nused to cope with and adapt to their life situation.\\n\\nSome relied on their faithVturning to prayer and\\n\\nmeditation. Others used distraction and described\\n\\n‘‘listening toVyou knowVsongs that mean a lot to\\n\\nme’’ or watching a movie or television. One partic-\\n\\nipant commented: ‘‘I am away from my wife, away\\n\\nfrom home. Right now my wife just insists that she\\n\\nI she’s there to do a lot of things. Emotionally it\\n\\ndrains you because you just don’t want I I mean I\\n\\nused to I you got to get used to something totally\\n\\ndifferent. The biggest thing is being away from each\\n\\nother. It makes you feel alone sometimes, lonesome.\\n\\nI try to listen to music to cope with it.’’\\n\\nMost participants developed a routine that helped\\n\\nthem get through each day. For example, several\\n\\ncommented on their morning routine. ‘‘I get up and\\n\\nmake up my bed. Every other day I clean up real\\n\\ngood, wash my hair I wait for breakfast.’’ ‘‘I get up\\n\\nin the morning, change, brush my teeth, try to get my\\n\\nducks in a row and then go about my business.’’ ‘‘I\\n\\nget up, stand up, get out of bed and sit in the chair,\\n\\nhave coffee I then have OTVscheduled one hourV\\n\\nthen I have physical therapy.’’ Others try to stay\\n\\nconnected to their work. Some get on the computer\\n\\nand ‘‘surf.’’\\n\\nSome participants were resigned to accepting their\\n\\nfate. For some, facing the situation meant being able\\n\\nto confront the possibility of dying. One participant\\n\\nseemed to accept this outcome and commented: ‘‘If\\n\\nI die, I die I I’ve had a good life.’’ For others, sharing\\n\\nplans for the future helped them remain positive. One\\n\\nof the most hopeful statements from a participant re-\\n\\nflected his plans for the futureVafter getting a trans-\\n\\nplant. ‘‘Nothing in the world is going to stop me from\\n\\ndoing I I get to see my wife and my daughters every\\n\\nday. I will walk over to see my daughter graduate I\\n\\nand I will walk each one of my daughters down the\\n\\naisle when they are ready to get married.’’\\n\\nE4 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nDiscussion\\n\\nThe purpose of this qualitative study was to examine\\n\\nthe patient’s experience of living with the TAH-t. Al-\\n\\nthough several studies have examined the experience\\n\\nof living with the LVAD,3Y5,8Y10 this is the first study\\n\\nexamining the experiences of living with this type of\\n\\nMCSD, providing clinicians and researchers with in-\\n\\nsight into these patients’ unique experiences as well as\\n\\ninto those that are similar in both populations.\\n\\nThe overarching theme in this study, hope for the\\n\\nfuture, was clearly articulated by the participants.\\n\\nHope has been defined in a variety of waysVfor ex-\\n\\nample, a positive future orientation,11Y13 keeping a\\n\\npositive outcome in mind in an uncertain situation,14\\n\\nand a positive expectation of realizing desired out-\\n\\ncomes.15Y17 Using Barnard’s15 definition in which ‘‘hop-\\n\\ning expresses an openness to novelty,’’ unique medical\\n\\nor technological breakthroughs may be seen as sources\\n\\nof hope for recovery. In the population of patients with\\n\\nthe TAH-t, the technology available to support them\\n\\nuntil a donor heart becomes available is a reality and\\n\\nprovides hope that this interim step will help them sur-\\n\\nvive to transplant. Lohne and Severinsson18 suggest that\\n\\nhope for a specific outcome and the expectation that it\\n\\nwill occur are fueled by the fulfillment of interim out-\\n\\ncomes. Consistent with being bridged to transplant, out-\\n\\ncomes achieved along the way to a return to a state of\\n\\nhealth that previously existed may bolster expectations of\\n\\nrecovery. In this study, hope for the future was demon-\\n\\nstrated in several ways, but, most prevalently, the par-\\n\\nticipants envisioned a future and described what they\\n\\nwould do after transplant.\\n\\nReflections\\n\\nAs the participants looked back on their health before\\n\\nthe TAH-t, they began to realize how ill they had been\\n\\nand the benefit of ‘‘Big Blue.’’ These narratives pro-\\n\\nvided an opportunity for the participants to tell their\\n\\nstory, and, in doing so, they came to envision their fu-\\n\\nture. These participants did not dwell on their past.\\n\\nInstead, their reflections on the progress they had made\\n\\nseemed to give them hope. A similar phenomenon was\\n\\ndescribed by Casida and colleagues5 in their phenom-\\n\\nenologic study of lifestyle adjustments in long-term\\n\\nrecipients of LVAD. In this study, the authors proposed\\n\\nthat it was the participants’ lived experiences before\\n\\nimplantation that set the stage for early adjustment to\\n\\nthe device. As the interviews with the participants com-\\n\\nmenced, the participants reflected on and began to\\n\\nrecall what life was like before the LVAD. They shared\\n\\nvivid descriptions of having a poor quality of life because\\n\\nof HF symptoms and the physical limitations imposed by\\n\\ntheir illness, which are similar to the descriptions of the\\n\\nparticipants in the current study.\\n\\nThe participants in this study also reflected on the\\n\\nexperience of having a mechanical device keeping them\\n\\nalive. This realization is consistent with the findings\\n\\nreported by Chapman and colleagues8 in their study of\\n\\npsychosocial issues in patients with the LVAD. The\\n\\npatients reported fear because they realized they were\\n\\ndependent on a machineVbut the fear lasted only for a\\n\\nshort period. In the current study, we observed a similar\\n\\nphenomenon. The participants were very much aware\\n\\nof their dependence on the technology, but this aware-\\n\\nness seemed to be heightened by the fact that their\\n\\nnative heart had been explanted to receive the TAH-t.\\n\\nChapman and colleagues8 attributed the resolution of\\n\\nfear to the trust the patients developed that the tech-\\n\\nnology would not fail. In our study, the participants\\n\\nacknowledged that the support from nurses and others\\n\\nwho had been part of their experience had made them\\n\\nmore confident about their situation, but other con-\\n\\ntributing factors were not addressed.\\n\\nFor Better or for Worse\\n\\nZambroski and colleagues3Vwho studied patients\\n\\nliving with the LVADVidentified facing the unknown,\\n\\nfeeling confined, living with fear, as well as hope for\\n\\nthe future as key issues for patients. The patients with\\n\\nthe TAH-t who participated in the current study also\\n\\nexpressed similar issues but specifically identified feel-\\n\\ning confined as a problem. Although it is clear that\\n\\nfunctional ability improved on the TAH-t, despite this\\n\\nbenefit, it is important to recognize that these patients\\n\\nalso had to deal with the psychological aspects of\\n\\nbeing technologically dependent on an artificial organ.\\n\\nBased on their descriptions of being a ‘‘prisoner’’ or\\n\\nbeing ‘‘in jail,’’ the patients reported feeling confined\\n\\nwhile on the TAH-t. Also contributing to feelings of\\n\\nconfinement was a lack of control expressed because\\n\\nthe patients had to rely on someone else just to leave\\n\\ntheir roomsVmaking them feel ‘‘locked in this room.’’\\n\\nSimilar circumstances were described by participants\\n\\nin a focus group study in which the patients and the\\n\\nfamily were asked about their experiences in waiting\\n\\nfor a donor heart.19 These patients also experienced\\n\\nconfinement, loss of independence, and lack of control.\\n\\nNurses responded by doing the ‘‘extra little things’’ for\\n\\nthese hospitalized patientsVthings that made them feel\\n\\nnormal. Strategies aimed at ‘‘normalizing’’ their hospital\\n\\nstay as much as possibleVcoupled with patients’ im-\\n\\nproved functional abilityVmay help to improve those\\n\\naspects of the TAH-t experience considered ‘‘the worst’’\\n\\nby patients requiring device support.\\n\\nSecret Club\\n\\nUnderstanding how patients respond when faced with\\n\\na life-changing situation such as the implant of the\\n\\nTAH-t can help significant others and healthcare\\n\\nLiving With a Total Artificial Heart E5\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nprofessionals better understand how to interact with and\\n\\nsupport them. In studies examining the experience of\\n\\npatients bridged to transplant with the LVAD, similar to\\n\\nthe findings of patients with the TAH-t in the current\\n\\nstudy, the patients with the LVAD all relied on the\\n\\nsupport from family, parents, spouses, and children to\\n\\nhelp them through the transition.9,20 In addition to the\\n\\nsupport from significant others, the professionals on\\n\\nthe unit became sources of support. Although reliance\\n\\non healthcare professionals was often because of their\\n\\ntechnical expertise, the patients became more confident\\n\\nas a consequence of their knowledge about the technol-\\n\\nogy. We speculate that this may have occurred because of\\n\\npatient and family education and the reassurance the\\n\\npatients received through these interactions.\\n\\nThis themeVthe secret clubValso suggested that\\n\\nthe participants got support from others who shared\\n\\ntheir experiencesVwho were living through the ex-\\n\\nperience as they were. They spoke of a bond that\\n\\nwould always exist. Several studies on the impact of\\n\\npeer support groups for patients with chronic health\\n\\nproblems (eg, implantable cardiac defibrillator, can-\\n\\ncer, chronic pulmonary disease) suggest that this type\\n\\nof social support provides encouragement, informa-\\n\\ntion, and understanding and, over time, can affect out-\\n\\ncomes.21Y23 The participants in our study were able to\\n\\nsupport one another because of an understanding about\\n\\nthe experience and an ability to provide encourage-\\n\\nment. Having a former or current patient with the\\n\\nTAH-t spend time to answer questions and describe\\n\\nhis/her experience could provide encouragement and\\n\\nhope for the new recipient. In addition, interdisciplin-\\n\\nary groups composed of nurses, occupational and phys-\\n\\nical therapists, chaplains, and social workers must take\\n\\nthe lead in identifying strategies for helping patients\\n\\nand family members deal with psychosocial and phys-\\n\\niologic issues. Weekly support group meetings for these\\n\\n‘‘Hopeful Hearts’’ may provide support for them dur-\\n\\ning their wait for a donor heart. Although it was not an\\n\\naim of this study to evaluate outcomes of peer support\\n\\ngroups for these patients, posttransplantation follow-up\\n\\nstudies might reveal improved outcomes such as adher-\\n\\nence to self-care requirements.\\n\\nCoping and Adaptation\\n\\nThe implantation of the TAH-t represents a health cri-\\n\\nsis for those patients with HF who require this life-\\n\\nsaving technology as a bridge to transplantation. The\\n\\npsychosocial disequilibrium experienced by patients dur-\\n\\ning the wait for a donor organ has been examined by\\n\\nseveral investigators who report that candidates, both\\n\\nthose requiring and those not requiring MCSD, expe-\\n\\nrience several stressors because of candidacy for a do-\\n\\nnor organ.10,24Y27 Although our study was limited to\\n\\npatients with the TAH-t who were waiting for a do-\\n\\nnor, they experienced stressors similar to those re-\\n\\nported in these previous studies (eg, dependency on\\n\\nothers, dependency on a device, uncertainty about their\\n\\nfuture, physical limitations, isolation, and loss of con-\\n\\ntrol). The patients described coping in a variety of ways\\n\\nthat are similar to those reported by other investiga-\\n\\ntors.19,24 One important strategy identified was estab-\\n\\nlishing a routine. It helped to normalize the experience.\\n\\nOthers distracted themselves using music and other\\n\\nforms of entertainment. This suggests that clinicians\\n\\nmight enable positive coping by providing opportunities\\n\\nfor engagement in these and other types of activities\\n\\nthat patients enjoy during their hospitalization.\\n\\nThose participants who engaged in spiritual activities\\n\\nsuch as prayer and meditation might benefit from what\\n\\nHays and colleagues28 described as clergy-laity support\\n\\nas a replacement for attendance at worship services.\\n\\nTheir study examined whether visits by clergy or laity\\n\\nprovide benefits to patients with serious illness who\\n\\ncould not attend (or may have had difficulty attending)\\n\\nreligious services. A similar type of support could be\\n\\nprovided in the hospital by chaplains and lay volun-\\n\\nteers from religious organizations.\\n\\nOver time, the patients were able to adapt to and\\n\\naccept their situation while remaining optimistic toward\\n\\nthe future. It was surprising that few focused on the\\n\\nmechanical aspect of the machine. Sleep disturbances\\n\\ndid not seem to be an issue for the participants. They\\n\\nidentified the ‘‘noise’’ to be distracting initially, but it\\n\\nbecame ‘‘soothing’’ to many. ‘‘I won’t lie I I was\\n\\nscared and I still am I’’ ‘‘It’s just part of you.’’ ‘‘I got\\n\\nto the point where I trust a lot more.’’ This type of\\n\\npositive outlook and expectation for the future is not\\n\\nunusual in the population with MCSD and has been\\n\\ndescribed in at least 1 other study of patients with\\n\\nLVADs.5 The participants spoke about limited mobil-\\n\\nity with the TAH-t, separation from family, and the\\n\\nneed to have structure in their day as well. No patients\\n\\ndied while awaiting heart transplantation.\\n\\nLimitations\\n\\nIn qualitative research, one limitation concerns the\\n\\ninterpretation of research findings. The interpretation\\n\\nof this data was vulnerable to alternative meaning that\\n\\nmay logically be made by other patients with other\\n\\nexperiences. These study findings were validated by\\n\\nthe participants and the staff participants. There are,\\n\\nhowever, limitations that must be addressed. Our find-\\n\\nings should be interpreted with caution because there\\n\\nwas wide variability in the length of time that the par-\\n\\nticipants had been receiving TAH-t therapy. Thus, some\\n\\nparticipants had more time to adjust and rehabilitate\\n\\nthan did others. Our findings may have been influenced\\n\\nby the length of time that some of the participants\\n\\nhad been receiving TAH-t therapy; that is, however, the\\n\\nE6 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nreality of waiting for a donor organ. The wait is often\\n\\nlong, and patients have time to adjust and envision\\n\\ntheir future after transplant.\\n\\nImplications\\n\\nThe findings from this study provide insight to cli-\\n\\nnicians and researchers regarding patients’ experiences\\n\\nin living with the TAH-t. This research, despite its\\n\\nlimitations, sensitizes healthcare providers who work\\n\\nwith this patient population to the need to address the\\n\\nissues illuminated by this qualitative study. First,\\n\\nallowing the patients to tell their stories may impress\\n\\nupon them and others the benefits derived from the\\n\\nTAH-t treatment and may help them deal with the\\n\\nrestrictions imposed by being device dependent. Social\\n\\nsupport from healthcare professionals is particularly\\n\\nimportant, but clinicians need to maintain therapeutic\\n\\nrelationships with these patients to provide effective\\n\\ncare. Relationships with other recipients of the TAH-t\\n\\nare also important, and clinicians caring for the patients\\n\\ncan enhance these opportunities through support groups\\n\\nthat bring patients and clinicians together. Future re-\\n\\nsearch efforts to determine the impact of these sup-\\n\\nportive relationships on coping and adaptation during\\n\\nthe wait for a donor, as well as after transplantation,\\n\\nmay provide further insight into strategies that pro-\\n\\nmote positive psychosocial outcomes.\\n\\nThe participants in this study described feeling con-\\n\\nfined because of their dependence on the TAH-t tech-\\n\\nnology. Both physical and occupational therapists\\n\\nshould be involved in helping devise activities that get\\n\\npatients out of their rooms and activities aimed at re-\\n\\nducing their feelings of confinement. Family visits pro-\\n\\nvide opportunities for much-needed socialization and\\n\\npromote supportive interaction among family members.\\n\\nAnother aspect to consider is the future of MCSDs.\\n\\nAs this research was ending, the Freedom Driver\\n\\n(SynCardia Systems, Inc; Tucson, Arizona) study was\\n\\nbeginning to enroll participants. This smaller portable\\n\\ndriver will allow patients to be discharged home on the\\n\\nTAH-t. How will patients cope at home? What will it be\\n\\nlike living with a smaller driver? What type of com-\\n\\nplications will they experience? Although some of their\\n\\nexperiences may mirror that of those confined to the\\n\\nhospital, these will be key questions to explore.\\n\\nSummary and Conclusions\\n\\nIn summary, the purpose of this study was to de-\\n\\nscribe the lived experience of patients currently sup-\\n\\nported by the TAH-t awaiting transplant. The findings\\n\\nprovide both clinicians and researchers with insight into\\n\\nthese patients’ unique experiences as well as into those\\n\\nthat are similar in both patients with LVAD and patients\\n\\nwith TAH-t and provide direction for interventions\\n\\nand future research. In the era of advancing technol-\\n\\nogy, it will be important to consider patients’ lived\\n\\nexperiences on the portable TAH-t as well.\\n\\nAcknowledgments\\n\\nThe authors would like thank the Adult Health and\\n\\nNursing Systems at the Virginia Commonwealth Uni-\\n\\nversity School of Nursing for their support.\\n\\nREFERENCES\\n\\n1. Heart Failure Society of America. Quick facts and infor-\\n\\nmation about heart failure. http://www.hfsa.org/heart_failure_\\n\\nfacts.asp. Accessed June 25, 2012.\\n\\n2. Platis A, Larson DF. Cardio West temporary total artificial\\n\\nheart. Perfusion. 2009;24(5):341Y346.\\n\\n3. Zambroski CH, Combs P, Cronin SN, Pfeffer C. Edgar\\n\\nAllan Poe, ‘‘The Pit and the Pendulum,’’ and ventricular\\n\\nassist devices. Crit Care Nurse. 2009;29(6):29Y39.\\n\\n4. Savage LS, Canody C. Life with a left ventricular assist device:\\n\\nthe patient’s perspective. Am J Crit Care. 1999;8(5):340Y343.\\n\\n5. Casida JM, Marcuccilli L, Peters RM, Wright S. Lifestyle\\n\\nadjustments of adults with long-term implantable left ven-\\n\\ntricular devices: a phenomenologic inquiry. Heart Lung. 2011;\\n\\n4(6):511Y520.\\n\\n6. Giorgi A. Phenomenology and Psychological Research.\\n\\nPittsburgh, PA: Duquesne University Press; 1985.\\n\\n7. Colaizzi P. Psychological research as phenomenologists view\\n\\nit. In: Valle R, King M, eds. Existential-Phenomenological\\n\\nAlternatives for Psychology. New York, NY: Oxford Uni-\\n\\nversity Press; 1978.\\n\\n8. Chapman E, Parameshwar J, Jenkins D, Large S, Tsui S.\\n\\nPsychosocial issues for patients with ventricular assist devices:\\n\\na qualitative pilot study. Am J Crit Care. 2007;16(1):72Y81.\\n\\n9. Hallas C, Banner NR, Wray J. A qualitative study of the\\n\\npsychosocial experience of patients during and after mechan-\\n\\nical cardiac support. J Cardiovasc Nurs. 2009;24(1):31Y39.\\n\\n10. Wray J, Hallas CN, Banner NR. Quality of life and psy-\\n\\nchosocial well-being during and after left ventricular assist\\n\\ndevice support. Clin Transplant. 2007;21(6):622Y627.\\n\\n11. Kylma J, Vehvilainen-Julkunen K, Lahvdevirta J. Dynamics\\n\\nof hope in HIV/AIDS affected people: an exploration of sig-\\n\\nnificant others’ experiences. Res Theory Nurs Pract. 2003;\\n\\n17(5):191Y205.\\n\\n12. Kylma J, Vehvilainen-Julkunen K. Hope in nursing research:\\n\\na meta-analysis of the ontological and epistemological foun-\\n\\ndations on hope. J Adv Nurs. 1997;25(6):364Y371.\\n\\n13. Scheier M, Carver C. Effects of optimism on psychological\\n\\nand physical well-being: theoretical overview and empiri-\\n\\ncal update. Cognit Ther Res. 1992;16(3):201Y228.\\n\\n14. Verhaeghe S, van Zuren F, Defloor T, Duijnstee M,\\n\\nGrypodonck M. The process and meaning of hope for fam-\\n\\nily members of traumatic coma patients in intensive care.\\n\\nQual Health Res. 2007;17:730Y743.\\n\\nWhat’s New and Important\\n\\nh This is the first study examining the experiences of\\n\\npatients living with the total artificial heart to provide\\n\\nclinicians and researchers with insight into these\\n\\npatients’ unique experiences.\\n\\nh It is important to recognize the psychological\\n\\naspects of being technologically dependent on an\\n\\nartificial organ.\\n\\nLiving With a Total Artificial Heart E7\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\n15. Barnard D. Chronic illness and the dynamics of hoping.\\n\\nIn: Toombs K, Barnard D, Carson R, eds. Chronic Illness:\\n\\nFrom Experience to Policy. Bloomington, Indiana: Indiana\\n\\nUniversity Press; 1995.\\n\\n16. Smith B, Sparks AC. Men, sport, spinal cord injury, and\\n\\nnarratives of hope. Soc Sci Med. 2005;61:1095Y1105.\\n\\n17. Ezzy D. Illness narratives: time, hope, and HIV. Soc Sci\\n\\nMed. 2000;50:605Y617.\\n\\n18. Lohne V, Severinsson E. Hope during the first months after\\n\\nacute spinal cord injury. J Adv Nurs. 2004;47:279Y286.\\n\\n19. Haugh KH, Salyer J. Needs of patients and families dur-\\n\\ning the wait for a donor heart. Heart Lung. 2007;36:\\n\\n319Y329.\\n\\n20. Overgaard D, Kjeldgaard HG, Egerod I. A qualitative study of\\n\\nthe illness experience and vocational adjustment of patients\\n\\nwith left ventricular assist device. J Cardiovasc Nurs. 2012;\\n\\n27(5):394Y402. http://www.ncbi.nlm.nih.gov/pubmed/21912269.\\n\\nAccessed June 26, 2012.\\n\\n21. Ahlberg K, Nordner A. The importance of participation in\\n\\nsupport groups for women with ovarian cancer. Oncol\\n\\nNurs Forum. 2006;33:E53YE61.\\n\\n22. Alberto J, Joyner B. Hope, optimism, and self-care among\\n\\nBetter Breathers Support Group members with chronic\\n\\nobstructive pulmonary disease. Appl Nurs Res. 2008;21:\\n\\n212Y217.\\n\\n23. Williams AM, Young J, Nikoletti S, McRae S. Reasons for\\n\\nattending and not attending a support group for recipients\\n\\nof implantable cardioverter defibrillators and their carers.\\n\\nInt J Nurs Pract. 2004;10:127Y133.\\n\\n24. Cupples SA, Nolan MT, Augustine SM, Kynoch D. Per-\\n\\nceived stressors and coping strategies among heart trans-\\n\\nplant candidates. J Transpl Coord. 1998;8:179Y187.\\n\\n25. Grady KL, Meyer PM, Dressler D, et al. Change in quality\\n\\nof life from after left ventricular assist device implantation\\n\\nto after heart transplantation. J Heart Lung Transplant.\\n\\n2003;22:1254Y1267.\\n\\n26. Jalowiec A, Grady KL, White-Williams C. Stressors in patients\\n\\nawaiting a heart transplant. Behav Med. 1994;19:145-154.\\n\\n27. Porter RR, Krout L, Parks V, et al. Perceived stress and\\n\\ncoping strategies among candidates for heart transplantation\\n\\nduring the organ waiting period. J Heart Lung Transplant.\\n\\n1994;13:102Y107.\\n\\n28. Hays JC, Wood L, Steinhauser K, Olson MK, Lindquist JH,\\n\\nTulsky JA. Clergy-laity support and patients’ mood during\\n\\nserious illness: a cross-sectional epidemiologic study. Palliat\\n\\nSupport Care. 2011;9:273Y280.\\n\\nE8 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='J THoRAc CARDIOVASC SURG 87:825-831, 1984\\n\\nThe artificial heart in human subjects\\n\\nIn preparationfor clinical implantationof the Utah J-7 pneumatic artificial heart as a permanentcardiac\\n\\nsubstitute, the device wasimplanted into five brain-deadhumansubjects.This report presentsour results\\n\\nand detailsour twomostsuccessfu1 trials.Three differentsurgicalimplanttechniques wereutilized in the\\n\\nfive subjects. Becauseof the unique \"no risk\" situationof the subjects,the function of the artificial heart\\n\\ncould be tested in a manner not advisable in patients, but necessary for clinical preparation. The\\n\\nimplantable total artificial heart wasable to maintain physiological hemodynamics in twosubjectsfor 41\\n\\nand 72 hours at which time the trials were electively terminated.\\n\\nJack Kolff, M.D., G. Michael Deeb, M.D., Nicholas C. Cavarocchi, M.D.,\\n\\nJerome B. Riebman, M.D., Donald B. Olsen, D.V.M.,* and Peter S. Robbins, M.D.,\\n\\nPhiladelphia. Pa.\\n\\nRtients with end-stage cardiac disease who are not\\n\\naccepted for cardiac transplantation may be candidates\\n\\nfor implantation of a total artificial heart (TAH). The\\n\\ndesign of a TAH was first undertaken by Drs. T. Akutsu\\n\\nand W. J. Kolff in 1958. They described a pneumati-\\n\\ncally driven, polyvinyl chloride heart consisting of two\\n\\ncollapsible sacs in one plastic air chamber. The simplic-\\n\\nity of design and the ability to control the heart from an\\n\\nexternally located energy and control module have made\\n\\npneumatic ventricles the most successful in terms of\\n\\nanimal longevity.2-4\\n\\nSeveral groups have reported calf survival for over 6\\n\\nmonths. These long-term experiments have resulted in\\n\\ncomplications that may well be unique to the calf.\\n\\nContinuous growth of the young calves causes their\\n\\nneeds to exceed the capabilities of the implanted TAH.\\n\\nCalcification of the polyurethane flexing diaphragm also\\n\\nhas been observed after prolonged survival and may be\\n\\nsimilar to the early calcification seen in valve hetero-\\n\\ngrafts implanted in children.\\' Because of the successful\\n\\nbench and animal trials with the Utah (J-7) TAH,t the\\n\\nFood and Drug Administration has given permission to\\n\\nproceed with clinical trials in selected human subjects at\\n\\nFrom the Department of Cardio-Thoracic Surgery, Temple University\\n\\nHospital, Philadelphia, Pa.\\n\\nReceived for publication April II, 1983.\\n\\nAccepted for publication July 18, 1983.\\n\\nAddress for reprints: Dr. Jack Kolff, Temple University Hospital,\\n\\n340IN. Broad St., Philadelphia, Pa. 19140.\\n\\nDepartment of Artificial Organs at the Universityof Utah, Salt Lake\\n\\nCity, Utah.\\n\\ntJ-7 ventricles obtained from Kolff Medical, Inc., Salt Lake City,\\n\\nUtah.\\n\\nthe University of Utah. Dr. Barney Clark was the first\\n\\npatient selected in that study. In preparation for these\\n\\nand future studies in living human subjects at Temple\\n\\nUniversity, our cardiac surgical team considered it\\n\\nnecessary to test the anatomic fit and the functional\\n\\ncapabilities of the ventricles in brain-dead human sub-\\n\\njects.\\n\\nMethods and materials\\n\\nThe Utah TAH is constructed of polyurethane and\\n\\nhas a continuous smooth inner surface. It is pneumati-\\n\\ncally powered and consists of two separate ventricles. As\\n\\nin the original design by Kwan-Gett, the blood chamber\\n\\nof the J-7 designed by Jarvik is separated from the air\\n\\nchamber by a flexible diaphragm.\" The maximum\\n\\nend-diastolic volume of each ventricle is 150 mI and its\\n\\nmaximum stroke volume is 100 mI, for an ejection\\n\\nfraction of 67%. Two Bjork-Shiley disc valves* achieve\\n\\nunidirectional flow in each ventricle. Connections to the\\n\\nnatural atria and great vessels are made with a \"quick-\\n\\nconnect\" system. This system consists of a cloth cuff or\\n\\ngraft with a flexible polyurethane ring which, after it is\\n\\nsewn onto the atrium or artery, snaps over a rigid collar\\n\\nonto either the inflow or outflow port of the ventricle.\\n\\nThe source of compressed air is controlled by electri-\\n\\ncally driven solenoid valves within the Utah Heart\\n\\nDriver (UHD).t The UHD controls heart rate, percent\\n\\nsystole, and maximum ventricular driving pressure for\\n\\neach ventricle. The UHD is connected to the intratho-\\n\\n\"Bjork-Shiley valves obtained from Shiley Laboratories,\\n\\nIrvine,\\n\\nCalif.\\n\\ntUtah Heart Driver obtained from Kolff Medical, Inc., Salt Lake\\n\\nCity, Utah.\\n\\n825\\n\\n8 2 6\\n\\nKolff et al.\\n\\nThe Journal of\\n\\nThoracic and Cardiovascular\\n\\nSurgery\\n\\nFig. lA. The pneumatic compressor, extra air tanks, and the Utah Heart Driver (on a wheelchair) needed to\\n\\npower the man with an artificial heart. Efforts are in progress to miniaturize the external hardware.\\n\\nracic ventricles VIa two 6 foot long air hoses (Fig.\\n\\nIA).\\n\\nThe artificial cardiac cycle consists of systole and\\n\\ndiastole. During systole a pulse of air enters the air\\n\\nchamber and empties the blood from the juxtaposed\\n\\nFig. 2. Chest roentgenogram of Case 4: The left ventricle is\\n\\nin the left pleural cavity and the right ventricle is inside the\\n\\npericardial sac.\\n\\nblood chamber. During diastole the air chamber is\\n\\nvented to the atmosphere so that venouspressure fillsthe\\n\\nventricle with blood.The stroke volumeof each ventricle\\n\\nis therefore controlled by the venous pressure in its\\n\\nrespective atrium, an arrangement which results in a\\n\\nbalanced circulation. This principle is considered to be\\n\\nStarling\\'s law of the TAH 7 (Fig. lB). Either ventricle\\n\\ncan be stopped by reducing the air driving pressure to\\n\\nzero.\\n\\nStandard radionuclide ventriculographic techniques\\n\\nvacuum\\n\\n15\\n\\n10\\n\\n5\\n\\n---\\n\\n,...- ---- ,.,---\\n\\n/\\'\\n\\n/\\'\\n\\n/\\'\\n\\n,/\\n\\n,/\\n\\n/\\'\\n\\n/\\n\\n/\\'\\n\\n/\\n\\n/\\'\\n\\n/\\n\\n/\\n\\nincreased./-\\n\\n/decreased\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\nI\\n\\n/\\n\\nL/min.\\n\\n8\\n\\n6\\n\\n4\\n\\no\\n\\n12\\n\\n10\\n\\nFig. lB. The \"Starling\" curve. Each ventricle contains a very\\n\\ncompliant diaphragm that allows it to fill in response to its\\n\\nfilling pressure. At a given heart rate an increase in atrial\\n\\npressure produces an increase in stroke volume and cardiac\\n\\noutput. The venous pressure-response curve can be shifted by\\n\\nadding some vacuum to the air exhaust tube during diastole.\\n\\nThe air pressure controls can be adjusted so that the heart\\n\\nfunctions on the steep portion of the \"Starling\" curve and each\\n\\nventricle has a degree of self regulation. The two ventricleswill\\n\\nthen seek equilibrium in the pulmonary and systemic circula-\\n\\ntions under various fluctuating conditions of left and right\\n\\natrial pressures.\\n\\nVolume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nArtificial heart in human subjects\\n\\n827\\n\\nTable I. Summary offive brain-dead, hemodynamically stable human subjects in whom the Utah (J-7) TAH\\n\\nwas implanted\\n\\nBleeding\\n\\nPulmonary\\n\\nedema\\n\\nBleeding\\n\\nElective\\n\\nElective\\n\\n2\\n\\n10\\n\\n1\\'/2\\n\\n41\\n\\n72\\n\\nHetero.\\n\\nOrtho,\\n\\nHetero.\\n\\nOrtho.\\n\\nOrtho.\\n\\nOrtho.\\n\\nOrtho.\\n\\nOrtho.\\n\\nHetero.\\n\\nOrtho.\\n\\nNeither\\n\\nLeft\\n\\nLeft\\n\\nLeft\\n\\nNeither\\n\\n19.5\\n\\n19.5\\n\\n132\\n\\nISO\\n\\n93\\n\\n160\\n\\n145\\n\\n5 7\"\\n\\n5\\'10\"\\n\\n4\\'11\"\\n\\n5\\'10\"\\n\\n6\\'2\"\\n\\nF\\n\\nM\\n\\nF\\n\\nM\\n\\nM\\n\\n54\\n\\n26\\n\\n20\\n\\n23\\n\\n19\\n\\nI\\n\\n2\\n\\n3\\n\\n4\\n\\n5\\n\\nCase\\n\\nAge\\n\\nWeight\\n\\nAP chest\\n\\nKidney\\n\\nVentricular position\\n\\nTAH pump\\n\\nReason\\n\\nNo.\\n\\n(yr)\\n\\nSex\\n\\nHeight\\n\\n(Ib)\\n\\ndiameter (em)\\n\\ndonated\\n\\nLeft\\n\\nI\\n\\nRight\\n\\ntime (hr)\\n\\nterminated\\n\\n,\\n\\nLegend: AP. Anterposterior. TAH. Total artificial heart. Ventricular position refers to whether or not the particular ventricle lies within its usual intrapericardial position.\\n\\nOrthotopic (Ortho.) means within and heterotopic (Hetero.) means outside the pericardial sac.\\n\\ngated to the UHD were used to obtain filling rates,\\n\\nemptying rates, and ejection fractions of either the right\\n\\nor the left ventricle.\\n\\nExperience in human subjects\\n\\nFrom May, 1981, to December, 1982, five TAHs\\n\\nwere implanted in five human cadavers, three of whom\\n\\nwere kidney donors. Informed consent for organ dona-\\n\\ntion and the implant studies was obtained from the\\n\\nrelatives. The fourth and fifth implants are presented in\\n\\ndetail.\\n\\nCASE 4. A young man 5 feet, 10 inches tall and weighing\\n\\n160 pounds,with an external anteroposterior chest diameter of\\n\\n19.5 em, was pronounced dead according to accepted criteria\\n\\nfor brain death.\\' In the operating room after one kidney was\\n\\ntaken for renal transplantation, the patient was placed on total\\n\\ncardiopulmonary bypass and the natural\\n\\nventricles were\\n\\nremoved along the atrioventricular groove.\\n\\nAtrial quick-connect rings were sewn onto the open tricus-\\n\\npid and mitral anuli and long arterial grafts were sutured to\\n\\nthe transected aorta and pulmonary artery. The left pleura was\\n\\nopened wide and the artificial left ventricle was placed inside\\n\\nthe pleural cavity so that there would be sufficient room in the\\n\\npericardial sac for the right ventricle.\\n\\nIn an atmosphere of carbon dioxide, the left and right\\n\\nventricles were attached to their inflow and outflow conduits.\\n\\nThe subject was slowlyweaned from cardiopulmonary bypass\\n\\nand the ventricles were allowed to take over full circulatory\\n\\nsupport. After decannulation the sternum and skin were\\n\\nclosed.\\n\\nIn the intensive care unit he required fluid and potassium\\n\\nreplacement, both depleted by diabetes insipidus. He also\\n\\nexhibitedhypoxia, acidosis,and pulmonary edema. These were\\n\\ncontrolled by positive end-expiratory pressure and by main-\\n\\ntaining low left atrial pressures while phenylephrine was used\\n\\nto support the blood pressure. Eventually, these pulmonary\\n\\ndifficulties were controlled and all pharmacologic agents\\n\\nexcept for vasopressin were stopped. Hemodynamically, the\\n\\nsubject\\'s condition became progressivelymore stable, and we\\n\\nwere able to test the heart by varying systolefrom 20%to 80%\\n\\nand the heart rate from 60 to 180 beats/min, while measuring\\n\\nejection fractions by radionuclide methods. The experiment\\n\\nwas electively terminated 41 hours after implantation to\\n\\naccommodate funeral arrangements.\\n\\nCASE 5. A young man 6 feet, two inches tall and weighing\\n\\n145 pounds, with an external arteroposterior chest diameter of\\n\\n19.5 em, was pronounced dead but was rejected for kidney\\n\\ndonation because of a prolonged hypotensiveepisode. Two J-7\\n\\nventricles were inserted to replace the natural heart, but their\\n\\npositioning was different from that used in Case 4. The\\n\\nartificial right ventricle was placed in the right pleural cavity\\n\\nand the left ventricle was placed within the pericardial sac. A\\n\\nnew right atrial outflow port was created on the lateral side of\\n\\nthe right atrium. The tricuspid anulus was closed with\\n\\ntricuspid valve tissue and an anterior flap of right ventricular\\n\\nmyocardium.\\n\\nCardiopulmonary bypass was discontinued and the TAH\\n\\nsupported the entire circulation. Postoperative bleeding ten-\\n\\ndencies were corrected with fresh-frozen plasma and platelets.\\n\\nAfter transfer of the subject to the intensive care unit, various\\n\\npneumatic, angiographic, computed axial tomographic and\\n\\nventricular radionuclide studies were done to determine\\n\\nmechanical fit and ventricular function. The experiment was\\n\\nelectively terminated after 72 hours to accommodate funeral\\n\\narrangements.\\n\\nResults\\n\\nAll five human subjects had a normal heart and\\n\\nnormal-sized pericardium for height and weight. A\\n\\nsummary of the pertinent clinical data of the five\\n\\nsubjects is shown in Table I.\\n\\nAnatomic considerations were critical for proper\\n\\nhemodynamic function. In Case 2, late pulmonary\\n\\nedema developed because of pulmonary venous com-\\n\\npression by the artificial ventricles. For subjects with a\\n\\nsmall natural heart, as in Case 3, we separated the two\\n\\nartificial ventricles and placed the right in the right\\n\\npleural cavity and the left in the pericardial sac. In Case\\n\\n4, we placed the left artificial ventricle in the left pleural\\n\\ncavity and allowed the right artificial ventricle an\\n\\northotopic position in the pericardial sac, as shown in\\n\\nFig. 2. Details of the surgical implantation techniques\\n\\nare described in another report.\"\\n\\nHemodynamic data in Cases 4 and 5 are shown in\\n\\nFigs. 3 and 4, respectively.\\n\\nThe adequacy of cardiac output in Case 4 is reflected\\n\\nin part by the urine output in Fig. 5. Excessive urine\\n\\n8 2 8\\n\\nKolff et al.\\n\\nThe Journal of\\n\\nThoracic and Cardiovascular\\n\\nSurgery\\n\\n140\\n\\n130\\n\\n:20\\n\\n110\\n\\n100\\n\\n90\\n\\n\\\\\\n\\n80\\n\\n.L---/\\n\\nMAP\\n\\n\\'\"\\n\\nJ:\\n\\nE\\n\\nE\\n\\nCVP\\n\\nLAP\\n\\n6\\n\\n7\\n\\n8\\n\\n9\\n\\n10 II\\n\\n12\\n\\nI\\n\\n2\\n\\n3\\n\\n4\\n\\ne\\n\\n6\\n\\n7\\n\\n8\\n\\n9 o\\n\\nII\\n\\n12\\n\\nI\\n\\n2\\n\\n3\\n\\n4\\n\\n5\\n\\n6\\n\\n7\\n\\n8\\n\\n9\\n\\n10 II\\n\\n12 I\\n\\n5/8/82\\n\\n5/9/82\\n\\nTIME\\n\\n5/10/82\\n\\nFig. 3. Hemodynamic course of Case 4, with normal parameters for both the left atrial pressure (LAP) and\\n\\ncentral venous pressure (CVP).The mean arterial blood pressure (MAP) was satisfactory throughout the 41 hours\\n\\nof the experiment.\\n\\n130\\n\\n120\\n\\n110\\n\\n100\\n\\n90\\n\\neo\\n\\nMM 0, HG\\n\\n10\\n\\n60\\n\\nso\\n\\n~o\\n\\n30\\n\\n20\\n\\n10\\n\\nMAP\\n\\n~\\n\\n8\\n\\n12\\n\\n/6\\n\\n20\\n\\n21\\n\\n1\\n\\n8\\n\\n12\\n\\n/6\\n\\n20\\n\\n21\\n\\n1\\n\\n8\\n\\n12\\n\\n/6\\n\\n20\\n\\n21\\n\\n1\\n\\n1213182\\n\\n/216182\\n\\nFig. 4. Hemodynamic data of Case 5 is shown for the 72 hour course of the experiment.\\n\\nproduction caused by diabetes insipidus was controlled\\n\\nby vasopressin. Actual cardiac outputs of each ventricle\\n\\nwere obtained by measuring the air flow exhausted from\\n\\neach ventricle during diastole. Fig. 6 shows a computer-\\n\\ngenerated* air exhaust curve obtained from a differen-\\n\\ntial pressure transducer placed across a small resistance\\n\\nin the air exhaust line. The computer calculates the\\n\\nApple Computers. Cupertino. Calif.\\n\\nvolume of blood that enters the ventricle during diastole\\n\\nand multiplies it by the heart rate for cardiac output of\\n\\neach ventricle.\\'? Fig. 7 shows that the cardiac output of\\n\\nthe left ventricle was consistently greater than that of\\n\\nthe right ventricle.\\n\\nDuring studies of ventricular function in Case 5, we\\n\\nfound that the right ventricle could be stopped from\\n\\nactively pumping while the subject still maintained an\\n\\nadequate blood pressure and a marginal cardiac output\\n\\nVolume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nArtificial heart in human subjects\\n\\n829\\n\\n\\'000\\n\\ntoo\\n\\n100\\n\\n700\\n\\nURINE\\n\\n100\\n\\nOUTPUT\\n\\ntOO.\\n\\nee\\n\\n400-\\n\\n10\\n\\n10\\n\\nII\\n\\nJI:\\n\\nI\\n\\nI\\n\\n\"\\'\\'\\'II\\n\\n\"till\\n\\nTIME\\n\\n.....\\n\\n51101l!\\n\\nFig. 5. Urine output was more then adequate and necessitated intermittent vasopressin to control diabetes\\n\\ninsipidus.\\n\\n5V=91\\n\\nCO=10. ?\\n\\nR\\n\\ncadaveric fit says little about the ability of the device to\\n\\nfunction when so placed.\\n\\nWe propose that there is a new opportunity for\\n\\nhuman experimental studies which far exceeds the\\n\\npurely anatomic and comparative studies of da Vinci.\\n\\nToday it is possible to test the functional capabilities of\\n\\nintrathoracic blood pumps in brain-dead but hemody-\\n\\nnamically stable human subjects at no risk, so that it is\\n\\nFig. 6. Air exhausted from the pneumatic ventricle during\\n\\ndiastole passes through a differential pressure transducer.\\n\\nPressure data are traced and computed to yield ventricular\\n\\nfillingor stroke volume (SV) and cardiac output (CO) for the\\n\\nleft and the right (R) ventricles. The early rapid exhaust phase\\n\\nwhen the compressed air from systole escapes to the atmo-\\n\\nsphere is discarded from the calculations. The blood that fills\\n\\nthe heart during diastole pushes air out. This later and much\\n\\nslowerair exhaust phase isshownas a plateau. The area under\\n\\nthis curve is used to compute stroke volume (accuracy is\\n\\n± 10%).10\\n\\n2\\n\\nX 100 MSEC\\n\\nfrom the left ventricle. A vacuum of 10 em H 20 on the\\n\\nUHD during left ventricular diastole and a central\\n\\nvenous pressure of 20 em H 20 were sufficient to allow\\n\\nblood to flow through the right ventricle and lungs. The\\n\\neffect of atrial contractility on pulmonary flow could not\\n\\nbe assessed.\\n\\nStandard radionuclide ventriculography techniques\\n\\nshow ventricular filling and emptying in Fig. 8. Under a\\n\\nfixed set of conditions, i.e., heart rate 120beats/min and\\n\\n33% systole, the ejection fraction was 53%. The curve\\n\\nindicates that the heart became slightly more than two\\n\\nthirds filled at the end of diastole and emptied complete-\\n\\nly to its minimal residual volume of 50 ml. The ventricle\\n\\nthus maintained an\\n\\ninherent degree of response to\\n\\nchanges in venous pressure.\\n\\nDiscussion\\n\\nDuring the fifteenth century Leonardo da Vinci\\n\\nattempted to study the anatomic and functional interac-\\n\\ntions of man\\'s internal organs. II However, da Vinci had\\n\\na very meager amount of human material to study, as it\\n\\nwas not popular to study human beings. In his drawings\\n\\nof the internal organs of man, he needed to borrow from\\n\\nthe anatomic knowledge of animal organs. He took\\n\\nsome artistic liberties to make the heart of an ox fit\\n\\ninside a man\\'s chest. He had no idea of its function,\\n\\nsince the course of the circulation of blood had not yet\\n\\nbeen discovered. Today, five centuries later, we were\\n\\nconfronted with the question of whether or not an\\n\\nartificial heart successfully tested in calves would fit and\\n\\nfunction in man. But how to proceed in man with some\\n\\nassurance of success? An artist\\'s drawing or a human\\n\\n8 3 0\\n\\nKoljf et al.\\n\\nc.o.\\n\\nL/MIN\\n\\nLO\\n\\nA\\n\\n,/\"\\n\\n(\\n\\n\\\\\\n\\n.\\n\\n\\\\\\n\\n,\"\\n\\nt.\\n\\n\"\\n\\n\\\\\\n\\n, \\\\.\\n\\ni>\\n\\nI\\n\\n\\\\\\n\\n/\\\\ /\\n\\n\"\"\"\\\\,\\' \\\\\\n\\n/\\n\\n\\\\\\n\\n\\\\/\\n\\n\\\\/\\n\\n\\\\/\\n\\n\\\\\\n\\n\"\\n\\nL=··--\\n\\nR=-\\n\\nThe Journal of\\n\\nThoracic and Cardiovascular\\n\\nSurgery\\n\\n..q\\n\\n8\\n\\n12\\n\\n16\\n\\n20\\n\\n2~\\n\\n~\\n\\n8\\n\\n12\\n\\n16 eo 21\\n\\n1\\n\\n8\\n\\n12\\n\\n16\\n\\n20\\n\\n21\\n\\n1\\n\\n1213182\\n\\n/211182\\n\\n1215 182\\n\\nFig. 7. The cardiac outputs (CO.) of the left (L) and right (R) ventricles were followedthroughout the duration of\\n\\nexperiment 5. The left ventricular output was consistently greater than the right ventricular output. The large\\n\\ndifference between right and left ventricular outputs is due in part to a physiological(bronchial arterial flow) and in\\n\\npart due to an inherent ± 10% error of each determination.\\n\\nnot necessary to learn the fundamentals of fit and\\n\\nfunction in patients. Permission to use the body or\\n\\norgans of brain-dead human subjects has benefited\\n\\nthousands of renal transplant recipients. It is in such\\n\\nkidney donors that the functional studies of the artificial\\n\\nheart were carried out. The relatives of these donors\\n\\nhave been extremely supportive of our experiments.\\n\\nTheir hope is that through these studies others may live\\n\\nlonger and more comfortably.\\n\\nIn regard to our fit studies, the fact that the artificial\\n\\nheart consists of two independent pneumatic ventricles\\n\\nallows them to be separated completely so that either\\n\\nventricle may be placed outside the pericardial sac in a\\n\\nheterotopic position. After encountering left atrial and\\n\\npulmonary venous compression with unilateral pulmo-\\n\\nnary edema in Case 2, we did not think it advisable to\\n\\nplace both ventricles in their usual intrapericardial\\n\\npositions in a small subject of 93 pounds (Case 3).\\n\\nTherefore, we utilized heterotopic positioning of either\\n\\nthe left or the right ventricle in Subjects 3, 4, and 5 and\\n\\nproved that this is a viable surgical option.\\n\\nIn regard to functional studies, one of our concerns\\n\\nwas to be able to maintain low filling pressures and\\n\\nadequate cardiac outputs to provide peripheral organ\\n\\nperfusion. It was also desirable to maintain a degree of\\n\\ninherent regulation so that a balanced but not necessar-\\n\\nily equal output between the right and the left ventricles\\n\\ncould be sustained for long periods without constant\\n\\nadjustments of the heart driving parameters. Although\\n\\nthe left ventricle was expected to pump more than the\\n\\nright because of the bronchial circulation, a rather larger\\n\\nthan expected difference occurred in the middle of the\\n\\ntime course of Case 5. Additional factors that could\\n\\naccount for this difference include a ± 10% inaccuracy\\n\\nof each measurement when determined on a mock\\n\\ncirculation and the increased regurgitation of the left-\\n\\nsided valves. Studies with electromagnetic flowmeters\\n\\naround the pulmonary artery and aorta are planned for\\n\\nthe future. The important point, however, is that the\\n\\nright and left ventricles never pump equal amounts, and\\n\\nthe TAH has to be designed to allow differences in\\n\\noutput while maintaining physiological atrial pressures.\\n\\nThe TAH functioned successfully for up to 72 hours.\\n\\nIn conclusion, these ongoing studies in brain-dead\\n\\nhuman subjects show that the Utah J-7 TAH can take\\n\\nover the role of the natural heart in a human being.This\\n\\nexperimental model is unique and necessary to evaluate\\n\\nthe fit and function of the device in preparation for\\n\\nfuture implantation into a wide selectionof personswho\\n\\nwould rather be tethered to this device then die of\\n\\nend-stage heart disease.\\n\\nWe would like to thank Dr. Alter and Dr. Buchheit, of\\n\\nTemple University Hospital for supporting these studies; Dr.\\n\\nVolume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nISO\\n\\nArtificial heart in human subjects\\n\\n83 1\\n\\nVOLUME\\n\\nCC\\n\\n__-]10\\n\\n50\\n\\n50\\n\\nlolA.: 120 IlPM\\n\\nSYSTOLE \"33\\\\\\n\\nEJECTI\"J~N\"33\\\\.\\n\\n..a\\n\\nMIN.RESIDUAL1101..\"50\"\\n\\nMAl(. STROKE VOL.: 100ce\\n\\nMAX.VOL. : lSOu\\n\\n20\\n\\n,\\n\\n1\\n\\n,\\n\\n,\\n\\n1\\'\"\\n\\nSYSTOLE\\n\\n1 1..\\n\\nDIASTOLE\\n\\n,\\n\\nI\\n\\n,\\n\\n,\\n\\nI\\n\\nI,\\n\\n01\\n\\nQZ\\n\\n01\\n\\nTIME\\n\\n(sec}\\n\\n04\\n\\nQ5\\n\\n10\\n\\nFig. 8. Ventricular volume curve of the left ventricle (L.v.) of Case 4 obtained by a gamma camera gated to the\\n\\nUtah Heart Driver. Technetium 99m pertechnetate in a standard clinical protocol was used to label the red blood\\n\\ncells. At the end of the maximum systolic position, 50 mIof residual blood remains in the ventricle. The maximum\\n\\ntotal volume of the ventricle is 150 ml. Illustrated here is a stroke volume of about 54 mI.\\n\\nGunther Boden for reviewing the manuscript; Dr. W. J. Kolff\\n\\nas head of the Divisionof Artificial Organs at the University of\\n\\nUtah for encouraging our approach; Dr. Robert Jarvik for\\n\\nconsultation on Case 4; and Drs. Summers and Bennet and\\n\\nMr. Stephen Sammut of the Greater Delaware Valley Kidney\\n\\nProcurement Center for coordinating renal transplantation.\\n\\nFinally, we thank the relatives of the donors that made this\\n\\nstudy possible.\\n\\nREFERENCES\\n\\nAkutsu T, Kolff WJ: Permanent substitutes for valves and\\n\\nhearts. Trans Am Soc Artif Intern Organs 4:230-235,\\n\\n1958\\n\\n2 Bucherl ES, Mfeld K, Baer P, Clevert HD, Frank J,\\n\\nGerlach K, Grosse-Siestrup C, Hennig E, Keilbach H,\\n\\nKrautzberger W, Kuhlmann V, Lemm W, Mohnhaupt A,\\n\\nRennekamp F, Unger V, Weidmann H, Zartrack F: Total\\n\\nartificial heart replacement. Int J Artif Organs 2:141-152,\\n\\n1979\\n\\n3 Pierce WS, Myers JL, Donachy JH, Rosenberg G, Landis\\n\\nDL, Proplet GA, Snyder AJ: Approaches to the artificial\\n\\nheart. Surgery 90:137-148, 1981\\n\\n4 Mochizuki T, Hastings WL, Olsen DB, Lawson JH,\\n\\nDaitoh N, Aaron JL, Razzeca KJ, Jarvik RK, Kessler TR,\\n\\nNielsen\\n\\nSD,\\n\\nKolff\\n\\nWJ:\\n\\nPostoperative\\n\\nhemodynamic\\n\\nchanges in calves implanted with total artificial hearts\\n\\ndesigned for human application. Trans Am Soc Artif\\n\\nIntern Organs 526:55-59, 1980\\n\\n5 Coleman DL, Liu D, Kessler T, Andrade JD: Calcification\\n\\nof non-textured implantable blood pumps. Trans Am Soc\\n\\nArtif Intern Organs 27:97-103, 1981\\n\\n6 Kwan-Gett C, Backman DK, Donovan FM, Eastwood N,\\n\\nFoote JL, Kawai J, Kessler TR, Kralios AC, Peters JL,\\n\\nVan Kampen KR, Wong HK, Zwart HHJ, Kolff WJ:\\n\\nArtificial heart with hemispherical ventricles and dissemi-\\n\\nnated intravascular coagulation. Trans Am Soc Artif\\n\\nIntern Organs 17:474-481, 1971\\n\\n7 Kwan-Gett CS, Wu Y, Collan R, Jacobson S, Kolff WJ:\\n\\nTotal replacement artificial heart and driving system with\\n\\ninherant regulation of cardiac output. Trans Am Soc Artif\\n\\nIntern Organs 15:245-251, 1969\\n\\n8 Guidelines for determination of death.\\n\\nReport to the\\n\\nPresident\\'s Commission for the Study of Ethical Problems\\n\\nin Medicine. JAMA 246:19:2184-2186, 1981\\n\\n9 Kolff J, Deeb GM, Riebman J: Preliminary study of a\\n\\npneumatic total artificial heart. Heart Trans 3:60-64,\\n\\n1983\\n\\n10 Nielsen SD, Willshaw P, Olsen DB: Non-invasive cardiac\\n\\noutput monitoring and diagnostics for pneumatic pumping\\n\\nchambers. Trans Am Soc Artif Intern Organs 29:589-592,\\n\\n1983\\n\\n11 O\\'Malley CD, de CM Saunders JB: Leonardo da Vinci on\\n\\nthe Human Body, New York, 1952, Henry Schuman,\\n\\nInc.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/284243177\\n\\nTotal Artiﬁcial Heart: State-of-the-art\\n\\nArticle\\xa0\\xa0in\\xa0\\xa0Biomedical Engineering · November 2015\\n\\nDOI: 10.1007/s10527-015-9528-4\\n\\nCITATIONS\\n\\n6\\n\\nREADS\\n\\n10,246\\n\\n3 authors:\\n\\nDmitry Petukhov\\n\\nNational Research University of Electronic Technology\\n\\n19 PUBLICATIONS\\xa0\\xa0\\xa054 CITATIONS\\n\\nSEE PROFILE\\n\\nSergey Selishchev\\n\\nNational Research University of Electronic Technology\\n\\n223 PUBLICATIONS\\xa0\\xa0\\xa0956 CITATIONS\\n\\nSEE PROFILE\\n\\nDmitry Telyshev\\n\\nNational Research University of Electronic Technology\\n\\n193 PUBLICATIONS\\xa0\\xa0\\xa0993 CITATIONS\\n\\nSEE PROFILE\\n\\nAll content following this page was uploaded by Dmitry Telyshev on 03 December 2015.\\n\\nThe user has requested enhancement of the downloaded file.\\n\\nIntroduction\\n\\nThe initial direction of the development of systems\\n\\nof mechanical circulatory support (MCS) was to try sim\\x02\\n\\nulating the biological mechanism of the heart by means of\\n\\nflexible diaphragms and unidirectional valves. The result\\n\\nof the development was steel pulsating machines such as\\n\\nthe fully artificial heart Liotta\\x02Heart and Jarvik 7.\\n\\nDespite successful implantation, these devices had disad\\x02\\n\\nvantages that limited their use: large size and low reliabil\\x02\\n\\nity due to the large number of moving parts [1\\x024].\\n\\nThe most clinically successful and widely used MCS\\n\\nsystems for treatment of heart failure are now the circula\\x02\\n\\ntory support devices of the third generation – constant\\n\\nflow rotary pumps [1, 2, 5].\\n\\nNevertheless, for total artificial hearts (TAH), there\\n\\nare still options for their application – the rescue of\\n\\npatients with cardiogenic shock, in case of unsuccessful\\n\\nheart transplantation, i.e. when immediate recovery of\\n\\nhemodynamics is needed [6]. TAH implantation also pro\\x02\\n\\nvides better six\\x02month survival compared with the appara\\x02\\n\\ntus of circulatory support of both heart ventricles [7].\\n\\nThe purpose of this review is to describe the state of\\n\\nthe art of pulsating MCS systems designed for complete\\n\\nreplacement of the heart. Features and characteristics of\\n\\nthese devices are discussed and are summarized in\\n\\nTable 1.\\n\\nSyncardia Total Artificial Heart\\n\\nThe most common version of the MCS system for\\n\\nthe replacement of both ventricles of the heart is the\\n\\nSyncardia device (SynCardia Systems, USA), a pulsating\\n\\ntotal artificial heart. Its weight is 160 g, and its volume is\\n\\n400 ml [8]. It is FDA approved for use as a bridge to trans\\x02\\n\\nplant (2004) and for voluntary implantation in patients\\n\\nwho have been refused a heart transplant (2012) [6].\\n\\nThis artificial heart includes the following compo\\x02\\n\\nnents: independent left and right polyurethane ventricles\\n\\n(Fig. 1), the volume of each being 70 ml, and a transder\\x02\\n\\nmal control cable connecting the ventricles with an exter\\x02\\n\\nnal pneumatic pump [6, 9].\\n\\nEach artificial ventricle has two Medtronic\\x02Hall sin\\x02\\n\\ngle\\x02leaf mechanical valves (27 mm – inlet valves, 25 mm –\\n\\noutlet valves), providing directional blood flow [6, 11].\\n\\nThe base unit is made of IsoPlast thermoplastic\\n\\npolyurethane. The ventricular chambers are manufac\\x02\\n\\ntured by sequentially pouring layers of polyurethane with\\n\\ndifferent hardness. Each ventricle is divided into two parts\\n\\nBiomedical Engineering, Vol. 49, No. 4, November, 2015, pp. 193\\x02196. Translated from Meditsinskaya Tekhnika, Vol. 49, No. 4, Jul.\\x02Aug., 2015, pp. 1\\x024.\\n\\nOriginal article submitted June 30, 2015.\\n\\n193\\n\\n0006\\x023398/15/4904\\x020193 © 2015 Springer Science+Business Media New York\\n\\n1 National Research University MIET, Moscow, Russia; E\\x02mail:\\n\\ndmitry.spetukhov@gmail.com\\n\\n2 Zelenograd Innovation Technological Center, Zelenograd, Moscow,\\n\\nRussia.\\n\\nTo whom correspondence should be addressed.\\n\\nModern variants of total artificial pulsating hearts such as Syncardia, Abiocor, and Carmat are reviewed.\\n\\nTechnical characteristics of these devices are considered in detail, given their limitations, which are traditional for\\n\\nartificial pulsating hearts: low reliability and limited applicability due to the large size of the implantable module.\\n\\nThe Carmat total artificial heart, which partially solves these problems and is currently at the stage of clinical tri\\x02\\n\\nals, is reviewed in detail.\\n\\nTotal Artificial Heart: State\\x02of\\x02the\\x02art\\n\\nD. S. Petukhov1*, S. V. Selishchev1, and D. V. Telyshev2\\n\\nTheory and Design\\n\\nDOI 10.1007/s10527-015-9528-4\\n\\n194\\n\\nPetukhov et al.\\n\\nby a membrane whose movement is controlled by the\\n\\npneumatic motor and provides pulsing blood flow. The\\n\\nmembranes consist of four independent layers. Such lay\\x02\\n\\nered structure provides necessary flexibility, hardness, and\\n\\na certain degree of security: in case of rupture of one of\\n\\nthe membrane layers, the presence of additional layers\\n\\nwill prevent instantaneous contact of air with blood,\\n\\nwhich can be fatal [6]. However, such cases of membrane\\n\\ndamage were recorded [12].\\n\\nSeveral control systems have been developed for\\n\\nSyncardia. The original version used in hospitals is the\\n\\nBig Blue control system. It contains two pneumatic actu\\x02\\n\\nators (main and reserve), compressed air cylinders, bat\\x02\\n\\nteries, and a console for operation control. Such system\\n\\nweighs more than 160 kg [13]. It enables manual control\\n\\nof the frequency of contractions, systole duration, and\\n\\nleft and right working pressure [6, 14].\\n\\nAnother option is the Freedom Driver control sys\\x02\\n\\ntem – a small portable drive that can be worn in a shoul\\x02\\n\\nder backpack, allowing patients with Syncardia to leave\\n\\nthe hospital and go home. This drive comprises two\\n\\nrechargeable batteries, each providing up to 2 h of work.\\n\\nIt can also operate from an external power source. The\\n\\ncontrol system displays the value of cardiac output and\\n\\nfrequency of contractions but enables manual adjustment\\n\\nof the contractions frequency only [6, 14].\\n\\nAbiocor Total Artificial Heart\\n\\nThe second MCS system, designed for long\\x02term\\n\\nreplacement of the heart in patients who are not suitable\\n\\nfor\\n\\ntransplantation,\\n\\nis\\n\\nthe\\n\\nAbiocor\\n\\ncompletely\\n\\nimplantable artificial heart (Abiomed, USA) [15].\\n\\nAmong implantable components of the Abiocor arti\\x02\\n\\nficial heart are the pump module shown in Fig. 2, battery\\n\\ncontroller, and coil of transcutaneous energy transfer.\\n\\nThe pump module consists of two ventricles surrounding\\n\\nthe electrohydraulic drive on two sides. An electrohy\\x02\\n\\ndraulic actuator comprises a centrifugal pump, which\\n\\nrotates at a speed of 5000\\x029000 rpm, moving low\\x02viscos\\x02\\n\\nity hydraulic fluid between the right and left liquid cham\\x02\\n\\nber separated from the ventricles by a membrane. As soon\\n\\nas one of the chambers is filled with liquid, the blood\\n\\nleaves the appropriate ventricle; at the same time, the\\n\\nother chamber empties, creating a negative pressure gra\\x02\\n\\ndient in the ventricle and leading to its active filling with\\n\\nblood from the atria. Titanium was selected as material\\n\\nfor the casing; all blood contacting surfaces, including\\n\\nfour tricuspid valves, are made of Angioflex polyether\\n\\nurethane [15]. The pump module weighs 1090 g and has\\n\\na volume of 800 ml [17].\\n\\nThe internal battery can provide power to the pump\\n\\nmodule when not connected to external power for 15\\x02\\n\\n30 min, depending on the charge level. In normal use, it\\n\\nis constantly recharged from an external power source.\\n\\nThe internal controller acts as communication between\\n\\nthe pump module and the external control console. It\\n\\nmonitors pressure in the ventricular chambers and the\\n\\nspeed of the pump, allows adjusting the frequency of\\n\\nemission and the ratio between the pressures in the right\\n\\nand left atria. It is similar to the internal battery in size\\n\\nand is placed with it in the abdomen.\\n\\nThe internal coil for power transmission is placed in\\n\\nthe subclavian area and is used to transfer energy by\\n\\ninductive coupling from an external coil, thus avoiding\\n\\nusing a transdermal cable to prevent possible infection.\\n\\nFig. 1. Artificial ventricles of the total artificial heart Syncardia [9].\\n\\nFig. 2. Abiocor total artificial heart implantable pump module\\n\\n[16].\\n\\nTotal Artificial Heart\\n\\n195\\n\\nThe external components of the Abiocor system are\\n\\nan outer coil to transmit power, control system of the size\\n\\nof a laptop computer, external radio frequency communi\\x02\\n\\ncation, and a battery container. The control unit receives\\n\\ninformation about the operation of the pump module from\\n\\nthe internal controller via radio\\x02frequency telemetry [15].\\n\\nThe Abiocor artificial heart was approved for volun\\x02\\n\\ntary use in 2006. Since then the device has been implant\\x02\\n\\ned only once, June 24, 2009, at the Robert Wood Johnson\\n\\nUniversity Hospital (New Jersey, USA) [3, 4].\\n\\nCarmat Total Artificial Heart\\n\\nThe most modern version of pulsating TAH is the\\n\\nCarmat artificial heart (Carmat SA, France) shown in\\n\\nFig. 3. Its development began in 1993 with the participa\\x02\\n\\ntion of the medical team of Alain Carpentier and techni\\x02\\n\\ncal team Matra Defense (a subsidiary of Airbus). One of\\n\\nthe main purposes of designing the device was its similar\\x02\\n\\nity to the shape of the biological heart. Its volume with\\n\\nartificial ventricles (65 ml each) and built\\x02in components\\n\\nis 750 ml. Each ventricle is separated by a membrane into\\n\\ncompartment for blood and a viscous fluid. Two electro\\x02\\n\\nhydraulic pumps move viscous fluid, which causes the\\n\\nmembrane to move and create a pulsating blood flow\\n\\n[3].\\n\\nBiological ventricular valves are located at the inputs\\n\\nand outputs. Pressure sensors and control electronics are\\n\\nintegrated into the device, partially covered with an elas\\x02\\n\\ntically deformable chamber with viscous fluid. A percuta\\x02\\n\\nneous cable transmits power and receives information\\n\\nabout the performance of the pumps. In the current con\\x02\\n\\nfiguration, the cable connects to a clinical control con\\x02\\n\\nsole.\\n\\nContacts with blood membrane surface made of\\n\\nbovine pericardium treated fabric are similar to biopros\\x02\\n\\nthetic valves developed by Dr. Carpentier in the early\\n\\n1980s. The suggested advantage of bioprosthetic materials\\n\\nis acceptable hemodynamic compatibility in future\\n\\nreducing the risk of thrombosis and the need for pro\\x02\\n\\nlonged anticoagulation. The main problems of their use\\n\\nare the reliability and durability of parts made of such\\n\\nmaterials [18].\\n\\nDue to the presence of embedded electrohydraulic\\n\\ndrive, there is no need for an external pneumatic actuator\\n\\nas for the Syncardia. This improves quality of life of the\\n\\npatient, for example, the drive does not generate audible\\n\\nnoise.\\n\\nThe control system reacts to changes in preload and\\n\\nafterload, as measured by pressure sensors in the ventri\\x02\\n\\ncles, by adjusting the contraction frequency (30 to\\n\\n150 beats/min) and stroke volume (30 to 65 ml). The\\n\\nresulting flow of blood varies from 2 to 9 liters/min [3].\\n\\nIn addition, Carmat SA provides a computer appli\\x02\\n\\ncation that helps selecting patients who have enough\\n\\nspace in the chest for the implantation of the TAH.\\n\\nClinical trials of the device began in late 2013 [3, 18].\\n\\nNevertheless, the options of the reviewed pulsating\\n\\ncompletely artificial hearts have disadvantages that limit\\n\\nthe scope of their application. The first drawback is the\\n\\nsize of the implantable module: for implantation of\\n\\nAbiocor a patient with body surface area greater than\\n\\n2.0 m2 is required, for Syncardia – more than 1.7 m2 [19].\\n\\nFig. 3. Carmat total artificial heart implantable pump module [3].\\n\\nTABLE 1. Specifications of Total Artificial Hearts\\n\\nProduct name\\n\\nSyncardia (SynCardia Systems, USA)\\n\\nAbiocor (Abiomed, USA)\\n\\nCarmat (Carmat SA, France)\\n\\nDrive type\\n\\npneumatic\\n\\nelectrohydraulic\\n\\nelectrohydraulic\\n\\nVolume, ml\\n\\n400\\n\\n800\\n\\n750\\n\\nWeight, g\\n\\n160\\n\\n1090\\n\\n900\\n\\nFlow, liter/min\\n\\nup to 9.5\\n\\nup to 10\\n\\nup to 9\\n\\nStatus\\n\\nimplantation as a bridge to transplant (2004) /\\n\\nvoluntary implantation for long\\x02term circulatory\\n\\nsupport (2012)\\n\\nvoluntary implantation in patients denied transplant\\n\\nclinical tests\\n\\n196\\n\\nPetukhov et al.\\n\\nThus, there is need for an artificial heart with smaller vol\\x02\\n\\numes of the ventricles (50 or 30 ml) for implantation into\\n\\na patient with small body surface area (less than 1.7 m2,\\n\\nbut more than 0.9 m2). Currently Syncardia Systems is\\n\\nsolving this problem by developing a new version of TAH\\n\\nwith ventricles of 50 ml [8, 10]. Furthermore, long\\x02term\\n\\noperation a TAH as an alternative to heart transplantation\\n\\nrequires optimization of thrombresistance and structural\\n\\nchanges, which ultimately will lead to an increase in\\n\\nworking life sufficient for reliable operation, at least for\\n\\nfive years [2].\\n\\nConclusion\\n\\nThis article provides an overview of pulsating\\n\\nmechanical circulatory support systems designed for the\\n\\ncomplete replacement of the heart: Syncardia, Abiocor,\\n\\nand Carmat. Specifications and features of these devices\\n\\nwere considered. Emphasis was placed on their short\\x02\\n\\ncomings, which are classic for pulsating completely artifi\\x02\\n\\ncial hearts: low reliability and limited applicability due to\\n\\nlarge size of the implantable module. Solutions to these\\n\\nproblems within the concept of an artificial heart, which\\n\\ncompletely mimics the operation of the biological heart,\\n\\nis possible only by ensuring fail\\x02safe operation of the main\\n\\ncomponents, minimizing the size and weight of the\\n\\ndevice, and reducing thrombus formation.\\n\\nThe study was financially supported by the Ministry\\n\\nof Education and Science of the Russian Federation\\n\\n(Federal Targeted Program “Research and developments\\n\\nin priority directions of the scientific\\x02technological com\\x02\\n\\nplex of Russia for 2014\\x022020”; agreement No.\\n\\n14.578.21.0057 from September 23, 2014).\\n\\nREFERENCES\\n\\n1. Ferrari M., Kruzliak P., Spiliopoulos K., Clin. Res. Cardiol., 104,\\n\\nNo. 2, 95\\x02111 (2015).\\n\\n2. Mallidi H.R., Anand J., Cohn W.E., Texas Heart Inst. J., 41, No.\\n\\n2, 115\\x02120 (2014).\\n\\n3. Mohacsi P., Leprince P.P., Europ. J. Cardio\\x02Thorac. Surg., 46, No.\\n\\n6, 933\\x02934 (2014).\\n\\n4. Pal S., Design of Artificial Human Joints and Organs, Springer (2013).\\n\\n5. Itkin G.P., Selishchev S.V., Med. Tekh., No. 6, 39\\x0245 (2010).\\n\\n6. Slepian M.J., Alemu Y., Soares J.S., et al., J. Biomechan., 46, No.\\n\\n2, 266\\x02275 (2013).\\n\\n7. Kirklin J.K., Naftel D.C., Pagani F.D., et al., J. Heart Lung\\n\\nTransplant., 33, No. 6, 555\\x02564 (2014).\\n\\n8. Copeland J.G., Texas Heart Inst. J., 40, No. 5, 587\\x02588 (2013).\\n\\n9. Mascio C.E., Artif. Organs, 39, No. 1, 14\\x0220 (2015).\\n\\n10. The Western PA Healthcare News Team. Allegheny General\\n\\nHospital Cardiac Surgeons Perform Region’s First SynCardia Total\\n\\nArtificial Heart Implantation (2012) (http://www.wphealthcare\\x02\\n\\nnews.com/allegheny\\x02general\\x02hospital\\x02syncardia).\\n\\n11. Park S., Sanders D., Smith B., et al., Perfusion, 29, No. 1, 82\\x0288 (2014).\\n\\n12. Torregrossa G., Morshuis M., Varghese R., et al., ASAIO J., 60,\\n\\nNo. 6, 626\\x02634 (2014).\\n\\n13. El Banayosy A., Kizner L., Arusoglu L., et al., ASAIO J., 60, No.\\n\\n2, 148\\x02153 (2014).\\n\\n14. Friedline K., Hassinger P.P., AANA J., 80, No. 2, 105\\x02112 (2012).\\n\\n15. Sale S.M., Smedira N.G., Best Pract. Res. Clin. Anaesthesiol., 26,\\n\\nNo. 2, 147\\x02165 (2012).\\n\\n16. AbioMed, Inc. The AbioCor Replacement Heart (2001)\\n\\n(http://www.heartpioneers.com/abiocorimages.html).\\n\\n17. Copeland J.G., Smith R.G., Arabia F.A., et al., J. Heart Lung\\n\\nTransplant., 23, No. 7, 823\\x02831 (2004).\\n\\n18. Jansen P., van Oeveren W., Capel A., Carpentier A., Europ. J.\\n\\nCardio\\x02Thorac. Surg., 41, No. 6, 166\\x02172 (2012).\\n\\n19. Bartoli C.R., Dowling R.D., Cardiol. Clin., 29, No. 4, 559\\x02582\\n\\n(2011).\\n\\nView publication stats')]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "loader = DirectoryLoader(\"data/txt\", glob=\"**/*.txt\")\n",
    "docs = loader.load()\n",
    "docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "c9f02374",
   "metadata": {},
   "outputs": [],
   "source": [
    "text_splitter = RecursiveCharacterTextSplitter(\n",
    "    chunk_size = 500,\n",
    "    chunk_overlap = 100\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "8cf4e5f2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='The ongoing quest for the first total artificial heart as\\n\\ndestination therapy\\n\\nCitation for published version (APA):\\n\\nVis, A., Arfaee, M., Khambati, H., Slaughter, M. S., Gummert, J. F., Overvelde, J. T. B., & Kluin, J. (2022). The\\n\\nongoing quest for the first total artificial heart as destination therapy. Nature Reviews. Cardiology, 19(12), 813-\\n\\n828. https://doi.org/10.1038/s41569-022-00723-8\\n\\nDOI:\\n\\n10.1038/s41569-022-00723-8\\n\\nDocument status and date:\\n\\nPublished: 01/12/2022'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='DOI:\\n\\n10.1038/s41569-022-00723-8\\n\\nDocument status and date:\\n\\nPublished: 01/12/2022\\n\\nDocument Version:\\n\\nAccepted manuscript including changes made at the peer-review stage\\n\\nPlease check the document version of this publication:\\n\\nA submitted manuscript is the version of the article upon submission and before peer-review. There can be\\n\\nimportant differences between the submitted version and the official published version of record. People'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content=\"interested in the research are advised to contact the author for the final version of the publication, or visit the\\n\\nDOI to the publisher's website.\\n\\nThe final author version and the galley proof are versions of the publication after peer review.\\n\\nThe final published version features the final layout of the paper including the volume, issue and page\\n\\nnumbers.\\n\\nLink to publication\\n\\nGeneral rights\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='numbers.\\n\\nLink to publication\\n\\nGeneral rights\\n\\nCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners\\n\\nand it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.\\n\\nUsers may download and print one copy of any publication from the public portal for the purpose of private study or research.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='You may not further distribute the material or use it for any profit-making activity or commercial gain\\n\\nYou may freely distribute the URL identifying the publication in the public portal.\\n\\nIf the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above, please\\n\\nfollow below link for the End User Agreement:\\n\\nwww.tue.nl/taverne\\n\\nTake down policy\\n\\nIf you believe that this document breaches copyright please contact us at:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Take down policy\\n\\nIf you believe that this document breaches copyright please contact us at:\\n\\nopenaccess@tue.nl\\n\\nproviding details and we will investigate your claim.\\n\\nDownload date: 24. Jul. 2025\\n\\nThe ongoing quest for the first total artificial heart\\n\\nas destination therapy\\n\\nAnnemijn Vis1,2, Maziar Arfaee1,2, Husain Khambati1,2, Mark S. Slaughter3, Jan F. Gummert4,\\n\\nJohannes T. B. Overvelde5,6 and Jolanda Kluin1,2\\n\\nAffiliations:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Johannes T. B. Overvelde5,6 and Jolanda Kluin1,2\\n\\nAffiliations:\\n\\n1. Cardiothoracic Surgery,Amsterdam UMC location University of Amsterdam, Amsterdam, The\\n\\nNetherlands.\\n\\n2. Heart Failure and Arrhythmias, Amsterdam Cardiovascular Sciences,Amsterdam, The Netherlands.\\n\\n3. Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, KY, USA.\\n\\n4. Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Bochum, Bad Oeynhausen, Germany.\\n\\n5. Autonomous Matter Department, AMOLF, Amsterdam, The Netherlands.\\n\\n6. Institute for ComplexMolecular Systems and Department of MechanicalEngineering, Eindhoven\\n\\nUniversity of Technology, Eindhoven, The Netherlands.\\n\\ne-mail: j.kluin@amsterdamumc.nl\\n\\nAbstract\\n\\nMany patients with end-stage heart disease die because of the scarcity of donor hearts.\\n\\nA total artificial heart (TAH), an implantable machine that replaces the heart, has so far been successfully'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='used in over 1,700 patients as a temporary life-saving technology for bridging to heart transplantation.\\n\\nHowever, after more than six decades of research on TAHs, a TAH that is suitable for destination therapy\\n\\nis not yet available. High complication rates, bulky devices, poor durability, poor biocompatibility and low\\n\\npatient quality of life are some of the major drawbacks of current TAH devices that must be addressed'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='before TAHs can be used as a destination therapy. Quickly emerging innovations in battery technology,\\n\\nwireless energy transmission, biocompatible materials and soft robotics are providing a promising\\n\\nopportunity for TAH development and might help to solve the drawbacks of current TAHs. In this Review,\\n\\nwe describe the milestones in the history of TAH research and reflect on lessons learned during TAH'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='development. We summarize the differences in the working mechanisms of these devices, discuss the\\n\\nnext generation of TAHs and highlight emerging technologies that will promote TAH development in the\\n\\ncoming decade. Finally, we present current challenges and future perspectives for the field.\\n\\nIntroduction\\n\\nCardiovascular disease is the leading cause of death globally, and heart failure, one of the end points of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='cardiovascular disease, affects approximately 2% of the adult population worldwide1. The estimated\\n\\nprevalence of heart failure will increase markedly owing to the ageing global population. It is predicted\\n\\nthat by 2030, more than 8 million people in the USA (1 in every 33) will have heart failure2. Heart\\n\\ntransplantation is currently considered the gold standard treatment for end-stage heart failure. However,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='a tremendous shortage of donor hearts exists worldwide. In 2018, more than 2,500 patients were actively\\n\\nawaiting heart transplantation in the USA alone3. To compensate for this shortage, mechanical devices to\\n\\nsupport the failing heart, such as left ventricular assist devices (LVADs), have been widely implanted over\\n\\nthe past two decades as an alternative therapy for end-stage heart failure. At present, over 3,000 LVADs'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='are implanted in North America every year, either as a bridge to heart transplantation or as destination\\n\\ntherapy4. LVADs are a treatment option for patients with left ventricular failure but are not suitable for\\n\\npatients with severe biventricular failure or other conditions that preclude the use of LVADs5.\\n\\nFurthermore, LVAD support is associated with poor quality of life and a risk of complications, such as'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='thromboembolic events, bleeding and driveline infections6,7,8,9. A total artificial heart (TAH) is a surgically\\n\\nimplanted pump that provides blood circulation and replaces cardiac ventricles that are diseased or\\n\\ndamaged10. The TAH is implanted in an orthotopic position and replaces both the left and right ventricle\\n\\nof the native heart. In 1969, a TAH was implanted in a patient for the first time11. However, TAHs have so'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='far primarily been implanted as a temporary bridging therapy for patients with advanced heart failure\\n\\nwho are awaiting heart transplantation. The SynCardia TAH (SynCardia Systems, Tucson, AZ, USA) is the\\n\\nTAH that is most frequently implanted as a bridge to heart transplantation therapy and is under\\n\\ninvestigation in a clinical trial to assess its applicability as destination therapy12. However, the limitations'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='of the SynCardia device, which include bulkiness, short durability, high complication rates and low patient\\n\\nquality of life owing to the need for percutaneous hoses and frequent hospitalizations, have so far\\n\\nprecluded its approval for this indication. An urgent need for destination therapies for (biventricular) end-\\n\\nstage heart disease exists because the majority of patients have no prospect of recovery with currently'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='available therapies. The rapidly emerging technologies in wireless energy transmission, biocompatible\\n\\nmaterials and soft robotics provide a promising outlook for TAH development. Many teams across the\\n\\nworld have tried different approaches to develop various types of TAHs, of which only a few are still under\\n\\ndevelopment. In this Review, we describe the historical milestones and lessons learned during TAH'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='development. In this Review, we describe the historical milestones and lessons learned during TAH\\n\\ndevelopment and discuss the current generation of TAHs and the differences in their working\\n\\nmechanisms. We also highlight new technologies that will promote TAH development in the coming\\n\\ndecade.\\n\\nHistory of TAH development\\n\\nAnimal experiments\\n\\nThe development of TAHs dates back to the previous century. One of the first experiments with a TAH'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='was reported in 1958, when pioneers Willem Kolff and Tetsuzo Akutsu at the Cleveland Clinic (Cleveland,\\n\\nOH, USA) implanted a TAH in a dog after removing its native heart13. The TAH sustained blood circulation\\n\\nin the dog for 90\\u2009min13. More experiments in dogs were conducted at the Cleveland Clinic in the 1960s,\\n\\nincluding implantation of a mechanical TAH with two blood chambers that were alternately emptied by a'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='motor pendulum14 and implantation of two different pneumatically driven TAHs15. In the same period,\\n\\nDomingo Liotta (School of Medicine, Cordoba, Argentina) implanted a pneumatic TAH, named the Liotta\\n\\nHeart, in dogs16. These experiments inspired more researchers across the world to start developing TAHs.\\n\\nIn Japan in 1963, Kazuhiko Atsumi (Tokyo University School of Medicine, Tokyo, Japan) developed several'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='types of pneumatic and mechanical TAH and tested them in 56 dogs17. In 1964, a national artificial heart\\n\\nprogramme was initiated in the USA, sponsored by the National Heart, Lung and Blood Institute. This big\\n\\nnationwide project, led by Frank Hastings, aimed to develop novel technical advances (similar to the aims\\n\\nof the USA space programme) for generating TAHs. Boosted by the national artificial heart programme,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='TAH experiments were conducted in numerous research centres in the USA, such as at the Penn State\\n\\nMilton S. Hershey Medical Center18 and the Cleveland Clinic19.\\n\\nFirst TAH implantation in humans\\n\\nIn 1969, Denton Cooley (Texas Heart Institute, Houston, TX, USA) performed the first TAH implantation in\\n\\nhumans, implanting the Liotta–Cooley TAH in a patient aged 47\\u2009years11 (Fig. 1). The Liotta–Cooley device'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='was a rigid pneumatic TAH with two ventricles implanted orthotopically. An external pump moved\\n\\ncompressed air into a pneumatic chamber inside the ventricle, which pushed a diaphragm and caused the\\n\\nejection of blood from the blood chamber on the other side of the membrane. The Liotta–Cooley TAH\\n\\nsupported the patient for 64\\u2009h, after which the patient underwent heart transplantation11. The patient'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='died owing to sepsis 32\\u2009h after the heart transplantation. Furthermore, the poor biocompatibility of the\\n\\nvalves and the surfaces that were in contact with the blood might have contributed to haemolysis and\\n\\nrenal impairment11. Therefore, although the first TAH implantation was ground-breaking, it was not\\n\\nconsidered a success20. However, this first implantation of a TAH in humans proved the concept that such'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='technology could support a patient as a bridge to heart transplantation. However, the procedure sparked\\n\\nethical and legal controversy regarding improper consent and experimentation21. In the years after the\\n\\nfirst implantation in humans, further research on TAH prototypes was conducted solely in large animal\\n\\nmodels by researchers from the University of Alberta (Edmonton, Alberta, Canada)22; the University of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Utah College of Medicine (Salt Lake City, UT, USA)23,24,25,26; the University of Mississippi Medical Centre\\n\\n(Jackson, MS, USA)27,28; the Cleveland Clinic29,30; the Baylor College of Medicine (Houston, TX, USA)31; and\\n\\nthe US Atomic Energy Commission (University of Utah, Salt Lake City, UT, USA)32,33,34. It took 12 years from\\n\\nthe first TAH implantation in humans until the next human TAH implantation in 1981, again at the Texas'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Heart Institute, when the pneumatic Akutsu III TAH was implanted as a bridge to transplantation in a man\\n\\naged 36\\u2009years35. The Akutsu III TAH worked similarly to the Liotta–Cooley TAH, with two inflatable air sacs\\n\\nto displace blood. The Akutsu III TAH supported the patient for 55\\u2009h, after which the patient received\\n\\nheart transplantation. However, in the last 27\\u2009h before the transplantation surgery, the patient could not'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='be fully supported by the TAH and died 7\\u2009days after the heart transplantation owing to multiorgan\\n\\nfailure35. The third TAH implantation in humans occurred in 1982 at the University of Utah, where William\\n\\nDeVries and Willem Kolff implanted the Jarvik-7 TAH as destination therapy in a patient aged 61\\u2009years\\n\\nwith congestive heart failure36. The Jarvik-7 was a pneumatic device with a similar working mechanism to'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='the Liotta–Cooley TAH. After implantation of the Jarvik-7 TAH, the patient was conscious and able to\\n\\ncommunicate with his family. Progressive circulatory shock led to his death 112\\u2009days after TAH\\n\\nimplantation36. This first successful clinical outcome with the Jarvik-7 TAH encouraged many teams across\\n\\nthe world to continue developing TAHs (Fig. 1). Most TAHs developed by the first pioneers were\\n\\npneumatically or hydraulically driven; later, researchers developed TAHs with different working'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='pneumatically or hydraulically driven; later, researchers developed TAHs with different working\\n\\nmechanisms. Currently available TAHs can be classified into three types on the basis of their working\\n\\nmechanism: fluid-driven TAHs, mechanical TAHs and continuous-flow TAHs (Fig. 2), which are discussed\\n\\nbelow.\\n\\nWorking mechanisms of TAHs\\n\\nFluid-driven TAHs\\n\\nFluid-driven TAHs are the oldest type of TAH, with a working mechanism similar to that of the Liotta–'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Cooley and Jarvik-7 TAHs. Fluid-driven devices have blood chambers separated by a membrane from a\\n\\nchamber filled with fluid (air or liquid). A pressure rise in the fluid chamber moves the flexible membrane\\n\\nso that the blood chamber empties and the blood is ejected (Fig. 2a). A pump is required to increase the\\n\\npressure in the pneumatic or hydraulic chamber. Often, these pumps are placed outside the body, which'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='requires percutaneous hoses to move the pressurized fluid from the pump to the TAH. Depending on the\\n\\ntype of pump used in these pneumatic and hydraulic devices, the left and right chamber eject blood either\\n\\nsimultaneously or alternatingly. More recently developed TAHs (such as the Carmat TAH (Aeson; Carmat,\\n\\nVélizy-villacoublay, France)) are designed to have the pump implanted in the body, avoiding the need for'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='percutaneous pneumatic or hydraulic pressure hoses. However, percutaneous cables to supply power to\\n\\nthe TAH are often still needed.\\n\\nHistorical devices\\n\\nSeveral pneumatic TAHs were developed in the 1980s, such as the Brno TAH (Vacord Bioengineering\\n\\nResearch Company, Brno, Czech Republic)37, Penn State pneumatic TAH (Pennsylvania State University,\\n\\nHershey, Pennsylvania)38, Phoenix (Southern Taiwan University, Tainan, Taiwan)39,40, Poisk TAH (Institute'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='of Organ and Tissue Transplantation, Moscow, Russia)41,42, POLTAH (Artificial Heart Laboratory, Zabrze,\\n\\nPoland)43 and Vienna TAH (University of Vienna, Vienna, Austria)44. In the same period, the\\n\\nelectrohydraulic TAH (EHTAH) was developed in Japan (Artificial Organs Department, Osaka, Japan)45.\\n\\nDevelopment of the hydraulically driven AbioCor (Abiomed, Danvers, MA, USA) started in the 1990s46,47,48.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='AbioCor was the first fully implantable system designed without any percutaneous cables; it consisted of\\n\\nfour internal components and a transcutaneous energy transfer (TET) system. The characteristics of all the\\n\\nTAHs discussed in this Review are summarized in Table 1.\\n\\nCurrent devices\\n\\nTwo fluid-driven devices, SynCardia49 and the Carmat TAH, are currently in use as a bridge to\\n\\ntransplantation and are undergoing further evaluation as destination therapy. Another fluid-driven TAH,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='SoftHeart (ETH Zurich, Zurich, Switzerland)50, is currently under development51,52. The working mechanism\\n\\nof these three prototypes is very similar to the earliest devices, such as the Liotta–Cooley and Akutsu III\\n\\nTAHs. The history of the development of SynCardia dates back 40\\u2009years to 1982, when Kolff and DeVries\\n\\nperformed the first successful implantation of a TAH in a patient36. This TAH, the Jarvik-7, is now known as'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='SynCardia. SynCardia is a pneumatically driven TAH consisting of two independent ventricles that collect\\n\\nand eject blood simultaneously in a pulsatile manner. A four-layer polyurethane membrane separates the\\n\\nblood in the ventricle from the pneumatic chamber. The pressures in the pneumatic chamber are\\n\\ngenerated by a pump placed outside the body and connected via percutaneous drivelines. SynCardia is'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='the first TAH that received CE approval (in 1999) and FDA approval (in 2004) for temporary use as a bridge\\n\\nto heart transplantation in eligible candidates who are at risk of imminent death from end-stage\\n\\nbiventricular failure53,54. This TAH has been implanted in over 1,700 patients worldwide55. The Carmat\\n\\nsystem is a hydraulic TAH developed in France that received CE approval as a bridge to transplantation'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='therapy in 2020. The Carmat TAH consists of left and right blood chambers separated from the hydraulic\\n\\npressure chamber by a two-layer biocompatible membrane made from bovine pericardium. The pumps\\n\\nthat pressurize the hydraulic pressure chambers of the Carmat TAH are built within the TAH itself, making\\n\\nthis device larger than SynCardia. Furthermore, the Carmat TAH ejects blood from the left and right blood'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='chambers alternatingly. Although percutaneous pressure hoses are not required to pressurize the\\n\\nhydraulic chamber, the Carmat system requires percutaneous cables to deliver the required electrical\\n\\npower to the TAH. The Carmat TAH has been implanted as a bridge to transplantation in 24 patients in\\n\\nclinical trials (as of February 2022)56. SoftHeart is a pneumatically driven TAH entirely made of silicone'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='rubber (except for its mechanical heart valves), and is the only completely soft TAH developed so far.\\n\\nSoftHeart has been tested only in vitro50,57. Although the durability of SoftHeart has been improved\\n\\ncompared with earlier iterations, it is still limited to only 110,000 cycles (approximately 30\\u2009h)50,57.\\n\\nMechanical TAHs\\n\\nThe functionality and clinical applicability of fluid-driven TAHs were demonstrated in the early 1990s, but'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='some of their disadvantages also became apparent. These TAHs were bulky, had poor durability and\\n\\nrequired percutaneous air pressure hoses and external drivers, which led scientists to explore alternative\\n\\nworking mechanisms and shift the focus to mechanically actuated TAHs58. Mechanically actuated TAHs\\n\\nhave many similarities to fluid-driven TAHs: both have two chambers to collect and eject blood, and inlet'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='and outlet valves to direct the flow (Fig. 2b). Like fluid-driven TAHs, mechanical TAHs have a moving\\n\\nmembrane to empty the blood chambers. However, instead of emptying the blood chambers with the use\\n\\nof pressurized gas or liquid (as in fluid-driven devices), mechanically actuated TAHs have an electric motor\\n\\nthat drives a pusher plate against the blood chambers. Compared with fluid-driven TAHs, mechanical\\n\\nTAHs are less bulky and, most importantly, do not require large external drivers.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='TAHs are less bulky and, most importantly, do not require large external drivers.\\n\\nHistorical devices\\n\\nMultiple mechanical TAHs were developed in the 1990s by different teams and institutions: AnyHeart\\n\\n(Seoul University, Seoul, South Korea)59,60,61, Baylor TAH (Baylor College of Medicine)62,63, Cleveland\\n\\nNimbus (Cleveland Clinic)64,65, eccentric roller TAH (Hiroshima University, Hiroshima, Japan)66, Linear TAH'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='(Shinshu University, Nagano, Japan)67,68, MagScrew (Cleveland Clinic)69, Milwaukee Heart (Milwaukee\\n\\nHeart Project, Milwaukee, WI, USA)70, Ovalis (Humboldt University, Hamburg, Germany)71 and Penn State\\n\\nelectric TAH (Pennsylvania State University)72. These TAHs can be classified on the basis of their working\\n\\nmechanism as TAHs with mechanical actuation parts with either linear or rotary motion.\\n\\nCurrent devices'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Current devices\\n\\nWe have identified three mechanically actuated devices that are still under development: Realheart TAH\\n\\n(Linköping University, Linköping, Sweden)73,74, ReinHeart (Helmholtz Institute, Aachen, Germany)75 and\\n\\nRollingHeart (University of Lausanne, Lausanne, Switzerland)76. None of these devices has been assessed\\n\\nin clinical trials. Realheart and ReinHeart are fully implantable systems, including a TET system and'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='internal battery packs. Both TAHs are actuated with magnets and are being assessed in animal studies.\\n\\nThe RollingHeart is a mechanically actuated TAH developed in Switzerland and has only been tested in\\n\\nvitro. This TAH has a spherical shape, and two moving disks divide the spherical cavity into four chambers.\\n\\nAn electrical motor moves the disks and thereby changes the volume of the chamber over time, which'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='An electrical motor moves the disks and thereby changes the volume of the chamber over time, which\\n\\nenables the filling and ejection of the blood. The design is unique because it does not require any valves.\\n\\nHowever, issues in the design of this TAH related to the recirculation and mixing of oxygenated with\\n\\ndeoxygenated blood need to be addressed76.\\n\\nContinuous-flow TAHs\\n\\nA major disadvantage of the above-mentioned fluid-driven and mechanical devices is that they require'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='several indispensable components, such as blood collecting chambers, flexible membranes and valves. As\\n\\na result, these devices are often bulky and usually do not fit inside petite patients, such as children and\\n\\nsome women. The flexible membranes present in these devices are often prone to wear and tear because\\n\\nthey deform with every heartbeat (about 35 million times a year). Continuous-flow pumps were'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='they deform with every heartbeat (about 35 million times a year). Continuous-flow pumps were\\n\\nintroduced as an alternative to traditional pulsatile devices. Because blood is pumped continuously in\\n\\nthese devices, they do not require valves, membranes or blood collecting chambers. Therefore,\\n\\ncontinuous-flow TAHs are smaller and lighter than other types of TAHs. In addition, their lifetime is longer'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='owing to the absence of flexible membranes and the continuous rotation of their motors in a single\\n\\ndirection. In the past two decades, substantial progress has been achieved in the field of continuous-flow\\n\\nLVADs, whose efficacy has been proved in clinical trials77. The longest reported duration of LVAD support\\n\\nwithout mechanical failure is 13\\u2009years77,78. These positive results inspired many TAH researchers to use'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='continuous-flow pumps for TAH development, mainly because of their superior power-to-size ratio and\\n\\ndurability compared with fluid-driven and mechanical TAHs. After implantation of a regular continuous-\\n\\nflow LVAD, some blood flow pulsatility remains because the native heart is left in place. By contrast,\\n\\ncontinuous-flow TAHs eject blood continuously and generate a true continuous blood flow. Given that the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='physiological response to long-term continuous blood flow is unclear79,80,81, most of the investigators\\n\\ndeveloping continuous-flow TAHs are exploring the possibility of modulating the flow to provide some\\n\\nlevel of pulsatilily79. So far, achieving the same pulsatility index as with the native heart or the pulsatile\\n\\nTAHs has not been possible.\\n\\nHistorical devices\\n\\nThe first continuous-flow TAHs were developed in the 1990s. We have identified three continuous-flow'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='TAH devices, which are no longer in use: the flow-transformed pulsatile TAH (University of Tokyo, Tokyo,\\n\\nJapan)82, the undulation pump TAH (UPTAH) (University of Tokyo, Tokyo, Japan)83 and the Impeller TAH\\n\\n(Jiangsu University, Zhenjiang, China)84.\\n\\nCurrent devices\\n\\nAlthough LVADs were developed to assist the native left ventricle, these devices are powerful enough to\\n\\ntake over the function of the native ventricle completely. Therefore, several research groups have'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='take over the function of the native ventricle completely. Therefore, several research groups have\\n\\ninvestigated the efficacy of two commercially available LVADs (such as HeartMate II, Heartmate III,\\n\\nHeartWare HVAD, Jarvik 2000 and HeartAssist 5) combined into a TAH configuration after removing the\\n\\nnative heart85,86,87,88,89,90,91,92,93,94. The configuration of two LVADs functioning as a TAH has been tested in'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='animal studies and clinical trials85,86,87,88,89,90,91,92,93,94. In this Review, we refer to the configuration of two\\n\\ncommercially available LVADs functioning as a TAH as ‘LVAD–TAH’. Many TAH developers have used\\n\\ncontinuous-flow pump technology to develop custom-built TAH devices. Several continuous-flow TAHs\\n\\nare currently under development: BiVACOR (BiVACOR, Houston, TX, USA)95, Cleveland continuous-flow'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='are currently under development: BiVACOR (BiVACOR, Houston, TX, USA)95, Cleveland continuous-flow\\n\\nTAH (CFTAH)96,97 and helical-flow TAH (HFTAH) (University of Tokyo, Tokyo, Japan)98 are being assessed in\\n\\nchronic animal experiments, and Hybrid CFTAH (Drexel University, Philadelphia, PA, USA)99 and\\n\\nOregonHeart (OregonHeart, Portland, OR, USA)100,101 are undergoing in vitro testing.\\n\\nBalancing right and left cardiac outputs of TAHs'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Balancing right and left cardiac outputs of TAHs\\n\\nA major issue that must be addressed for successful TAH implantation is the balancing of the right and left\\n\\ncardiac outputs20. In a physiological setting, the cardiac output of the left ventricle is slightly greater than\\n\\nthe cardiac output of the right ventricle102, because part of the oxygen-rich blood from the aorta goes into\\n\\nthe bronchial arteries that supply the lung parenchyma, which then drains back to the left atrium103,104.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Therefore, part of the blood ejected by the left ventricle returns to the left atrium without passing\\n\\nthrough the right circulation, resulting in a larger systemic flow than pulmonary flow. In healthy\\n\\nindividuals, the bronchial shunt flow is approximately 1% of the cardiac output103. However, various\\n\\npulmonary diseases increase the bronchial shunt flow to up to one-third of the left ventricular output103.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='A study showed that three out of five patients with an implanted AbioCor TAH had increases in bronchial\\n\\nflow of up to 1.4\\u2009l/min, which is 28% of a cardiac output of 5\\u2009l/min105. The native heart continuously\\n\\nbalances the systemic and pulmonary flows by ventricular interdependence, via the Frank–Starling\\n\\nmechanism102, but this balancing mechanism is difficult to implement in TAHs. If a TAH cannot\\n\\ncompensate for flow differences in venous return, severe complications such as lung oedema and'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='compensate for flow differences in venous return, severe complications such as lung oedema and\\n\\nrespiratory failure will arise20. Therefore, balancing the outputs to the systemic and pulmonary\\n\\ncirculations during TAH support is one of the biggest challenges in TAH design20,106. Pulsatile TAHs can\\n\\nalter the stroke volume of one of the blood chambers if a sudden change in atrial pressure occurs. The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='stroke volume can be adjusted in two ways: by adjusting the filling volume inside the chamber or by\\n\\nadjusting the ejection fraction. This adjustment is an active process that requires either manual control or\\n\\nautomatic control by feedback from incorporated sensors. In the Carmat system, many internal\\n\\nelectronics, microprocessors and sensors are needed to constantly monitor different internal pressures,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='as well as an ultrasound transducer to monitor the position of the membrane107. In SynCardia, the system\\n\\nparameters are manually set to fill the ventricles to 70–85% of their capacity, to create a buffer that\\n\\npassively enables the augmentation of venous return108. As a result, SynCardia is sensitive to preload,\\n\\ndemonstrating Frank–Starling-like behaviour under normal conditions108. Therefore, Syncardia can'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='demonstrating Frank–Starling-like behaviour under normal conditions108. Therefore, Syncardia can\\n\\nprovide increased output in response to increased preload. However, the shape of the Syncardia Frank–\\n\\nStarling curve differs from that of the human heart, because this TAH is inelastic108,109. ReinHeart’s design\\n\\nuses the concept of passive and active limitation of the right-sided filling, in combination with the right'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='ventricle having a fixed volume that is 10% smaller than that of the left ventricle110. A balancing\\n\\nmechanism is also required for continuous-flow TAHs, because a sudden drop in atrial pressure quickly\\n\\nresults in negative atrial pressures (suction event). Continuous-flow TAHs that have two separate pumps\\n\\nfor the left and right circulation (such as in the LVAD–TAH, Hybrid CFTAH and HFTAH) have some inherent'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='flow-balancing capacity98,99,106. However, a study testing the performance of several types of continuous-\\n\\nflow TAHs made from two separate pumps in an in vitro set-up in which systemic and pulmonary\\n\\nresistance were changed to mimic the human cardiovascular system during daily activities showed that,\\n\\nalthough all the devices had some flow-balancing capacity, none was able to accommodate all resistance'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='settings106. Cleveland CFTAH, BiVACOR and OregonHeart use a single moving rotor to perfuse the\\n\\npulmonary and systemic circulations. The rotor of the OregonHeart is typically set to pump 60% of each\\n\\nbeat time to the left circulation and 40% to the right circulation, but this ratio can be adjusted manually to\\n\\nmeet the needs of a wide range of physiological conditions101. BiVACOR incorporates an axial magnetic'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='levitation system, which enables active control of the position of the single moving rotor95. A leftward\\n\\nshift of the rotor causes an increase in left-sided flow95. The Cleveland CFTAH uses a similar mechanism,\\n\\nbut in this TAH, the rotor can have passive axial movements inside the stator, enabling the TAH to balance\\n\\nthe left and right outputs passively, without any sensors111. The axial position of the rotor is determined'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='by the pressure gradient between the left and right blood chambers. When the pressure drops in one of\\n\\nthe blood chambers, the rotor passively moves to that side, which helps to prevent atrium wall suction\\n\\nand balances the cardiac outputs111. This low-complexity passive feedback mechanism inherently reduces\\n\\nthe risk of device failure compared with the complex active feedback mechanisms in other TAHs.\\n\\nChronic animal trials'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Chronic animal trials\\n\\nChronic animal trials are an important step in the preclinical testing of new TAHs. Chronic animal trials\\n\\nhave been conducted for AbioCor, AnyHeart, Baylor TAH, BiVACOR, Brno TAH, Carmat TAH, Cleveland\\n\\nCFTAH, Cleveland Nimbus, EHTAH, HFTAH, LVAD–TAH, MagScrew, Penn State electric TAH, Penn State\\n\\npneumatic TAH, Phoenix, ReinHeart, SynCardia, UPTAH and Vienna TAH (Table 2). Calves are the most'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='pneumatic TAH, Phoenix, ReinHeart, SynCardia, UPTAH and Vienna TAH (Table 2). Calves are the most\\n\\nfrequently used animal model for TAH implantation, followed by goats and sheep. In most of the older\\n\\nchronic animal trials, the animal was implanted with a TAH and was followed up until death. In\\n\\ncontemporary studies, researchers often terminate the experiments after a given follow-up period'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='contemporary studies, researchers often terminate the experiments after a given follow-up period\\n\\n(usually 30–90\\u2009days, according to FDA regulations), by taking out the TAH. For the latter studies, elective\\n\\ntermination is assigned as the cause of death in Table 2. Nevertheless, the follow-up time in chronic\\n\\nanimal trials is often short. Only ten TAH devices were associated with a maximum survival time'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='animal trials is often short. Only ten TAH devices were associated with a maximum survival time\\n\\nexceeding 100\\u2009days (AbioCor112, Brno TAH37, Cleveland Nimbus113, EHTAH114, HFTAH98, Penn State electric\\n\\nTAH115, Penn State pneumatic TAH38, SynCardia25, UPTAH83 and Vienna TAH44) and only one device was\\n\\nassociated with a maximum survival time of over a year (Penn State electric TAH)115. Overall, the most'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='frequently reported cause of death in chronic animal trials is mechanical failure of the device. Examples of\\n\\nmechanical failure that occurred in chronic animal trials include an electrical short circuit caused by fluid\\n\\nentering the electronics, dislocation of TET coils, obstruction of the inflow or outflow grafts of the TAH,\\n\\nmembrane ruptures, air leakage in pneumatic devices, failure of the implantable battery and a defect or'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='lock in pump bearings26,69,83,93,98,114,116,117,118,119. The second- and third-most frequently reported reasons\\n\\nof death are thromboembolic complications and respiratory failure, respectively.\\n\\nClinical trials\\n\\nSince the first successful implantation of a TAH in humans in 1982, a total of nine different TAH devices\\n\\nhave been assessed in patients in clinical trials: AbioCor, Brno TAH, Carmat TAH, LVAD–TAH, Penn State'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='pneumatic TAH, Phoenix, Poisk TAH, SynCardia and Vienna TAH (Table 3). These TAHs are pneumatic or\\n\\nhydraulic pulsatile devices, except the continuous-flow LVAD–TAH.\\n\\nEarly studies in humans\\n\\nSeveral fluid-driven TAHs were tested in humans in the 1980s and 1990s. Overall, the outcomes were\\n\\npoor, and many patients died within the first days after receiving a TAH or could not successfully receive a'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='heart transplant120,121,122. The Brno TAH, developed in the Czech Republic, was implanted in six patients120.\\n\\nAll patients died of serious complications related to poor device biocompatibility, with a maximum\\n\\nsurvival of 10\\u2009days120. The Phoenix TAH was implanted in two patients121,123. One patient received a heart\\n\\ntransplant on the same day as TAH implantation but died 1\\u2009day after receiving the heart transplant121. The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='other patient was successfully bridged to heart transplantation after 15\\u2009days of support with the Phoenix\\n\\nTAH123. The Poisk TAH was developed in Russia and has been implanted in 13 patients122. Of these\\n\\npatients, 12 died during support with the Poisk TAH, for unknown reasons. The maximum period of\\n\\nsupport was 15\\u2009days122. The Vienna TAH was implanted in five patients, and three of these patients were'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='successfully bridged to heart transplantation44,124. The maximum duration of support was 22 days44,124.\\n\\nThe Penn State pneumatic TAH was implanted in three patients38. Two of the patients were bridged to\\n\\nheart transplantation, and the third patient did not receive a heart transplant because a suitable donor\\n\\nwas not found. After 70\\u2009days of support, the patient had a cerebrovascular accident, manifested by'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='was not found. After 70\\u2009days of support, the patient had a cerebrovascular accident, manifested by\\n\\naphasia. The TAH support stopped on day 379 when this patient had a respiratory arrest and could not be\\n\\nresuscitated38.\\n\\nLatest clinical trials\\n\\nAbioCor, the first fully implantable TAH that used a TET system, was implanted in 14 patients between\\n\\n2001 and 200348. The maximum duration of support was 512\\u2009days, which occurred in a patient who died'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='owing to a membrane rupture in the device125. The most frequently observed causes of death were\\n\\nthromboembolic complications and multiorgan failure125. The development of AbioCor stopped in 2007\\n\\nowing to concerns related to the high number of patients who died because of complications of stroke\\n\\n(caused by an ineffective anticoagulation regimen), the low quality of life of the patients and the poor'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='commercial viability20,79. Since 2011, several teams worldwide have studied the use of a combination of\\n\\ntwo commercially available rotary LVADs (HeartMate II, HeartMate III or HeartWare HVAD) adapted to a\\n\\nTAH configuration to replace the native heart completely86,87,89,90,91,94. These LVAD–TAHs have been\\n\\nimplanted in nine patients86,87,89,90,91,94, with a maximum reported duration of support of 6\\u2009months89. The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='most frequently reported complications were related to thromboembolic and haemorrhagic\\n\\nevents86,87,89,90,91,94. The pneumatically actuated SynCardia, the first TAH that became commercially\\n\\navailable as a bridge to transplantation therapy, is currently available in two sizes (70\\u2009cm3 or 50\\u2009cm3\\n\\nventricles), which enables its implantation in patients of various body sizes. The youngest recipient of a'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='50\\u2009cm3 SynCardia is a boy aged 10\\u2009years126. So far, Syncardia has been implanted in over 1,700 patients\\n\\nworldwide, with a maximum reported duration of support of 4.5\\u2009years receiving permanent SynCardia\\n\\nsupport55,127. Despite the poor prognosis that the SynCardia recipients have before TAH implantation, the\\n\\nlong-term survival of recipients of a heart transplant after temporary support with SynCardia is'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='long-term survival of recipients of a heart transplant after temporary support with SynCardia is\\n\\nencouraging and comparable with the long-term survival of recipients of a heart transplant who did not\\n\\nreceive SynCardia support128. Twelve\\u2009months after the SynCardia implantation, 55% of the patients had\\n\\nreceived heart transplantation, 14% were still supported by the SynCardia device and 31% died before'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='undergoing a heart transplantation129. SynCardia is currently being evaluated in an approved\\n\\ninvestigational device exemption clinical trial for use as destination therapy12.\\n\\nThe care of patients receiving SynCardia support remains challenging128. The percutaneous hoses are\\n\\nfrequently associated with driveline infections, and the TAH material itself often causes mediastinitis and\\n\\nconstrictive pericarditis128. The period after heart transplantation is associated with a high risk of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='(temporary) haemodialysis owing to impaired renal perfusion and postoperative compression of the\\n\\ndonor heart128. The risk of post-transplantation complications increases with prolonged TAH support128.\\n\\nThe most frequently reported causes of death during support with a SynCardia device are multiorgan\\n\\nfailure (40%), thromboembolic complications (13%) and infection (10%)129,130,131,132,133,134,135,136. Although'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='minor device malfunctions are frequently described in the literature, severe device malfunctions that lead\\n\\nto death are rare (<2% of the deaths during SynCardia support)129,130,131,132,133,134,135,136. The hydraulic TAH\\n\\ndeveloped by Carmat received CE approval as bridge to transplantation therapy in 2020, but the company\\n\\nis continuing clinical research with the aim of ultimately using the Carmat TAH as destination therapy56.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='The Carmat TAH has been implanted as a bridge to transplantation in 24 patients (as of February\\n\\n2022)107,137,138. Patient enrollment for the second clinical trial on the Carmat TAH is ongoing56. Although\\n\\nthe Carmat TAH was designed to promote biocompatibility, given that its diaphragms and valves are made\\n\\nfrom bovine pericardium, all patients must receive a strict anticoagulation regimen138. Thus far, the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='clinical outcomes of 11 recipients of the Carmat TAH have been described in the literature107,138, with a\\n\\nmaximum support duration of 308\\u2009days138. Of these patients, six died during TAH support, and the other\\n\\nfive were successfully bridged to heart transplantation107,138. The causes of death were multiorgan failure\\n\\n(50%), mechanical failure (33%) and respiratory failure (17%). No thromboembolic complications were'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='observed107,138. To date, no TAH has been approved as destination therapy. Only the SynCardia and\\n\\nCarmat TAH are approved as temporary therapy to bridge a severely ill patient to heart transplantation.\\n\\nThe percutaneous drivelines of both TAHs are associated with low quality of life and a high risk of\\n\\ninfection128. Long-term support with the SynCardia TAH is associated with serious risks such as stroke and\\n\\nmultiorgan failure128,129,130,131,132,133,134,135,136.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='multiorgan failure128,129,130,131,132,133,134,135,136.\\n\\nTechnological advances and future perspectives\\n\\nTET systems to improve quality of life\\n\\nThe TAHs currently available for clinical use (SynCardia and Carmat TAH) have percutaneous cables to\\n\\nsupply power to the devices. Percutaneous drivelines are associated with a high risk of infection and\\n\\nreduce the patient’s quality of life owing to the limited freedom of movement of the patient. Therefore,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='TAH devices intended for approval as destination therapy should ideally omit these percutaneous cables.\\n\\nPercutaneous cables can be avoided when all TAH components are implanted inside the body and the\\n\\nelectrical power is wirelessly transferred via a TET system.A TET system transfers all the electrical power\\n\\nrequired by the TAH across the patient’s skin via an internal and external coil. Part of this energy is stored'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='in internal battery packs, enabling the patient to have free-from-charging periods. In the past decade,\\n\\nbatteries have become smaller and have longer battery life, enabling implantation in the body. In addition\\n\\nto small and high-capacity batteries, high efficiency of the TAH is also essential when energy is provided\\n\\nthrough a TET system. Figure 3 shows the efficiencies of all types of TAH. The methodology we used to'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='calculate the efficiencies is described in Box 1. Generally, fluid-driven TAHs are slow systems because they\\n\\nfirst have to move fluid or air to empty the blood-containing chambers. Therefore, emptying the\\n\\nchambers in fluid-driven systems is easier and more efficient at low beat rates than at high beat rates.\\n\\nFluid-driven TAHs generally show a decline in efficiency at high beat rates. For example, the efficiency of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='the hydraulic EHTAH declines at cardiac outputs exceeding 6\\u2009l/min (Fig. 3a). Like fluid-driven TAHs,\\n\\nmechanical TAHs also have blood chambers, and higher cardiac output can be achieved by maximizing\\n\\nstroke volume and, if needed, by increasing the beat rate. In general, mechanical TAHs become more\\n\\nefficient at higher beat rates and, therefore, at higher cardiac outputs (Fig. 3b). The highest efficiency'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='reported for mechanical TAHs is often reached at a cardiac output of approximately 10\\u2009l/min60,63,64,66,69,70.\\n\\nCompared with pulsatile devices, continuous-flow devices do not have blood-collecting chambers because\\n\\nthey pump blood continuously. In general, the efficiency of continuous-flow pumps increases with higher\\n\\ncardiac outputs. The optimal efficiency of most continuous-flow TAHs is at a much higher cardiac output\\n\\nthan the average cardiac output of 5\\u2009l/min (Fig. 3c).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='than the average cardiac output of 5\\u2009l/min (Fig. 3c).\\n\\nProlonging the free-from-charging periods during support with TAHs using TET\\n\\nsystems\\n\\nEfficient TAHs prolong the period that the patient can engage in activities without charging the TAH,\\n\\nwhich will improve the quality of life of TAH recipients in the future. The most up-to-date battery\\n\\ntechnology used for TET systems in TAHs has been described by the team developing ReinHeart139. The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='ReinHeart system has implantable 12\\u2009volt lithium–iron–phosphate batteries with 1.1\\u2009Ah capacity139. We\\n\\nhave used this battery as a standard to compare the running time (defined as the maximum time in which\\n\\nthe TAH recipient can engage in activities without charging the TAH) of current TAHs if they hypothetically\\n\\nhad TET systems with this specific internal battery capacity (Fig. 3d). The running time was calculated for a'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='cardiac output of at least 5\\u2009l/min against a physiological mean left afterload (≥90\\u2009mmHg). The data show\\n\\nthat current TAH devices can hypothetically support the patients with a physiological cardiac output for\\n\\napproximately 1\\u2009h with the current battery technology (Fig. 3c; Table 4). For reference, the AbioCor\\n\\n(implanted for the first time in 2001) had the capacity to support the patient for up to 20\\u2009min without'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='connection to a power source47. Our comparison results suggest that continuous-flow devices (Cleveland\\n\\nCFTAH and OregonHeart) are better than mechanically actuated devices in terms of their working time\\n\\nwith internal batteries alone because continuous-flow TAHs require less input power than other TAH\\n\\ntypes to generate a higher cardiac output (Fig. 3d). Among continuous-flow devices, OregonHeart'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='types to generate a higher cardiac output (Fig. 3d). Among continuous-flow devices, OregonHeart\\n\\nperforms slightly better than the Cleveland CFTAH with regards to efficiency and the required input power\\n\\n(Fig. 3d). The mechanical ReinHeart has a relatively high power consumption (12.5\\u2009W) and provides less\\n\\ncardiac output than the other four TAHs analysed, resulting in the lowest efficiency (10.8%). Overall, we'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='can conclude that for most TAHs, either the power consumption or the efficiency does not yet reach the\\n\\nlevels required to use a TET system. To date, the AbioCor is the only fully implantable TAH that used a TET\\n\\nsystem that has been implanted in patients. The latest technological advances in TET systems are\\n\\npromising for future TAH development. Battery technology is rapidly evolving, resulting in more powerful'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='and compact batteries. Powerful implantable batteries will prolong the time frame in which the patient\\n\\ncan be free from having to use an electrical power source for the TAH. Furthermore, improving the overall\\n\\nefficiency of the TAH itself will help to use the stored energy of the internal battery packs more\\n\\neffectively. Therefore, we expect that transcutaneous charging of a fully implantable TAH with charging-\\n\\nfree periods of >1\\u2009h will be feasible in the near future.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='free periods of >1\\u2009h will be feasible in the near future.\\n\\nBioinspired TAHs aim to improve biocompatibility\\n\\nSince the beginning of TAH development in the 1960s, TAHs have been associated with limited\\n\\nbiocompatibility resulting in frequently occurring pannus and thrombus formation. Although many\\n\\nattempts have been made to improve the design of TAHs, the biocompatibility issues could not be'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='attempts have been made to improve the design of TAHs, the biocompatibility issues could not be\\n\\nresolved. By the 1970s, the realization came that no implanted artificial material will ever come close to\\n\\nthe anti-thrombogenic properties of the patient’s endothelium. Current TAH devices are still associated\\n\\nwith numerous complications related to biocompatibility. A high number of thromboembolic events have'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='been reported in clinical trials and animal studies. All TAH recipients require a strict anticoagulation\\n\\nregimen that results in a high risk of haemorrhagic events. Devices such as the Carmat TAH improved\\n\\nbiocompatibility by using membranes and heart valves containing sheep pericardial tissue. The available\\n\\ndata on the Carmat TAH suggest that patients receiving a Carmat TAH need less anticoagulation'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='data on the Carmat TAH suggest that patients receiving a Carmat TAH need less anticoagulation\\n\\nmedication than patients receiving a SynCardia device138. Upcoming solutions to address biocompatibility\\n\\nissues can be found in new developments in biomaterials science. If growing endothelium derived from\\n\\nthe patient on the blood-contacting surfaces of the TAH becomes possible, this strategy would probably'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='resolve many biocompatibility issues. The developers of the HybridHeart aim to grow a layer of patient-\\n\\nderived endothelium on the inside of the soft ventricles with the use of biofunctionalization and in situ\\n\\ntissue-engineering techniques140. However, owing to the large surface area and the continuous movement\\n\\nof the TAH ventricles, applying tissue engineering techniques on TAH devices remains challenging. Even'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='after five decades of research, we are still far from being able to create a living endothelium inside the\\n\\nventricles of a TAH141. The interaction of rigid components with the blood is associated with many adverse\\n\\neffects. These effects have been most widely studied for the rotors in LVAD devices and include risks of\\n\\nthrombus formation and non-surgical bleeding caused by the device-altered haemostatic function9,142.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='The artificial surface of the rotary blood pumps can induce platelet adhesion, which increases the risk of\\n\\nthrombosis, and the rotating parts can induce loss of haemostasis-related receptors on platelets, which\\n\\nincreases the risk of bleeding142. Haemolysis is the second-most common LVAD-related complication,\\n\\npresumably caused by the destruction of erythrocytes in the rotating LVAD devices143. Problems related to'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='the incompatibility between hard machines and soft human tissue might be solved if the machine is as\\n\\nsoft as the human tissue. Soft robotics is an emerging research field that focuses on developing robots\\n\\nmade of soft materials. In the past year, a few research groups have shifted their focus to developing\\n\\nTAHs that are completely soft on the inside and outside, such as SoftHeart and HybridHeart50,144,145. The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='primary benefit of developing soft TAHs is that they mimic the natural movement of the heart, potentially\\n\\nreducing the stress on the blood and thereby resulting in fewer adverse effects57. The second benefit of\\n\\nsoft robotic cardiac devices is that they are compliant because they can stretch, contract or bend. As a\\n\\nresult, soft robotic cardiac devices can promote both the contraction and the relaxation phases of the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='heart146. Owing to its elastic behaviour, the ventricle of a soft TAH has higher passive filling and contracts\\n\\nmore forcefully at high filling pressures than at low filling pressures. Therefore, the soft robotic cardiac\\n\\ndevice passively ejects higher cardiac outputs at larger end-diastolic volumes, like the Frank–Starling\\n\\nmechanism of the native heart. This compliance is inherent to soft robotic cardiac devices147 and works'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='without the need for any sensors or manual control. A soft robotic cardiac sleeve developed in 2017, the\\n\\nfirst soft robotic cardiac assist device under development, shows Frank–Starling behaviour146. This Frank–\\n\\nStarling mechanism could mean that the expansible volume capabilities of future soft robotic TAHs can\\n\\nbalance the left and right outputs to achieve Frank–Starling curve behaviour that resembles human'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='balance the left and right outputs to achieve Frank–Starling curve behaviour that resembles human\\n\\nphysiology. Given that TAHs need to work for a high number of cycles (one cycle for every heartbeat),\\n\\nachieving high durability and reliability remains a major challenge for TAH development. The SoftHeart\\n\\nhad a maximum working duration of 110,000\\u2009cycles (approximately 30\\u2009h), after which a fatigue crack'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='had a maximum working duration of 110,000\\u2009cycles (approximately 30\\u2009h), after which a fatigue crack\\n\\ncaused device failure57. Although current soft TAHs are at early development stages, with future\\n\\noptimization their benefits might outweigh those of traditionally rigid TAH devices.\\n\\nConclusions\\n\\nAfter more than six decades of TAH research, TAHs have been successfully used in over 1,700 patients as a'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='bridge to heart transplantation, but a TAH suitable for destination therapy has not yet been developed.\\n\\nSome of the major drawbacks of current TAHs are high complication rates, bulkiness, short durability,\\n\\npoor biocompatibility and low quality of life for the patients. These issues need to be resolved before the\\n\\npotential of TAHs as destination therapy can be realized. Nevertheless, the field of TAH research is rapidly'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='evolving, and various approaches are emerging that could potentially improve the quality of life of TAH\\n\\nrecipients. With the development of TET systems and improved TAH efficiency, percutaneous cables will\\n\\nno longer be necessary to provide electrical power to the implanted TAH. The field of battery technology\\n\\nis continuously improving, delivering more compact batteries that are easier to implant internally and that'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='prolong the period during which the patient can engage in activities without charging the TAH. New\\n\\ninsights into soft robotics might result in the development of completely soft TAHs that reduce the\\n\\noccurrence of adverse effects associated with traditionally rigid TAHs. Meanwhile, smart biomaterials\\n\\nmight solve current biocompatibility issues. In the future, these new technologies have the potential to\\n\\nenable the development of the first TAH approved for destination therapy.\\n\\nKey points'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='enable the development of the first TAH approved for destination therapy.\\n\\nKey points\\n\\nAfter decades of research on total artificial hearts, only two devices are clinically available as a\\n\\nbridge to transplantation therapy; a total artificial heart suitable for destination therapy has not\\n\\nyet been developed.\\n\\nCurrently available total artificial hearts have major drawbacks, including bulkiness, limited'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Currently available total artificial hearts have major drawbacks, including bulkiness, limited\\n\\ndurability, poor biocompatibility, high complication rates and low quality of life for the recipients.\\n\\nWe are on the verge of an era in total artificial heart development in which rapidly evolving\\n\\ntechnologies from different fields will lead to new approaches in total artificial heart design and\\n\\ndevelopment.\\n\\nMore powerful and more compact batteries and transcutaneous energy transfer systems will'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='More powerful and more compact batteries and transcutaneous energy transfer systems will\\n\\nomit the need for percutaneous cables and will improve the quality of life of the recipients of a\\n\\ntotal artificial heart.\\n\\nWith the rise of soft robotic technologies and smart biomaterials, completely soft total artificial\\n\\nhearts might soon be developed and are likely to have fewer biocompatibility issues than current\\n\\ndevices.\\n\\nFigures'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='devices.\\n\\nFigures\\n\\nFigure 1. Timeline of the milestones in the development of total artificial hearts\\n\\nAll current TAH devices and the most historically important TAH devices are shown. The red bars\\n\\nrepresent the period of development and/or reporting of testing results in literature for each TAH. CFTAH,\\n\\ncontinuous-flow total artificial heart; EHTAH, electrohydraulic total artificial heart; ERTAH, eccentric roller'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='total artificial heart; FTPTAH, flow-transformed pulsatile total artificial heart; HFTAH, helical flow total\\n\\nartificial heart; LVAD–TAH, total artificial heart made with two left ventricular assist devices; UPTAH,\\n\\nundulation pump total artificial heart. Images reproduced with permission from ref.171, Springer Nature\\n\\n(AbioCor); ref.48, Science Museum Group/Academic (Akutsu III); ref.172, Wiley (BiVACOR); ref.173,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='(AbioCor); ref.48, Science Museum Group/Academic (Akutsu III); ref.172, Wiley (BiVACOR); ref.173,\\n\\nCarmat/OUP (Carmat TAH); ref.96, Springer Nature (Cleveland CFTAH); ref.98, Wiley (HFTAH); The Board\\n\\nof Trustees of the Science Museum (Jarvik-7); ref.11, Elsevier (Liotta–Cooley TAH); ref.100, Wiley\\n\\n(OregonHeart); ref.174, Wiley (Realheart TAH); and ref.108, Elsevier (SynCardia).\\n\\nFigure 2. Working mechanism for different types of total artificial hearts'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Figure 2. Working mechanism for different types of total artificial hearts\\n\\na. Fluid-driven total artificial hearts (TAHs) are composed of blood chambers and pneumatic or hydraulic\\n\\nchambers, which are separated by a membrane. A pump moves pressurized air or liquid into the\\n\\npneumatic or hydraulic chambers, which moves the membrane and causes the ejection of the blood in a\\n\\npulsatile manner. In the example shown in the figure, blood is ejected from both blood chambers'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='pulsatile manner. In the example shown in the figure, blood is ejected from both blood chambers\\n\\nalternately; however, some devices eject blood simultaneously from both chambers. The pump that\\n\\nmoves the air or fluid can be implanted in the body or can be placed externally. For the latter,\\n\\npercutaneous hoses are required. Phase 1 shows the filling of the right blood chamber and the ejection of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='the left blood chamber. In phase 2, the pump rotates in the opposite direction, resulting in the filling of\\n\\nthe left blood chamber and the ejection of the right blood chamber. B. Mechanical TAHs have two blood\\n\\nchambers and a mechanical motor, separated by a membrane. A motor pushes a mechanical part (pusher\\n\\nplate) against the membrane so that blood is ejected from that blood chamber. In the example, blood is'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='ejected from the blood chambers alternately; however, some devices eject blood simultaneously from\\n\\nboth chambers. In phase 1, the mechanical motor moves the pusher plate against the membrane of the\\n\\nleft chamber, which ejects blood while the right chamber fills. In phase 2, the mechanical motor moves\\n\\nthe pusher plate against the membrane of the right chamber, which ejects blood while the left ventricle'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='fills. c .Continuous-flow TAHs have two continuous-flow pumps that pump blood continuously in one\\n\\ndirection. Valves are usually not required. There is no filling or ejection phase because the blood is\\n\\ncontinuously being pumped. CFTAH, continuous-flow total artificial heart; EHTAH, electrohydraulic total\\n\\nartificial heart; ERTAH, eccentric roller total artificial heart; FTPTAH, flow-transformed pulsatile total'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart; HFTAH, helical flow total artificial heart; LVAD–TAH, total artificial heart made with two\\n\\nleft ventricular assist devices; UPTAH, undulation pump total artificial heart.\\n\\nFigure 3. Efficiency of total artificial hearts\\n\\nOverall efficiencies of total artificial hearts (TAHs) are depicted against the cardiac output. The method of\\n\\ncalculation for the overall efficiencies of the TAHs is explained in Box 1. All values are measured under'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='physiological mean left afterload conditions (≥90\\u2009mmHg). If right afterload was not reported when tested\\n\\nin a double-sided mock loop, we assumed it to be 20\\u2009mmHg. For some TAH devices, we were not able to\\n\\nobtain data to calculate efficiencies. Data for ReinHeart were shared by the authors upon request. a.\\n\\nOverall efficiencies for fluid-driven TAHs45,175. b. Overall efficiencies for mechanical'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Overall efficiencies for fluid-driven TAHs45,175. b. Overall efficiencies for mechanical\\n\\nTAHs60,63,64,66,67,69,70,71,76,176. c. Overall efficiencies for continuous-flow TAHs84,95,98,157,168,170. d .Running time\\n\\n(defined as the maximum time in which the TAH recipient can engage in activities without charging the\\n\\nTAH) of TAHs developed since 201576,157,170, calculated as though these TAHs hypothetically had'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='TAH) of TAHs developed since 201576,157,170, calculated as though these TAHs hypothetically had\\n\\ntranscutaneous energy transfer systems with the internal battery capacity of the most recently available\\n\\nbattery technology (from the ReinHeart system). CFTAH, continuous-flow total artificial heart; EHTAH,\\n\\nelectrohydraulic total artificial heart; ERTAH, eccentric roller total artificial heart; HFTAH, helical flow total\\n\\nartificial heart; UPTAH, undulation pump total artificial heart.\\n\\nTables'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart; UPTAH, undulation pump total artificial heart.\\n\\nTables\\n\\nTAH\\n\\nRegion\\n\\nType\\n\\nDimensions\\n\\n(mm)\\n\\nWeight\\n\\n(g)\\n\\nVolume\\n\\n(ml)\\n\\nPower\\n\\nsupply\\n\\nValve\\n\\ntypes\\n\\nDevelopment\\n\\nstage\\n\\nRefs\\n\\nAbioCor\\n\\nUSA\\n\\nFluid-\\n\\ndriven\\n\\n85\\u2009×\\u200985\\u2009×\\u2009100\\n\\n907\\n\\n723a\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n46,47,48\\n\\nAnyHeart\\n\\nSouth\\n\\nKorea\\n\\nMechanical\\n\\n60\\u2009×\\u2009100\\u2009×\\u2009100\\n\\n650\\n\\n600\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n59,60,61\\n\\nBaylor TAH\\n\\nUSA and\\n\\nJapan\\n\\nMechanical\\n\\n97\\u2009×\\u200997\\u2009×\\u200983\\n\\n620\\n\\n510\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n62,63\\n\\nBiVACOR\\n\\nUSA'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='USA and\\n\\nJapan\\n\\nMechanical\\n\\n97\\u2009×\\u200997\\u2009×\\u200983\\n\\n620\\n\\n510\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n62,63\\n\\nBiVACOR\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\nNR\\n\\n650\\n\\nNR\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels\\n\\n95,148\\n\\nBrno TAH\\n\\nCzech\\n\\nRepublic\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n37\\n\\nCarmat TAH\\n\\n(Aeson)\\n\\nFrance\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n900\\n\\n750\\n\\nPercutaneous\\n\\nBiological\\n\\nApproved\\n\\n51,52\\n\\nCleveland\\n\\ncontinuous-\\n\\nflow TAH\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n60\\u2009×\\u200960\\u2009×\\u2009100\\n\\n486\\n\\n160\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='flow TAH\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n60\\u2009×\\u200960\\u2009×\\u2009100\\n\\n486\\n\\n160\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels\\n\\n96,97\\n\\nCleveland\\n\\nNimbus\\n\\nUSA\\n\\nMechanical\\n\\n90\\u2009×\\u200997\\u2009×\\u2009134\\n\\nNR\\n\\n700\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n64,65\\n\\nEccentric roller\\n\\nTAH\\n\\nJapan\\n\\nMechanical\\n\\n100\\u2009×\\u2009100\\u2009×\\u200980\\n\\n1,800\\n\\n800a\\n\\nPercutaneous\\n\\nNo valves\\n\\nStopped\\n\\n66\\n\\nElectrohydraulic\\n\\nTAH\\n\\nJapan\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n2,492\\n\\n872\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n45\\n\\nFlow-\\n\\ntransformed\\n\\npulsatile TAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\nNR\\n\\n2,000\\n\\n550\\n\\nPercutaneous'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='45\\n\\nFlow-\\n\\ntransformed\\n\\npulsatile TAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\nNR\\n\\n2,000\\n\\n550\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n82\\n\\nHelical flow\\n\\nTAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\n80\\u2009×\\u200980\\u2009×\\u200977\\n\\n565\\n\\n493a\\n\\nPercutaneous\\n\\nNo valves\\n\\nAnimal\\n\\nmodels\\n\\n98\\n\\nHybrid\\n\\ncontinuous-\\n\\nflow TAH\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n50\\u2009×\\u200950\\u2009×\\u200950b\\n\\nNR\\n\\n125a,b\\n\\nPercutaneous\\n\\nNo valves\\n\\nIn vitro\\n\\n99\\n\\nImpeller TAH\\n\\nChina\\n\\nContinuous\\n\\nflow\\n\\n40\\u2009×\\u200940\\u2009×\\u200980\\n\\n250\\n\\n128a\\n\\nTET\\n\\nNo valves\\n\\nStopped\\n\\n84\\n\\nLinear TAH\\n\\nJapan\\n\\nMechanical\\n\\n85\\u2009×\\u200985\\u2009×\\u200994\\n\\n1,900'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='250\\n\\n128a\\n\\nTET\\n\\nNo valves\\n\\nStopped\\n\\n84\\n\\nLinear TAH\\n\\nJapan\\n\\nMechanical\\n\\n85\\u2009×\\u200985\\u2009×\\u200994\\n\\n1,900\\n\\n560\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n67,68\\n\\nLVAD–TAH\\n\\nVarious\\n\\nContinuous\\n\\nflow\\n\\nVarious\\n\\nVarious\\n\\nVarious\\n\\nPercutaneous\\n\\nNo valves\\n\\nClinical trials\\n\\nMagScrew\\n\\nUSA\\n\\nMechanical\\n\\nNR\\n\\n890\\n\\n506\\n\\nTET\\n\\nBiological\\n\\nStopped\\n\\n69\\n\\nMilwaukee\\n\\nHeart\\n\\nUSA\\n\\nMechanical\\n\\n83\\u2009×\\u200983\\u2009×\\u200962\\n\\n600\\n\\n490\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n70\\n\\nOregonHeart\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n85\\u2009×\\u200975\\u2009×\\u200960b\\n\\nNR\\n\\n130\\n\\nPercutaneous\\n\\nNo valves'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Stopped\\n\\n70\\n\\nOregonHeart\\n\\nUSA\\n\\nContinuous\\n\\nflow\\n\\n85\\u2009×\\u200975\\u2009×\\u200960b\\n\\nNR\\n\\n130\\n\\nPercutaneous\\n\\nNo valves\\n\\nIn vitro\\n\\n100,101\\n\\nOvalis\\n\\nGermany\\n\\nMechanical\\n\\n75\\u2009×\\u200975\\u2009×\\u200995\\n\\n950\\n\\n560\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n71\\n\\nPenn State\\n\\nelectric TAH\\n\\nUSA\\n\\nMechanical\\n\\n91\\u2009×\\u200991\\u2009×\\u200994\\n\\n700\\n\\n778a\\n\\nTET\\n\\nMechanical\\n\\nStopped\\n\\n72\\n\\nPenn State\\n\\npneumatic TAH\\n\\nUSA\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n38\\n\\nPhoenix\\n\\nTaiwan\\n\\nFluid-\\n\\ndriven\\n\\n70\\u2009×\\u200970\\u2009×\\u2009130\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='38\\n\\nPhoenix\\n\\nTaiwan\\n\\nFluid-\\n\\ndriven\\n\\n70\\u2009×\\u200970\\u2009×\\u2009130\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n39,40\\n\\nPoisk TAH\\n\\nRussia\\n\\nFluid-\\n\\ndriven\\n\\n125\\u2009×\\u2009100\\u2009×\\u200970\\n\\n220\\n\\nNR\\n\\nPercutaneous\\n\\nNR\\n\\nStopped\\n\\n41,42\\n\\nPOLTAH\\n\\nPoland\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\nNR\\n\\nNR\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n43\\n\\nRealheart TAH\\n\\nSweden\\n\\nMechanical\\n\\n148\\u2009×\\u2009126\\u2009×\\u200996\\n\\n800\\n\\n1,790a\\n\\nTET\\n\\nMechanical\\n\\nAnimal\\n\\nmodels\\n\\n73,74\\n\\nReinHeart\\n\\nGermany\\n\\nMechanical\\n\\n87\\u2009×\\u200987\\u2009×\\u200990\\n\\n940\\n\\n550\\n\\nTET\\n\\nMechanical\\n\\nAnimal\\n\\nmodels\\n\\n75\\n\\nRollingHeart'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Germany\\n\\nMechanical\\n\\n87\\u2009×\\u200987\\u2009×\\u200990\\n\\n940\\n\\n550\\n\\nTET\\n\\nMechanical\\n\\nAnimal\\n\\nmodels\\n\\n75\\n\\nRollingHeart\\n\\nSwitzerland\\n\\nMechanical\\n\\n80\\u2009×\\u200980\\u2009×\\u2009110\\n\\nNR\\n\\n704a\\n\\nPercutaneous\\n\\nNo valves\\n\\nIn vitro\\n\\n76\\n\\nSoftHeart\\n\\nSwitzerland\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n136\\n\\n447\\n\\nPercutaneous\\n\\nMechanical\\n\\nIn vitro\\n\\n57\\n\\nTable 1. Baseline characteristics of total artificial hearts.\\n\\nLVAD–TAH, total artificial heart made with two left ventricular assist devices; NR, not reported, TAH, total'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart; TET, transcutaneous energy transfer. aCalculated with the reported dimensions. bReported\\n\\ntarget size (not the current prototype).\\n\\nTAH\\n\\nType\\n\\nStudy\\n\\nperiod\\n\\nNumber of\\n\\nanimals\\n\\nMaximum\\n\\nsurvival\\n\\n(days)\\n\\nMost reported causes of death (n)\\n\\nRefs\\n\\nAbioCora\\n\\nFluid-driven\\n\\n1990–\\n\\n2001\\n\\n120\\n\\n108\\n\\nElective termination (16),\\n\\nmechanical failure (5)\\n\\n20,112,117,149,150\\n\\nAnyHeart\\n\\nMechanical\\n\\n1990\\n\\n1\\n\\n4\\n\\nRespiratory failure (1)\\n\\n59\\n\\nBaylor TAHa\\n\\nMechanical\\n\\n1993–\\n\\n1994\\n\\n8\\n\\n7\\n\\nNR'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='1990\\n\\n1\\n\\n4\\n\\nRespiratory failure (1)\\n\\n59\\n\\nBaylor TAHa\\n\\nMechanical\\n\\n1993–\\n\\n1994\\n\\n8\\n\\n7\\n\\nNR\\n\\n151,152\\n\\nBiVACORa\\n\\nContinuous flow\\n\\n2017\\n\\n15\\n\\n90\\n\\nNR\\n\\n148,153\\n\\nBrno TAHa\\n\\nFluid-driven\\n\\n1983–\\n\\n1995\\n\\n168\\n\\n314\\n\\nThromboembolic complications (6),\\n\\nmechanical failure (5)\\n\\n37,119,154,155\\n\\nCarmat TAH\\n\\n(Aeson)\\n\\nFluid-driven\\n\\n2014–\\n\\n2017\\n\\n12\\n\\n10\\n\\nThromboembolic complications (4),\\n\\nbleeding (2), respiratory failure (2)\\n\\n118,156\\n\\nCleveland\\n\\ncontinuous-\\n\\nflow TAH\\n\\nContinuous flow\\n\\n2015\\n\\n17\\n\\n90'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='118,156\\n\\nCleveland\\n\\ncontinuous-\\n\\nflow TAH\\n\\nContinuous flow\\n\\n2015\\n\\n17\\n\\n90\\n\\nElective termination (4), bleeding (3)\\n\\n157\\n\\nCleveland\\n\\nNimbus\\n\\nMechanical\\n\\n1992–\\n\\n1994\\n\\n12\\n\\n120\\n\\nMechanical failure (10),\\n\\nthromboembolic complications (1),\\n\\ninfection (1)\\n\\n64,113\\n\\nElectrohydraulic\\n\\nTAHa\\n\\nFluid-driven\\n\\n1990–\\n\\n2003\\n\\n57\\n\\n159\\n\\nMechanical failure (14),\\n\\nthromboembolic complications (7),\\n\\nrespiratory failure (7)\\n\\n114,158,159,160,161,162\\n\\nHelical flow\\n\\nTAH\\n\\nContinuous flow\\n\\n2015\\n\\n13\\n\\n100'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='114,158,159,160,161,162\\n\\nHelical flow\\n\\nTAH\\n\\nContinuous flow\\n\\n2015\\n\\n13\\n\\n100\\n\\nMechanical failure (7)\\n\\n98\\n\\nLVAD–TAH\\n\\nContinuous flow\\n\\n2009–\\n\\n2021\\n\\n40\\n\\n92\\n\\nThromboembolic complications (23),\\n\\nelective termination (8)\\n\\n85,88,92,93\\n\\nMagScrew\\n\\nMechanical\\n\\n2001-2005\\n\\n12\\n\\n92\\n\\nMechanical failure (5), respiratory\\n\\nfailure (3)\\n\\n69,163\\n\\nPenn State\\n\\nelectric TAH\\n\\nMechanical\\n\\n1990–\\n\\n2000\\n\\n54\\n\\n388\\n\\nMechanical failure (17), respiratory\\n\\nfailure (13)\\n\\n72,115,164,165,166\\n\\nPenn State\\n\\npneumatic TAHa\\n\\nFluid-driven'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='failure (13)\\n\\n72,115,164,165,166\\n\\nPenn State\\n\\npneumatic TAHa\\n\\nFluid-driven\\n\\n1979–\\n\\n1989\\n\\n47\\n\\n353\\n\\nMechanical failure (22),\\n\\nthromboembolic complications (6)\\n\\n38,167\\n\\nPhoenix\\n\\nFluid-driven\\n\\n2001\\n\\n41\\n\\n60\\n\\nRespiratory failure (22),\\n\\nthromboembolic (6), multiorgan\\n\\nfailure (6)\\n\\n40\\n\\nReinhearta\\n\\nMechanical\\n\\n2015\\n\\n12\\n\\n2\\n\\nNR\\n\\n75\\n\\nSynCardia\\n\\nFluid-driven\\n\\n1979–\\n\\n1981\\n\\n31\\n\\n268\\n\\nThromboembolic complications (8),\\n\\nbleeding (5)\\n\\n25,26\\n\\nUndulation\\n\\npump TAH\\n\\nContinuous flow\\n\\n2000–\\n\\n2011\\n\\n68\\n\\n153'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='bleeding (5)\\n\\n25,26\\n\\nUndulation\\n\\npump TAH\\n\\nContinuous flow\\n\\n2000–\\n\\n2011\\n\\n68\\n\\n153\\n\\nMechanical failure (30), bleeding\\n\\n(15)\\n\\n83,116,168,169\\n\\nVienna TAHa\\n\\nFluid-driven\\n\\n1991\\n\\n15\\n\\n180\\n\\nMechanical failure (3)\\n\\n44\\n\\nTable 2. Total artificial hearts assessed in chronic animal trials\\n\\nAll devices that have been assessed in published chronic animal trials are listed. The cause of death of the\\n\\nanimals was not always reported in the literature, especially for AbioCor, Baylor TAH, BiVACOR, Brno TAH,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='electrohydraulic TAH, ReinHeart, Penn State pneumatic TAH and Vienna TAH. LVAD–TAH, total artificial heart\\n\\nmade with two left ventricular assist devices; NR, not reported; TAH, total artificial heart. aDevices with high\\n\\nnumbers of missing animal data.\\n\\nSynCardia 70cc\\n\\nUSA\\n\\nFluid-\\n\\ndriven\\n\\nNR\\n\\n240\\n\\n400\\n\\nPercutaneous\\n\\nMechanical\\n\\nApproved\\n\\n49\\n\\nUndulation\\n\\npump TAH\\n\\nJapan\\n\\nContinuous\\n\\nflow\\n\\n77\\u2009×\\u200977\\u2009×\\u200979\\n\\n660\\n\\n310\\n\\nPercutaneous\\n\\nNo valves\\n\\nStopped\\n\\n83\\n\\nVienna TAH\\n\\nAustria\\n\\nFluid-\\n\\ndriven'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='77\\u2009×\\u200977\\u2009×\\u200979\\n\\n660\\n\\n310\\n\\nPercutaneous\\n\\nNo valves\\n\\nStopped\\n\\n83\\n\\nVienna TAH\\n\\nAustria\\n\\nFluid-\\n\\ndriven\\n\\n72\\u2009×\\u200972\\u2009×\\u2009120\\n\\nNR\\n\\n622a\\n\\nPercutaneous\\n\\nMechanical\\n\\nStopped\\n\\n44\\n\\nTAH\\n\\nType\\n\\nNumber\\n\\nof\\n\\nimplanted\\n\\ndevices\\n\\nTAH support\\n\\nduration (days)\\n\\nNumber\\n\\nimplanted as\\n\\nbridge to\\n\\ntransplantation\\n\\n(%)\\n\\nNumber of\\n\\ndeaths\\n\\nduring TAH\\n\\nsupport (%)\\n\\nMost reported causes of\\n\\ndeath during TAH support\\n\\n(%)\\n\\nRefs\\n\\nMean\\n\\nMaximum\\n\\nAbioCor\\n\\nFluid-driven\\n\\n11\\n\\n142\\n\\n512\\n\\n0 (0)\\n\\n10 (100)\\n\\nThromboembolic'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='(%)\\n\\nRefs\\n\\nMean\\n\\nMaximum\\n\\nAbioCor\\n\\nFluid-driven\\n\\n11\\n\\n142\\n\\n512\\n\\n0 (0)\\n\\n10 (100)\\n\\nThromboembolic\\n\\ncomplications (50),\\n\\nmultiorgan failure (33)\\n\\n125\\n\\nBrno TAH\\n\\nFluid-driven\\n\\n6\\n\\n5\\n\\n10\\n\\n0 (0)\\n\\n6 (100)\\n\\nThromboembolic\\n\\ncomplications (50),\\n\\nbleeding (33)\\n\\n120\\n\\nCarmat\\n\\nTAH\\n\\n(Aeson)a\\n\\nFluid-driven\\n\\n24\\n\\n166\\n\\n308\\n\\n(45)\\n\\n(55)\\n\\nMultiorgan failure (50),\\n\\nmechanical failure (33)\\n\\n107,138\\n\\nLVAD–\\n\\nTAH\\n\\nContinuous\\n\\nflow\\n\\n9\\n\\n92\\n\\n180\\n\\n4 (44)\\n\\n4 (44)\\n\\nMultiorgan failure (50),\\n\\nbleeding (50)\\n\\n86,87,89,90\\n\\n,91,94'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='flow\\n\\n9\\n\\n92\\n\\n180\\n\\n4 (44)\\n\\n4 (44)\\n\\nMultiorgan failure (50),\\n\\nbleeding (50)\\n\\n86,87,89,90\\n\\n,91,94\\n\\nPenn\\n\\nState\\n\\npneumatic\\n\\nTAH\\n\\nFluid-driven\\n\\n3\\n\\n135\\n\\n379\\n\\n2 (67)\\n\\n1 (33)\\n\\nAspiration pneumonia\\n\\n(100)\\n\\n38\\n\\nPhoenix\\n\\nFluid-driven\\n\\n2\\n\\n8\\n\\n15\\n\\n2 (100)\\n\\n0 (0)\\n\\n–\\n\\n121,123\\n\\nPoisk TAH\\n\\nFluid-driven\\n\\n13\\n\\n5\\n\\n15\\n\\n1 (8)\\n\\n12 (92)\\n\\nUnknown\\n\\n122\\n\\nSynCardiab\\n\\nFluid-driven\\n\\n>1,700\\n\\n94\\n\\n4.5 years\\n\\n(65)\\n\\n(33)\\n\\nMultiorgan failure (40),\\n\\nthromboembolic\\n\\ncomplications (13),\\n\\ninfection (10)\\n\\n127,129,130,131\\n\\n,132,133,134,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='thromboembolic\\n\\ncomplications (13),\\n\\ninfection (10)\\n\\n127,129,130,131\\n\\n,132,133,134,\\n\\n135,136\\n\\nVienna\\n\\nTAH\\n\\nFluid-driven\\n\\n5\\n\\n12\\n\\n22\\n\\n3 (60)\\n\\n2 (40)\\n\\nInfection (50), multiorgan\\n\\nfailure (50)\\n\\n44,124\\n\\nTable 3. Total artificial hearts assessed in clinical trials.\\n\\nAll TAH devices that were implanted in patients are listed. LVAD–TAH, total artificial heart made with two left\\n\\nventricular assist devices; TAH, total artificial heart. aThe trial on the Carmat TAH is currently enrolling'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='patients56; a total of 24 patients received the Carmat TAH (as of February 2022), of which data from only 11\\n\\npatients are described in the literature; the mean duration of support, bridge to transplantation, death during\\n\\nTAH support and most reported causes of death are based on data from these 11 patients. bSynCardia TAHs\\n\\nhave been implanted in over 1,700 patients, of which only a fraction has been reported in the literature; we'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='used data from eight clinical trials describing 574 patients implanted with a SynCardia TAH to calculate the\\n\\nmean duration of support, bridge to transplantation, death during TAH support and most reported causes of\\n\\ndeath116,117,118,119,120,121,122,123.\\n\\nTAH\\n\\nType\\n\\nCardiac output\\n\\n(l/min)\\n\\nInput\\n\\npower (W)\\n\\nOutput\\n\\npower (W)\\n\\nEfficiency\\n\\n(%)\\n\\nRunning time without\\n\\ncharging (min)\\n\\nReferences\\n\\nCleveland\\n\\ncontinuous-flow\\n\\nTAH\\n\\nContinuous\\n\\nflow\\n\\n7.4\\n\\n12.9\\n\\n1.7\\n\\n13.3\\n\\n61\\n\\n157\\n\\nOregonHeart'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Cleveland\\n\\ncontinuous-flow\\n\\nTAH\\n\\nContinuous\\n\\nflow\\n\\n7.4\\n\\n12.9\\n\\n1.7\\n\\n13.3\\n\\n61\\n\\n157\\n\\nOregonHeart\\n\\nContinuous\\n\\nflow\\n\\n7.5\\n\\n10.0\\n\\n1.7\\n\\n17.5\\n\\n79\\n\\n170\\n\\nReinHeart\\n\\nMechanical\\n\\n5.5\\n\\n12.5\\n\\n1.3\\n\\n10.8\\n\\n63\\n\\nUnpublished dataa\\n\\nRollingHeart\\n\\nMechanical\\n\\n5.3\\n\\n14.0\\n\\n2.0\\n\\n14.1\\n\\n57\\n\\n76\\n\\nTable 4. Power requirements and efficiency of total artificial hearts.\\n\\nAll TAHs currently being investigated with published power requirements are listed. For the TAHs not'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='listed in the table, no power requirements have been reported in the literature. All parameters were\\n\\nmeasured at a physiological mean left afterload (≥90\\u2009mmHg). TAH, total artificial heart. aData for\\n\\nReinHeart was shared by the authors upon request.\\n\\nGlossary\\n\\nDriveline: Percutaneous cable that transmits electrical power from an external driver to the\\n\\ninternally implanted device such as a TAH or LVAD.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='internally implanted device such as a TAH or LVAD.\\n\\nTranscutaneous energy transfer (TET) system: A wireless power delivery system that uses magnetic\\n\\nfields to transfer power across the skin without the need for direct electrical connectivity.\\n\\nBronchial shunt: The physiological passage of oxygenated blood from the aorta to the bronchial\\n\\ncirculation. This blood returns directly to the left atrium, thereby bypassing the right side of the\\n\\nheart.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='heart.\\n\\nFrank–Starling mechanism: This law states that the stroke volume of the heart increases in response\\n\\nto an increase in the volume of blood in the ventricles before contraction (the end diastolic volume),\\n\\nwhen all other factors remain constant.\\n\\nPreload: The filling pressure of the ventricle at the end of diastole, which is determined by the atrial\\n\\npressure.\\n\\nStator: The stationary part of a rotary machine or device.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='pressure.\\n\\nStator: The stationary part of a rotary machine or device.\\n\\nInvestigational device exemption: Type of FDA approval that allows the investigational device to be\\n\\nused in a clinical study in order to collect safety and efficacy data.\\n\\nAfterload: The amount of pressure that the ventricle needs to exert to eject the blood during\\n\\nventricular contraction.\\n\\nBox 1 Calculation of TAH efficiencies'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='ventricular contraction.\\n\\nBox 1 Calculation of TAH efficiencies\\n\\nTo compare the efficiency of the different types of total artificial heart (TAH) shown in Fig. 3, we used\\n\\na consistent measure of the power consumed by the TAH (input power) and the amount of work\\n\\n(output power) performed by the TAH to pump blood against physiological pressures. The numerical\\n\\nvalue of the output power is the product of the difference in outlet and inlet pressure (pressure'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='value of the output power is the product of the difference in outlet and inlet pressure (pressure\\n\\nhead) and the flow of blood generated by the heart (cardiac output). For pulsatile TAHs, we\\n\\ncalculated the pressure head as the difference between the mean afterload and the intraventricular\\n\\npressure. We assume that during diastole, the pressure inside the TAH ventricle drops to near\\n\\n0\\u2009mmHg, as in the native heart177. For continuous-flow TAHs, we calculated the pressure head as'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='0\\u2009mmHg, as in the native heart177. For continuous-flow TAHs, we calculated the pressure head as\\n\\nthe difference between the mean afterload and the mean preload. We have used the following\\n\\nequation to calculate the output power of the TAHs:\\n\\nwhere the output power is in watt, Qsys and Qpul are the resulting cardiac output (in m3/s) for the\\n\\nsystemic and pulmonary circulations, respectively, and Hsys and Hpul are the pressure heads (in'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='systemic and pulmonary circulations, respectively, and Hsys and Hpul are the pressure heads (in\\n\\nN/m2) for systemic and pulmonary circulations, respectively, against which the TAH must pump. The\\n\\ninput power to the TAH is an individual number unique to the device. Therefore, we analysed only\\n\\nthe TAHs that have the corresponding input power reported in the literature. We have used the\\n\\nfollowing equation for calculating the efficiency (η) of a TAH on the basis of input power and output\\n\\npower:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='power:\\n\\nAcknowledgements\\n\\nThe authors are grateful to L. C. van Laake (AMOLF, Netherlands), D. Zrinscak (Scuola Superiore\\n\\nSant’Anna, Italy) and A. Henseler (evos GmbH, Germany) for their contributions and discussions; D.\\n\\nvan Urk (Amsterdam UMC, The Netherlands) for assisting with screening and selecting articles; T.\\n\\nAzami (Amsterdam UMC, The Netherlands) and C. M. van de Beek (Amsterdam UMC, The\\n\\nNetherlands) for assistance with data extraction; C. E. J. M. Limpens (Amsterdam UMC, The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Netherlands) for assistance with data extraction; C. E. J. M. Limpens (Amsterdam UMC, The\\n\\nNetherlands) and A. Malekzadeh (Amsterdam UMC, The Netherlands) for their help with the\\n\\nliterature search; and ReinHeart TAH GmbH, Germany for providing additional data upon request.\\n\\nThe authors’ work is part of the HybridHeart project and is funded by the European Union Horizon\\n\\n2020 research and innovation programme under grant agreement no. 767195.\\n\\nContributions'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='2020 research and innovation programme under grant agreement no. 767195.\\n\\nContributions\\n\\nA.V. and M.A. did the major literature search and wrote the first draft. All of the authors contributed\\n\\nto the discussion of content and reviewed and edited the manuscript before submission.\\n\\nCorresponding author\\n\\nCorrespondence to Jolanda Kluin.\\n\\nCompeting interests\\n\\nA.V., M.A., H.K., J.T.B.O. and J.K. are part of the HybridHeart consortium. The other authors declare\\n\\nno competing interests.\\n\\nReferences'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='no competing interests.\\n\\nReferences\\n\\n1.\\n\\nMetra, M. & Teerlink, J. R. Heart failure. Lancet 390, 1981–1995 (2017).\\n\\n2.\\n\\nHeidenreich, P. A. et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart\\n\\nAssociation. Circ. Heart Fail. 6, 606–619 (2013).\\n\\n3.\\n\\nColvin, M. et al. OPTN/SRTR 2018 annual data report: heart. Am. J. Transpl. 20, 340–426 (2020).\\n\\n4.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='4.\\n\\nMolina, E. J. et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann. Thorac. Surg. 111, 778–792 (2021).\\n\\n5.\\n\\nHan, J. J., Acker, M. A. & Atluri, P. Left ventricular assist devices. Circulation 138, 2841–2851 (2018).\\n\\n6.\\n\\nGurvits, G. E. & Fradkov, E. Bleeding with the artificial heart: gastrointestinal hemorrhage in CF-LVAD patients. World J.\\n\\nGastroenterol. 23, 3945–3953 (2017).\\n\\n7.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Gastroenterol. 23, 3945–3953 (2017).\\n\\n7.\\n\\nGaland, V. et al. Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular\\n\\nassist devices. JACC Clin. Electrophysiol. 4, 1166–1175 (2018).\\n\\n8.\\n\\nRoss, D. W. et al. Left ventricular assist devices and the kidney. Clin. J. Am. Soc. Nephrol. 13, 348–355 (2018).\\n\\n9.\\n\\nAissaoui, N. et al. Understanding left ventricular assist devices. Blood Purif. 46, 292–300 (2018).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='10. National Heart Lung and Blood Institute. What Is Total Artificial Heart? Total Artificial Heart https://www.nhlbi.nih.gov/health-\\n\\ntopics/total-artificial-heart (NIH, 2020).\\n\\n11. Cooley, D. A. et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am. J. Cardiol. 24, 723–730 (1969).\\n\\n12. US National Library of Medicine. SynCardia 70cc TAH-t for Destination Therapy (DT) (RA-540). ClinicalTrials.gov\\n\\nhttps://ClinicalTrials.gov/show/NCT02232659 (2021).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='https://ClinicalTrials.gov/show/NCT02232659 (2021).\\n\\n13. Akutsu, T. & Kolff, W. J. Permanent substitutes for valves and hearts. ASAIO J. 4, 230–234 (1958).\\n\\n14. Houston, C. S., Akutsu, T. & Kolff, W. J. Pendulum type of artificial heart within the chest: preliminiary report. Am. Heart J. 59,\\n\\n723–730 (1960).\\n\\n15. 15. Seidel, W., Akutsu, T., Mirkovitch, V., Brown, F. & Kolff, W. J. Air-driven artificial hearts inside the chest. Trans. Am. Soc. Artif.\\n\\nIntern. Organs 7, 378–387 (1961).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Intern. Organs 7, 378–387 (1961).\\n\\n16. Liotta, D. et al. Artificial heart in the chest: preliminary report. Trans. Am. Soc. Artif. Intern. Organs 7,318–322 (1961).\\n\\n17. Atsumi, K. et al. Artificial heart incorporated in the chest. Trans. Am. Soc. Artif. Intern. Organs 9, 292–298 (1963).\\n\\n18. Pierce, W. S. et al. Total heart replacement by a single intrathoracic blood pump. J. Surg. Res. 5, 387–394 (1965).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='19. Nosé, Y., Tretbar, L. L., SenGupta, A., Topaz, S. R. & Kolff, W. J. An artificial heart inside the chest. J. Thorac. Cardiovasc. Surg. 50,\\n\\n792–799 (1965).\\n\\n20. Cohn, W. E., Timms, D. L. & Frazier, O. H. Total artificial hearts: past, present, and future. Nat. Rev. Cardiol. 12, 609–617 (2015).\\n\\n21. Curran, W. J. Law-medicine notes. The first mechanical heart transplant: informed consent and experimentation. N. Engl. J.\\n\\nMed. 291, 1015–1016 (1974).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Med. 291, 1015–1016 (1974).\\n\\n22. Morris, D. T. & Couves, C. M. Experiences with a sac-type artificial heart. Can. Med. Assoc. J. 105, 483–487 (1971).\\n\\n23. Kwan-Gett, C. S., Van Kampen, K. R., Kawai, J., Eastwood, N. & Kolff, W. J. Results of total artificial heart implantation in calves. J.\\n\\nThorac. Cardiovasc. Surg. 62, 880–889 (1971).\\n\\n24. Kawai, J. et al. Implantation of a total artificial heart in calves under hypothermia with 10 day survival. J. Thorac. Cardiovasc.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Surg. 64, 45–60 (1972).\\n\\n25. Hastings, W. L. et al. A retrospective study of nine calves surviving five months on the pneumatic total artificial heart. Trans. Am.\\n\\nSoc. Artif. Intern. Organs 27, 71–76 (1981).\\n\\n26. Fukumasu, H., Iwaya, F., Olsen, D. B., Lawson, J. H. & Kolff, W. J. Surgical implantation of the Jarvik-5 total artificial heart in a\\n\\ncalf. Trans. Am. Soc. Artif. Intern. Organs 25, 232–238 (1979).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='calf. Trans. Am. Soc. Artif. Intern. Organs 25, 232–238 (1979).\\n\\n27. Akutsu, T., Takagi, H. & Takano, H. Total artificial hearts with built-in valves. Trans. Am. Soc. Artif. Intern. Organs 16, 392–397\\n\\n(1970).\\n\\n28. Honda, T. et al. One 25 day survivor with total artificial heart. J. Thorac. Cardiovasc. Surg. 69, 92–101 (1975).\\n\\n29. Nakazono, M. et al. A case report of 17 days survival with an implanted artificial heart in a calf. Jpn Heart J. 15, 485–497 (1974).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='30. Kasai, S. et al. Survival for 145 days with a total artificial heart. J. Thorac. Cardiovasc. Surg. 73, 637–646 (1977).\\n\\n31. Kennedy, J. H. et al. Development of an orthotopic cardiac prosthesis. J. Thorac. Cardiovasc. Surg. 65, 673–683 (1973).\\n\\n32. Backman, D. K., Donovan, F. M., Sandquist, G., Kessler, T. & Kolff, W. J. The design and evaluation of ventricles for the aec\\n\\nartificial heart nuclear power source. ASAIO J. 19, 542–552 (1973).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart nuclear power source. ASAIO J. 19, 542–552 (1973).\\n\\n33. Smith, L. et al. Development on the implantation of a total nuclear-powered artificial heart system. ASAIO J. 20, 732–735 (1974).\\n\\n34. Urzua, J., Sudilovsky, O., Panke, T., Kiraly, R. J. & Nosé, Y. Preliminary report: anatomic constraints for the implantation of an\\n\\nartificial heart. J. Surg. Res. 17, 262–268 (1974).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart. J. Surg. Res. 17, 262–268 (1974).\\n\\n35. Cooley, D. A., Akutsu, T., Norman, J. C., Serrato, M. A. & Frazier, O. H. Total artificial heart in two-staged cardiac transplantation.\\n\\nCardiovasc. Dis. 8, 305–319 (1981).\\n\\n36. DeVries, W. C. et al. Clinical use of the total artificial heart. N. Engl. J. Med. 310, 273–278 (1984).\\n\\n37. Vasků, J. & Urbánek, P. Constructional and functional characteristics of recent total artificial heart models TNS Brno VII, VIII, and'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='IX. Artif. Organs 19, 535–543 (1995).\\n\\n38. Davis, P. K., Pae, W. E. Jr & Pierce, W. S. Toward an implantable artificial heart. Experimental and clinical experience at The\\n\\nPennsylvania State University. Invest. Radiol. 24, 81–87 (1989).\\n\\n39. Hsu, C. H. Fuzzy logic automatic control of the Phoenix-7 total artificial heart. J. Artif. Organs 7, 69–76 (2004).\\n\\n40. Hsu, C. H. In vivo and clinical study of Phoenix-7 total artificial heart. Biomed. Eng. Appl. Basis Commun. 13, 133–139 (2001).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='41. Shumakov, V. I. et al. Use of an ellipsoid artificial heart. Artif. Organs 11, 16–19 (1987).\\n\\n42. Shumakov, V. I. et al. New design of an orthotopic fluorosiloxane rubber heart prosthesis. Biomed. Eng. 10, 223–224 (1976).\\n\\n43. Nawrat, Z. & Malota, Z. The analysis of driving mode influence on energy dissipation in pneumatic artificial heart chambers.\\n\\nArtif. Organs 22, 898–904 (1998).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Artif. Organs 22, 898–904 (1998).\\n\\n44. Rokitansky, A. et al. The new small Viennese total artificial heart: experimental and first clinical experiences. Artif. Organs 15,\\n\\n129–135 (1991).\\n\\n45. Homma, A. et al. Development of an electrohydraulic total artificial heart system: improvement of pump unit. Electron.\\n\\nCommun. Jpn. 93, 34–46 (2010).\\n\\n46. Ford, B. J. A new generation of cardiology: the AbioCor implantable replacement heart. Air Med. J. 22, 26–30 (2003).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='47. Dowling, R. D. et al. The AbioCor implantable replacement heart. Ann. Thorac. Surg. 75, S93–S99 (2003).\\n\\n48. Smith, P. A., Cohn, W. E. & Frazier, O. H. in Mechanical Circulatory and Respiratory Support (eds Gregory, S. D., Stevens, M. C. &\\n\\nFraser, J. F.) Ch. 7, 221–244 (Academic, 2018).\\n\\n49. Spiliopoulos, S., Dimitriou, A. M., Guersoy, D., Koerfer, R. & Tenderich, G. Expanding applicability of total artificial heart therapy:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='the 50-cc SynCardia total artificial heart. Ann. Thorac. Surg. 100, e55–e57 (2015).\\n\\n50. Cohrs, N. H. et al. A soft total artificial heart-first concept evaluation on a hybrid mock circulation. Artif. Organs 41, 948–958\\n\\n(2017).\\n\\n51. Stepanenko, A. & Kaufmann, F. A novel total artificial heart: search for haemocompatibility. Lancet 386, 1517–1519 (2015).\\n\\n52. CARMAT. Artificial hearts: devices from France’s Carmat to go on sale in Europe. YouTube https://'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='www.youtube.com/watch?v=j9T2HnSfVME (2021).\\n\\n53. US Food and Drug Administration. SynCardia Temporary Cardio West Total Artificial Heart (TAH-T). AccessData\\n\\nhttps://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P030011 (2004).\\n\\n54. EC Design-Examination Certificate. SynCardia temporary Total Artificial Heart (TAH-t) and external drivers. SynCardia\\n\\nhttp://syncardia.com/wp-content/uploads/2018/02/CE-665479-Design-Examination-26-May-2017.pdf (2017).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='55. SynCardia. SynCardia 70cc total artificial heart. SynCardia https://syncardia.com/clinicians/our-products/see-all-our-products/\\n\\n(2021).\\n\\n56. US National Library of Medicine. Carmat TAH early feasibility study. ClinicalTrials.gov\\n\\nhttps://clinicaltrials.gov/ct2/show/NCT04117295 (2022).\\n\\n57. Guex, L. G. et al. Increased longevity and pumping performance of an injection molded soft total artificial heart. Soft Robot. 23,\\n\\n23 (2020).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='23 (2020).\\n\\n58. Mihaylov, D., Verkerke, G. J. & Rakhorst, G. Mechanical circulatory support systems — a review. Technol. Health Care 8, 251–\\n\\n266 (2000).\\n\\n59. Min, B. G. et al. A moving-actuator type electromechanical total artificial heart — Part II: circular type and animal experiment.\\n\\nIEEE Trans. Biomed. Eng. 37, 1195–1200 (1990).\\n\\n60. Min, B. G. et al. A moving-actuator type electromechanical total artificial heart — Part I: linear type and mock circulation'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='experiments. IEEE Trans. Biomed. Eng. 37, 1186–1194 (1990).\\n\\n61. Ahn, J. M., Kang, D. W., Kim, H. C. & Min, B. G. In vivo performance evaluation of a transcutaneous energy and information\\n\\ntransmission system for the total artificial heart. ASAIO J. 39, M208–M212 (1993).\\n\\n62. Ohashi, Y., de Andrade, A. & Nosé, Y. Hemolysis in an electromechanical driven pulsatile total artificial heart. Artif. Organs 27,\\n\\n1089–1093 (2003).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='1089–1093 (2003).\\n\\n63. Takatani, S. et al. One piece ultracompact totally implantable electromechanical total artificial heart for permanent use. ASAIO J.\\n\\n48, 538–545 (2002).\\n\\n64. Irié, H. et al. Initial in vivo tests of an electrohydraulic actuated total artificial heart. ASAIO J. 38, M497–M500 (1992).\\n\\n65. Fukamachi, K. et al. Anatomic fitting studies of a total artificial heart in heart transplant recipients. Critical dimensions and\\n\\nprediction of fit. ASAIO J. 42, M337–M342 (1996).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='prediction of fit. ASAIO J. 42, M337–M342 (1996).\\n\\n66. Sueshiro, M., Fukunaga, S., Hirai, S., Sueda, T. & Matsuura, Y. Eccentric roller type total artificial heart designed for implantation.\\n\\nArtif. Organs 22, 451–457 (1998).\\n\\n67. Kobayashi, M. et al. In vitro evaluation of linear motor-driven total artificial heart. Artif. Organs 20, 1320–1324 (1996).\\n\\n68. Yamada, H., Yamaguchi, M., Kobayashi, K., Matsuura, Y. & Takano, H. Development and test of a linear motor-driven total'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart. IEEE Eng. Med. Biol. Mag. 14, 84–90 (1995).\\n\\n69. Weber, S. et al. MagScrew TAH: an update. ASAIO J. 51, xxxvi–xlvi (2005).\\n\\n70. Gao, H. et al. In vitro assessment of the Milwaukee heart and right to left balance. ASAIO J. 38, M722–M725 (1992).\\n\\n71. Sauer, I. M., Frank, J., Spiegelberg, A. & Bücherl, E. S. Ovalis TAH: development and in vitro testing of a new electromechanical\\n\\nenergy converter for a total artificial heart. ASAIO J. 46, 744–748 (2000).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='energy converter for a total artificial heart. ASAIO J. 46, 744–748 (2000).\\n\\n72. Mehta, S. M. et al. Testing of a 50 cc stroke volume completely implantable artificial heart: expanding chronic mechanical\\n\\ncirculatory support to women, adolescents, and small stature men. ASAIO J. 46, 779–782 (2000).\\n\\n73. Szabó, Z. et al. Scandinavian real heart (SRH) 11 implantation as total artificial heart (TAH)-experimental update. J. Clin. Exp.\\n\\nCardiol. 9, 2 (2018).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Cardiol. 9, 2 (2018).\\n\\n74. Sonntag, S. J. et al. Virtual implantations to transition from porcine to bovine animal models for a total artificial heart. Artif.\\n\\nOrgans 44, 384–393 (2020).\\n\\n75. Pelletier, B. et al. System overview of the fully implantable destination therapy — ReinHeart total artificial heart. Eur. J.\\n\\nCardiothorac. Surg. 47, 80–86 (2015).\\n\\n76. Tozzi, P. et al. An original valveless artificial heart providing pulsatile flow tested in mock circulatory loops. Int. J. Artif. Organs'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='40, 683–689 (2017).\\n\\n77. Kirklin, J. K. et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J. Heart Lung Transpl.\\n\\n36, 1080–1086 (2017).\\n\\n78. Potapov, E. V., Kaufmann, F., Müller, M., Mulzer, J. & Falk, V. Longest ongoing support (13 years) with magnetically levitated left\\n\\nventricular assist device. ASAIO J. 66, e121–e122 (2020).\\n\\n79. Yang, M. in Technology and Therapy Management 99–100 (Springer, 2020).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='79. Yang, M. in Technology and Therapy Management 99–100 (Springer, 2020).\\n\\n80. Healy, A. H. et al. Physiologic effects of continuousflow left ventricular assist devices. J. Surg. Res. 202, 363–371 (2016).\\n\\n81. Bhimaraj, A., Uribe, C. & Suarez, E. E. Physiological impact of continuous flow on end-organ function: clinical implications in the\\n\\ncurrent era of left ventricular assist devices. Methodist. Debakey Cardiovasc. J. 11, 12–17 (2015).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='82. Isoyama, T. et al. New version of flow-transformed pulsatile total artificial heart with no electrical switching valve. Artif. Organs\\n\\n19, 694–696 (1995).\\n\\n83. Abe, Y. et al. Results of animal experiments with the fourth model of the undulation pump total artificial heart. Artif. Organs 35,\\n\\n781–790 (2011).\\n\\n84. Qian, K. X., Ru, W. M., Zeng, P. & Yuan, H. Y. A novel impeller TAH using magnetic bearings for load reduction. J. Med. Eng.\\n\\nTechnol. 26, 214–216 (2002).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Technol. 26, 214–216 (2002).\\n\\n85. Feng, J. et al. New continuous-flow total artificial  heart and vascular permeability. J. Surg. Res. 199, 296–305 (2015).\\n\\n86. Lebreton, G., Mastroianni, C., Amour, J. & Leprince, P. Implantation of two HVADs used as a total artificial heart: a new\\n\\napproach. Ann. Thorac. Surg. 107, e165–e167 (2019).\\n\\n87. Mulvihill, M. S. et al. Usefulness of two centrifugal ventricular assist devices in a total artificial heart configuration: a preliminary'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='report. J. Heart Lung Transpl. 36, 1266–1268 (2017).\\n\\n88. Cohn, W. E. et al. Eight-year experience with a continuous-flow total artificial heart in calves. ASAIO J. 60, 25–30 (2014).\\n\\n89. Pirk, J. et al. Total artificial heart support with two continuous-flow ventricular assist devices in a patient with an infiltrating\\n\\ncardiac sarcoma. ASAIO J. 59, 178–180 (2013).\\n\\n90. Frazier, O. H. & Cohn, W. E. Continuous-flow total heart replacement device implanted in a 55-year-old man with end-stage'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='heart failure and severe amyloidosis. Tex. Heart Inst. J. 39, 542–546 (2012).\\n\\n91. Strueber, M., Schmitto, J. D., Kutschka, I. & Haverich, A. Placement of two implantable centrifugal pumps to serve as a total\\n\\nartificial heart after cardiectomy. J. Thorac. Cardiovasc. Surg. 143, 507–509 (2012).\\n\\n92. Frazier, O. H., Cohn, W. E., Tuzun, E., Winkler, J. A. & Gregoric, I. D. Continuous-flow total artificial heart supports long-term\\n\\nsurvival of a calf. Tex. Heart Inst. J. 36, 568–574 (2009).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='survival of a calf. Tex. Heart Inst. J. 36, 568–574 (2009).\\n\\n93. Baldwin, A. C., Gemmato, C. J., Cohn, W. E. & Frazier, O. H. Feasibility of long-term continuous flow total heart replacement in\\n\\ncalves. Int. J. Artif. Organs 45, 44–51 (2021).\\n\\n94. Daneshmand, M. A., Bishawi, M., Milano, C. A. & Schroder, J. N. The HeartMate 6. ASAIO J. 66, e46–e49 (2020).\\n\\n95. Kleinheyer, M. et al. Rapid speed modulation of a rotary total artificial heart impeller. Artif. Organs 40, 824–833 (2016).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='96. Fukamachi, K. et al. Generating pulsatility by pump speed modulation with continuous-flow total artificial heart in awake calves.\\n\\nJ. Artif. Organs 20, 381–385 (2017).\\n\\n97. Miyamoto, T. et al. Analysis of Cleveland clinic continuous-flow total artificial heart performance using the virtual mock loop:\\n\\ncomparison with an in vivo study. Artif. Organs 44, 375–383 (2020).\\n\\n98. Abe, Y. et al. Animal experiments of the helical flow total artificial heart. Artif. Organs 39, 670–680 (2015).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='99. Fox, C. et al. Hybrid continuous-flow total artificial heart. Artif. Organs 42, 500–509 (2018).\\n\\n100. Glynn, J. et al. The OregonHeart total artificial heart: design and performance on a mock circulatory loop. Artif. Organs 41, 904–\\n\\n910 (2017).\\n\\n101. Jurney, P. L. et al. Characterization of a pulsatile rotary total artificial heart. Artif. Organs 45, 135–142 (2021).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='102. Franklin, D. L., Van Citters, R. L. & Rushmer, R. F. Balance between right and left ventricular output. Circ. Res. 10, 17–26 (1962).\\n\\n103. Ley, S., Kreitner, K. F., Morgenstern, I., Thelen, M. & Kauczor, H. U. Bronchopulmonary shunts in patients with chronic\\n\\nthromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. Am. J. Roentgenol. 179, 1209–1215\\n\\n(2002).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='(2002).\\n\\n104. Baile, E. M., Ling, H., Heyworth, J. R., Hogg, J. C. & Pare, P. D. Bronchopulmonary anastomotic and noncoronary collateral blood\\n\\nflow in humans during cardiopulmonary bypass. Chest 87, 749–754 (1985).\\n\\n105. Bhunia, S. K. & Kung, R. T. Indirect bronchial shunt flow measurements in AbioCor implantable replacement heart recipients.\\n\\nASAIO J. 50, 211–214 (2004).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='ASAIO J. 50, 211–214 (2004).\\n\\n106. Nestler, F. et al. Investigation of the inherent left-right flow balancing of rotary total artificial hearts by means of a resistance\\n\\nbox. Artif. Organs 44, 584–593 (2020).\\n\\n107. Latrémouille, C. et al. A bioprosthetic total artificial heart for end-stage heart failure: results from a pilot study. J. Heart Lung\\n\\nTranspl. 37, 33–37 (2018).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Transpl. 37, 33–37 (2018).\\n\\n108. Slepian, M. J. et al. The Syncardia™ total artificial heart: in vivo, in vitro, and computational modelling studies. J. Biomech. 46,\\n\\n266–275 (2013).\\n\\n109. Crosby, J. R. et al. Physiological characterization of the SynCardia total artificial heart in a mock  circulation system. ASAIO J. 61,\\n\\n274–281 (2015).\\n\\n110. Diedrich, M. et al. Experimental investigation of right–left flow balance concepts for a total artificial heart. Artif. Organs 45, 364–\\n\\n372 (2021).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='372 (2021).\\n\\n111. Horvath, D. et al. Mechanism of self-regulation and in vivo performance of the cleveland clinic continuous-flow total artificial\\n\\nheart. Artif. Organs 41, 411–417 (2017).\\n\\n112. Kung, R. T. et al. Progress in the development of the ABIOMED total artificial heart. ASAIO J. 41, M245–M248 (1995).\\n\\n113. Harasaki, H. et al. Progress in Cleveland Clinic — Nimbus total artificial heart development. ASAIO J. 40, M494–M498 (1994).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='114. Kim, H. C., Khanwilkar, P. S., Bearnson, G. B. & Olsen, D. B. Development of a microcontroller-based automatic control system\\n\\nfor the electrohydraulic total artificial heart. IEEE Trans. Biomed. Eng. 44, 77–89 (1997).\\n\\n115. Snyder, A. J. et al. An electrically powered total artificial heart. Over 1 year survival in the calf. ASAIO J. 38, M707–M712 (1992).\\n\\n116. Abe, Y. et al. Third model of the undulation pump total artificial heart. ASAIO J. 49, 123–127 (2003).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='117. Dowling, R. D. et al. Initial experience with the AbioCor implantable replacement heart at the University of Louisville. ASAIO J.\\n\\n46, 579–581 (2000).\\n\\n118. Latrémouille, C. et al. Animal studies with the Carmat bioprosthetic total artificial heart. Eur. J.  Cardiothorac. Surg. 47, e172–\\n\\ne179 (2015).\\n\\n119. Vasků, J. et al. A comparative study of a group of eight calves, surviving longer than 1 month with the total artificial heart. Artif.\\n\\nOrgans 7, 470–478 (1983).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Organs 7, 470–478 (1983).\\n\\n120. Vasků, J., Urbánek, P., Dostál, M. & Vasků, J. The applicability of experimental experience with the total artificial heart to its\\n\\nclinical use. Int. J. Artif. Organs 15, 307–311 (1992).\\n\\n121. Copeland, J. G. et al. The total artificial heart as a bridge to transplantation. A report of two cases. JAMA 256, 2991–2995 (1986).\\n\\n122. Shumakov, V. et al. Clinical indications for the use of the “Poisk-IOM” total artificial heart: the experience of 13 implantations in'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='humans. Artif. Organs 15, 372–375 (1991).\\n\\n123. Wei, J. et al. Successful use of Phoenix-7 total artificial heart. Transpl. Proc. 30, 3403–3404 (1998).\\n\\n124. Trubel, W. et al. Clinical total artificial heart bridging: Viennese strategy and experiences. Artif. Organs 13, 470–475 (1989).\\n\\n125. Frazier, O. H. et al. The total artificial heart: where we stand. Cardiology 101, 117–121 (2004).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='126. Alaeddine, M., Ploutz, M., Arabia, F. A. & Velez, D. A. Implantation of total artificial heart in a 10-year-old after support with a\\n\\ntemporary perventricular assist device. J. Thorac. Cardiovasc. Surg. 159, e227–e229 (2020).\\n\\n127. SynCardia. Turkish man becomes world’s longest supported syncardia temporary total artificial heart patient. SynCardia\\n\\nhttps://syncardia.com/news/ turkish-man-becomes-worlds-longest-supported-syncardia-temporary-total-artificial-heart-\\n\\npatient/ (2017).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='patient/ (2017).\\n\\n128. David, C. H. et al. A heart transplant after total artificial heart support: initial and long-term results. Eur. J. Cardiothorac. Surg.\\n\\n58, 1175–1181 (2020).\\n\\n129. Carrier, M. et al. Outcomes after heart transplantation and total artificial heart implantation: a multicentre study. J. Heart Lung\\n\\nTransplant. 28, 28 (2020).\\n\\n130. Hulman, M., Artemiou, P., Hudec, V., Olejarova, I. & Goncalvesova, E. SynCardia, total artificial heart, as a bridge to transplant.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='Bratisl. Lek. Listy 120, 325–330 (2019).\\n\\n131. Nguyen, A. et al. Experience with the SynCardia total artificial heart in a Canadian centre. Can. J. Surg. 60, 375–379 (2017).\\n\\n132. Kirsch, M. E. et al. SynCardia temporary total artificial heart as bridge to transplantation: current results at La Pitié hospital. Ann.\\n\\nThorac. Surg. 95, 1640–1646 (2013).\\n\\n133. Copeland, J. G. et al. Experience with more than 100 total artificial heart implants. J. Thorac. Cardiovasc. Surg. 143, 727–734\\n\\n(2012).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='(2012).\\n\\n134. Roussel, J. C. et al. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann. Thorac. Surg. 87,\\n\\n124–130 (2009).\\n\\n135. El-Banayosy, A. et al. CardioWest total artificial heart: bad Oeynhausen experience. Ann. Thorac. Surg. 80, 548–552 (2005).\\n\\n136. Thanavaro, K. L., Tang, D. G., Kasirajan, V. & Shah, K. B. Clinical indications for implantation of the total artificial heart. ASAIO J.\\n\\n60, 594–596 (2014).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='60, 594–596 (2014).\\n\\n137. Carmat. Carmat outlines commercial and development plan for its total artificial heart. Carmat\\n\\nhttps://www.carmatsa.com/carmat-content/uploads/2021/01/pr_carmat_conference_06-01-21.pdf (2021).\\n\\n138. Netuka, I. et al. Initial bridge to transplant experience with a bioprosthetic autoregulated artificial heart. J. Heart Lung Transpl.\\n\\n39, 1491–1493 (2020).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='39, 1491–1493 (2020).\\n\\n139. Unthan, K. et al. Design and evaluation of a fully implantable control unit for blood pumps. Biomed. Res. Int. 2015, 257848\\n\\n(2015).\\n\\n140. Kluin, J. et al. In situ heart valve tissue engineering using a bioresorbable elastomeric implant — from material design to 12\\n\\nmonths follow-up in sheep. Biomaterials 125, 101–117 (2017).\\n\\n141. Zilla, P., Deutsch, M., Bezuidenhout, D., Davies, N. H. & Pennel, T. Progressive reinvention or destination lost? Half a century of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='cardiovascular tissue engineering. Front. Cardiovasc. Med. 7, 159 (2020).\\n\\n142. Chen, Z. et al. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and\\n\\nbleeding. Artif. Organs 43, 745–755 (2019).\\n\\n143. Zaiser, A. S. et al. Adverse events of percutaneous microaxial left ventricular assist devices-a retrospective, single-centre cohort\\n\\nstudy. J. Clin. Med. 10, 3710 (2021).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='study. J. Clin. Med. 10, 3710 (2021).\\n\\n144. HybridHeart. The development of a soft biocompatible artificial heart. HybridHeart https://www.hybridheart.eu/(2021).\\n\\n145. Kohll, A. X. et al. Long-term performance of a pneumatically actuated soft pump manufactured byrubber compression molding.\\n\\nSoft Robot. 6, 206–213 (2019).\\n\\n146. Roche, E. T. et al. Soft robotic sleeve supports heart function. Sci. Transl. Med. 9, eaaf3925 (2017).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='147. Banerjee, H., Tse, Z. T. H. & Ren, H. Soft robotics with compliance and adaptation for biomedical applications and forthcoming\\n\\nchallenges. Int. J. Robot. Autom. 33, 69–80 (2018).\\n\\n148. Greatrex, N., Kleinheyer, M., Nestler, F. & Timms, D. The Maglev heart. IEEE Spectr. 56, 22–29 (2019).\\n\\n149. Parnis, S. M. et al. Chronic in vivo evaluation of an electrohydraulic total artificial heart. ASAIO J. 40, M489–M493 (1994).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='150. Dowling, R. D., Etoch, S. W., Stevens, K. A., Johnson, A. C. & Gray, L. A. Jr Current status of the AbioCor implantable replacement\\n\\nheart. Ann. Thorac. Surg. 71, S147–S149 (2001).\\n\\n151. Takatani, S. et al. Totally implantable total artificial heart and ventricular assist device with multipurpose miniature\\n\\nelectromechanical energy system. Artif. Organs 18, 80–92 (1994).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='electromechanical energy system. Artif. Organs 18, 80–92 (1994).\\n\\n152. Takatani, S. et al. Left and right pump output control in one-piece electromechanical total artificial heart. Artif. Organs 17, 176–\\n\\n184 (1993).\\n\\n153. Cohn, W. E. et al. Pulsatile outflow in cows supported long-term with the BiVACOR rotary TAH. J. Heart Lung Transplant. 36, S14\\n\\n(2017).\\n\\n154. Dostál, M. et al. Hematological and biochemical studies in calves living over 100 days with the polymethylmethacrylate total'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='artificial heart TNS Brno II. Int. J. Artif. Organs 9, 39–48 (1986).\\n\\n155. Vasků, J. et al. Recent efforts in artificial heart research in Czechoslovakia. ASAIO Trans. 35, 805–811 (1989).\\n\\n156. Smadja, D. M. et al. The Carmat bioprosthetic total artificial heart is associated with early hemostatic recovery and no acquired\\n\\nvon Willebrand syndrome in calves. J. Cardiothorac. Vasc. Anesth. 31, 1595–1602 (2017).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='von Willebrand syndrome in calves. J. Cardiothorac. Vasc. Anesth. 31, 1595–1602 (2017).\\n\\n157. Karimov, J. H. et al. First report of 90-day support of two calves with a continuous-flow total artificial heart. J. Thorac.\\n\\nCardiovasc. Surg. 150, 687–693. e681 (2015).\\n\\n158. Taenaka, Y. et al. Development and evaluation of components for a totally implantable artificial heart system. ASAIO J. 40,\\n\\nM314–M318 (1994).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='M314–M318 (1994).\\n\\n159. Taenaka, Y. et al. An electrohydraulic total artificial heart with a separately placed actuator. ASAIO Trans. 36, M242–M245\\n\\n(1990).\\n\\n160. Tatsumi, E. et al. A blood pump with an interatrial shunt for use as an electrohydraulic total artificial heart. ASAIO J. 38, M425–\\n\\nM430 (1992).\\n\\n161. Tatsumi, E. et al. The National Cardiovascular Center electrohydraulic total artificial heart and ventricular assist device systems:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='current status of development. ASAIO J. 49, 243–249 (2003).\\n\\n162. Tatsumi, E. et al. Current status of development and in vivo evaluation of the National Cardiovascular Center electrohydraulic\\n\\ntotal artificial heart system. J. Artif. Organs 3, 62–69 (2000).\\n\\n163. Doi, K. et al. In vivo studies of the MagScrew total artificial heart in calves. ASAIO J. 48, 222–225 (2002).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='164. Kuroda, H. et al. Postoperative pulmonary complications in calves after implantation of an electric total artificial heart. ASAIO J.\\n\\n44, M613–M618 (1998).\\n\\n165. Pierce, W. S. et al. An electric artificial heart for clinical use. Ann. Surg. 212, 339–343 (1990). 166.\\n\\n166. Snyder, A. J. et al. In vivo testing of a completely implanted total artificial heart system. ASAIO J. 39, M177–M184 (1993).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='167. Shaffer, L. J. et al. Total artificial heart implantation in calves with pump on an angled port design. Trans. Am. Soc. Artif. Intern.\\n\\nOrgans 25, 254–259 (1979).\\n\\n168. Abe, Y. et al. Development of mechanical circulatory support devices at the University of Tokyo. J. Artif. Organs 10, 60–70\\n\\n(2007).\\n\\n169. Mochizuki, S. et al. Results of animal experiments using an undulation pump total artificial heart: analysis of 10 day and 19 day\\n\\nsurvival. ASAIO J. 46, 500–504 (2000).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='survival. ASAIO J. 46, 500–504 (2000).\\n\\n170. Wampler, R. et al. Performance of a novel shuttling total artificial heart on a on a mock circulatory loop. J. Heart Lung\\n\\nTransplant. 36, S56–S57 (2017).\\n\\n171. Cooley, D. The total artificial heart. Nat. Med. 9, 108–111 (2003).\\n\\n172. Emmanuel, S. et al. Anatomical human fitting of the BiVACOR total artificial heart. Artif. Organs 46, 50–56 (2022).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='173. Mohacsi, P. & Leprince, P. The Carmat total artificial heart. Eur. J. Cardiothorac. Surg. 46, 933–934 (2014).\\n\\n174. Pieper, I. L. et al. Evaluation of the novel total artificial heart Realheart in a pilot human fitting study. Artif. Organs 44, 174–177\\n\\n(2020).\\n\\n175. Yu, L. S. et al. A compact and noise free electrohydraulic total artificial heart. ASAIO J. 39, M386–M391 (1993).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\16877accepted_Version.txt'}, page_content='176. Rosenberg, G. et al. Dynamic in vitro and in vivo performance of a permanent total artificial heart. Artif. Organs 22, 87–94\\n\\n(1998).\\n\\n177. Marieb, E. N. & Hoehn, K. in The Heart 679–681 (Pearson, 2013).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='Artificial Hearts\\n\\nRuba Hadidi\\n\\nAn artificial heart is a prosthetic device that is implanted into the body to replace the biological heart.\\n\\n2 types of artificial heart: \\uf0a7 TAH(Total Artificial Heart) \\uf0a7 Cardiac Assist device\\n\\nBenefit of a functional artificial heart would be to lower the need for heart transplants.\\n\\nThe first artificial heart implanted in a living being was placed in a dog at the Cleveland Clinic in 1957; it survived about 90 minutes.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='April 4, 1969 Liotta and Cooley replaced a dying man’s heart with a mechanical heart inside the chest.  The patient woke up and recovered well. After 64 hours the artificial heart was removed and replaced by a donor heart. However; thirty\\n\\ntwo hours after transplantation the patient died of what was later proved to be an acute pulmonary infection, most likely caused by an immunosuppressive drugs complication. If they left the artificial heart in place the patient may have lived longer.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='Modifications: \\uf0fc A ventricle with hemispherical diaphragms that did not crush red blood cells \\uf0fc An external heart driver that inherently regulated blood flow without needing complex control systems. \\uf0fc An ovoid shape to fit inside the human chest. \\uf0fc A more blood\\n\\ncompatible polyurethane that made the inside of the ventricles smooth and seamless to reduce dangerous stroke\\n\\ncausing blood clots.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='causing blood clots.\\n\\nIn 1982,  Dr. DeVries implanted the artificial heart into retired dentist who survived 112 days with the device. Bill Schroeder became the second recipient, and lived for a record 620 days.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='AbioCor is the first fully implantable total artificial heart which unlike previous total artificial hearts does not require wires to external devices. The internal battery lasts for half an hour and a wearable external battery pack lasts for 4 hours. It is intended for critically ill patients who cannot receive a heart transplant. Some limitations of the current AbioCor is that because of its size it is implantable in only 50% of the male population and has a life span of 1 to 2 years.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='In 2006, an artificial heart was implanted into a 15\\n\\nyear old girl in Canada. It was intended to act as a temporary fixture until a donor heart could be found. Instead, the artificial heart (called a Berlin Heart) allowed for natural processes to occur and her heart healed on its own. After 146 days the Berlin Heart was removed.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Artificial_hearts.txt'}, page_content='Disadvantages of artificial hearts : \\uf0d8 Even though they should be permanent they are only functioning less than two years \\uf0d8 An artificial Heart costs around $250,000 without the cost of surgery.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Journal of Cardiovascular Nursing\\n\\nVol. 29, No. 1, pp E1YE8 x Copyright B 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins\\n\\nLiving With a Total Artificial Heart\\n\\nPatients’ Perspectives\\n\\nLaura S. Savage, RN, MSN, PCCN; Jeanne Salyer, PhD, RN; Maureen P. Flattery, RN, MS, ANP;\\n\\nLucy Alburger, RN; Kenna Joyce, RN, BSN, PCCN; Barbara Mann, RN;\\n\\nMalliga Ravindar, RN, MSN; Maranatha Gonzalez, RN, MS'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Malliga Ravindar, RN, MSN; Maranatha Gonzalez, RN, MS\\n\\nBackground: Advances in mechanical circulatory support have reduced morbidity and mortality in end-stage\\n\\nheart failure. To date, there have been no published studies examining the psychosocial impact on patients who\\n\\nare supported with a total artificial heart (TAH-t). Purpose: The purpose of this study was to describe the lived'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='experience of patients currently supported by the TAH-t awaiting transplant. Methods: A qualitative method using\\n\\nGiorgi’s modification of phenomenologic inquiry guided the investigation, which was conducted at a transplant\\n\\ncenter located in the mid-Atlantic region of the United States. A purposive sample was selected to reflect\\n\\nparticipants currently supported by the TAH-t. All participants (9 men, 1 woman; mean age, 48.2 years; nonischemic'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='etiology, 80%) were in-patients on the progressive care unit at the time of the interview and had been supported for\\n\\nat least 30 days. The mean length of device therapy was 84.7 days (range, 33Y245 days). Findings: Hope for the\\n\\nfuture was the overarching theme. Subthemes included reflections, for better or for worse, the secret club, and\\n\\ncoping and adaptation. The patients reflected on severity of illness, progress, and expressed optimism. For better'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='or for worse described how symptoms improved but were offset by restrictions imposed by the technology. The\\n\\nsecret club described the support provided to help deal with their life situation. Coping and adaptation suggested\\n\\nthat the patients came to terms with and accepted their circumstances. Conclusions: The findings will help clinicians\\n\\nunderstand patients experiencing a life-changing situation and implications for psychosocial interventions.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='KEY WORDS: heart transplantation, lived experience, total artificial heart\\n\\nH\\n\\neart failure (HF) is a common health problem\\n\\ncausing approximately 250,000 deaths per year\\n\\nin the United States. From 1979 to 2001, deaths caused\\n\\nby HF increased dramaticallyVmaking it the only ma-\\n\\njor cardiovascular health problem that is increasing in\\n\\nincidence and prevalence.1 Although advances in medical\\n\\ntherapy have resulted in improved survival in patients'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='therapy have resulted in improved survival in patients\\n\\nwith moderate and severe HF, the gold standard therapy in\\n\\nend-stage HF remains to be cardiac transplantation. Ad-\\n\\nvances in mechanical support, such as the development of\\n\\nthe left ventricular assist device (LVAD) and the total\\n\\nartificial heart (TAH-t), have reduced morbidity and mor-\\n\\ntality in this population with end-stage HF and offers a\\n\\nbridge to transplantation for many patients with severe'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='bridge to transplantation for many patients with severe\\n\\nillness as they wait for a donor heart. Our understanding\\n\\nof the psychosocial impact of this experience is, how-\\n\\never, limited. Thus, the purpose of this study was to\\n\\ndescribe the lived experience of patients currently sup-\\n\\nported by the TAH-t and ‘‘bridged to transplant’’ with\\n\\nE1\\n\\nLaura S. Savage, RN, MSN, PCCN\\n\\nTransplant Coordinator, Heart Failure/Heart Transplant Program, Pauley'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Transplant Coordinator, Heart Failure/Heart Transplant Program, Pauley\\n\\nHeart Center, Virginia Commonwealth University Health System, Richmond.\\n\\nJeanne Salyer, PhD, RN\\n\\nAssociate Professor, School of Nursing, Virginia Commonwealth\\n\\nUniversity, Richmond.\\n\\nMaureen P. Flattery, RN, MS, ANP\\n\\nTransplant Coordinator, Heart Failure/Heart Transplant Program,\\n\\nPauley Heart Center, Virginia Commonwealth University Health\\n\\nSystem, Richmond.\\n\\nLucy Alburger, RN'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Pauley Heart Center, Virginia Commonwealth University Health\\n\\nSystem, Richmond.\\n\\nLucy Alburger, RN\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nKenna Joyce, RN, BSN, PCCN\\n\\nClinical Coordinator, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nBarbara Mann, RN\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nMalliga Ravindar, RN, MSN'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='University Health System, Richmond.\\n\\nMalliga Ravindar, RN, MSN\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nMaranatha Gonzalez, RN, MS\\n\\nStaff Nurse, Pauley Heart Center, Virginia Commonwealth\\n\\nUniversity Health System, Richmond.\\n\\nMaureen P. Flattery, RN, MS, ANP, is a member of the Speaker’s\\n\\nBureau of Xdx, Inc., Brisbane, California. All other authors have\\n\\nno funding or conflicts of interest to disclose.\\n\\nCorrespondence'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='no funding or conflicts of interest to disclose.\\n\\nCorrespondence\\n\\nLaura S. Savage, RN, MSN, PCCN, Heart Failure/Heart Transplant\\n\\nProgram, Pauley Heart Center, Virginia Commonwealth University\\n\\nHealth System, 1200 E Broad St, West Hospital, 5th Fl, Richmond,\\n\\nVA 23298 (lsavage@mcvh-vcu.edu).\\n\\nDOI: 10.1097/JCN.0b013e318272391e\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='this device. Understanding patients’ experiences with\\n\\nthis new technology will sensitize healthcare profes-\\n\\nsionals to better address both physical and psycho-\\n\\nsocial needs during the wait for a donor heart.\\n\\nBecause medical management has improved, patients\\n\\nwith end-stage heart disease are living longer. Moreover,\\n\\nmechanical circulatory support devices (MCSDs) are\\n\\nbecoming more commonplace because there is a short-\\n\\nage of donor organs and the wait for a donor heart is'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='age of donor organs and the wait for a donor heart is\\n\\noften long. Research has shown that the TAH-t offers\\n\\nsignificant physiologic benefit. For example, Platis and\\n\\nLarson2 found that 79% of patients survive to trans-\\n\\nplant when bridged with the TAH-t as compared with\\n\\n46% of matched controls in the control group who did\\n\\nnot receive any type of MCSD (P G 0.0001). In addi-\\n\\ntion, these researchers reported a 70% 1-year survival of\\n\\npatients after transplant as compared with 31% in the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='patients after transplant as compared with 31% in the\\n\\ncontrol group (P G 0.001). Although these survival sta-\\n\\ntistics are impressive, there is little research related to\\n\\nthe psychological impact of living with this life-sustaining\\n\\ndevice. There is, however, evidence that patients with HF\\n\\nbridged to transplant with a ventricular assist device ex-\\n\\nperience physical as well as psychosocial concerns. For ex-\\n\\nample,Zambroski and colleagues3 identified facing the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='ample,Zambroski and colleagues3 identified facing the\\n\\nunknown, feeling confined, living with fear, as well as\\n\\nhope for the future as key issues for patients living with\\n\\nan LVAD. Savage and Canody4 reported adaptive behav-\\n\\niors and improved quality of life for patients, and Casida\\n\\nand colleagues5 provided further insight regarding early\\n\\nversus late adjustment. There is, however, no literature\\n\\nthat addresses the lived experience of patients with the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='that addresses the lived experience of patients with the\\n\\nTAH-t. This study, therefore, adds to the body of knowl-\\n\\nedge related to providing care to patients with this MCSD.\\n\\nMethods\\n\\nDesign, Sample, and Setting\\n\\nA descriptive, phenomenologic qualitative inquiry was\\n\\nused to allow participants to freely describe their ex-\\n\\nperiences while being supported by the TAH-t. The inves-\\n\\ntigation was conducted at a transplant center located in'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='tigation was conducted at a transplant center located in\\n\\nthe mid Atlantic region of the United States. This center\\n\\nhas been implanting the TAH-t (SynCardia Systems, Inc;\\n\\nTucson, Arizona) as a bridge to heart transplant for the\\n\\nlast 6 years. One of 67 centers worldwide, this center\\n\\nhas performed 65 of these procedures since 2006.\\n\\nA purposive sample was selected to reflect partic-\\n\\nipants currently supported by the TAH-t. All partic-\\n\\nipants (9 men, 1 woman; mean age, 48.2 years [range,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='ipants (9 men, 1 woman; mean age, 48.2 years [range,\\n\\n32Y60 years]; nonischemic etiology, 80%) were in-\\n\\npatients at the time of the interview. On average, the\\n\\nlength of device therapy was 84.7 days (range, 33Y245;\\n\\nsee Table). Giorgi’s modification of phenomenologic\\n\\ninquiry, which preserves the meaning of the phenom-\\n\\nenon within the context of each participant’s experience\\n\\nand allows free expression of their lived experience,\\n\\nguided the investigation.6\\n\\nData Collection Procedures'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='guided the investigation.6\\n\\nData Collection Procedures\\n\\nAfter informed consent was obtained, pertinent\\n\\ndemographic and clinical information was extracted\\n\\nfrom the medical record. Unstructured interviews were\\n\\nconducted and audiotape recorded in the participant’s\\n\\nhospital room. The interviews were conducted in the\\n\\nparticipant’s hospital room by 2 researchers trained in\\n\\nqualitative interviewing. The interviews lasted from 15\\n\\nto 45 minutes. Some participants were more descrip-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='to 45 minutes. Some participants were more descrip-\\n\\ntive than were others. Each subject was interviewed\\n\\nonce. The participants were allowed to direct the pace of\\n\\nthe interview. The interviewers started by prompting the\\n\\nparticipants to describe their lives before they became ill\\n\\nby saying ‘‘Tell me about your life before you got sick.’’\\n\\nFollow-up questions included queries as to what it was\\n\\nlike living with t TAH-t. Data collection, which occurred'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='like living with t TAH-t. Data collection, which occurred\\n\\nbetween June 2010 and January 2011, was continued\\n\\nuntilredundancyorsaturationoccurred.De-identifiedin-\\n\\nterviews were transcribed for analysis. In addition, an\\n\\nindependent author (J.S.), with no previous knowledge\\n\\nof the participants, reviewed all transcripts for meaning.\\n\\nData Analysis\\n\\nData analysis occurred in accordance with Colaizzi’s\\n\\nphenomenologic method. This process includes (1) read-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='phenomenologic method. This process includes (1) read-\\n\\ning all of the participants’ descriptions, (2) extracting\\n\\nsignificant statements, (3) creating meaning by coding\\n\\nTABLE\\n\\nDemographic and Clinical\\n\\nCharacteristics of Participants (n = 10)\\n\\nVariable\\n\\nFrequency\\n\\nMean (SD)\\n\\nRange\\n\\nAge, y\\n\\n48.2 (11.5)\\n\\n32Y60\\n\\nGender\\n\\nFemale\\n\\n1\\n\\nMale\\n\\n9\\n\\nMarital Status\\n\\nNever married\\n\\n1\\n\\nPreviously married\\n\\n2\\n\\nMarried\\n\\n7\\n\\nEducation\\n\\nLower than high school\\n\\n1\\n\\nHigh school\\n\\n0\\n\\nHigher than high school\\n\\n9'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='2\\n\\nMarried\\n\\n7\\n\\nEducation\\n\\nLower than high school\\n\\n1\\n\\nHigh school\\n\\n0\\n\\nHigher than high school\\n\\n9\\n\\nEthnicity\\n\\nWhite\\n\\n7\\n\\nAfrican American\\n\\n2\\n\\nIndian\\n\\n1\\n\\nDiagnosis\\n\\nNICM\\n\\n8\\n\\nICM\\n\\n2\\n\\nLength of device therapy\\n\\n(at time of interview)\\n\\n84.7 (65.1)\\n\\n33Y245\\n\\nAbbreviations: ICM, ischemic cardiomyopathy; NICM, nonischemic\\n\\ncardiomyopathy.\\n\\nE2 Journal of Cardiovascular Nursing x January/February 2014'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='cardiomyopathy.\\n\\nE2 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nrepetitive issues, (4) aggregating issues into clusters of\\n\\nthemes, (5) writing an exhaustive description, (6) deter-\\n\\nmining similar concepts, and (7) returning to the partic-\\n\\nipants for validation, as necessary.7 Verbatim transcripts'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='ipants for validation, as necessary.7 Verbatim transcripts\\n\\nof the interviews were distributed to the investigators. The\\n\\ninvestigators were staff nurses from the cardiothoracic\\n\\nstep-down unit. The investigators were blinded to the\\n\\nidentity of the participants. Each investigator indepen-\\n\\ndently reviewed the transcripts for meaning. The group\\n\\nmet multiple times to discuss content and phrases and\\n\\nto come to agreement on identified themes. Once the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='to come to agreement on identified themes. Once the\\n\\nthemes were agreed upon, each investigator was as-\\n\\nsigned a theme to validate with the statements from\\n\\nthe verbatim transcripts.\\n\\nFindings\\n\\nOne overarching theme and 4 subthemes were gen-\\n\\nerated from the analysis of the transcripts. The overarch-\\n\\ning theme was hope for the future. The 4 subthemes\\n\\nincluded reflections, for better or for worse, the secret\\n\\nclub, and coping and adaptation. Reflections were char-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='club, and coping and adaptation. Reflections were char-\\n\\nacterized by looking back at how serious their illness\\n\\nhad becomeVand yet, they also described their pro-\\n\\ngress and expressed that they were looking forward to\\n\\ngoing home after transplant. For better or for worse\\n\\ndescribed specifically how symptoms and function-\\n\\ning improved after TAH-t implantation but were offset\\n\\nby awareness of the restrictions imposed by the tech-\\n\\nnology. The secret club described a ‘‘club’’ of which'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='nology. The secret club described a ‘‘club’’ of which\\n\\nneither the patients nor the family members wanted to\\n\\nbe members. However, what emerged was a type of\\n\\nsupport provided by the staff and other patients to help\\n\\nthe patients deal with the isolation posed by friends’\\n\\nand family members’ need to travel long distances to\\n\\nvisit. The final subtheme, coping and adaptation, sug-\\n\\ngested that the patients eventually came to terms with\\n\\nand accepted their life situation.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='gested that the patients eventually came to terms with\\n\\nand accepted their life situation.\\n\\nHope for the future was characterized by state-\\n\\nments such as:\\n\\nIt was very I. I can say uplifting or eye opening. You\\n\\nknow I realized that I could, you know, live longer. And\\n\\nthey had put this in me for that reason, you know. They\\n\\nwould work with me to go through the rehab and all the\\n\\nother things until I got to the point of receiving a\\n\\nheartVand that gave I it made me feel good. And my'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='heartVand that gave I it made me feel good. And my\\n\\nconfidence is very high now. And ever since they put it in,\\n\\nI’ve had no adjustment at all and see the light in the\\n\\ntunnel I you know it was psychologicalVthe physical\\n\\nside that improved with my body and the psychological\\n\\nside from my mind I.\\n\\nThe participants consistently discussed feeling that\\n\\nlife had become ‘‘very difficult’’ before the TAH-t. Their\\n\\nsymptoms limited their ability to not only perform ac-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='symptoms limited their ability to not only perform ac-\\n\\ntivities of daily living but also to ‘‘enjoy’’ life. The TAH-t\\n\\ngave them hope for the future because they found that\\n\\nthey were able to perform simple activities without\\n\\nbecoming fatigued or short-breathed. One stated: ‘‘I\\n\\nwasn’t in the same place that I was I And the bridge\\n\\nwas gone behind me but, you know, the bridge went\\n\\nall the way across and I could see the end of it.’’ Another'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='all the way across and I could see the end of it.’’ Another\\n\\nparticipant stated: ‘‘I It’s a step towards where you need\\n\\nto go. I You want to see the finish line.’’\\n\\nReflections\\n\\nThe participants reflected on their experiences before\\n\\nand after receiving the TAH-t. Some of these descriptions\\n\\nwere very general and reflected their HF symptoms.\\n\\n‘‘Tired all the time,’’ ‘‘lethargic,’’ ‘‘unable to do anything,’’\\n\\nand ‘‘exhausted by it’’ were recurring comments. One'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='and ‘‘exhausted by it’’ were recurring comments. One\\n\\nparticipant was more descriptiveVcommenting that\\n\\n‘‘My heart just went to pot. You know, I just went\\n\\ndownhill.’’ Requiring an internal cardiac defibrillator\\n\\nwas described by several participants. One com-\\n\\nmented: ‘‘Every minute of the day I was scared about\\n\\nthe shock.’’ Another participantVreflecting on how\\n\\nhe had deterioratedVcommented:\\n\\nThey couldn’t control my fluid build-up with IV lasix, so'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='he had deterioratedVcommented:\\n\\nThey couldn’t control my fluid build-up with IV lasix, so\\n\\nthey started some other drugs. I by the time I got to four\\n\\nIV bags hanging off four pumps they said ‘‘we’re gonna\\n\\nhave to send you down to Richmond.’’ I spent three days\\n\\nin what a lot of people say is ICU psychosis. I think it’s a\\n\\nvision questVsome people say a near death experience. I\\n\\ndon’t care what it was, it scared the hell out of me. I\\n\\nthey started running testsVGod, so many testsVand'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='they started running testsVGod, so many testsVand\\n\\ncome to find out, an LVAD wouldn’t have done it. So\\n\\nthey started a balloon pump which actually didn’t make\\n\\nme feel better. Ok, I’m fine with that. And then they took\\n\\nme in, split me open, basically rendered me heartless and\\n\\nconnected me to ‘‘big blue’’ as it’s called.\\n\\nIn addition to reflecting about the severity of their\\n\\nHF, some shared their thoughts about dependence on\\n\\nthe TAH-t technology. One participant commented:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='the TAH-t technology. One participant commented:\\n\\n‘‘I was kinda scared because it kept me alive.’’ An-\\n\\nother commented: ‘‘I know that I am married to this\\n\\nmachine now.’’ Another, reflecting on how he got to\\n\\nthe point of needing a transplant, commented: ‘‘I need\\n\\na whole new heartVit was that bad. And like now,\\n\\nit’s like I don’t have one. You know I have this I\\n\\nthing in there I you know how fragile your life is.\\n\\nA machine is keeping me alive.’’\\n\\nFor Better or for Worse'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='A machine is keeping me alive.’’\\n\\nFor Better or for Worse\\n\\nMost participants indicated that symptoms and func-\\n\\ntioning had improved since receiving the TAH-t, but\\n\\nthere were trade-offs that included restrictions imposed\\n\\nby the technology. Comments like ‘‘I feel I like I\\n\\ncompletely normal. That’s the hardest part I like, I feel\\n\\nlike I could just go home, you know, but I have this 400\\n\\npound thing hooked up to me’’ were representative.\\n\\nEven though the participants noted that their symp-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Even though the participants noted that their symp-\\n\\ntoms had improved after insertion of the TAH-t, they\\n\\nfelt that, in some ways, things had gotten worse for\\n\\nLiving With a Total Artificial Heart E3\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nthem. Nearly all of them felt that, in some way, they\\n\\nhad lost some of their freedom. The drive lines are\\n\\n‘‘only so long,’’ the console is ‘‘big and cumbersome,’’'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='‘‘only so long,’’ the console is ‘‘big and cumbersome,’’\\n\\nand they needed nurses to help them walk around in\\n\\nthe hallways. They could no longer independently do\\n\\nthings they had been accustomed to doing, for ex-\\n\\nample, playing with their pets or just getting up and\\n\\ndoing what they wanted to do. Some participants felt\\n\\nas if they were ‘‘in jail’’ or a ‘‘prisoner.’’ One thing\\n\\nthey discussed was the fact that they could not get out\\n\\nof their rooms without someone to pull the console.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='of their rooms without someone to pull the console.\\n\\n‘‘You can’t walk as freely as you want to.’’ This made\\n\\ninteractions with people other than staff members\\n\\ndifficult. ‘‘I am married to this machine now.’’ ‘‘I am\\n\\nlocked in this room. I don’t have the freedom to do\\n\\nwhat I normally would be doing.’’ ‘‘I just lay and look\\n\\nat the pictures and wonder at all the fun I used to\\n\\nhave. I feel a little deprived.’’ ‘‘I am very protective\\n\\nwith that machine. I’m an emotional mess.’’ In addition'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='with that machine. I’m an emotional mess.’’ In addition\\n\\nto feeling like they had lost their freedom, many com-\\n\\nmented on how the wait for a donor was so impersonal.\\n\\n‘‘I have been turned into 12 hour shiftsVgo to bed\\n\\nwith one nurse, wake up with another. But this is\\n\\nwhat waiting for a heart is like.’’ One participant\\n\\nsummed it up by saying: ‘‘It’s like you got a place\\n\\nthat’s called ‘wait.’ You have to wait on this and wait\\n\\non that. Now I’m waiting on a heart.’’\\n\\nSecret Club'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='on that. Now I’m waiting on a heart.’’\\n\\nSecret Club\\n\\nThe secret club was a source of support for the par-\\n\\nticipants. Some described their cardiac rehabilitation\\n\\nsessions as a ‘‘social hour.’’ One participant stated:\\n\\n‘‘You gotta keep your hope. After ‘R’ talked with\\n\\nme I felt better. I get a lot of support from the others.’’\\n\\nThe participants also described the support provided\\n\\nby the staff. Although most of the support these par-\\n\\nticipants described was technical, it made them feel'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='ticipants described was technical, it made them feel\\n\\nsecure about their dependence on the technology. One\\n\\ncommented: ‘‘The staff knows what to do, and are\\n\\nvery well educated, the ones I’ve had know the machine\\n\\nand they’re very well trained on it. And when you see\\n\\nthat, it gives you confidence.’’ Other sources of support\\n\\nfor the participants included social work, chaplains, oc-\\n\\ncupational and physical therapists, as well as family\\n\\nand friends.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='cupational and physical therapists, as well as family\\n\\nand friends.\\n\\nThe participants also felt that their need to be\\n\\nwith family when they could come to the hospital\\n\\nwas supported. One expressed appreciation about\\n\\n‘‘my family being able to come to the room, come\\n\\nhere to the room. We have barbecue, couple friends\\n\\nover, have barbeque here with my wife and a lot of\\n\\nfamily members. You have conversations with them.\\n\\nNot only about how you are, or your family, but'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='family members. You have conversations with them.\\n\\nNot only about how you are, or your family, but\\n\\nwhat are we gonna do to try to get better and get to\\n\\nthe next step. Supportive type roles. That’s a very\\n\\ngood feeling, you know.’’ One comment character-\\n\\nized the bond between and among the participants:\\n\\nI’ve met a lot of other people going through this I you\\n\\nknow, it’s kind of like a secret club I you don’t really\\n\\nwant to be in but it just reminds you that there I there is'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='want to be in but it just reminds you that there I there is\\n\\nso much I too many other things going on in life that\\n\\nwhen you’re out in the regular world living you forget\\n\\nabout what’s happening to other people in a way I you\\n\\nknow, meeting people going through the same, it’s like a\\n\\nweird kind of community that you suddenly become a\\n\\npart ofVand I can’t imagine ever not feeling a part of it\\n\\nfor the rest of our lives ’cause it’s something that we’ll'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='for the rest of our lives ’cause it’s something that we’ll\\n\\nalways be dealing with and I it’s kind of a special\\n\\nexperience even though it’s scary. It just makes you look\\n\\nat life differently and what’s important.\\n\\nCoping and Adaptation\\n\\nThe participants described a variety of strategies they\\n\\nused to cope with and adapt to their life situation.\\n\\nSome relied on their faithVturning to prayer and\\n\\nmeditation. Others used distraction and described\\n\\n‘‘listening toVyou knowVsongs that mean a lot to'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='‘‘listening toVyou knowVsongs that mean a lot to\\n\\nme’’ or watching a movie or television. One partic-\\n\\nipant commented: ‘‘I am away from my wife, away\\n\\nfrom home. Right now my wife just insists that she\\n\\nI she’s there to do a lot of things. Emotionally it\\n\\ndrains you because you just don’t want I I mean I\\n\\nused to I you got to get used to something totally\\n\\ndifferent. The biggest thing is being away from each\\n\\nother. It makes you feel alone sometimes, lonesome.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='other. It makes you feel alone sometimes, lonesome.\\n\\nI try to listen to music to cope with it.’’\\n\\nMost participants developed a routine that helped\\n\\nthem get through each day. For example, several\\n\\ncommented on their morning routine. ‘‘I get up and\\n\\nmake up my bed. Every other day I clean up real\\n\\ngood, wash my hair I wait for breakfast.’’ ‘‘I get up\\n\\nin the morning, change, brush my teeth, try to get my\\n\\nducks in a row and then go about my business.’’ ‘‘I'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='ducks in a row and then go about my business.’’ ‘‘I\\n\\nget up, stand up, get out of bed and sit in the chair,\\n\\nhave coffee I then have OTVscheduled one hourV\\n\\nthen I have physical therapy.’’ Others try to stay\\n\\nconnected to their work. Some get on the computer\\n\\nand ‘‘surf.’’\\n\\nSome participants were resigned to accepting their\\n\\nfate. For some, facing the situation meant being able\\n\\nto confront the possibility of dying. One participant\\n\\nseemed to accept this outcome and commented: ‘‘If'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='seemed to accept this outcome and commented: ‘‘If\\n\\nI die, I die I I’ve had a good life.’’ For others, sharing\\n\\nplans for the future helped them remain positive. One\\n\\nof the most hopeful statements from a participant re-\\n\\nflected his plans for the futureVafter getting a trans-\\n\\nplant. ‘‘Nothing in the world is going to stop me from\\n\\ndoing I I get to see my wife and my daughters every\\n\\nday. I will walk over to see my daughter graduate I\\n\\nand I will walk each one of my daughters down the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='and I will walk each one of my daughters down the\\n\\naisle when they are ready to get married.’’\\n\\nE4 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nDiscussion\\n\\nThe purpose of this qualitative study was to examine\\n\\nthe patient’s experience of living with the TAH-t. Al-\\n\\nthough several studies have examined the experience'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='though several studies have examined the experience\\n\\nof living with the LVAD,3Y5,8Y10 this is the first study\\n\\nexamining the experiences of living with this type of\\n\\nMCSD, providing clinicians and researchers with in-\\n\\nsight into these patients’ unique experiences as well as\\n\\ninto those that are similar in both populations.\\n\\nThe overarching theme in this study, hope for the\\n\\nfuture, was clearly articulated by the participants.\\n\\nHope has been defined in a variety of waysVfor ex-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Hope has been defined in a variety of waysVfor ex-\\n\\nample, a positive future orientation,11Y13 keeping a\\n\\npositive outcome in mind in an uncertain situation,14\\n\\nand a positive expectation of realizing desired out-\\n\\ncomes.15Y17 Using Barnard’s15 definition in which ‘‘hop-\\n\\ning expresses an openness to novelty,’’ unique medical\\n\\nor technological breakthroughs may be seen as sources\\n\\nof hope for recovery. In the population of patients with\\n\\nthe TAH-t, the technology available to support them'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='the TAH-t, the technology available to support them\\n\\nuntil a donor heart becomes available is a reality and\\n\\nprovides hope that this interim step will help them sur-\\n\\nvive to transplant. Lohne and Severinsson18 suggest that\\n\\nhope for a specific outcome and the expectation that it\\n\\nwill occur are fueled by the fulfillment of interim out-\\n\\ncomes. Consistent with being bridged to transplant, out-\\n\\ncomes achieved along the way to a return to a state of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='comes achieved along the way to a return to a state of\\n\\nhealth that previously existed may bolster expectations of\\n\\nrecovery. In this study, hope for the future was demon-\\n\\nstrated in several ways, but, most prevalently, the par-\\n\\nticipants envisioned a future and described what they\\n\\nwould do after transplant.\\n\\nReflections\\n\\nAs the participants looked back on their health before\\n\\nthe TAH-t, they began to realize how ill they had been\\n\\nand the benefit of ‘‘Big Blue.’’ These narratives pro-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='and the benefit of ‘‘Big Blue.’’ These narratives pro-\\n\\nvided an opportunity for the participants to tell their\\n\\nstory, and, in doing so, they came to envision their fu-\\n\\nture. These participants did not dwell on their past.\\n\\nInstead, their reflections on the progress they had made\\n\\nseemed to give them hope. A similar phenomenon was\\n\\ndescribed by Casida and colleagues5 in their phenom-\\n\\nenologic study of lifestyle adjustments in long-term'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='enologic study of lifestyle adjustments in long-term\\n\\nrecipients of LVAD. In this study, the authors proposed\\n\\nthat it was the participants’ lived experiences before\\n\\nimplantation that set the stage for early adjustment to\\n\\nthe device. As the interviews with the participants com-\\n\\nmenced, the participants reflected on and began to\\n\\nrecall what life was like before the LVAD. They shared\\n\\nvivid descriptions of having a poor quality of life because'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='vivid descriptions of having a poor quality of life because\\n\\nof HF symptoms and the physical limitations imposed by\\n\\ntheir illness, which are similar to the descriptions of the\\n\\nparticipants in the current study.\\n\\nThe participants in this study also reflected on the\\n\\nexperience of having a mechanical device keeping them\\n\\nalive. This realization is consistent with the findings\\n\\nreported by Chapman and colleagues8 in their study of\\n\\npsychosocial issues in patients with the LVAD. The'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='psychosocial issues in patients with the LVAD. The\\n\\npatients reported fear because they realized they were\\n\\ndependent on a machineVbut the fear lasted only for a\\n\\nshort period. In the current study, we observed a similar\\n\\nphenomenon. The participants were very much aware\\n\\nof their dependence on the technology, but this aware-\\n\\nness seemed to be heightened by the fact that their\\n\\nnative heart had been explanted to receive the TAH-t.\\n\\nChapman and colleagues8 attributed the resolution of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Chapman and colleagues8 attributed the resolution of\\n\\nfear to the trust the patients developed that the tech-\\n\\nnology would not fail. In our study, the participants\\n\\nacknowledged that the support from nurses and others\\n\\nwho had been part of their experience had made them\\n\\nmore confident about their situation, but other con-\\n\\ntributing factors were not addressed.\\n\\nFor Better or for Worse\\n\\nZambroski and colleagues3Vwho studied patients\\n\\nliving with the LVADVidentified facing the unknown,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='living with the LVADVidentified facing the unknown,\\n\\nfeeling confined, living with fear, as well as hope for\\n\\nthe future as key issues for patients. The patients with\\n\\nthe TAH-t who participated in the current study also\\n\\nexpressed similar issues but specifically identified feel-\\n\\ning confined as a problem. Although it is clear that\\n\\nfunctional ability improved on the TAH-t, despite this\\n\\nbenefit, it is important to recognize that these patients'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='benefit, it is important to recognize that these patients\\n\\nalso had to deal with the psychological aspects of\\n\\nbeing technologically dependent on an artificial organ.\\n\\nBased on their descriptions of being a ‘‘prisoner’’ or\\n\\nbeing ‘‘in jail,’’ the patients reported feeling confined\\n\\nwhile on the TAH-t. Also contributing to feelings of\\n\\nconfinement was a lack of control expressed because\\n\\nthe patients had to rely on someone else just to leave'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='the patients had to rely on someone else just to leave\\n\\ntheir roomsVmaking them feel ‘‘locked in this room.’’\\n\\nSimilar circumstances were described by participants\\n\\nin a focus group study in which the patients and the\\n\\nfamily were asked about their experiences in waiting\\n\\nfor a donor heart.19 These patients also experienced\\n\\nconfinement, loss of independence, and lack of control.\\n\\nNurses responded by doing the ‘‘extra little things’’ for\\n\\nthese hospitalized patientsVthings that made them feel'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='these hospitalized patientsVthings that made them feel\\n\\nnormal. Strategies aimed at ‘‘normalizing’’ their hospital\\n\\nstay as much as possibleVcoupled with patients’ im-\\n\\nproved functional abilityVmay help to improve those\\n\\naspects of the TAH-t experience considered ‘‘the worst’’\\n\\nby patients requiring device support.\\n\\nSecret Club\\n\\nUnderstanding how patients respond when faced with\\n\\na life-changing situation such as the implant of the\\n\\nTAH-t can help significant others and healthcare'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='TAH-t can help significant others and healthcare\\n\\nLiving With a Total Artificial Heart E5\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nprofessionals better understand how to interact with and\\n\\nsupport them. In studies examining the experience of\\n\\npatients bridged to transplant with the LVAD, similar to\\n\\nthe findings of patients with the TAH-t in the current\\n\\nstudy, the patients with the LVAD all relied on the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='study, the patients with the LVAD all relied on the\\n\\nsupport from family, parents, spouses, and children to\\n\\nhelp them through the transition.9,20 In addition to the\\n\\nsupport from significant others, the professionals on\\n\\nthe unit became sources of support. Although reliance\\n\\non healthcare professionals was often because of their\\n\\ntechnical expertise, the patients became more confident\\n\\nas a consequence of their knowledge about the technol-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='as a consequence of their knowledge about the technol-\\n\\nogy. We speculate that this may have occurred because of\\n\\npatient and family education and the reassurance the\\n\\npatients received through these interactions.\\n\\nThis themeVthe secret clubValso suggested that\\n\\nthe participants got support from others who shared\\n\\ntheir experiencesVwho were living through the ex-\\n\\nperience as they were. They spoke of a bond that\\n\\nwould always exist. Several studies on the impact of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='would always exist. Several studies on the impact of\\n\\npeer support groups for patients with chronic health\\n\\nproblems (eg, implantable cardiac defibrillator, can-\\n\\ncer, chronic pulmonary disease) suggest that this type\\n\\nof social support provides encouragement, informa-\\n\\ntion, and understanding and, over time, can affect out-\\n\\ncomes.21Y23 The participants in our study were able to\\n\\nsupport one another because of an understanding about\\n\\nthe experience and an ability to provide encourage-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='the experience and an ability to provide encourage-\\n\\nment. Having a former or current patient with the\\n\\nTAH-t spend time to answer questions and describe\\n\\nhis/her experience could provide encouragement and\\n\\nhope for the new recipient. In addition, interdisciplin-\\n\\nary groups composed of nurses, occupational and phys-\\n\\nical therapists, chaplains, and social workers must take\\n\\nthe lead in identifying strategies for helping patients\\n\\nand family members deal with psychosocial and phys-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='and family members deal with psychosocial and phys-\\n\\niologic issues. Weekly support group meetings for these\\n\\n‘‘Hopeful Hearts’’ may provide support for them dur-\\n\\ning their wait for a donor heart. Although it was not an\\n\\naim of this study to evaluate outcomes of peer support\\n\\ngroups for these patients, posttransplantation follow-up\\n\\nstudies might reveal improved outcomes such as adher-\\n\\nence to self-care requirements.\\n\\nCoping and Adaptation'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='ence to self-care requirements.\\n\\nCoping and Adaptation\\n\\nThe implantation of the TAH-t represents a health cri-\\n\\nsis for those patients with HF who require this life-\\n\\nsaving technology as a bridge to transplantation. The\\n\\npsychosocial disequilibrium experienced by patients dur-\\n\\ning the wait for a donor organ has been examined by\\n\\nseveral investigators who report that candidates, both\\n\\nthose requiring and those not requiring MCSD, expe-\\n\\nrience several stressors because of candidacy for a do-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='rience several stressors because of candidacy for a do-\\n\\nnor organ.10,24Y27 Although our study was limited to\\n\\npatients with the TAH-t who were waiting for a do-\\n\\nnor, they experienced stressors similar to those re-\\n\\nported in these previous studies (eg, dependency on\\n\\nothers, dependency on a device, uncertainty about their\\n\\nfuture, physical limitations, isolation, and loss of con-\\n\\ntrol). The patients described coping in a variety of ways'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='trol). The patients described coping in a variety of ways\\n\\nthat are similar to those reported by other investiga-\\n\\ntors.19,24 One important strategy identified was estab-\\n\\nlishing a routine. It helped to normalize the experience.\\n\\nOthers distracted themselves using music and other\\n\\nforms of entertainment. This suggests that clinicians\\n\\nmight enable positive coping by providing opportunities\\n\\nfor engagement in these and other types of activities'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='for engagement in these and other types of activities\\n\\nthat patients enjoy during their hospitalization.\\n\\nThose participants who engaged in spiritual activities\\n\\nsuch as prayer and meditation might benefit from what\\n\\nHays and colleagues28 described as clergy-laity support\\n\\nas a replacement for attendance at worship services.\\n\\nTheir study examined whether visits by clergy or laity\\n\\nprovide benefits to patients with serious illness who\\n\\ncould not attend (or may have had difficulty attending)'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='could not attend (or may have had difficulty attending)\\n\\nreligious services. A similar type of support could be\\n\\nprovided in the hospital by chaplains and lay volun-\\n\\nteers from religious organizations.\\n\\nOver time, the patients were able to adapt to and\\n\\naccept their situation while remaining optimistic toward\\n\\nthe future. It was surprising that few focused on the\\n\\nmechanical aspect of the machine. Sleep disturbances\\n\\ndid not seem to be an issue for the participants. They'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='did not seem to be an issue for the participants. They\\n\\nidentified the ‘‘noise’’ to be distracting initially, but it\\n\\nbecame ‘‘soothing’’ to many. ‘‘I won’t lie I I was\\n\\nscared and I still am I’’ ‘‘It’s just part of you.’’ ‘‘I got\\n\\nto the point where I trust a lot more.’’ This type of\\n\\npositive outlook and expectation for the future is not\\n\\nunusual in the population with MCSD and has been\\n\\ndescribed in at least 1 other study of patients with\\n\\nLVADs.5 The participants spoke about limited mobil-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='LVADs.5 The participants spoke about limited mobil-\\n\\nity with the TAH-t, separation from family, and the\\n\\nneed to have structure in their day as well. No patients\\n\\ndied while awaiting heart transplantation.\\n\\nLimitations\\n\\nIn qualitative research, one limitation concerns the\\n\\ninterpretation of research findings. The interpretation\\n\\nof this data was vulnerable to alternative meaning that\\n\\nmay logically be made by other patients with other\\n\\nexperiences. These study findings were validated by'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='experiences. These study findings were validated by\\n\\nthe participants and the staff participants. There are,\\n\\nhowever, limitations that must be addressed. Our find-\\n\\nings should be interpreted with caution because there\\n\\nwas wide variability in the length of time that the par-\\n\\nticipants had been receiving TAH-t therapy. Thus, some\\n\\nparticipants had more time to adjust and rehabilitate\\n\\nthan did others. Our findings may have been influenced\\n\\nby the length of time that some of the participants'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='by the length of time that some of the participants\\n\\nhad been receiving TAH-t therapy; that is, however, the\\n\\nE6 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\nreality of waiting for a donor organ. The wait is often\\n\\nlong, and patients have time to adjust and envision\\n\\ntheir future after transplant.\\n\\nImplications'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='long, and patients have time to adjust and envision\\n\\ntheir future after transplant.\\n\\nImplications\\n\\nThe findings from this study provide insight to cli-\\n\\nnicians and researchers regarding patients’ experiences\\n\\nin living with the TAH-t. This research, despite its\\n\\nlimitations, sensitizes healthcare providers who work\\n\\nwith this patient population to the need to address the\\n\\nissues illuminated by this qualitative study. First,\\n\\nallowing the patients to tell their stories may impress'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='allowing the patients to tell their stories may impress\\n\\nupon them and others the benefits derived from the\\n\\nTAH-t treatment and may help them deal with the\\n\\nrestrictions imposed by being device dependent. Social\\n\\nsupport from healthcare professionals is particularly\\n\\nimportant, but clinicians need to maintain therapeutic\\n\\nrelationships with these patients to provide effective\\n\\ncare. Relationships with other recipients of the TAH-t\\n\\nare also important, and clinicians caring for the patients'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='are also important, and clinicians caring for the patients\\n\\ncan enhance these opportunities through support groups\\n\\nthat bring patients and clinicians together. Future re-\\n\\nsearch efforts to determine the impact of these sup-\\n\\nportive relationships on coping and adaptation during\\n\\nthe wait for a donor, as well as after transplantation,\\n\\nmay provide further insight into strategies that pro-\\n\\nmote positive psychosocial outcomes.\\n\\nThe participants in this study described feeling con-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='mote positive psychosocial outcomes.\\n\\nThe participants in this study described feeling con-\\n\\nfined because of their dependence on the TAH-t tech-\\n\\nnology. Both physical and occupational therapists\\n\\nshould be involved in helping devise activities that get\\n\\npatients out of their rooms and activities aimed at re-\\n\\nducing their feelings of confinement. Family visits pro-\\n\\nvide opportunities for much-needed socialization and\\n\\npromote supportive interaction among family members.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='promote supportive interaction among family members.\\n\\nAnother aspect to consider is the future of MCSDs.\\n\\nAs this research was ending, the Freedom Driver\\n\\n(SynCardia Systems, Inc; Tucson, Arizona) study was\\n\\nbeginning to enroll participants. This smaller portable\\n\\ndriver will allow patients to be discharged home on the\\n\\nTAH-t. How will patients cope at home? What will it be\\n\\nlike living with a smaller driver? What type of com-\\n\\nplications will they experience? Although some of their'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='plications will they experience? Although some of their\\n\\nexperiences may mirror that of those confined to the\\n\\nhospital, these will be key questions to explore.\\n\\nSummary and Conclusions\\n\\nIn summary, the purpose of this study was to de-\\n\\nscribe the lived experience of patients currently sup-\\n\\nported by the TAH-t awaiting transplant. The findings\\n\\nprovide both clinicians and researchers with insight into\\n\\nthese patients’ unique experiences as well as into those'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='these patients’ unique experiences as well as into those\\n\\nthat are similar in both patients with LVAD and patients\\n\\nwith TAH-t and provide direction for interventions\\n\\nand future research. In the era of advancing technol-\\n\\nogy, it will be important to consider patients’ lived\\n\\nexperiences on the portable TAH-t as well.\\n\\nAcknowledgments\\n\\nThe authors would like thank the Adult Health and\\n\\nNursing Systems at the Virginia Commonwealth Uni-\\n\\nversity School of Nursing for their support.\\n\\nREFERENCES'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='versity School of Nursing for their support.\\n\\nREFERENCES\\n\\n1. Heart Failure Society of America. Quick facts and infor-\\n\\nmation about heart failure. http://www.hfsa.org/heart_failure_\\n\\nfacts.asp. Accessed June 25, 2012.\\n\\n2. Platis A, Larson DF. Cardio West temporary total artificial\\n\\nheart. Perfusion. 2009;24(5):341Y346.\\n\\n3. Zambroski CH, Combs P, Cronin SN, Pfeffer C. Edgar\\n\\nAllan Poe, ‘‘The Pit and the Pendulum,’’ and ventricular\\n\\nassist devices. Crit Care Nurse. 2009;29(6):29Y39.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='assist devices. Crit Care Nurse. 2009;29(6):29Y39.\\n\\n4. Savage LS, Canody C. Life with a left ventricular assist device:\\n\\nthe patient’s perspective. Am J Crit Care. 1999;8(5):340Y343.\\n\\n5. Casida JM, Marcuccilli L, Peters RM, Wright S. Lifestyle\\n\\nadjustments of adults with long-term implantable left ven-\\n\\ntricular devices: a phenomenologic inquiry. Heart Lung. 2011;\\n\\n4(6):511Y520.\\n\\n6. Giorgi A. Phenomenology and Psychological Research.\\n\\nPittsburgh, PA: Duquesne University Press; 1985.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Pittsburgh, PA: Duquesne University Press; 1985.\\n\\n7. Colaizzi P. Psychological research as phenomenologists view\\n\\nit. In: Valle R, King M, eds. Existential-Phenomenological\\n\\nAlternatives for Psychology. New York, NY: Oxford Uni-\\n\\nversity Press; 1978.\\n\\n8. Chapman E, Parameshwar J, Jenkins D, Large S, Tsui S.\\n\\nPsychosocial issues for patients with ventricular assist devices:\\n\\na qualitative pilot study. Am J Crit Care. 2007;16(1):72Y81.\\n\\n9. Hallas C, Banner NR, Wray J. A qualitative study of the'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='9. Hallas C, Banner NR, Wray J. A qualitative study of the\\n\\npsychosocial experience of patients during and after mechan-\\n\\nical cardiac support. J Cardiovasc Nurs. 2009;24(1):31Y39.\\n\\n10. Wray J, Hallas CN, Banner NR. Quality of life and psy-\\n\\nchosocial well-being during and after left ventricular assist\\n\\ndevice support. Clin Transplant. 2007;21(6):622Y627.\\n\\n11. Kylma J, Vehvilainen-Julkunen K, Lahvdevirta J. Dynamics\\n\\nof hope in HIV/AIDS affected people: an exploration of sig-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='of hope in HIV/AIDS affected people: an exploration of sig-\\n\\nnificant others’ experiences. Res Theory Nurs Pract. 2003;\\n\\n17(5):191Y205.\\n\\n12. Kylma J, Vehvilainen-Julkunen K. Hope in nursing research:\\n\\na meta-analysis of the ontological and epistemological foun-\\n\\ndations on hope. J Adv Nurs. 1997;25(6):364Y371.\\n\\n13. Scheier M, Carver C. Effects of optimism on psychological\\n\\nand physical well-being: theoretical overview and empiri-\\n\\ncal update. Cognit Ther Res. 1992;16(3):201Y228.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='cal update. Cognit Ther Res. 1992;16(3):201Y228.\\n\\n14. Verhaeghe S, van Zuren F, Defloor T, Duijnstee M,\\n\\nGrypodonck M. The process and meaning of hope for fam-\\n\\nily members of traumatic coma patients in intensive care.\\n\\nQual Health Res. 2007;17:730Y743.\\n\\nWhat’s New and Important\\n\\nh This is the first study examining the experiences of\\n\\npatients living with the total artificial heart to provide\\n\\nclinicians and researchers with insight into these\\n\\npatients’ unique experiences.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='clinicians and researchers with insight into these\\n\\npatients’ unique experiences.\\n\\nh It is important to recognize the psychological\\n\\naspects of being technologically dependent on an\\n\\nartificial organ.\\n\\nLiving With a Total Artificial Heart E7\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.\\n\\n15. Barnard D. Chronic illness and the dynamics of hoping.\\n\\nIn: Toombs K, Barnard D, Carson R, eds. Chronic Illness:'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='In: Toombs K, Barnard D, Carson R, eds. Chronic Illness:\\n\\nFrom Experience to Policy. Bloomington, Indiana: Indiana\\n\\nUniversity Press; 1995.\\n\\n16. Smith B, Sparks AC. Men, sport, spinal cord injury, and\\n\\nnarratives of hope. Soc Sci Med. 2005;61:1095Y1105.\\n\\n17. Ezzy D. Illness narratives: time, hope, and HIV. Soc Sci\\n\\nMed. 2000;50:605Y617.\\n\\n18. Lohne V, Severinsson E. Hope during the first months after\\n\\nacute spinal cord injury. J Adv Nurs. 2004;47:279Y286.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='acute spinal cord injury. J Adv Nurs. 2004;47:279Y286.\\n\\n19. Haugh KH, Salyer J. Needs of patients and families dur-\\n\\ning the wait for a donor heart. Heart Lung. 2007;36:\\n\\n319Y329.\\n\\n20. Overgaard D, Kjeldgaard HG, Egerod I. A qualitative study of\\n\\nthe illness experience and vocational adjustment of patients\\n\\nwith left ventricular assist device. J Cardiovasc Nurs. 2012;\\n\\n27(5):394Y402. http://www.ncbi.nlm.nih.gov/pubmed/21912269.\\n\\nAccessed June 26, 2012.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='27(5):394Y402. http://www.ncbi.nlm.nih.gov/pubmed/21912269.\\n\\nAccessed June 26, 2012.\\n\\n21. Ahlberg K, Nordner A. The importance of participation in\\n\\nsupport groups for women with ovarian cancer. Oncol\\n\\nNurs Forum. 2006;33:E53YE61.\\n\\n22. Alberto J, Joyner B. Hope, optimism, and self-care among\\n\\nBetter Breathers Support Group members with chronic\\n\\nobstructive pulmonary disease. Appl Nurs Res. 2008;21:\\n\\n212Y217.\\n\\n23. Williams AM, Young J, Nikoletti S, McRae S. Reasons for'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='212Y217.\\n\\n23. Williams AM, Young J, Nikoletti S, McRae S. Reasons for\\n\\nattending and not attending a support group for recipients\\n\\nof implantable cardioverter defibrillators and their carers.\\n\\nInt J Nurs Pract. 2004;10:127Y133.\\n\\n24. Cupples SA, Nolan MT, Augustine SM, Kynoch D. Per-\\n\\nceived stressors and coping strategies among heart trans-\\n\\nplant candidates. J Transpl Coord. 1998;8:179Y187.\\n\\n25. Grady KL, Meyer PM, Dressler D, et al. Change in quality'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='25. Grady KL, Meyer PM, Dressler D, et al. Change in quality\\n\\nof life from after left ventricular assist device implantation\\n\\nto after heart transplantation. J Heart Lung Transplant.\\n\\n2003;22:1254Y1267.\\n\\n26. Jalowiec A, Grady KL, White-Williams C. Stressors in patients\\n\\nawaiting a heart transplant. Behav Med. 1994;19:145-154.\\n\\n27. Porter RR, Krout L, Parks V, et al. Perceived stress and\\n\\ncoping strategies among candidates for heart transplantation'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='coping strategies among candidates for heart transplantation\\n\\nduring the organ waiting period. J Heart Lung Transplant.\\n\\n1994;13:102Y107.\\n\\n28. Hays JC, Wood L, Steinhauser K, Olson MK, Lindquist JH,\\n\\nTulsky JA. Clergy-laity support and patients’ mood during\\n\\nserious illness: a cross-sectional epidemiologic study. Palliat\\n\\nSupport Care. 2011;9:273Y280.\\n\\nE8 Journal of Cardiovascular Nursing x January/February 2014'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\Living_With_a_Total_Artificial_Heart.txt'}, page_content='Support Care. 2011;9:273Y280.\\n\\nE8 Journal of Cardiovascular Nursing x January/February 2014\\n\\nCopyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='J THoRAc CARDIOVASC SURG 87:825-831, 1984\\n\\nThe artificial heart in human subjects\\n\\nIn preparationfor clinical implantationof the Utah J-7 pneumatic artificial heart as a permanentcardiac\\n\\nsubstitute, the device wasimplanted into five brain-deadhumansubjects.This report presentsour results\\n\\nand detailsour twomostsuccessfu1 trials.Three differentsurgicalimplanttechniques wereutilized in the\\n\\nfive subjects. Becauseof the unique \"no risk\" situationof the subjects,the function of the artificial heart'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='could be tested in a manner not advisable in patients, but necessary for clinical preparation. The\\n\\nimplantable total artificial heart wasable to maintain physiological hemodynamics in twosubjectsfor 41\\n\\nand 72 hours at which time the trials were electively terminated.\\n\\nJack Kolff, M.D., G. Michael Deeb, M.D., Nicholas C. Cavarocchi, M.D.,\\n\\nJerome B. Riebman, M.D., Donald B. Olsen, D.V.M.,* and Peter S. Robbins, M.D.,\\n\\nPhiladelphia. Pa.\\n\\nRtients with end-stage cardiac disease who are not'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Philadelphia. Pa.\\n\\nRtients with end-stage cardiac disease who are not\\n\\naccepted for cardiac transplantation may be candidates\\n\\nfor implantation of a total artificial heart (TAH). The\\n\\ndesign of a TAH was first undertaken by Drs. T. Akutsu\\n\\nand W. J. Kolff in 1958. They described a pneumati-\\n\\ncally driven, polyvinyl chloride heart consisting of two\\n\\ncollapsible sacs in one plastic air chamber. The simplic-\\n\\nity of design and the ability to control the heart from an'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='ity of design and the ability to control the heart from an\\n\\nexternally located energy and control module have made\\n\\npneumatic ventricles the most successful in terms of\\n\\nanimal longevity.2-4\\n\\nSeveral groups have reported calf survival for over 6\\n\\nmonths. These long-term experiments have resulted in\\n\\ncomplications that may well be unique to the calf.\\n\\nContinuous growth of the young calves causes their\\n\\nneeds to exceed the capabilities of the implanted TAH.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"needs to exceed the capabilities of the implanted TAH.\\n\\nCalcification of the polyurethane flexing diaphragm also\\n\\nhas been observed after prolonged survival and may be\\n\\nsimilar to the early calcification seen in valve hetero-\\n\\ngrafts implanted in children.' Because of the successful\\n\\nbench and animal trials with the Utah (J-7) TAH,t the\\n\\nFood and Drug Administration has given permission to\\n\\nproceed with clinical trials in selected human subjects at\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='proceed with clinical trials in selected human subjects at\\n\\nFrom the Department of Cardio-Thoracic Surgery, Temple University\\n\\nHospital, Philadelphia, Pa.\\n\\nReceived for publication April II, 1983.\\n\\nAccepted for publication July 18, 1983.\\n\\nAddress for reprints: Dr. Jack Kolff, Temple University Hospital,\\n\\n340IN. Broad St., Philadelphia, Pa. 19140.\\n\\nDepartment of Artificial Organs at the Universityof Utah, Salt Lake\\n\\nCity, Utah.\\n\\ntJ-7 ventricles obtained from Kolff Medical, Inc., Salt Lake City,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='City, Utah.\\n\\ntJ-7 ventricles obtained from Kolff Medical, Inc., Salt Lake City,\\n\\nUtah.\\n\\nthe University of Utah. Dr. Barney Clark was the first\\n\\npatient selected in that study. In preparation for these\\n\\nand future studies in living human subjects at Temple\\n\\nUniversity, our cardiac surgical team considered it\\n\\nnecessary to test the anatomic fit and the functional\\n\\ncapabilities of the ventricles in brain-dead human sub-\\n\\njects.\\n\\nMethods and materials'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='capabilities of the ventricles in brain-dead human sub-\\n\\njects.\\n\\nMethods and materials\\n\\nThe Utah TAH is constructed of polyurethane and\\n\\nhas a continuous smooth inner surface. It is pneumati-\\n\\ncally powered and consists of two separate ventricles. As\\n\\nin the original design by Kwan-Gett, the blood chamber\\n\\nof the J-7 designed by Jarvik is separated from the air\\n\\nchamber by a flexible diaphragm.\" The maximum\\n\\nend-diastolic volume of each ventricle is 150 mI and its'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='end-diastolic volume of each ventricle is 150 mI and its\\n\\nmaximum stroke volume is 100 mI, for an ejection\\n\\nfraction of 67%. Two Bjork-Shiley disc valves* achieve\\n\\nunidirectional flow in each ventricle. Connections to the\\n\\nnatural atria and great vessels are made with a \"quick-\\n\\nconnect\" system. This system consists of a cloth cuff or\\n\\ngraft with a flexible polyurethane ring which, after it is\\n\\nsewn onto the atrium or artery, snaps over a rigid collar'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='sewn onto the atrium or artery, snaps over a rigid collar\\n\\nonto either the inflow or outflow port of the ventricle.\\n\\nThe source of compressed air is controlled by electri-\\n\\ncally driven solenoid valves within the Utah Heart\\n\\nDriver (UHD).t The UHD controls heart rate, percent\\n\\nsystole, and maximum ventricular driving pressure for\\n\\neach ventricle. The UHD is connected to the intratho-\\n\\n\"Bjork-Shiley valves obtained from Shiley Laboratories,\\n\\nIrvine,\\n\\nCalif.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='\"Bjork-Shiley valves obtained from Shiley Laboratories,\\n\\nIrvine,\\n\\nCalif.\\n\\ntUtah Heart Driver obtained from Kolff Medical, Inc., Salt Lake\\n\\nCity, Utah.\\n\\n825\\n\\n8 2 6\\n\\nKolff et al.\\n\\nThe Journal of\\n\\nThoracic and Cardiovascular\\n\\nSurgery\\n\\nFig. lA. The pneumatic compressor, extra air tanks, and the Utah Heart Driver (on a wheelchair) needed to\\n\\npower the man with an artificial heart. Efforts are in progress to miniaturize the external hardware.\\n\\nracic ventricles VIa two 6 foot long air hoses (Fig.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='racic ventricles VIa two 6 foot long air hoses (Fig.\\n\\nIA).\\n\\nThe artificial cardiac cycle consists of systole and\\n\\ndiastole. During systole a pulse of air enters the air\\n\\nchamber and empties the blood from the juxtaposed\\n\\nFig. 2. Chest roentgenogram of Case 4: The left ventricle is\\n\\nin the left pleural cavity and the right ventricle is inside the\\n\\npericardial sac.\\n\\nblood chamber. During diastole the air chamber is\\n\\nvented to the atmosphere so that venouspressure fillsthe'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"vented to the atmosphere so that venouspressure fillsthe\\n\\nventricle with blood.The stroke volumeof each ventricle\\n\\nis therefore controlled by the venous pressure in its\\n\\nrespective atrium, an arrangement which results in a\\n\\nbalanced circulation. This principle is considered to be\\n\\nStarling's law of the TAH 7 (Fig. lB). Either ventricle\\n\\ncan be stopped by reducing the air driving pressure to\\n\\nzero.\\n\\nStandard radionuclide ventriculographic techniques\\n\\nvacuum\\n\\n15\\n\\n10\\n\\n5\\n\\n---\\n\\n,...- ---- ,.,---\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Standard radionuclide ventriculographic techniques\\n\\nvacuum\\n\\n15\\n\\n10\\n\\n5\\n\\n---\\n\\n,...- ---- ,.,---\\n\\n/\\'\\n\\n/\\'\\n\\n/\\'\\n\\n,/\\n\\n,/\\n\\n/\\'\\n\\n/\\n\\n/\\'\\n\\n/\\n\\n/\\'\\n\\n/\\n\\n/\\n\\nincreased./-\\n\\n/decreased\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\n/\\n\\nI\\n\\n/\\n\\nL/min.\\n\\n8\\n\\n6\\n\\n4\\n\\no\\n\\n12\\n\\n10\\n\\nFig. lB. The \"Starling\" curve. Each ventricle contains a very\\n\\ncompliant diaphragm that allows it to fill in response to its\\n\\nfilling pressure. At a given heart rate an increase in atrial'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='filling pressure. At a given heart rate an increase in atrial\\n\\npressure produces an increase in stroke volume and cardiac\\n\\noutput. The venous pressure-response curve can be shifted by\\n\\nadding some vacuum to the air exhaust tube during diastole.\\n\\nThe air pressure controls can be adjusted so that the heart\\n\\nfunctions on the steep portion of the \"Starling\" curve and each\\n\\nventricle has a degree of self regulation. The two ventricleswill'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"ventricle has a degree of self regulation. The two ventricleswill\\n\\nthen seek equilibrium in the pulmonary and systemic circula-\\n\\ntions under various fluctuating conditions of left and right\\n\\natrial pressures.\\n\\nVolume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nArtificial heart in human subjects\\n\\n827\\n\\nTable I. Summary offive brain-dead, hemodynamically stable human subjects in whom the Utah (J-7) TAH\\n\\nwas implanted\\n\\nBleeding\\n\\nPulmonary\\n\\nedema\\n\\nBleeding\\n\\nElective\\n\\nElective\\n\\n2\\n\\n10\\n\\n1'/2\\n\\n41\\n\\n72\\n\\nHetero.\\n\\nOrtho,\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Bleeding\\n\\nPulmonary\\n\\nedema\\n\\nBleeding\\n\\nElective\\n\\nElective\\n\\n2\\n\\n10\\n\\n1\\'/2\\n\\n41\\n\\n72\\n\\nHetero.\\n\\nOrtho,\\n\\nHetero.\\n\\nOrtho.\\n\\nOrtho.\\n\\nOrtho.\\n\\nOrtho.\\n\\nOrtho.\\n\\nHetero.\\n\\nOrtho.\\n\\nNeither\\n\\nLeft\\n\\nLeft\\n\\nLeft\\n\\nNeither\\n\\n19.5\\n\\n19.5\\n\\n132\\n\\nISO\\n\\n93\\n\\n160\\n\\n145\\n\\n5 7\"\\n\\n5\\'10\"\\n\\n4\\'11\"\\n\\n5\\'10\"\\n\\n6\\'2\"\\n\\nF\\n\\nM\\n\\nF\\n\\nM\\n\\nM\\n\\n54\\n\\n26\\n\\n20\\n\\n23\\n\\n19\\n\\nI\\n\\n2\\n\\n3\\n\\n4\\n\\n5\\n\\nCase\\n\\nAge\\n\\nWeight\\n\\nAP chest\\n\\nKidney\\n\\nVentricular position\\n\\nTAH pump\\n\\nReason\\n\\nNo.\\n\\n(yr)\\n\\nSex\\n\\nHeight\\n\\n(Ib)\\n\\ndiameter (em)\\n\\ndonated\\n\\nLeft\\n\\nI\\n\\nRight\\n\\ntime (hr)\\n\\nterminated\\n\\n,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='No.\\n\\n(yr)\\n\\nSex\\n\\nHeight\\n\\n(Ib)\\n\\ndiameter (em)\\n\\ndonated\\n\\nLeft\\n\\nI\\n\\nRight\\n\\ntime (hr)\\n\\nterminated\\n\\n,\\n\\nLegend: AP. Anterposterior. TAH. Total artificial heart. Ventricular position refers to whether or not the particular ventricle lies within its usual intrapericardial position.\\n\\nOrthotopic (Ortho.) means within and heterotopic (Hetero.) means outside the pericardial sac.\\n\\ngated to the UHD were used to obtain filling rates,\\n\\nemptying rates, and ejection fractions of either the right'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='emptying rates, and ejection fractions of either the right\\n\\nor the left ventricle.\\n\\nExperience in human subjects\\n\\nFrom May, 1981, to December, 1982, five TAHs\\n\\nwere implanted in five human cadavers, three of whom\\n\\nwere kidney donors. Informed consent for organ dona-\\n\\ntion and the implant studies was obtained from the\\n\\nrelatives. The fourth and fifth implants are presented in\\n\\ndetail.\\n\\nCASE 4. A young man 5 feet, 10 inches tall and weighing'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"detail.\\n\\nCASE 4. A young man 5 feet, 10 inches tall and weighing\\n\\n160 pounds,with an external anteroposterior chest diameter of\\n\\n19.5 em, was pronounced dead according to accepted criteria\\n\\nfor brain death.' In the operating room after one kidney was\\n\\ntaken for renal transplantation, the patient was placed on total\\n\\ncardiopulmonary bypass and the natural\\n\\nventricles were\\n\\nremoved along the atrioventricular groove.\\n\\nAtrial quick-connect rings were sewn onto the open tricus-\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Atrial quick-connect rings were sewn onto the open tricus-\\n\\npid and mitral anuli and long arterial grafts were sutured to\\n\\nthe transected aorta and pulmonary artery. The left pleura was\\n\\nopened wide and the artificial left ventricle was placed inside\\n\\nthe pleural cavity so that there would be sufficient room in the\\n\\npericardial sac for the right ventricle.\\n\\nIn an atmosphere of carbon dioxide, the left and right\\n\\nventricles were attached to their inflow and outflow conduits.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='ventricles were attached to their inflow and outflow conduits.\\n\\nThe subject was slowlyweaned from cardiopulmonary bypass\\n\\nand the ventricles were allowed to take over full circulatory\\n\\nsupport. After decannulation the sternum and skin were\\n\\nclosed.\\n\\nIn the intensive care unit he required fluid and potassium\\n\\nreplacement, both depleted by diabetes insipidus. He also\\n\\nexhibitedhypoxia, acidosis,and pulmonary edema. These were\\n\\ncontrolled by positive end-expiratory pressure and by main-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"controlled by positive end-expiratory pressure and by main-\\n\\ntaining low left atrial pressures while phenylephrine was used\\n\\nto support the blood pressure. Eventually, these pulmonary\\n\\ndifficulties were controlled and all pharmacologic agents\\n\\nexcept for vasopressin were stopped. Hemodynamically, the\\n\\nsubject's condition became progressivelymore stable, and we\\n\\nwere able to test the heart by varying systolefrom 20%to 80%\\n\\nand the heart rate from 60 to 180 beats/min, while measuring\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='and the heart rate from 60 to 180 beats/min, while measuring\\n\\nejection fractions by radionuclide methods. The experiment\\n\\nwas electively terminated 41 hours after implantation to\\n\\naccommodate funeral arrangements.\\n\\nCASE 5. A young man 6 feet, two inches tall and weighing\\n\\n145 pounds, with an external arteroposterior chest diameter of\\n\\n19.5 em, was pronounced dead but was rejected for kidney\\n\\ndonation because of a prolonged hypotensiveepisode. Two J-7'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='donation because of a prolonged hypotensiveepisode. Two J-7\\n\\nventricles were inserted to replace the natural heart, but their\\n\\npositioning was different from that used in Case 4. The\\n\\nartificial right ventricle was placed in the right pleural cavity\\n\\nand the left ventricle was placed within the pericardial sac. A\\n\\nnew right atrial outflow port was created on the lateral side of\\n\\nthe right atrium. The tricuspid anulus was closed with'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='the right atrium. The tricuspid anulus was closed with\\n\\ntricuspid valve tissue and an anterior flap of right ventricular\\n\\nmyocardium.\\n\\nCardiopulmonary bypass was discontinued and the TAH\\n\\nsupported the entire circulation. Postoperative bleeding ten-\\n\\ndencies were corrected with fresh-frozen plasma and platelets.\\n\\nAfter transfer of the subject to the intensive care unit, various\\n\\npneumatic, angiographic, computed axial tomographic and\\n\\nventricular radionuclide studies were done to determine'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='ventricular radionuclide studies were done to determine\\n\\nmechanical fit and ventricular function. The experiment was\\n\\nelectively terminated after 72 hours to accommodate funeral\\n\\narrangements.\\n\\nResults\\n\\nAll five human subjects had a normal heart and\\n\\nnormal-sized pericardium for height and weight. A\\n\\nsummary of the pertinent clinical data of the five\\n\\nsubjects is shown in Table I.\\n\\nAnatomic considerations were critical for proper\\n\\nhemodynamic function. In Case 2, late pulmonary'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Anatomic considerations were critical for proper\\n\\nhemodynamic function. In Case 2, late pulmonary\\n\\nedema developed because of pulmonary venous com-\\n\\npression by the artificial ventricles. For subjects with a\\n\\nsmall natural heart, as in Case 3, we separated the two\\n\\nartificial ventricles and placed the right in the right\\n\\npleural cavity and the left in the pericardial sac. In Case\\n\\n4, we placed the left artificial ventricle in the left pleural'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='4, we placed the left artificial ventricle in the left pleural\\n\\ncavity and allowed the right artificial ventricle an\\n\\northotopic position in the pericardial sac, as shown in\\n\\nFig. 2. Details of the surgical implantation techniques\\n\\nare described in another report.\"\\n\\nHemodynamic data in Cases 4 and 5 are shown in\\n\\nFigs. 3 and 4, respectively.\\n\\nThe adequacy of cardiac output in Case 4 is reflected\\n\\nin part by the urine output in Fig. 5. Excessive urine\\n\\n8 2 8\\n\\nKolff et al.\\n\\nThe Journal of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='in part by the urine output in Fig. 5. Excessive urine\\n\\n8 2 8\\n\\nKolff et al.\\n\\nThe Journal of\\n\\nThoracic and Cardiovascular\\n\\nSurgery\\n\\n140\\n\\n130\\n\\n:20\\n\\n110\\n\\n100\\n\\n90\\n\\n\\\\\\n\\n80\\n\\n.L---/\\n\\nMAP\\n\\n\\'\"\\n\\nJ:\\n\\nE\\n\\nE\\n\\nCVP\\n\\nLAP\\n\\n6\\n\\n7\\n\\n8\\n\\n9\\n\\n10 II\\n\\n12\\n\\nI\\n\\n2\\n\\n3\\n\\n4\\n\\ne\\n\\n6\\n\\n7\\n\\n8\\n\\n9 o\\n\\nII\\n\\n12\\n\\nI\\n\\n2\\n\\n3\\n\\n4\\n\\n5\\n\\n6\\n\\n7\\n\\n8\\n\\n9\\n\\n10 II\\n\\n12 I\\n\\n5/8/82\\n\\n5/9/82\\n\\nTIME\\n\\n5/10/82\\n\\nFig. 3. Hemodynamic course of Case 4, with normal parameters for both the left atrial pressure (LAP) and'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='central venous pressure (CVP).The mean arterial blood pressure (MAP) was satisfactory throughout the 41 hours\\n\\nof the experiment.\\n\\n130\\n\\n120\\n\\n110\\n\\n100\\n\\n90\\n\\neo\\n\\nMM 0, HG\\n\\n10\\n\\n60\\n\\nso\\n\\n~o\\n\\n30\\n\\n20\\n\\n10\\n\\nMAP\\n\\n~\\n\\n8\\n\\n12\\n\\n/6\\n\\n20\\n\\n21\\n\\n1\\n\\n8\\n\\n12\\n\\n/6\\n\\n20\\n\\n21\\n\\n1\\n\\n8\\n\\n12\\n\\n/6\\n\\n20\\n\\n21\\n\\n1\\n\\n1213182\\n\\n/216182\\n\\nFig. 4. Hemodynamic data of Case 5 is shown for the 72 hour course of the experiment.\\n\\nproduction caused by diabetes insipidus was controlled\\n\\nby vasopressin. Actual cardiac outputs of each ventricle'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='by vasopressin. Actual cardiac outputs of each ventricle\\n\\nwere obtained by measuring the air flow exhausted from\\n\\neach ventricle during diastole. Fig. 6 shows a computer-\\n\\ngenerated* air exhaust curve obtained from a differen-\\n\\ntial pressure transducer placed across a small resistance\\n\\nin the air exhaust line. The computer calculates the\\n\\nApple Computers. Cupertino. Calif.\\n\\nvolume of blood that enters the ventricle during diastole\\n\\nand multiplies it by the heart rate for cardiac output of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"and multiplies it by the heart rate for cardiac output of\\n\\neach ventricle.'? Fig. 7 shows that the cardiac output of\\n\\nthe left ventricle was consistently greater than that of\\n\\nthe right ventricle.\\n\\nDuring studies of ventricular function in Case 5, we\\n\\nfound that the right ventricle could be stopped from\\n\\nactively pumping while the subject still maintained an\\n\\nadequate blood pressure and a marginal cardiac output\\n\\nVolume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nArtificial heart in human subjects\\n\\n829\\n\\n'000\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Volume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nArtificial heart in human subjects\\n\\n829\\n\\n\\'000\\n\\ntoo\\n\\n100\\n\\n700\\n\\nURINE\\n\\n100\\n\\nOUTPUT\\n\\ntOO.\\n\\nee\\n\\n400-\\n\\n10\\n\\n10\\n\\nII\\n\\nJI:\\n\\nI\\n\\nI\\n\\n\"\\'\\'\\'II\\n\\n\"till\\n\\nTIME\\n\\n.....\\n\\n51101l!\\n\\nFig. 5. Urine output was more then adequate and necessitated intermittent vasopressin to control diabetes\\n\\ninsipidus.\\n\\n5V=91\\n\\nCO=10. ?\\n\\nR\\n\\ncadaveric fit says little about the ability of the device to\\n\\nfunction when so placed.\\n\\nWe propose that there is a new opportunity for'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='function when so placed.\\n\\nWe propose that there is a new opportunity for\\n\\nhuman experimental studies which far exceeds the\\n\\npurely anatomic and comparative studies of da Vinci.\\n\\nToday it is possible to test the functional capabilities of\\n\\nintrathoracic blood pumps in brain-dead but hemody-\\n\\nnamically stable human subjects at no risk, so that it is\\n\\nFig. 6. Air exhausted from the pneumatic ventricle during\\n\\ndiastole passes through a differential pressure transducer.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='diastole passes through a differential pressure transducer.\\n\\nPressure data are traced and computed to yield ventricular\\n\\nfillingor stroke volume (SV) and cardiac output (CO) for the\\n\\nleft and the right (R) ventricles. The early rapid exhaust phase\\n\\nwhen the compressed air from systole escapes to the atmo-\\n\\nsphere is discarded from the calculations. The blood that fills\\n\\nthe heart during diastole pushes air out. This later and much\\n\\nslowerair exhaust phase isshownas a plateau. The area under'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='slowerair exhaust phase isshownas a plateau. The area under\\n\\nthis curve is used to compute stroke volume (accuracy is\\n\\n± 10%).10\\n\\n2\\n\\nX 100 MSEC\\n\\nfrom the left ventricle. A vacuum of 10 em H 20 on the\\n\\nUHD during left ventricular diastole and a central\\n\\nvenous pressure of 20 em H 20 were sufficient to allow\\n\\nblood to flow through the right ventricle and lungs. The\\n\\neffect of atrial contractility on pulmonary flow could not\\n\\nbe assessed.\\n\\nStandard radionuclide ventriculography techniques'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='be assessed.\\n\\nStandard radionuclide ventriculography techniques\\n\\nshow ventricular filling and emptying in Fig. 8. Under a\\n\\nfixed set of conditions, i.e., heart rate 120beats/min and\\n\\n33% systole, the ejection fraction was 53%. The curve\\n\\nindicates that the heart became slightly more than two\\n\\nthirds filled at the end of diastole and emptied complete-\\n\\nly to its minimal residual volume of 50 ml. The ventricle\\n\\nthus maintained an\\n\\ninherent degree of response to\\n\\nchanges in venous pressure.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"thus maintained an\\n\\ninherent degree of response to\\n\\nchanges in venous pressure.\\n\\nDiscussion\\n\\nDuring the fifteenth century Leonardo da Vinci\\n\\nattempted to study the anatomic and functional interac-\\n\\ntions of man's internal organs. II However, da Vinci had\\n\\na very meager amount of human material to study, as it\\n\\nwas not popular to study human beings. In his drawings\\n\\nof the internal organs of man, he needed to borrow from\\n\\nthe anatomic knowledge of animal organs. He took\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"the anatomic knowledge of animal organs. He took\\n\\nsome artistic liberties to make the heart of an ox fit\\n\\ninside a man's chest. He had no idea of its function,\\n\\nsince the course of the circulation of blood had not yet\\n\\nbeen discovered. Today, five centuries later, we were\\n\\nconfronted with the question of whether or not an\\n\\nartificial heart successfully tested in calves would fit and\\n\\nfunction in man. But how to proceed in man with some\\n\\nassurance of success? An artist's drawing or a human\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='assurance of success? An artist\\'s drawing or a human\\n\\n8 3 0\\n\\nKoljf et al.\\n\\nc.o.\\n\\nL/MIN\\n\\nLO\\n\\nA\\n\\n,/\"\\n\\n(\\n\\n\\\\\\n\\n.\\n\\n\\\\\\n\\n,\"\\n\\nt.\\n\\n\"\\n\\n\\\\\\n\\n, \\\\.\\n\\ni>\\n\\nI\\n\\n\\\\\\n\\n/\\\\ /\\n\\n\"\"\"\\\\,\\' \\\\\\n\\n/\\n\\n\\\\\\n\\n\\\\/\\n\\n\\\\/\\n\\n\\\\/\\n\\n\\\\\\n\\n\"\\n\\nL=··--\\n\\nR=-\\n\\nThe Journal of\\n\\nThoracic and Cardiovascular\\n\\nSurgery\\n\\n..q\\n\\n8\\n\\n12\\n\\n16\\n\\n20\\n\\n2~\\n\\n~\\n\\n8\\n\\n12\\n\\n16 eo 21\\n\\n1\\n\\n8\\n\\n12\\n\\n16\\n\\n20\\n\\n21\\n\\n1\\n\\n1213182\\n\\n/211182\\n\\n1215 182\\n\\nFig. 7. The cardiac outputs (CO.) of the left (L) and right (R) ventricles were followedthroughout the duration of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='experiment 5. The left ventricular output was consistently greater than the right ventricular output. The large\\n\\ndifference between right and left ventricular outputs is due in part to a physiological(bronchial arterial flow) and in\\n\\npart due to an inherent ± 10% error of each determination.\\n\\nnot necessary to learn the fundamentals of fit and\\n\\nfunction in patients. Permission to use the body or\\n\\norgans of brain-dead human subjects has benefited'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='organs of brain-dead human subjects has benefited\\n\\nthousands of renal transplant recipients. It is in such\\n\\nkidney donors that the functional studies of the artificial\\n\\nheart were carried out. The relatives of these donors\\n\\nhave been extremely supportive of our experiments.\\n\\nTheir hope is that through these studies others may live\\n\\nlonger and more comfortably.\\n\\nIn regard to our fit studies, the fact that the artificial\\n\\nheart consists of two independent pneumatic ventricles'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='heart consists of two independent pneumatic ventricles\\n\\nallows them to be separated completely so that either\\n\\nventricle may be placed outside the pericardial sac in a\\n\\nheterotopic position. After encountering left atrial and\\n\\npulmonary venous compression with unilateral pulmo-\\n\\nnary edema in Case 2, we did not think it advisable to\\n\\nplace both ventricles in their usual intrapericardial\\n\\npositions in a small subject of 93 pounds (Case 3).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='positions in a small subject of 93 pounds (Case 3).\\n\\nTherefore, we utilized heterotopic positioning of either\\n\\nthe left or the right ventricle in Subjects 3, 4, and 5 and\\n\\nproved that this is a viable surgical option.\\n\\nIn regard to functional studies, one of our concerns\\n\\nwas to be able to maintain low filling pressures and\\n\\nadequate cardiac outputs to provide peripheral organ\\n\\nperfusion. It was also desirable to maintain a degree of\\n\\ninherent regulation so that a balanced but not necessar-'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='inherent regulation so that a balanced but not necessar-\\n\\nily equal output between the right and the left ventricles\\n\\ncould be sustained for long periods without constant\\n\\nadjustments of the heart driving parameters. Although\\n\\nthe left ventricle was expected to pump more than the\\n\\nright because of the bronchial circulation, a rather larger\\n\\nthan expected difference occurred in the middle of the\\n\\ntime course of Case 5. Additional factors that could'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='time course of Case 5. Additional factors that could\\n\\naccount for this difference include a ± 10% inaccuracy\\n\\nof each measurement when determined on a mock\\n\\ncirculation and the increased regurgitation of the left-\\n\\nsided valves. Studies with electromagnetic flowmeters\\n\\naround the pulmonary artery and aorta are planned for\\n\\nthe future. The important point, however, is that the\\n\\nright and left ventricles never pump equal amounts, and\\n\\nthe TAH has to be designed to allow differences in'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='the TAH has to be designed to allow differences in\\n\\noutput while maintaining physiological atrial pressures.\\n\\nThe TAH functioned successfully for up to 72 hours.\\n\\nIn conclusion, these ongoing studies in brain-dead\\n\\nhuman subjects show that the Utah J-7 TAH can take\\n\\nover the role of the natural heart in a human being.This\\n\\nexperimental model is unique and necessary to evaluate\\n\\nthe fit and function of the device in preparation for\\n\\nfuture implantation into a wide selectionof personswho'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='future implantation into a wide selectionof personswho\\n\\nwould rather be tethered to this device then die of\\n\\nend-stage heart disease.\\n\\nWe would like to thank Dr. Alter and Dr. Buchheit, of\\n\\nTemple University Hospital for supporting these studies; Dr.\\n\\nVolume 87\\n\\nNumber 6\\n\\nJune 1984\\n\\nISO\\n\\nArtificial heart in human subjects\\n\\n83 1\\n\\nVOLUME\\n\\nCC\\n\\n__-]10\\n\\n50\\n\\n50\\n\\nlolA.: 120 IlPM\\n\\nSYSTOLE \"33\\\\\\n\\nEJECTI\"J~N\"33\\\\.\\n\\n..a\\n\\nMIN.RESIDUAL1101..\"50\"\\n\\nMAl(. STROKE VOL.: 100ce\\n\\nMAX.VOL. : lSOu\\n\\n20\\n\\n,\\n\\n1\\n\\n,\\n\\n,\\n\\n1\\'\"'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='..a\\n\\nMIN.RESIDUAL1101..\"50\"\\n\\nMAl(. STROKE VOL.: 100ce\\n\\nMAX.VOL. : lSOu\\n\\n20\\n\\n,\\n\\n1\\n\\n,\\n\\n,\\n\\n1\\'\"\\n\\nSYSTOLE\\n\\n1 1..\\n\\nDIASTOLE\\n\\n,\\n\\nI\\n\\n,\\n\\n,\\n\\nI\\n\\nI,\\n\\n01\\n\\nQZ\\n\\n01\\n\\nTIME\\n\\n(sec}\\n\\n04\\n\\nQ5\\n\\n10\\n\\nFig. 8. Ventricular volume curve of the left ventricle (L.v.) of Case 4 obtained by a gamma camera gated to the\\n\\nUtah Heart Driver. Technetium 99m pertechnetate in a standard clinical protocol was used to label the red blood'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='cells. At the end of the maximum systolic position, 50 mIof residual blood remains in the ventricle. The maximum\\n\\ntotal volume of the ventricle is 150 ml. Illustrated here is a stroke volume of about 54 mI.\\n\\nGunther Boden for reviewing the manuscript; Dr. W. J. Kolff\\n\\nas head of the Divisionof Artificial Organs at the University of\\n\\nUtah for encouraging our approach; Dr. Robert Jarvik for\\n\\nconsultation on Case 4; and Drs. Summers and Bennet and'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='consultation on Case 4; and Drs. Summers and Bennet and\\n\\nMr. Stephen Sammut of the Greater Delaware Valley Kidney\\n\\nProcurement Center for coordinating renal transplantation.\\n\\nFinally, we thank the relatives of the donors that made this\\n\\nstudy possible.\\n\\nREFERENCES\\n\\nAkutsu T, Kolff WJ: Permanent substitutes for valves and\\n\\nhearts. Trans Am Soc Artif Intern Organs 4:230-235,\\n\\n1958\\n\\n2 Bucherl ES, Mfeld K, Baer P, Clevert HD, Frank J,\\n\\nGerlach K, Grosse-Siestrup C, Hennig E, Keilbach H,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Gerlach K, Grosse-Siestrup C, Hennig E, Keilbach H,\\n\\nKrautzberger W, Kuhlmann V, Lemm W, Mohnhaupt A,\\n\\nRennekamp F, Unger V, Weidmann H, Zartrack F: Total\\n\\nartificial heart replacement. Int J Artif Organs 2:141-152,\\n\\n1979\\n\\n3 Pierce WS, Myers JL, Donachy JH, Rosenberg G, Landis\\n\\nDL, Proplet GA, Snyder AJ: Approaches to the artificial\\n\\nheart. Surgery 90:137-148, 1981\\n\\n4 Mochizuki T, Hastings WL, Olsen DB, Lawson JH,\\n\\nDaitoh N, Aaron JL, Razzeca KJ, Jarvik RK, Kessler TR,\\n\\nNielsen\\n\\nSD,\\n\\nKolff'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Daitoh N, Aaron JL, Razzeca KJ, Jarvik RK, Kessler TR,\\n\\nNielsen\\n\\nSD,\\n\\nKolff\\n\\nWJ:\\n\\nPostoperative\\n\\nhemodynamic\\n\\nchanges in calves implanted with total artificial hearts\\n\\ndesigned for human application. Trans Am Soc Artif\\n\\nIntern Organs 526:55-59, 1980\\n\\n5 Coleman DL, Liu D, Kessler T, Andrade JD: Calcification\\n\\nof non-textured implantable blood pumps. Trans Am Soc\\n\\nArtif Intern Organs 27:97-103, 1981\\n\\n6 Kwan-Gett C, Backman DK, Donovan FM, Eastwood N,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content='Artif Intern Organs 27:97-103, 1981\\n\\n6 Kwan-Gett C, Backman DK, Donovan FM, Eastwood N,\\n\\nFoote JL, Kawai J, Kessler TR, Kralios AC, Peters JL,\\n\\nVan Kampen KR, Wong HK, Zwart HHJ, Kolff WJ:\\n\\nArtificial heart with hemispherical ventricles and dissemi-\\n\\nnated intravascular coagulation. Trans Am Soc Artif\\n\\nIntern Organs 17:474-481, 1971\\n\\n7 Kwan-Gett CS, Wu Y, Collan R, Jacobson S, Kolff WJ:\\n\\nTotal replacement artificial heart and driving system with'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"Total replacement artificial heart and driving system with\\n\\ninherant regulation of cardiac output. Trans Am Soc Artif\\n\\nIntern Organs 15:245-251, 1969\\n\\n8 Guidelines for determination of death.\\n\\nReport to the\\n\\nPresident's Commission for the Study of Ethical Problems\\n\\nin Medicine. JAMA 246:19:2184-2186, 1981\\n\\n9 Kolff J, Deeb GM, Riebman J: Preliminary study of a\\n\\npneumatic total artificial heart. Heart Trans 3:60-64,\\n\\n1983\\n\\n10 Nielsen SD, Willshaw P, Olsen DB: Non-invasive cardiac\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\PIIS0022522319384089.txt'}, page_content=\"1983\\n\\n10 Nielsen SD, Willshaw P, Olsen DB: Non-invasive cardiac\\n\\noutput monitoring and diagnostics for pneumatic pumping\\n\\nchambers. Trans Am Soc Artif Intern Organs 29:589-592,\\n\\n1983\\n\\n11 O'Malley CD, de CM Saunders JB: Leonardo da Vinci on\\n\\nthe Human Body, New York, 1952, Henry Schuman,\\n\\nInc.\"),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/284243177\\n\\nTotal Artiﬁcial Heart: State-of-the-art\\n\\nArticle\\xa0\\xa0in\\xa0\\xa0Biomedical Engineering · November 2015\\n\\nDOI: 10.1007/s10527-015-9528-4\\n\\nCITATIONS\\n\\n6\\n\\nREADS\\n\\n10,246\\n\\n3 authors:\\n\\nDmitry Petukhov\\n\\nNational Research University of Electronic Technology\\n\\n19 PUBLICATIONS\\xa0\\xa0\\xa054 CITATIONS\\n\\nSEE PROFILE\\n\\nSergey Selishchev\\n\\nNational Research University of Electronic Technology'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='SEE PROFILE\\n\\nSergey Selishchev\\n\\nNational Research University of Electronic Technology\\n\\n223 PUBLICATIONS\\xa0\\xa0\\xa0956 CITATIONS\\n\\nSEE PROFILE\\n\\nDmitry Telyshev\\n\\nNational Research University of Electronic Technology\\n\\n193 PUBLICATIONS\\xa0\\xa0\\xa0993 CITATIONS\\n\\nSEE PROFILE\\n\\nAll content following this page was uploaded by Dmitry Telyshev on 03 December 2015.\\n\\nThe user has requested enhancement of the downloaded file.\\n\\nIntroduction\\n\\nThe initial direction of the development of systems'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='Introduction\\n\\nThe initial direction of the development of systems\\n\\nof mechanical circulatory support (MCS) was to try sim\\x02\\n\\nulating the biological mechanism of the heart by means of\\n\\nflexible diaphragms and unidirectional valves. The result\\n\\nof the development was steel pulsating machines such as\\n\\nthe fully artificial heart Liotta\\x02Heart and Jarvik 7.\\n\\nDespite successful implantation, these devices had disad\\x02\\n\\nvantages that limited their use: large size and low reliabil\\x02'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='vantages that limited their use: large size and low reliabil\\x02\\n\\nity due to the large number of moving parts [1\\x024].\\n\\nThe most clinically successful and widely used MCS\\n\\nsystems for treatment of heart failure are now the circula\\x02\\n\\ntory support devices of the third generation – constant\\n\\nflow rotary pumps [1, 2, 5].\\n\\nNevertheless, for total artificial hearts (TAH), there\\n\\nare still options for their application – the rescue of\\n\\npatients with cardiogenic shock, in case of unsuccessful'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='patients with cardiogenic shock, in case of unsuccessful\\n\\nheart transplantation, i.e. when immediate recovery of\\n\\nhemodynamics is needed [6]. TAH implantation also pro\\x02\\n\\nvides better six\\x02month survival compared with the appara\\x02\\n\\ntus of circulatory support of both heart ventricles [7].\\n\\nThe purpose of this review is to describe the state of\\n\\nthe art of pulsating MCS systems designed for complete\\n\\nreplacement of the heart. Features and characteristics of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='replacement of the heart. Features and characteristics of\\n\\nthese devices are discussed and are summarized in\\n\\nTable 1.\\n\\nSyncardia Total Artificial Heart\\n\\nThe most common version of the MCS system for\\n\\nthe replacement of both ventricles of the heart is the\\n\\nSyncardia device (SynCardia Systems, USA), a pulsating\\n\\ntotal artificial heart. Its weight is 160 g, and its volume is\\n\\n400 ml [8]. It is FDA approved for use as a bridge to trans\\x02\\n\\nplant (2004) and for voluntary implantation in patients'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='plant (2004) and for voluntary implantation in patients\\n\\nwho have been refused a heart transplant (2012) [6].\\n\\nThis artificial heart includes the following compo\\x02\\n\\nnents: independent left and right polyurethane ventricles\\n\\n(Fig. 1), the volume of each being 70 ml, and a transder\\x02\\n\\nmal control cable connecting the ventricles with an exter\\x02\\n\\nnal pneumatic pump [6, 9].\\n\\nEach artificial ventricle has two Medtronic\\x02Hall sin\\x02\\n\\ngle\\x02leaf mechanical valves (27 mm – inlet valves, 25 mm –'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='gle\\x02leaf mechanical valves (27 mm – inlet valves, 25 mm –\\n\\noutlet valves), providing directional blood flow [6, 11].\\n\\nThe base unit is made of IsoPlast thermoplastic\\n\\npolyurethane. The ventricular chambers are manufac\\x02\\n\\ntured by sequentially pouring layers of polyurethane with\\n\\ndifferent hardness. Each ventricle is divided into two parts\\n\\nBiomedical Engineering, Vol. 49, No. 4, November, 2015, pp. 193\\x02196. Translated from Meditsinskaya Tekhnika, Vol. 49, No. 4, Jul.\\x02Aug., 2015, pp. 1\\x024.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='Original article submitted June 30, 2015.\\n\\n193\\n\\n0006\\x023398/15/4904\\x020193 © 2015 Springer Science+Business Media New York\\n\\n1 National Research University MIET, Moscow, Russia; E\\x02mail:\\n\\ndmitry.spetukhov@gmail.com\\n\\n2 Zelenograd Innovation Technological Center, Zelenograd, Moscow,\\n\\nRussia.\\n\\nTo whom correspondence should be addressed.\\n\\nModern variants of total artificial pulsating hearts such as Syncardia, Abiocor, and Carmat are reviewed.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='Technical characteristics of these devices are considered in detail, given their limitations, which are traditional for\\n\\nartificial pulsating hearts: low reliability and limited applicability due to the large size of the implantable module.\\n\\nThe Carmat total artificial heart, which partially solves these problems and is currently at the stage of clinical tri\\x02\\n\\nals, is reviewed in detail.\\n\\nTotal Artificial Heart: State\\x02of\\x02the\\x02art\\n\\nD. S. Petukhov1*, S. V. Selishchev1, and D. V. Telyshev2'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='Total Artificial Heart: State\\x02of\\x02the\\x02art\\n\\nD. S. Petukhov1*, S. V. Selishchev1, and D. V. Telyshev2\\n\\nTheory and Design\\n\\nDOI 10.1007/s10527-015-9528-4\\n\\n194\\n\\nPetukhov et al.\\n\\nby a membrane whose movement is controlled by the\\n\\npneumatic motor and provides pulsing blood flow. The\\n\\nmembranes consist of four independent layers. Such lay\\x02\\n\\nered structure provides necessary flexibility, hardness, and\\n\\na certain degree of security: in case of rupture of one of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='a certain degree of security: in case of rupture of one of\\n\\nthe membrane layers, the presence of additional layers\\n\\nwill prevent instantaneous contact of air with blood,\\n\\nwhich can be fatal [6]. However, such cases of membrane\\n\\ndamage were recorded [12].\\n\\nSeveral control systems have been developed for\\n\\nSyncardia. The original version used in hospitals is the\\n\\nBig Blue control system. It contains two pneumatic actu\\x02\\n\\nators (main and reserve), compressed air cylinders, bat\\x02'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='ators (main and reserve), compressed air cylinders, bat\\x02\\n\\nteries, and a console for operation control. Such system\\n\\nweighs more than 160 kg [13]. It enables manual control\\n\\nof the frequency of contractions, systole duration, and\\n\\nleft and right working pressure [6, 14].\\n\\nAnother option is the Freedom Driver control sys\\x02\\n\\ntem – a small portable drive that can be worn in a shoul\\x02\\n\\nder backpack, allowing patients with Syncardia to leave\\n\\nthe hospital and go home. This drive comprises two'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='the hospital and go home. This drive comprises two\\n\\nrechargeable batteries, each providing up to 2 h of work.\\n\\nIt can also operate from an external power source. The\\n\\ncontrol system displays the value of cardiac output and\\n\\nfrequency of contractions but enables manual adjustment\\n\\nof the contractions frequency only [6, 14].\\n\\nAbiocor Total Artificial Heart\\n\\nThe second MCS system, designed for long\\x02term\\n\\nreplacement of the heart in patients who are not suitable\\n\\nfor\\n\\ntransplantation,\\n\\nis\\n\\nthe'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='replacement of the heart in patients who are not suitable\\n\\nfor\\n\\ntransplantation,\\n\\nis\\n\\nthe\\n\\nAbiocor\\n\\ncompletely\\n\\nimplantable artificial heart (Abiomed, USA) [15].\\n\\nAmong implantable components of the Abiocor arti\\x02\\n\\nficial heart are the pump module shown in Fig. 2, battery\\n\\ncontroller, and coil of transcutaneous energy transfer.\\n\\nThe pump module consists of two ventricles surrounding\\n\\nthe electrohydraulic drive on two sides. An electrohy\\x02\\n\\ndraulic actuator comprises a centrifugal pump, which'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='draulic actuator comprises a centrifugal pump, which\\n\\nrotates at a speed of 5000\\x029000 rpm, moving low\\x02viscos\\x02\\n\\nity hydraulic fluid between the right and left liquid cham\\x02\\n\\nber separated from the ventricles by a membrane. As soon\\n\\nas one of the chambers is filled with liquid, the blood\\n\\nleaves the appropriate ventricle; at the same time, the\\n\\nother chamber empties, creating a negative pressure gra\\x02\\n\\ndient in the ventricle and leading to its active filling with'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='dient in the ventricle and leading to its active filling with\\n\\nblood from the atria. Titanium was selected as material\\n\\nfor the casing; all blood contacting surfaces, including\\n\\nfour tricuspid valves, are made of Angioflex polyether\\n\\nurethane [15]. The pump module weighs 1090 g and has\\n\\na volume of 800 ml [17].\\n\\nThe internal battery can provide power to the pump\\n\\nmodule when not connected to external power for 15\\x02\\n\\n30 min, depending on the charge level. In normal use, it'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='30 min, depending on the charge level. In normal use, it\\n\\nis constantly recharged from an external power source.\\n\\nThe internal controller acts as communication between\\n\\nthe pump module and the external control console. It\\n\\nmonitors pressure in the ventricular chambers and the\\n\\nspeed of the pump, allows adjusting the frequency of\\n\\nemission and the ratio between the pressures in the right\\n\\nand left atria. It is similar to the internal battery in size\\n\\nand is placed with it in the abdomen.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='and is placed with it in the abdomen.\\n\\nThe internal coil for power transmission is placed in\\n\\nthe subclavian area and is used to transfer energy by\\n\\ninductive coupling from an external coil, thus avoiding\\n\\nusing a transdermal cable to prevent possible infection.\\n\\nFig. 1. Artificial ventricles of the total artificial heart Syncardia [9].\\n\\nFig. 2. Abiocor total artificial heart implantable pump module\\n\\n[16].\\n\\nTotal Artificial Heart\\n\\n195\\n\\nThe external components of the Abiocor system are'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='[16].\\n\\nTotal Artificial Heart\\n\\n195\\n\\nThe external components of the Abiocor system are\\n\\nan outer coil to transmit power, control system of the size\\n\\nof a laptop computer, external radio frequency communi\\x02\\n\\ncation, and a battery container. The control unit receives\\n\\ninformation about the operation of the pump module from\\n\\nthe internal controller via radio\\x02frequency telemetry [15].\\n\\nThe Abiocor artificial heart was approved for volun\\x02\\n\\ntary use in 2006. Since then the device has been implant\\x02'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='tary use in 2006. Since then the device has been implant\\x02\\n\\ned only once, June 24, 2009, at the Robert Wood Johnson\\n\\nUniversity Hospital (New Jersey, USA) [3, 4].\\n\\nCarmat Total Artificial Heart\\n\\nThe most modern version of pulsating TAH is the\\n\\nCarmat artificial heart (Carmat SA, France) shown in\\n\\nFig. 3. Its development began in 1993 with the participa\\x02\\n\\ntion of the medical team of Alain Carpentier and techni\\x02\\n\\ncal team Matra Defense (a subsidiary of Airbus). One of'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='cal team Matra Defense (a subsidiary of Airbus). One of\\n\\nthe main purposes of designing the device was its similar\\x02\\n\\nity to the shape of the biological heart. Its volume with\\n\\nartificial ventricles (65 ml each) and built\\x02in components\\n\\nis 750 ml. Each ventricle is separated by a membrane into\\n\\ncompartment for blood and a viscous fluid. Two electro\\x02\\n\\nhydraulic pumps move viscous fluid, which causes the\\n\\nmembrane to move and create a pulsating blood flow\\n\\n[3].'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='membrane to move and create a pulsating blood flow\\n\\n[3].\\n\\nBiological ventricular valves are located at the inputs\\n\\nand outputs. Pressure sensors and control electronics are\\n\\nintegrated into the device, partially covered with an elas\\x02\\n\\ntically deformable chamber with viscous fluid. A percuta\\x02\\n\\nneous cable transmits power and receives information\\n\\nabout the performance of the pumps. In the current con\\x02\\n\\nfiguration, the cable connects to a clinical control con\\x02\\n\\nsole.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='figuration, the cable connects to a clinical control con\\x02\\n\\nsole.\\n\\nContacts with blood membrane surface made of\\n\\nbovine pericardium treated fabric are similar to biopros\\x02\\n\\nthetic valves developed by Dr. Carpentier in the early\\n\\n1980s. The suggested advantage of bioprosthetic materials\\n\\nis acceptable hemodynamic compatibility in future\\n\\nreducing the risk of thrombosis and the need for pro\\x02\\n\\nlonged anticoagulation. The main problems of their use'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='longed anticoagulation. The main problems of their use\\n\\nare the reliability and durability of parts made of such\\n\\nmaterials [18].\\n\\nDue to the presence of embedded electrohydraulic\\n\\ndrive, there is no need for an external pneumatic actuator\\n\\nas for the Syncardia. This improves quality of life of the\\n\\npatient, for example, the drive does not generate audible\\n\\nnoise.\\n\\nThe control system reacts to changes in preload and\\n\\nafterload, as measured by pressure sensors in the ventri\\x02'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='afterload, as measured by pressure sensors in the ventri\\x02\\n\\ncles, by adjusting the contraction frequency (30 to\\n\\n150 beats/min) and stroke volume (30 to 65 ml). The\\n\\nresulting flow of blood varies from 2 to 9 liters/min [3].\\n\\nIn addition, Carmat SA provides a computer appli\\x02\\n\\ncation that helps selecting patients who have enough\\n\\nspace in the chest for the implantation of the TAH.\\n\\nClinical trials of the device began in late 2013 [3, 18].\\n\\nNevertheless, the options of the reviewed pulsating'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='Nevertheless, the options of the reviewed pulsating\\n\\ncompletely artificial hearts have disadvantages that limit\\n\\nthe scope of their application. The first drawback is the\\n\\nsize of the implantable module: for implantation of\\n\\nAbiocor a patient with body surface area greater than\\n\\n2.0 m2 is required, for Syncardia – more than 1.7 m2 [19].\\n\\nFig. 3. Carmat total artificial heart implantable pump module [3].\\n\\nTABLE 1. Specifications of Total Artificial Hearts\\n\\nProduct name'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='TABLE 1. Specifications of Total Artificial Hearts\\n\\nProduct name\\n\\nSyncardia (SynCardia Systems, USA)\\n\\nAbiocor (Abiomed, USA)\\n\\nCarmat (Carmat SA, France)\\n\\nDrive type\\n\\npneumatic\\n\\nelectrohydraulic\\n\\nelectrohydraulic\\n\\nVolume, ml\\n\\n400\\n\\n800\\n\\n750\\n\\nWeight, g\\n\\n160\\n\\n1090\\n\\n900\\n\\nFlow, liter/min\\n\\nup to 9.5\\n\\nup to 10\\n\\nup to 9\\n\\nStatus\\n\\nimplantation as a bridge to transplant (2004) /\\n\\nvoluntary implantation for long\\x02term circulatory\\n\\nsupport (2012)\\n\\nvoluntary implantation in patients denied transplant'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='support (2012)\\n\\nvoluntary implantation in patients denied transplant\\n\\nclinical tests\\n\\n196\\n\\nPetukhov et al.\\n\\nThus, there is need for an artificial heart with smaller vol\\x02\\n\\numes of the ventricles (50 or 30 ml) for implantation into\\n\\na patient with small body surface area (less than 1.7 m2,\\n\\nbut more than 0.9 m2). Currently Syncardia Systems is\\n\\nsolving this problem by developing a new version of TAH\\n\\nwith ventricles of 50 ml [8, 10]. Furthermore, long\\x02term'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='with ventricles of 50 ml [8, 10]. Furthermore, long\\x02term\\n\\noperation a TAH as an alternative to heart transplantation\\n\\nrequires optimization of thrombresistance and structural\\n\\nchanges, which ultimately will lead to an increase in\\n\\nworking life sufficient for reliable operation, at least for\\n\\nfive years [2].\\n\\nConclusion\\n\\nThis article provides an overview of pulsating\\n\\nmechanical circulatory support systems designed for the\\n\\ncomplete replacement of the heart: Syncardia, Abiocor,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='complete replacement of the heart: Syncardia, Abiocor,\\n\\nand Carmat. Specifications and features of these devices\\n\\nwere considered. Emphasis was placed on their short\\x02\\n\\ncomings, which are classic for pulsating completely artifi\\x02\\n\\ncial hearts: low reliability and limited applicability due to\\n\\nlarge size of the implantable module. Solutions to these\\n\\nproblems within the concept of an artificial heart, which\\n\\ncompletely mimics the operation of the biological heart,'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='completely mimics the operation of the biological heart,\\n\\nis possible only by ensuring fail\\x02safe operation of the main\\n\\ncomponents, minimizing the size and weight of the\\n\\ndevice, and reducing thrombus formation.\\n\\nThe study was financially supported by the Ministry\\n\\nof Education and Science of the Russian Federation\\n\\n(Federal Targeted Program “Research and developments\\n\\nin priority directions of the scientific\\x02technological com\\x02\\n\\nplex of Russia for 2014\\x022020”; agreement No.'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='plex of Russia for 2014\\x022020”; agreement No.\\n\\n14.578.21.0057 from September 23, 2014).\\n\\nREFERENCES\\n\\n1. Ferrari M., Kruzliak P., Spiliopoulos K., Clin. Res. Cardiol., 104,\\n\\nNo. 2, 95\\x02111 (2015).\\n\\n2. Mallidi H.R., Anand J., Cohn W.E., Texas Heart Inst. J., 41, No.\\n\\n2, 115\\x02120 (2014).\\n\\n3. Mohacsi P., Leprince P.P., Europ. J. Cardio\\x02Thorac. Surg., 46, No.\\n\\n6, 933\\x02934 (2014).\\n\\n4. Pal S., Design of Artificial Human Joints and Organs, Springer (2013).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='6, 933\\x02934 (2014).\\n\\n4. Pal S., Design of Artificial Human Joints and Organs, Springer (2013).\\n\\n5. Itkin G.P., Selishchev S.V., Med. Tekh., No. 6, 39\\x0245 (2010).\\n\\n6. Slepian M.J., Alemu Y., Soares J.S., et al., J. Biomechan., 46, No.\\n\\n2, 266\\x02275 (2013).\\n\\n7. Kirklin J.K., Naftel D.C., Pagani F.D., et al., J. Heart Lung\\n\\nTransplant., 33, No. 6, 555\\x02564 (2014).\\n\\n8. Copeland J.G., Texas Heart Inst. J., 40, No. 5, 587\\x02588 (2013).\\n\\n9. Mascio C.E., Artif. Organs, 39, No. 1, 14\\x0220 (2015).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='9. Mascio C.E., Artif. Organs, 39, No. 1, 14\\x0220 (2015).\\n\\n10. The Western PA Healthcare News Team. Allegheny General\\n\\nHospital Cardiac Surgeons Perform Region’s First SynCardia Total\\n\\nArtificial Heart Implantation (2012) (http://www.wphealthcare\\x02\\n\\nnews.com/allegheny\\x02general\\x02hospital\\x02syncardia).\\n\\n11. Park S., Sanders D., Smith B., et al., Perfusion, 29, No. 1, 82\\x0288 (2014).\\n\\n12. Torregrossa G., Morshuis M., Varghese R., et al., ASAIO J., 60,\\n\\nNo. 6, 626\\x02634 (2014).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='12. Torregrossa G., Morshuis M., Varghese R., et al., ASAIO J., 60,\\n\\nNo. 6, 626\\x02634 (2014).\\n\\n13. El Banayosy A., Kizner L., Arusoglu L., et al., ASAIO J., 60, No.\\n\\n2, 148\\x02153 (2014).\\n\\n14. Friedline K., Hassinger P.P., AANA J., 80, No. 2, 105\\x02112 (2012).\\n\\n15. Sale S.M., Smedira N.G., Best Pract. Res. Clin. Anaesthesiol., 26,\\n\\nNo. 2, 147\\x02165 (2012).\\n\\n16. AbioMed, Inc. The AbioCor Replacement Heart (2001)\\n\\n(http://www.heartpioneers.com/abiocorimages.html).'),\n",
       " Document(metadata={'source': 'data\\\\txt\\\\TAH2015.txt'}, page_content='(http://www.heartpioneers.com/abiocorimages.html).\\n\\n17. Copeland J.G., Smith R.G., Arabia F.A., et al., J. Heart Lung\\n\\nTransplant., 23, No. 7, 823\\x02831 (2004).\\n\\n18. Jansen P., van Oeveren W., Capel A., Carpentier A., Europ. J.\\n\\nCardio\\x02Thorac. Surg., 41, No. 6, 166\\x02172 (2012).\\n\\n19. Bartoli C.R., Dowling R.D., Cardiol. Clin., 29, No. 4, 559\\x02582\\n\\n(2011).\\n\\nView publication stats')]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chunks = text_splitter.split_documents(docs)\n",
    "chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "b4384cb8",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain.vectorstores import Chroma\n",
    "from langchain_community.document_loaders import TextLoader\n",
    "from langchain.embeddings import HuggingFaceEmbeddings \n",
    "\n",
    "embedding = HuggingFaceEmbeddings(model_name=\"sentence-transformers/all-MiniLM-L6-v2\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "8a749282",
   "metadata": {},
   "outputs": [],
   "source": [
    "question = \"the use of artificial heart ?\" \n",
    "question_embedding = embedding.embed_query(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "b8493842",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1024"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(question_embedding)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "fa14db7a",
   "metadata": {},
   "outputs": [],
   "source": [
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")  # now you can access it"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "9949ddc9",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import OpenAI\n",
    "\n",
    "llm = OpenAI(\n",
    "    api_key=api_key,\n",
    "    base_url=\"https://api.groq.com/openai/v1\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "2675fe8c",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.vectorstores import Chroma\n",
    "\n",
    "vectorstore = Chroma.from_documents(chunks, embedding=embedding, persist_directory=\"chroma_store\")\n",
    "retriever = vectorstore.as_retriever()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "195047ac",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\gito2\\AppData\\Local\\Temp\\ipykernel_12600\\753400081.py:1: LangChainDeprecationWarning: The class `Chroma` was deprecated in LangChain 0.2.9 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-chroma package and should be used instead. To use it run `pip install -U :class:`~langchain-chroma` and import as `from :class:`~langchain_chroma import Chroma``.\n",
      "  vectorstore = Chroma(\n"
     ]
    }
   ],
   "source": [
    "vectorstore = Chroma(\n",
    "    persist_directory=\"chroma_db\",\n",
    "    embedding_function=embedding\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "ab126e6d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "9349d03beed042f9bb3381d325d29e35",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "config.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\gito2\\anaconda3\\Lib\\site-packages\\huggingface_hub\\file_download.py:143: UserWarning: `huggingface_hub` cache-system uses symlinks by default to efficiently store duplicated files but your machine does not support them in C:\\Users\\gito2\\.cache\\huggingface\\hub\\models--google--flan-t5-base. Caching files will still work but in a degraded version that might require more space on your disk. This warning can be disabled by setting the `HF_HUB_DISABLE_SYMLINKS_WARNING` environment variable. For more details, see https://huggingface.co/docs/huggingface_hub/how-to-cache#limitations.\n",
      "To support symlinks on Windows, you either need to activate Developer Mode or to run Python as an administrator. In order to activate developer mode, see this article: https://docs.microsoft.com/en-us/windows/apps/get-started/enable-your-device-for-development\n",
      "  warnings.warn(message)\n",
      "Xet Storage is enabled for this repo, but the 'hf_xet' package is not installed. Falling back to regular HTTP download. For better performance, install the package with: `pip install huggingface_hub[hf_xet]` or `pip install hf_xet`\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "078c779636c1454a9b1f74b260166d5a",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "model.safetensors:   0%|          | 0.00/990M [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "c760407ee9d9432e94aa10e402e9399c",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "generation_config.json:   0%|          | 0.00/147 [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "2cbb74304a034ed5bd3f68b85e136d63",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "tokenizer_config.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Xet Storage is enabled for this repo, but the 'hf_xet' package is not installed. Falling back to regular HTTP download. For better performance, install the package with: `pip install huggingface_hub[hf_xet]` or `pip install hf_xet`\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "60714787c7d240248ba375c9c22c4904",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "spiece.model:   0%|          | 0.00/792k [00:00<?, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "0af1116f5fa148998ac8e91af93a1054",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "tokenizer.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bcc9e7c9394b4a1088c30de78e4b9f2e",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "special_tokens_map.json: 0.00B [00:00, ?B/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cpu\n",
      "The model 'T5ForConditionalGeneration' is not supported for text-generation. Supported models are ['PeftModelForCausalLM', 'ArceeForCausalLM', 'AriaTextForCausalLM', 'BambaForCausalLM', 'BartForCausalLM', 'BertLMHeadModel', 'BertGenerationDecoder', 'BigBirdForCausalLM', 'BigBirdPegasusForCausalLM', 'BioGptForCausalLM', 'BitNetForCausalLM', 'BlenderbotForCausalLM', 'BlenderbotSmallForCausalLM', 'BloomForCausalLM', 'CamembertForCausalLM', 'LlamaForCausalLM', 'CodeGenForCausalLM', 'CohereForCausalLM', 'Cohere2ForCausalLM', 'CpmAntForCausalLM', 'CTRLLMHeadModel', 'Data2VecTextForCausalLM', 'DbrxForCausalLM', 'DeepseekV3ForCausalLM', 'DiffLlamaForCausalLM', 'Dots1ForCausalLM', 'ElectraForCausalLM', 'Emu3ForCausalLM', 'ErnieForCausalLM', 'FalconForCausalLM', 'FalconH1ForCausalLM', 'FalconMambaForCausalLM', 'FuyuForCausalLM', 'GemmaForCausalLM', 'Gemma2ForCausalLM', 'Gemma3ForConditionalGeneration', 'Gemma3ForCausalLM', 'Gemma3nForConditionalGeneration', 'Gemma3nForCausalLM', 'GitForCausalLM', 'GlmForCausalLM', 'Glm4ForCausalLM', 'GotOcr2ForConditionalGeneration', 'GPT2LMHeadModel', 'GPT2LMHeadModel', 'GPTBigCodeForCausalLM', 'GPTNeoForCausalLM', 'GPTNeoXForCausalLM', 'GPTNeoXJapaneseForCausalLM', 'GPTJForCausalLM', 'GraniteForCausalLM', 'GraniteMoeForCausalLM', 'GraniteMoeHybridForCausalLM', 'GraniteMoeSharedForCausalLM', 'HeliumForCausalLM', 'JambaForCausalLM', 'JetMoeForCausalLM', 'LlamaForCausalLM', 'Llama4ForCausalLM', 'Llama4ForCausalLM', 'MambaForCausalLM', 'Mamba2ForCausalLM', 'MarianForCausalLM', 'MBartForCausalLM', 'MegaForCausalLM', 'MegatronBertForCausalLM', 'MiniMaxForCausalLM', 'MistralForCausalLM', 'MixtralForCausalLM', 'MllamaForCausalLM', 'MoshiForCausalLM', 'MptForCausalLM', 'MusicgenForCausalLM', 'MusicgenMelodyForCausalLM', 'MvpForCausalLM', 'NemotronForCausalLM', 'OlmoForCausalLM', 'Olmo2ForCausalLM', 'OlmoeForCausalLM', 'OpenLlamaForCausalLM', 'OpenAIGPTLMHeadModel', 'OPTForCausalLM', 'PegasusForCausalLM', 'PersimmonForCausalLM', 'PhiForCausalLM', 'Phi3ForCausalLM', 'Phi4MultimodalForCausalLM', 'PhimoeForCausalLM', 'PLBartForCausalLM', 'ProphetNetForCausalLM', 'QDQBertLMHeadModel', 'Qwen2ForCausalLM', 'Qwen2MoeForCausalLM', 'Qwen3ForCausalLM', 'Qwen3MoeForCausalLM', 'RecurrentGemmaForCausalLM', 'ReformerModelWithLMHead', 'RemBertForCausalLM', 'RobertaForCausalLM', 'RobertaPreLayerNormForCausalLM', 'RoCBertForCausalLM', 'RoFormerForCausalLM', 'RwkvForCausalLM', 'SmolLM3ForCausalLM', 'Speech2Text2ForCausalLM', 'StableLmForCausalLM', 'Starcoder2ForCausalLM', 'TransfoXLLMHeadModel', 'TrOCRForCausalLM', 'WhisperForCausalLM', 'XGLMForCausalLM', 'XLMWithLMHeadModel', 'XLMProphetNetForCausalLM', 'XLMRobertaForCausalLM', 'XLMRobertaXLForCausalLM', 'XLNetLMHeadModel', 'XmodForCausalLM', 'ZambaForCausalLM', 'Zamba2ForCausalLM'].\n",
      "C:\\Users\\gito2\\AppData\\Local\\Temp\\ipykernel_12600\\1837797942.py:5: LangChainDeprecationWarning: The class `HuggingFacePipeline` was deprecated in LangChain 0.0.37 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFacePipeline``.\n",
      "  llm = HuggingFacePipeline(pipeline=llm_pipeline)\n"
     ]
    }
   ],
   "source": [
    "from langchain import HuggingFacePipeline\n",
    "from transformers import pipeline\n",
    "\n",
    "llm_pipeline = pipeline(\"text-generation\", model=\"google/flan-t5-base\", device=0)\n",
    "llm = HuggingFacePipeline(pipeline=llm_pipeline)\n",
    "\n",
    "qa = RetrievalQA.from_chain_type(\n",
    "    llm=llm,\n",
    "    chain_type=\"stuff\",\n",
    "    retriever=vectorstore.as_retriever()\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "6cace80d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Use the following pieces of context to answer the question at the end. If you don't know the answer, just say that you don't know, don't try to make up an answer.\n",
      "\n",
      "Qual Health Res. 2007;17:730Y743.\n",
      "\n",
      "What’s New and Important\n",
      "\n",
      "h This is the first study examining the experiences of\n",
      "\n",
      "patients living with the total artificial heart to provide\n",
      "\n",
      "clinicians and researchers with insight into these\n",
      "\n",
      "patients’ unique experiences.\n",
      "\n",
      "h It is important to recognize the psychological\n",
      "\n",
      "aspects of being technologically dependent on an\n",
      "\n",
      "artificial organ.\n",
      "\n",
      "Living With a Total Artificial Heart E7\n",
      "\n",
      "Intern. Organs 7, 378–387 (1961).\n",
      "\n",
      "16. Liotta, D. et al. Artificial heart in the chest: preliminary report. Trans. Am. Soc. Artif. Intern. Organs 7,318–322 (1961).\n",
      "\n",
      "17. Atsumi, K. et al. Artificial heart incorporated in the chest. Trans. Am. Soc. Artif. Intern. Organs 9, 292–298 (1963).\n",
      "\n",
      "18. Pierce, W. S. et al. Total heart replacement by a single intrathoracic blood pump. J. Surg. Res. 5, 387–394 (1965).\n",
      "\n",
      "Intern. Organs 7, 378–387 (1961).\n",
      "\n",
      "16. Liotta, D. et al. Artificial heart in the chest: preliminary report. Trans. Am. Soc. Artif. Intern. Organs 7,318–322 (1961).\n",
      "\n",
      "17. Atsumi, K. et al. Artificial heart incorporated in the chest. Trans. Am. Soc. Artif. Intern. Organs 9, 292–298 (1963).\n",
      "\n",
      "18. Pierce, W. S. et al. Total heart replacement by a single intrathoracic blood pump. J. Surg. Res. 5, 387–394 (1965).\n",
      "\n",
      "Artificial Hearts\n",
      "\n",
      "Ruba Hadidi\n",
      "\n",
      "An artificial heart is a prosthetic device that is implanted into the body to replace the biological heart.\n",
      "\n",
      "2 types of artificial heart:  TAH(Total Artificial Heart)  Cardiac Assist device\n",
      "\n",
      "Benefit of a functional artificial heart would be to lower the need for heart transplants.\n",
      "\n",
      "The first artificial heart implanted in a living being was placed in a dog at the Cleveland Clinic in 1957; it survived about 90 minutes.\n",
      "\n",
      "Question: What is artificial heart ?\n",
      "Helpful Answer:\n"
     ]
    }
   ],
   "source": [
    "query = \"What is artificial heart ?\"\n",
    "response = qa.run(query)\n",
    "\n",
    "print(response)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bd938577",
   "metadata": {},
   "source": [
    "Saya mengusulkan judul  artificial heart karena judul ini terus mengalami perkembangan dari teknologi pembuatan artificial heart atau biasa disebut jantung buatan saya menggunakan model embbedding sentence transformer karena cepat dan ringan untuk real-time aplikasi.vector database nya saya menggunakan chroma karena tidak memperlukan database eksternal,model dapat update knowledge dengan menambah dokumen atau update Dokumen Hapus lalu Tambah lagi.kekurangan dari model kurang akurat dalam menjawab pertanyaan dan hanya dapat pada dimasukan dokumen sedikit\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
